var graphJson = {"directed": false, "multigraph": false, "graph": {"node_default": {}, "edge_default": {}}, "nodes": [{"entity_type": "GENE", "description": "SEC16B is a gene that encodes an endoplasmic reticulum export factor and has SNPs associated with obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "SEC16 HOMOLOG B"}, {"entity_type": "GENE", "description": "DNAJC27 is a gene that encodes a heat shock protein and has SNPs associated with obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27"}, {"entity_type": "GENE", "description": "CDKAL1 is a gene and has SNPs associated with obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1"}, {"entity_type": "GENE", "description": "TFAP2B is a gene that encodes a transcription factor and has SNPs associated with obesity risk.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "TRANSCRIPTION FACTOR AP-2 BETA"}, {"entity_type": "DISEASE", "description": "Obesity is a complex multifactorial disease characterized by excessive body fat accumulation.<SEP>The risk of developing obesity.", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "OBESITY RISK"}, {"entity_type": "GENE", "description": "SEC16B is a gene that encodes for an endoplasmic reticulum export factor.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "SEC16B"}, {"entity_type": "GENOMIC VARIANT", "description": "rs543874 is a genetic variant in the SEC16B gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS543874"}, {"entity_type": "GENE", "description": "DNAJC27 is a gene that encodes for a protein belonging to the heat shock protein family (Hsp40).", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "DNAJC27"}, {"entity_type": "GENOMIC VARIANT", "description": "rs713586 is a genetic variant in the DNAJC27 gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS713586"}, {"entity_type": "GENE", "description": "CDKAL1 is a gene associated with type 2 diabetes.<SEP>CDKAL1 is a gene involved in pancreatic development.<SEP>CDKAL1 is a gene involved in regulating insulin secretion and glucose metabolism.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "CDKAL1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9356744 is a genetic variant in the CDKAL1 gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS9356744"}, {"entity_type": "GENE", "description": "TFAP2B is a transcription factor that plays a role in development and cellular differentiation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "TFAP2B"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2206277 is a genetic variant in the TFAP2B gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS2206277"}, {"entity_type": "GENE", "description": "BDNF is a gene that encodes for brain-derived neurotrophic factor, a protein involved in neuronal growth and survival.<SEP>The BDNF gene encodes a protein involved in neuronal growth and survival.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 95}]", "id": "BDNF"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6265 is a genetic variant in the BDNF gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS6265"}, {"entity_type": "GENE", "description": "MYL2 is a gene located in the region associated with coffee consumption.<SEP>MYL2 is a gene that encodes for myosin light chain-2, a protein involved in muscle contraction.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "MYL2"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3782889 is a genetic variant in the MYL2 gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS3782889"}, {"entity_type": "GENE", "description": "OLFM4 is a gene that encodes for olfactomedin-4, a protein involved in olfactory perception.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "OLFM4"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9568856 is a genetic variant in the OLFM4 gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS9568856"}, {"entity_type": "GENE", "description": "FTO is a gene associated with obesity and CRP.<SEP>FTO is a gene associated with obesity.<SEP>FTO is a gene involved in regulating energy homeostasis and body weight.<SEP>The FTO gene is associated with obesity risk.<SEP>The FTO gene is involved in regulating appetite and energy expenditure.<SEP>FTO is a gene containing variants associated with BMI and body weight.)<SEP>FTO is a gene previously associated with smoking, alcohol consumption, coffee consumption, and snoring.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 100}]", "id": "FTO"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1421085 is a genetic variant in the FTO gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS1421085"}, {"entity_type": "GENE", "description": "MC4R is a gene containing variants associated with BMI.)<SEP>MC4R is a gene involved in energy homeostasis and CRP.<SEP>MC4R is a gene that encodes for melanocortin-4 receptor, a protein involved in regulating appetite and energy expenditure.<SEP>The MC4R gene plays a role in appetite regulation and energy balance, potentially influencing susceptibility to type 2 diabetes.<SEP>The MC4R gene plays a role in regulating appetite and energy balance.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-6794be47bcde46ad4a07e0cc372ea3d2", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "MC4R"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6567160 is a genetic variant in the MC4R gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS6567160"}, {"entity_type": "GENE", "description": "GIPR is a gene that encodes for glucose-dependent insulinotropic polypeptide receptor, a protein involved in regulating insulin secretion.<SEP>The GIPR gene is involved in decreasing insulin secretion.<SEP>GIPR is a gene whose variants are nominally associated with AcAc or BHB levels.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 93}]", "id": "GIPR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1444988703 is a genetic variant in the GIPR gene.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "RS1444988703"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Energy intake refers to the consumption of food and beverages, providing the body with calories.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "ENERGY INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Energy expenditure encompasses all the energy used by the body for various functions, including metabolism, movement, and temperature regulation.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "ENERGY EXPENDITURE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMI (Body Mass Index) is a measure of body fat based on height and weight, influencing various metabolic processes.<SEP>BMI (Body Mass Index) is a measure of body fat based on height and weight.<SEP>BMI (Body Mass Index) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI), a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>BMI stands for Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>BMI stands for Body Mass Index, a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) was slightly higher in controls compared to cases.<SEP>BMI stands for Body Mass Index, a measure of body fat based on height and weight.<SEP>Body mass index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index (BMI) is a measure of body fat based on height and weight.<SEP>Body Mass Index, a measure of body fat based on height and weight.<SEP>BMI is a measure of body fat based on height and weight.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-3ad8ef794841d749e48b3223741e91d3<SEP>chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-b3d775642c43fa3524a531a3f6ec1e41<SEP>chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "BMI"}, {"entity_type": "PHYSICAL MEASUREMENT", "description": "Waist circumference is a measure of abdominal fat.<SEP>Waist circumference is a measurement of the distance around the waist, often used as an indicator of abdominal obesity.<SEP>Waist circumference measures the distance around the waist, often used as an indicator of abdominal fat.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 107}]", "id": "WAIST CIRCUMFERENCE"}, {"entity_type": "MEASURE", "description": "Skinfold Thickness Measurements (SMI) assess subcutaneous fat thickness at various body sites.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "SMI"}, {"entity_type": "MEASURE", "description": "Fat mass refers to the amount of adipose tissue in the body.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "FAT MASS"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Menarche is the onset of menstruation, marking the beginning of a girl\'s reproductive years.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MENARCHE"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Menopause is the end of menstruation, signifying the decline in reproductive hormones and female fertility.", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "id": "MENOPAUSAL AGE"}, {"entity_type": "GENOMIC VARIANT", "description": "Polygenic Risk Score (PRS), a measure of genetic predisposition.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 109}]", "id": "PRS"}, {"entity_type": "DIETARY PATTERN", "description": "A diet emphasizing fruits, vegetables, whole grains, and legumes.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 109}]", "id": "PLANT-BASED DIET"}, {"entity_type": "DIETARY PATTERN", "description": "Consumption of foods high in saturated fat, trans fat, and sodium.", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 109}]", "id": "FRIED-FOOD INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The age at which a girl\'s first menstrual period begins.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 109}]", "id": "MENARCHE AGE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-2c91cdebb36ef064eb01a7021a961302<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "A measure of time elapsed since birth.<SEP>Age refers to the biological or chronological time since birth.<SEP>Age refers to the duration of an individual\'s life and is related to various biological changes.<SEP>Age refers to the number of years a person has lived.<SEP>Men were older than women in the study group.)<SEP>Age was considered but not found to differ between cases and controls as they were matched on this criterion.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "AGE"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "Men refers to the male sex.<SEP>Men were older than women in the study group.)", "entity_type": "SEX", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 49}]", "id": "MEN"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "Obese women were older than nonobese women in the study group.)<SEP>Women refers to the female sex.", "entity_type": "SEX", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 52}]", "id": "WOMEN"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-fa6293a0a10f175b4aebac8e885c0d20<SEP>chunk-c63d60b991cd7442f690dcc364af47dd", "description": "An individual\'s stature<SEP>Height is a physiological process influenced by genetic variants.<SEP>Obese women were shorter than nonobese women in the study group.)", "entity_type": "PHENOTYPE", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 124}]", "id": "HEIGHT"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Obese women were shorter than nonobese women in the study group.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 124}]", "id": "NONOBESE WOMEN"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "The average BMI of the obese group was approximately 27.1 kg/m2, higher than the nonobese group.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 107}]", "id": "OBESE GROUP"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "The average BMI of the nonobese group was approximately 22.5 kg/m2 in both gender groups.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "NONOBESE GROUP"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Skeletal muscle and fat mass were higher in the obese group than the nonobese group for both genders.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 107}]", "id": "SKELETAL MUSCLE MASS"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "The incidence of metabolic syndrome was much higher in the obese groups in both genders, and the risk increased 5.86-fold in the obese group.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 94}]", "id": "METABOLIC SYNDROME"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Serum total cholesterol and LDL concentrations were much higher in women than men.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 52}]", "id": "TOTAL CHOLESTEROL"}, {"source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "description": "Serum triglyceride concentrations were higher in men than women.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 49}]", "id": "TRIGLYCERIDES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant (rs1558902) located within the FTO gene influences an individual\'s susceptibility to weight changes and body composition alterations.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "FTO RS1558902"}, {"entity_type": "DIETARY PATTERN", "description": "A high-protein diet is a dietary pattern characterized by increased protein intake compared to standard diets. It can influence body composition and fat distribution.<SEP>A high-protein diet was associated with a greater decrease in fat distribution in individuals with the AA genotype.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "HIGH-PROTEIN DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A low-protein diet is a dietary pattern characterized by decreased protein intake compared to standard diets. It can influence body composition and fat distribution.<SEP>A low-protein diet was associated with less loss in TAT and SAT in individuals with the AA genotype.<SEP>Patients with GLUD1 defects were started on a low-protein diet (1.5 g/kg/day of natural protein intake).", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "LOW-PROTEIN DIET"}, {"entity_type": "MEASURABLE QUANTITY", "description": "The primary outcome measured was long-term weight loss, based on weight observations after surgery.<SEP>Weight is a physiological process that refers to the mass of an individual\'s body.<SEP>Weight refers to the mass of a body.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "WEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Body composition refers to the relative amounts of fat mass, lean mass, and bone mass in the body.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "BODY COMPOSITION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total fat refers to the overall amount of fat in an individual\'s body.<SEP>Total fat refers to the total amount of adipose tissue (fat) in the body.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "TOTAL FAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fat mass percentage (FM%) is the proportion of total body weight that is composed of fat.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "FAT MASS PERCENTAGE (FM%)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Trunk fat refers to fat stored in the abdominal and upper body regions.<SEP>Trunk fat refers to the amount of adipose tissue located in the abdominal and chest regions.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "TRUNK FAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Visceral adipose tissue (VAT) is fat stored within the abdominal cavity surrounding vital organs.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "VISCERAL ADIPOSE TISSUE (VAT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Subcutaneous adipose tissue (SAT) is fat stored beneath the skin.", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 86}]", "id": "SUBCUTANEOUS ADIPOSE TISSUE (SAT)"}, {"entity_type": "GENOTYPE", "description": "AA genotype refers to an individual having two copies of the A allele for a given genetic locus.<SEP>The AA genotype is associated with changes in fat distribution in response to different diets.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "AA GENOTYPE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAT refers to total abdominal fat.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "TAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "SAT refers to subcutaneous abdominal fat.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "SAT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FM% stands for fat mass percentage.", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "FM%"}, {"entity_type": "DIETARY PATTERN", "description": "A low-fat diet (LF diet) serves as a control for comparison with high-fat feeding.<SEP>A low-fat diet emphasizes consuming foods with minimal amounts of fat.<SEP>A low-fat diet was associated with changes in total fat, FM%, and trunk fat percentage.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-a321a6d63755366a1fc3eafbd9fbce83", "id": "LOW-FAT DIET"}, {"source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-2926e6216bf945b12ea4daa6345cad1f<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "A decrease in body weight, often associated with disease.<SEP>A high-protein diet can lead to greater weight loss when combined with the FTO rs1558902 risk allele.)", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "WEIGHT LOSS"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "Individuals carrying the FTO rs1558902 risk allele experience greater fat reduction when following a high-protein diet.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "FAT REDUCTION"}, {"source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "description": "A high-protein diet, especially for those with the FTO rs1558902 risk allele, can lead to significant changes in body fat distribution.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 87}]", "id": "CHANGES IN FAT DISTRIBUTION"}, {"entity_type": "GENOMIC VARIANT", "description": "The FTO rs9939609 polymorphism is a genetic variant associated with anthropometric variables.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "FTO RS9939609"}, {"entity_type": "DISEASE", "description": "A condition characterized by excessive body fat<SEP>Obesity is a chronic disease characterized by excessive body fat accumulation.<SEP>Obesity is a chronic disease characterized by excessive body fat accumulation.<SEP>Obesity is a disease characterized by excess body fat.<SEP>Obesity is a condition characterized by excessive body fat, associated with genetic and environmental factors.<SEP>Obesity is a condition characterized by excessive body fat.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-607feda7df4db8151b99560074c91eea<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "OBESITY"}, {"entity_type": "DISEASE", "description": "Diabetes is a metabolic disorder characterized by high blood sugar levels.<SEP>Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels.<SEP>Diabetes refers to a group of metabolic disorders characterized by elevated blood sugar levels.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "DIABETES"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Cases smoked more than controls.<SEP>Smoking involves the inhalation of tobacco smoke, which can negatively affect health.<SEP>Smoking is a harmful habit that increases the risk of various diseases.<SEP>Smoking status affects alcohol self-administration behaviors.<SEP>Smoking is an environmental factor potentially associated with health outcomes, such as cancer risk.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1<SEP>chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6<SEP>chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 144}]", "id": "SMOKING"}, {"entity_type": "DIETARY PATTERN", "description": "Educational level may influence lifestyle choices, including diet and physical activity.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "EDUCATIONAL LEVEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "General practice refers to primary healthcare provided in community settings.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "GENERAL PRACTICE (GP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Overweight and obese hypertensive population is a group of individuals with high blood pressure who are overweight or obese.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "OVERWEIGHT/OBESE HYPERTENSIVE POPULATION (OHP)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Healthy, controlled risk refers to individuals maintaining good health with effectively managed risk factors.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "HEALTHY, CONTROLLED RISK (HCR)"}, {"entity_type": "DIETARY PATTERN", "description": "Individuals with primary education level may have different dietary habits compared to those with higher education.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "PRIMARY STUDIES"}, {"entity_type": "DIETARY PATTERN", "description": "Individuals with secondary education level may have different dietary habits compared to those with primary or university education.", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "id": "SECONDARY STUDIES"}, {"entity_type": "DIETARY PATTERN", "description": "Individuals with university education level may have different dietary habits compared to those with lower levels of education.<SEP>Individuals with university studies.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-3135befd0c3140ad097d96ace6de86a1", "id": "UNIVERSITY STUDIES"}, {"entity_type": "GENOMIC VARIANT", "description": "The A-allele of the FTO SNP is associated with an increased risk of obesity.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "A-ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (single nucleotide polymorphism) is a type of genomic variant where a single nucleotide is changed.<SEP>A SNP is a specific variation in the DNA sequence.<SEP>A Single Nucleotide Polymorphism (SNP) is a variation in a DNA sequence.<SEP>SNPs are variations in DNA sequences and were chosen to define the FADS1/2 haplotype.<SEP>A Single Nucleotide Polymorphism (SNP) is a variation at a single position in a DNA sequence.<SEP>A SNP is a single nucleotide polymorphism, which is a variation in a DNA sequence.<SEP>SNPs are single nucleotide polymorphisms, variations in DNA sequence.<SEP>Single Nucleotide Polymorphism, a type of genetic variation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-46227b557f62c59155b1b9cef71d0d17<SEP>chunk-1f50436a36721971a0a256131d7fca62<SEP>chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-055177812e320344d131432b292111b0<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-b803830d07bff8ae14550f6458048707", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "SNP"}, {"entity_type": "STATISTIC", "description": "Odds Ratio (OR) is a measure of association between an exposure and an outcome.<SEP>Odds Ratio (OR) quantifies the association between exposure and outcome.<SEP>Odds ratio (OR) is a measure of association between an exposure and an outcome.<SEP>The Odds Ratio (OR) for the T allele was 0.68.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 138}]", "id": "OR"}, {"entity_type": "STATISTICAL MEASURE", "description": "95% Confidence Interval (CI) provides a range of values within which the true population parameter is likely to fall.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "95%CI"}, {"entity_type": "STUDY GROUP", "description": "General Practice study group.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "GP"}, {"entity_type": "STUDY GROUP", "description": "Oxford Health Policy study group.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "OHP"}, {"entity_type": "STUDY GROUP", "description": "Health Care Research study group.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "HCR"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Physical Activity (PA) is a lifestyle factor.", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "id": "PA"}, {"source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "description": "The FTO rs9939609 polymorphism is associated with higher BMI in individuals.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "FTO RS9939609 POLYMORPHISM"}, {"source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "description": "The FTO rs9939609 polymorphism is associated with increased BMI in the General Practice population.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "BMI IN GP"}, {"source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "description": "The FTO rs9939609 polymorphism exhibits a recessive association with BMI in the Overweight/Obese Hypertensive Population.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "BMI IN OHP"}, {"source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "description": "No significant association was observed between the FTO rs9939609 polymorphism and BMI in the Healthy, Controlled Risk population.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 96}]", "id": "BMI IN HCR"}, {"entity_type": "GENE", "description": "TCF7L2 is a gene associated with T2D.<SEP>TCF7L2 is a gene frequently investigated for its interaction with dietary factors in relation to type 2 diabetes risk.<SEP>The TCF7L2 gene is associated with type 2 diabetes risk.<SEP>The TCF7L2 gene is involved in regulating insulin secretion and has been linked to an increased risk of type 2 diabetes.<SEP>TCF7L2 is a gene associated with type 2 diabetes.<SEP>TCF7L2 is a gene.<SEP>TCF7L2 is a gene associated with obesity.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "TCF7L2"}, {"entity_type": "NUTRIENT", "description": "Fiber is a dietary component that has been studied for its interaction with genetic variants in the context of type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 46}]", "id": "FIBER"}, {"entity_type": "FOOD", "description": "Whole grains are a food source rich in fiber and have been investigated for their potential interaction with genetic variants.<SEP>Whole grains are a type of dietary staple rich in fiber and other nutrients.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 46}]", "id": "WHOLE GRAIN"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood sugar levels resulting from defects in insulin production, action, or both.<SEP>Type 2 Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels.<SEP>Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels due to the body\'s inability to effectively use insulin.<SEP>Type 2 diabetes is a chronic metabolic disorder characterized by high blood sugar levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "TYPE 2 DIABETES"}, {"entity_type": "THERAPY", "description": "A lifestyle intervention involves strategies to modify behavior and promote healthier habits, often including dietary changes and increased physical activity.<SEP>Lifestyle intervention includes dietary and exercise changes aimed at preventing or managing type 2 diabetes.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "LIFESTYLE INTERVENTION"}, {"entity_type": "DRUG", "description": "Metformin is a medication commonly used to treat type 2 diabetes.<SEP>Metformin is an antidiabetic drug used to lower blood glucose levels.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "METFORMIN"}, {"entity_type": "NUTRIENT", "description": "Olive oil is a fat source rich in monounsaturated fatty acids, often included in the Mediterranean diet.<SEP>Olive oil is a food item that may interact with genetic factors to influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "OLIVE OIL"}, {"entity_type": "FOOD", "description": "Mixed nuts are a food containing various types of nuts, often consumed as part of a healthy dietary pattern.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "MIXED NUTS"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean diet is a dietary pattern associated with reduced T2D risk.<SEP>The Mediterranean diet is characterized by high consumption of fruits, vegetables, whole grains, legumes, olive oil, and moderate intake of fish and poultry.<SEP>The Mediterranean diet is a dietary pattern characterized by high intake of fruits, vegetables, olive oil, and fish.<SEP>The Mediterranean diet is characterized by high intake of fruits, vegetables, whole grains, and healthy fats, as well as reduced intake of saturated fats and processed foods.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "clusters": "[{level: 0, cluster: 30}]", "id": "MEDITERRANEAN DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The glycemic index measures how quickly a food raises blood glucose levels.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GLYCEMIC INDEX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The glycemic load considers both the glycemic index and the amount of carbohydrates in a food, providing a more comprehensive measure of its impact on blood glucose.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "GLYCEMIC LOAD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cases were less physically active than controls.<SEP>Physical activity encompasses various types of movement that improve health and well-being.<SEP>Physical activity refers to any form of movement that uses energy and can be beneficial for health.<SEP>Physical activity refers to any bodily movement that requires energy expenditure.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-0d8bc9a093c56fefc8b7af3fb9bc2862<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "PHYSICAL ACTIVITY"}, {"entity_type": "DIAGNOSTIC PROCEDURE", "description": "The IGT is a test used to diagnose prediabetes, characterized by elevated blood glucose levels after consuming a sugary drink.", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "id": "INTERNATIONAL GLUCOSE TOLERANCE TEST (IGT)"}, {"entity_type": "DISEASE", "description": "T2D stands for Type 2 Diabetes, a metabolic disorder characterized by high blood sugar levels.<SEP>T2D stands for Type 2 Diabetes.<SEP>Type 2 Diabetes.<SEP>Type 2 diabetes (T2D) is a chronic metabolic disorder characterized by high blood sugar levels.<SEP>Type 2 diabetes (T2D) is a metabolic disorder.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-f9a60d3cf951d77afa115859755dac43<SEP>chunk-8276370dea9f12d2b305c355f74c7f6e<SEP>chunk-44a871da300abc9be525b468f502f5cb<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "T2D"}, {"entity_type": "GENOMIC VARIANT", "description": "The rs7903146 variant is a specific genetic variation within the TCF7L2 gene.<SEP>rs7903146 is a genetic variant that may influence susceptibility to type 2 diabetes.<SEP>rs7903146 is a risk variant in the TCF7L2 gene.<SEP>rs7903146 is a SNP located in the TCF7L2 gene, and it is associated with an increased BMI at baseline.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 46}]", "id": "RS7903146"}, {"entity_type": "GENE", "description": "The NOTCH2 gene plays a role in Wnt signaling pathways.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 46}]", "id": "NOTCH2"}, {"entity_type": "GENE", "description": "The ZBED3 gene is involved in Wnt signaling pathway.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 46}]", "id": "ZBED3"}, {"entity_type": "GENE", "description": "The IRS1 gene plays a role in increasing insulin sensitivity.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 93}]", "id": "IRS1"}, {"entity_type": "PROTEIN", "description": "PPAR\u03b3 (Peroxisome proliferator-activated receptor gamma) is involved in glucose metabolism and insulin sensitivity.<SEP>The PPAR\u03b3 gene is a receptor for fatty acid storage.<SEP>PPAR\u03b3 is a protein that regulates adipogenesis and suppresses inflammation.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 45}]", "id": "PPAR\u0393"}, {"entity_type": "GENE", "description": "The FFAR4 gene is involved in G\u03b1q signaling.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 45}]", "id": "FFAR4"}, {"entity_type": "GENE", "description": "The CAV2 gene is involved in various cellular functions.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 45}]", "id": "CAV2"}, {"entity_type": "GENE", "description": "The ADH1C gene is involved in ethanol oxidation.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "ADH1C"}, {"entity_type": "GENE", "description": "HFE is a gene associated with hemochromatosis.<SEP>The HFE gene is involved in iron homeostasis.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 34}]", "id": "HFE"}, {"entity_type": "GENE", "description": "SLC40A1 is a gene involved in iron transport.<SEP>The SLC40A1 gene encodes an iron-regulated transporter.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 34}]", "id": "SLC40A1"}, {"entity_type": "GENE", "description": "TMPRSS6 is a gene involved in iron regulation.<SEP>The TMPRSS6 gene encodes a transmembrane serine protease.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "clusters": "[{level: 0, cluster: 34}]", "id": "TMPRSS6"}, {"entity_type": "GENE", "description": "LEPR is a gene that interacts with fasting plasma glucose (FPG) to influence BMI.<SEP>The LEPR gene encodes the leptin receptor, involved in appetite and satiety.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "LEPR"}, {"entity_type": "GENE", "description": "The APOE gene plays a role in lipid metabolism.", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "id": "APOE"}, {"entity_type": "GENE", "description": "SLC30A8 is a gene associated with proinsulin levels.<SEP>SLC30A8 is a gene encoding for a zinc transporter.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "SLC30A8"}, {"entity_type": "STUDY", "description": "DPP is a study investigating the interactions between genes and dietary factors.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "DPP"}, {"entity_type": "FOOD", "description": "Red meat is a food item that may interact with genetic factors to influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "RED MEAT"}, {"entity_type": "FOOD", "description": "Processed meat is a food item that may interact with genetic factors to influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PROCESSED MEAT"}, {"entity_type": "FOOD", "description": "Dairy products are a food item that may interact with genetic factors to influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "DAIRY"}, {"entity_type": "FOOD", "description": "Coffee is a food item that may interact with genetic factors to influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "COFFEE"}, {"entity_type": "DIETARY PATTERN", "description": "The Western diet is a dietary pattern associated with increased T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "WESTERN DIET"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Physical activity is a lifestyle factor that can influence T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "PHYSICAL ACTIVITY (PA)"}, {"entity_type": "GENE", "description": "HNF1B rs4430796 is a genetic variant that can modify the effect of physical activity on T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "HNF1B RS4430796"}, {"entity_type": "GENE", "description": "IRS1 rs1522813 is a genetic variant that can modify the effect of physical activity on T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "id": "IRS1 RS1522813"}, {"entity_type": "GENE", "description": "PPAR\u03b3 rs1801282 is a genetic variant that can modify the effect of physical activity on T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 5}]", "id": "PPAR\u0393 RS1801282"}, {"entity_type": "GENE", "description": "ADRA2B Glu12 is a genetic variant that can modify the effect of physical activity on T2D risk.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 5}]", "id": "ADRA2B GLU12"}, {"entity_type": "GENE", "description": "KCNJ11 is a gene involved in potassium channel function.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "KCNJ11"}, {"entity_type": "GENE", "description": "IGF2BP2 is a gene involved in mRNA binding and stability.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "IGF2BP2"}, {"entity_type": "GENE", "description": "CAPN10 is a gene involved in insulin signaling.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "CAPN10"}, {"entity_type": "GENE", "description": "WFS1 is a gene associated with type 2 diabetes.<SEP>WFS1 is a gene involved in endoplasmic reticulum stress response.", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447<SEP>chunk-f9a60d3cf951d77afa115859755dac43", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "WFS1"}, {"entity_type": "GENE", "description": "SLC2A2 is a gene involved in glucose transport and its variants are nominally associated with AcAc or BHB levels.<SEP>The SLC2A2 gene is involved in the transport of glucose and may influence the response to physical activity.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 5}]", "id": "SLC2A2"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the GCK gene can cause MODY, affecting glucose regulation and leading to hyperglycemia.<SEP>Polymorphisms (variants) in the SLC2A2 gene, rs5393, rs5394, rs5400, and rs5404, may influence an individual\'s response to physical activity.<SEP>Genomic variant rs142786317 involves c.*118_*119delCA.<SEP>SNP rs10797300 causes a Pro19Leu amino acid change in the SULT1A2 protein.<SEP>SNP rs4149403 results in an Ile7Thr amino acid change in the SULT1A2 protein.<SEP>Variant c.3536C>G was detected in the 3\u2019 untranslated region of the TUFM gene.<SEP>Single nucleotide polymorphisms (SNPs) in the VDBP gene.<SEP>A genomic variant is a change in the DNA sequence that can be small or large.<SEP>Genomic variants in the OPRM1 gene can influence individual responses to alcohol.<SEP>Mutations in the LPL gene can lead to LPL deficiency, a disorder characterized by high triglyceride levels.<SEP>Mutations in the RPS19 gene cause DBA.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-607feda7df4db8151b99560074c91eea<SEP>chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-180ca3d6d27d84b30ebf5d20f135de18<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86<SEP>chunk-617cab4d8c10048a1335bf565693bf97<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "GENOMIC VARIANT"}, {"entity_type": "GENE", "description": "The ENPP1 gene may have a role in the development of type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "ENPP1"}, {"entity_type": "GENE", "description": "TNF\u03b1 (Tumor necrosis factor alpha) plays a role in inflammation, which can contribute to the development of type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "TNF\u0391"}, {"entity_type": "GENE", "description": "ADRA2B (Adrenergic receptor alpha-2B) is involved in regulating blood pressure and may influence glucose metabolism.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "ADRA2B"}, {"entity_type": "GENE", "description": "LIPC (Lipoprotein lipase C) plays a role in lipid metabolism.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "LIPC"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12255372 is a genetic variant within the TCF7L2 gene associated with type 2 diabetes risk.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS12255372"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1044498 is a genetic variant within the ENPP1 gene and is associated with an increased risk of developing type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "RS1044498"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17066829 is a genetic variant within the MC4R gene that may play a role in appetite regulation and energy balance, influencing susceptibility to type 2 diabetes.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "RS17066829"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1152003 is a genetic variant within the PPAR\u03b3 gene involved in glucose metabolism and insulin sensitivity.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS1152003"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800629 is a genetic variant within the TNF\u03b1 gene associated with inflammatory responses, which can contribute to type 2 diabetes development.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS1800629"}, {"entity_type": "GENOMIC VARIANT", "description": "Glu9 (glutamine allele) is a specific variation within the ADRA2B gene that may influence blood pressure regulation and glucose metabolism.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "GLU9"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2070895 is a genetic variant within the LIPC gene involved in lipid metabolism.", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "id": "RS2070895"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Genetic variants in the TCF7L2 gene are associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "TCF7L2 VARIANTS"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Interaction of carbohydrates and total fat with IRS1 rs2943641 was reported by MDCS.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 93}]", "id": "CARBOHYDRATES & FAT"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "A trend for interaction (P = .05) was observed between fat intake and the PPAR\u03b3 variants rs1801282 and rs3856806 in DESIR.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 45}]", "id": "FAT"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-27c6611dceafae880176ce8a7e7fc07e<SEP>chunk-2c91cdebb36ef064eb01a7021a961302<SEP>chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Alcohol consumption can have both positive and negative health effects.<SEP>Alcohol consumption during pregnancy can have negative impacts on fetal development.<SEP>An interaction of alcohol with the ADH1C *1/*2 variant was reported by NHS. The ADH1C*2 allele attenuated the lower diabetes risk among alcohol drinking US women.)<SEP>Alcohol is a nutrient that can have rewarding effects and is the focus of the study.<SEP>Alcohol is a psychoactive substance and commonly consumed recreational drug.", "entity_type": "ENVIRONMENTAL FACTOR", "id": "ALCOHOL"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Higher heme iron intake was associated with increased T2D risk among women with the haemochromatosis-associated HFE variants rs1799945 (H63D) or rs1800562 (C282Y).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 34}]", "id": "HEME IRON"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "Variations in the BDNF gene have been linked to an increased risk of depression and other mental health disorders.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 16}, {level: 1, cluster: 95}]", "id": "MENTAL HEALTH"}, {"source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "description": "The APOE \u03b54 allele is a significant genetic risk factor for Alzheimer\'s disease.)", "entity_type": "UNKNOWN", "id": "ALZHEIMER\'S DISEASE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "HFE variants, such as rs1799945 (H63D) and rs1800562 (C282Y), are linked to an increased risk of type 2 diabetes (T2D).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "T2D RISK"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC40A1 rs744653 variant interacts with heme iron intake, potentially influencing T2D risk in men.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 34}]", "id": "IRON INTAKE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The SLC30A8 variants rs16889462, 8_118252314, and 8_118252435 interacted with zinc intake in DPP.)", "entity_type": "UNKNOWN", "id": "ZINC INTAKE"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The DPP study investigated the interaction of SLC30A8 variants with zinc intake, but no clear trend for association with T2D incidence was observed.)", "entity_type": "UNKNOWN", "id": "SLC30A8 VARIANTS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "High intake of red meat increased the risk of developing T2D in men with a high T2D-genetic risk score (GRS) but not in those with a low GRS.)", "entity_type": "UNKNOWN", "id": "T2D\u2010GRS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "A marginally nonsignificant interaction (P = .05) was observed between olive oil intake and the GIPR variant rs10423928 in EPIC-InterAct.)", "entity_type": "UNKNOWN", "id": "GIPR VARIANT RS10423928"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "The association of dairy products with T2D incidence may be modified by the LCT gene variant rs4988235, with higher risk among non-consumers carrying the lactase persistence allele.)", "entity_type": "UNKNOWN", "id": "LCT GENE RS4988235"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "In EPIC-InterAct, coffee intake showed a stronger T2D risk-lowering effect for individuals with the risk allele of the TCF7L2 variant rs12255372.)", "entity_type": "UNKNOWN", "id": "TCF7L2 VARIANT RS12255372"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "In KARE, coffee consumers with specific genetic variants (IGF2BP2 rs4402960, CDKAL1 rs7754840, and KCNJ11 rs5215) had a reduced risk of prediabetes and T2D compared to non-consumers.)", "entity_type": "UNKNOWN", "id": "IGF2BP2 RS4402960, CDKAL1 RS7754840, AND KCNJ11 RS5215 VARIANTS"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "In PREDIMED, a borderline significant interaction between the CLOCK variant rs4580704 and the Mediterranean diet was observed.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 30}]", "id": "CLOCK VARIANT RS4580704"}, {"source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "description": "Reduced leisure-time physical activity (LTPA) was associated with higher T2D incidence among individuals with the PPAR\u03b3 rs1801282 Ala-allele.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 5}]", "id": "LTPA"}, {"entity_type": "GENE", "description": "JAZF1 is a gene associated with type 2 diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "JAZF1"}, {"entity_type": "GENE", "description": "ADAMTS9 is a gene associated with type 2 diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "ADAMTS9"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes with End Stage Renal Disease.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "T2D-ESRD"}, {"entity_type": "STUDY SET", "description": "A specific group of participants in the study.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "SET 1"}, {"entity_type": "STUDY SET", "description": "A specific group of participants in the study.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "SET 2"}, {"entity_type": "POPULATION GROUP", "description": "Individuals without T2D used for comparison.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "CONTROL SUBJECTS"}, {"entity_type": "ETHNICITY", "description": "The population group from which the study samples were drawn.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "AFRICAN AMERICANS"}, {"entity_type": "PHYSIOLOGICAL VARIABLE", "description": "The age of participants when they joined the study.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "AGE AT ENROLLMENT"}, {"entity_type": "PHYSIOLOGICAL EVENT", "description": "The age at which participants were diagnosed with Type 2 Diabetes.", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "id": "AGE OF ONSET OF T2D"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk allele is a variant associated with an increased risk of a disease or trait.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 139}]", "id": "RISK ALLELE"}, {"entity_type": "STATISTICAL MEASURE", "description": "Confidence interval (CI) is a range of values that likely contains the true population parameter.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 138}]", "id": "CI"}, {"entity_type": "STATISTIC", "description": "A probability value used to assess the statistical significance of an association. A lower p-value indicates stronger evidence against the null hypothesis.<SEP>P-value indicates the probability of observing the results if there were no true association between variables.<SEP>P-value is a statistical measure used to assess the significance of findings in hypothesis testing.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-814fe155e9cb953da61f6a79d1d25784", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 138}]", "id": "P-VALUE"}, {"entity_type": "STATISTICAL METHOD", "description": "Nominal analysis considers categorical data without an inherent order.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 139}]", "id": "NOMINAL ANALYSIS"}, {"entity_type": "STATISTICAL METHOD", "description": "Ordinal analysis considers categorical data with an inherent order.", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 139}]", "id": "ORDINAL ANALYSIS"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs10010131 variant is located in the WFS1 gene and is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "RS10010131"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs10946398 variant is located in the CDKAL1 gene and is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 50}]", "id": "RS10946398"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs864745 variant is located in the JAZF1 gene and is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "RS864745"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The rs4607103 variant is located in the ADAMTS9 gene and is associated with a decreased risk of type 2 diabetes, opposite to what was reported in European samples.)", "entity_type": "UNKNOWN", "id": "RS4607103"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Individuals with higher cumulative risk scores based on their genetic variants are more likely to have T2D.)", "entity_type": "UNKNOWN", "id": "CUMULATIVE RISK SCORE"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Individuals with higher cumulative risk scores based on their genetic variants are more likely to have T2D.)", "entity_type": "UNKNOWN", "id": "T2D CASE"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Participants in Set 1 had a higher mean age at enrollment for the T2D-ESRD group compared to the control group.)", "entity_type": "UNKNOWN", "id": "T2D-ESRD GROUP"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The participants in Set 2 with T2D had a higher mean age at enrollment than the control group.)", "entity_type": "UNKNOWN", "id": "T2D GROUP"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "Mean BMI was not significantly different between T2D-ESRD case and nondiabetic control subjects.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "T2D-ESRD CASE AND NONDIABETIC CONTROL SUBJECTS"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The mean African ancestry proportion in the study samples was estimated to be around 0.79, indicating a largely African American population.)", "entity_type": "UNKNOWN", "id": "AFRICAN ANCESTRY PROPORTION"}, {"source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "description": "The mean African ancestry proportion in the study samples was estimated to be around 0.79, indicating a largely African American population.)", "entity_type": "UNKNOWN", "id": "STUDY SAMPLES"}, {"entity_type": "DISEASE", "description": "Normal glucose tolerance is a condition where blood sugar levels are within the healthy range.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "NORMAL GLUCOSE TOLERANCE (NGT)"}, {"entity_type": "DISEASE", "description": "Impaired fasting glucose/impaired glucose tolerance refers to elevated blood sugar levels, especially after fasting.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "IMPAIRED FASTING GLUCOSE/IMPAIRED GLUCOSE TOLERANCE (IFG/IGT)"}, {"entity_type": "DISEASE", "description": "Type 2 diabetes is a chronic condition characterized by high blood sugar levels due to the body\'s inability to effectively use insulin.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "TYPE 2 DIABETES (T2D)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A measure of body fat based on height and weight.<SEP>Body mass index (BMI) is a measure of body fat based on height and weight.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-c9badb9a0fb813f42383cc8afc57ad45", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "BODY MASS INDEX (BMI)"}, {"entity_type": "ETHNICITY", "description": "East Asian refers to individuals of East Asian descent.<SEP>East Asian refers to people of East Asian descent, originating from countries in East Asia.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EAST ASIAN"}, {"entity_type": "ETHNICITY", "description": "African refers to individuals of African descent.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "AFRICAN"}, {"entity_type": "ETHNICITY", "description": "European refers to individuals of European descent.<SEP>European refers to people of European descent, often considered a distinct ethnic group.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "EUROPEAN"}, {"entity_type": "ETHNICITY", "description": "Native North American refers to individuals of indigenous North American descent.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "NATIVE NORTH AMERICAN"}, {"entity_type": "ETHNICITY", "description": "Latino American refers to individuals of Latin American descent.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "LATINO AMERICAN"}, {"entity_type": "ETHNICITY", "description": "South Asian refers to individuals of South Asian descent.", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "id": "SOUTH ASIAN"}, {"entity_type": "GENE", "description": "TAL1 is a gene associated with obesity.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 159}]", "id": "TAL1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9939609 is a SNP located in the FTO gene, and it is associated with an increased BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 100}]", "id": "RS9939609"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2984618 is a SNP located in the TAL1 gene, and it is associated with an increased BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 159}]", "id": "RS2984618"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1011527 is a SNP located in the LEPR gene and interacts with fasting plasma glucose (FPG) to influence BMI at baseline.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "RS1011527"}, {"entity_type": "NUTRIENT", "description": "Fasting plasma glucose (FPG) is the level of glucose in the blood after a period of fasting.", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "FASTING PLASMA GLUCOSE (FPG)"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "IFG/IGT status was positively associated with BMI at baseline compared to NGT subjects.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "IFG/IGT"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Baseline 2hPG levels were positively associated with BMI at baseline.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "TWO-HOUR PLASMA GLUCOSE (2HPG)"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Change in FPG levels was significantly associated with a positive increase in BMI change.)", "entity_type": "UNKNOWN", "id": "BMI CHANGE"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Change in FPG levels was significantly associated with a positive increase in BMI change.)", "entity_type": "UNKNOWN", "id": "FASTING PLASMA GLUCOSE CHANGE"}, {"source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "description": "Change in 2hPG levels was associated with an increase in BMI change.)", "entity_type": "UNKNOWN", "id": "TWO-HOUR PLASMA GLUCOSE CHANGE"}, {"source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "FPG stands for fasting plasma glucose, a measure of blood sugar levels after an overnight fast.<SEP>The rs1011527 SNP interacts with fasting plasma glucose (FPG) to influence BMI at baseline.)<SEP>Fasting Plasma Glucose (FPG) refers to the blood glucose level after a period of fasting.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "FPG"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MTHFR gene.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298A>C"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the MS gene.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756A>G"}, {"entity_type": "GENOMIC VARIANT", "description": " Genotype of MTHFR 1298A>C polymorphism with AC and CC alleles.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298AC/CC"}, {"entity_type": "GENOMIC VARIANT", "description": "Genotype of MTHFR 1298A>C polymorphism with AA allele.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MTHFR 1298AA"}, {"entity_type": "GENOMIC VARIANT", "description": "Genotype of MS 2756A>G polymorphism with AA alleles.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756AA"}, {"entity_type": "GENOMIC VARIANT", "description": "Genotype of MS 2756A>G polymorphism with AG and GG alleles.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS 2756AG/GG"}, {"entity_type": "GENE", "description": "MTHFR is a gene involved in folate metabolism.<SEP>The MTHFR gene is involved in folate metabolism.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "MTHFR"}, {"entity_type": "GENE", "description": "MS is a gene.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "id": "MS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "PEGDH (Paced Visual Serial Addition Task) is a cognitive test used to assess processing speed.<SEP>PEGDH assesses fine motor skills.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PEGDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "PEGNDH (Paced Verbal Serial Addition Task) is a cognitive test used to assess processing speed.<SEP>PEGNDH assesses fine motor skills.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "PEGNDH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DIG (Digits Forward and Backward) is a cognitive test used to assess working memory.<SEP>DIG assesses working memory.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "DIG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CFL (Category Fluency List) is a cognitive test used to assess verbal fluency.<SEP>CFL assesses executive function.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "CFL"}, {"entity_type": "TEST", "description": "TMTA (Test of Memory and Attention) is a cognitive test used to assess memory and attention.<SEP>TMTA is a test that measures focused attention and processing speed.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTA"}, {"entity_type": "TEST", "description": "TMTB (Trail Making Test, Part B) is a cognitive test used to assess visual scanning and attention.<SEP>TMTB is a test that measures shifting attention and processing speed.", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29<SEP>chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "TMTB"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "DIVERGT is a neuropsychological battery that assesses various cognitive domains.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "DIVERGT"}, {"entity_type": "GENOMIC VARIANT", "description": "The GRS is a measure of genetic risk calculated based on the presence of certain polymorphisms.", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "id": "GRS"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with MTHFR 1298AC/CC genotypes had a 3.0-fold increased risk of impairment (95% CI 1.1-8.1).)", "entity_type": "UNKNOWN", "id": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 10 points lower on TMTA (p=0.07).)", "entity_type": "UNKNOWN", "id": "TSER 2R/3R AND 3R/3R"}, {"source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "description": "Survivors with the MTRR 66AA genotype scored on average 10.7 points lower on PEGNDH.)", "entity_type": "UNKNOWN", "id": "MTRR 66AA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs13266634 is a risk allele in the SLC30A8 gene.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "RS13266634"}, {"entity_type": "PROTEIN", "description": "Proinsulin is a hormone precursor to insulin.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "PROINSULIN"}, {"entity_type": "PROTEIN", "description": "Fasting insulin is a measure of blood insulin levels while fasting.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING INSULIN"}, {"entity_type": "NUTRIENT", "description": "Fasting glucose is a measure of blood glucose levels while fasting.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "FASTING GLUCOSE"}, {"entity_type": "DISEASE", "description": "DPP cohort refers to participants in the Diabetes Prevention Program.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "DPP COHORT"}, {"entity_type": "DRUG", "description": "Troglitazone is a drug that was previously used to treat type 2 diabetes, but its use has been discontinued due to safety concerns.", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "id": "TROGLITAZONE"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-0c7ab28db433187759e760725a105836<SEP>chunk-8f23bd741f82dc8ca1e2600d790b690f<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6<SEP>chunk-7542fe4e6d1c727325a6be02a71f8e59", "description": "A placebo is a control treatment given to participants in a study.<SEP>Placebo is a control treatment with no active ingredients.<SEP>Proinsulin levels increased in the placebo group over the course of the study.)<SEP>Placebo is an inactive substance used as a control in clinical trials.<SEP>Placebo is a control medication with no active ingredients.", "entity_type": "DRUG", "id": "PLACEBO"}, {"source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "description": "There was no significant genotype \u00d7 treatment interaction, suggesting that the dosage of SLC30A8 risk alleles did not modify the effectiveness of any treatment.)", "entity_type": "UNKNOWN", "id": "GENOTYPE \u00d7 TREATMENT INTERACTION"}, {"entity_type": "GENE", "description": "PNPLA3 is a gene that encodes an enzyme involved in lipid metabolism.<SEP>PNPLA3 is a gene whose expression is regulated by various factors, including glucose metabolism and fatty acids.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "PNPLA3"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet increases PNPLA3 expression in the liver of mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH CARBOHYDRATE DIET"}, {"entity_type": "FOOD", "description": "Lipid emulsion attenuates the expression of PNPLA3 in the liver of mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "LIPID EMULSION"}, {"entity_type": "DIETARY PATTERN", "description": "A stock diet (normal chow, NC) serves as a control diet for comparison.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "STOCK DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet (HC diet) induces PNPLA3 expression in the liver of mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HC DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet supplemented with 4% lipid emulsion (HC-4% LE diet).", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HC-4% LE DIET"}, {"entity_type": "DIETARY PATTERN", "description": "A high carbohydrate diet supplemented with 13.5% lipid emulsion (HC-13.5% LE diet).", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HC-13.5% LE DIET"}, {"entity_type": "PROTEIN", "description": "SREBP1c is a gene involved in lipid metabolism and its expression is suppressed by unsaturated fatty acids like OA, LA, EPA, and DHA.<SEP>Sterol regulatory element binding protein (SREBP1c) is a transcriptional factor that regulates lipid metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "SREBP1C"}, {"entity_type": "PROTEIN", "description": "ACC-1 is a gene involved in fatty acid synthesis and its expression patterns are similar to those of PNPLA3.<SEP>Acetyl-CoA carboxylase (ACC-1) is involved in the synthesis of fatty acids.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ACC-1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Total triglyceride content in liver tissue correlates with PNPLA3 mRNA levels.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "TOTAL TG CONTENT"}, {"entity_type": "DIETARY PATTERN", "description": "A high-fat diet (HF diet) induces fatty liver in mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HIGH-FAT DIET"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Voluntary exercise reduces PNPLA3 mRNA levels in mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "EXERCISE"}, {"entity_type": "PROTEIN", "description": "Fatty acid synthase (FAS) is involved in fatty acid synthesis.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "FATTY ACID SYNTHASE (FAS)"}, {"entity_type": "CELL TYPE", "description": "Hepatocytes are liver cells.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "HEPATOCYTES"}, {"entity_type": "TISSUE", "description": "Liver tissue is the organ where PNPLA3 is predominantly expressed.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "LIVER TISSUE"}, {"entity_type": "TISSUE", "description": "Epididymal tissue is a reproductive tissue in mice.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "EPIDIDYMAL TISSUE"}, {"entity_type": "TISSUE", "description": "Adipose tissue is a major endocrine organ that produces cytokines.<SEP>Adipose tissue is fat tissue where PNPLA3 expression is higher compared to other tissues.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "ADIPOSE TISSUE"}, {"entity_type": "DISEASE", "description": "Fatty liver is a condition characterized by excessive fat accumulation in the liver.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "FATTY LIVER"}, {"entity_type": "NUTRIENT", "description": "Triglycerides (TG) are a type of fat found in the blood.<SEP>Triglycerides (TG) are lipids stored in adipose tissue and liver.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "TG"}, {"entity_type": "PROTEIN", "description": "Carbohydrate response element binding protein (ChREBP) is a transcription factor that regulates glucose metabolism.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "CHREBP"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Glucose media provides different levels of glucose to HepG2 cells for experimentation.)  (entity", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "id": "GLUCOSE MEDIA"}, {"entity_type": "METABOLITE", "description": "Pyruvate is a metabolite involved in cellular respiration.<SEP>Pyruvate, a product of glycolysis, does not affect PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "PYRUVATE"}, {"entity_type": "METABOLITE", "description": "Acetate is a molecule produced during metabolism and can be utilized as an energy source.)  (relationship<SEP>Acetate, a molecule involved in metabolism, does not affect PNPLA3 expression.", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ACETATE"}, {"entity_type": "NUTRIENT", "description": "Citrate is a Krebs cycle intermediate that can upregulate PNPLA3 levels.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "CITRATE"}, {"entity_type": "NUTRIENT", "description": "2-deoxy-D-glucose is a glucose analog that suppresses lipid accumulation and PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "2-DEOXY-D-GLUCOSE"}, {"entity_type": "NUTRIENT", "description": "Isocitrate, an isomer of citrate, does not regulate PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "ISOCITRATE"}, {"entity_type": "PROTEIN", "description": "Insulin is a hormone produced by beta cells in the pancreas that regulates glucose uptake and metabolism.<SEP>Insulin is a hormone produced by beta cells in the pancreas, responsible for lowering blood glucose levels.<SEP>Insulin is a hormone produced by the pancreas that regulates blood glucose levels.<SEP>Insulin is a hormone that regulates glucose metabolism and can stimulate the expression of some genes, including FAS but not PNPLA3 in HepG2 cells.<SEP>Patient 7 was treated with insulin...)<SEP>Insulin is a hormone that regulates blood sugar levels.<SEP>Insulin is a hormone produced by \u03b2 cells that regulates blood glucose levels.<SEP>Insulin is a hormone secreted by the pancreas that regulates blood glucose levels.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-2c178ae99eeffdddbea511cafbe4a7d5<SEP>chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INSULIN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucagon is a hormone that stimulates gluconeogenesis and does not affect PNPLA3 expression in HepG2 cells.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "GLUCAGON"}, {"entity_type": "NUTRIENT", "description": "Glucose is a primary source of energy for cells.<SEP>Glucose is a simple sugar that is the primary source of energy for the body.<SEP>Glucose is the primary energy source for cells and influences PNPLA3 expression, with high glucose levels inducing PNPLA3 expression.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "GLUCOSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lipid accumulation refers to the buildup of lipids within cells. High glucose induces lipid accumulation while 2-deoxy-D-glucose reduces it.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LIPID ACCUMULATION"}, {"entity_type": "DISEASE", "description": "FAS is a gene involved in fatty acid synthesis and its expression is induced by insulin but not affected by PNPLA3 knockdown.<SEP>Fetal Alcohol Spectrum Disorders, a range of conditions caused by prenatal alcohol exposure.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11<SEP>chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "FAS"}, {"entity_type": "CELL TYPE", "description": "HepG2 cells are human hepatocellular carcinoma cells used as a model for liver function studies.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "HEPG2 CELLS"}, {"entity_type": "CELL TYPE", "description": "3T3-L1 adipocytes are mouse preadipocyte cells commonly used to study adipogenesis and lipid metabolism.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "3T3-L1 ADIPOCYTES"}, {"entity_type": "TISSUE", "description": "Adipose tissue is the primary site of fat storage in the body.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "HUMAN ADIPOSE TISSUE"}, {"entity_type": "CELL TYPE", "description": "Chinese hamster ovary (CHO) cells are commonly used for protein expression and other biological research.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "CHINESE HAMSTER OVARY CELLS"}, {"entity_type": "FOOD", "description": "Intralipid\u00ae is an intravenous fat emulsion containing linoleic acid, oleic acid, and \u03b1-linolenic acid.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "INTRALIPID\u00ae"}, {"entity_type": "NUTRIENT", "description": "Linoleic acid is a polyunsaturated fatty acid that suppresses PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LINOLEIC ACID (LA)"}, {"entity_type": "NUTRIENT", "description": "Oleic acid is a monounsaturated fatty acid that suppresses PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "OLEIC ACID (OA)"}, {"entity_type": "NUTRIENT", "description": "\u03b1-linolenic acid is a polyunsaturated fatty acid that does not affect PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "\u0391-LINOLENIC ACID (ALA)"}, {"entity_type": "NUTRIENT", "description": "Eicosapentaenoic acid is a polyunsaturated fatty acid that suppresses PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "EICOSAPENTAENOIC ACID (EPA)"}, {"entity_type": "NUTRIENT", "description": "Docosahexaenoic acid is a polyunsaturated fatty acid that suppresses PNPLA3 expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "DOCOSAHEXAENOIC ACID (DHA)"}, {"entity_type": "METABOLIC PATHWAY", "description": "The Krebs cycle is a central metabolic pathway responsible for energy production from glucose.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "KREBS CYCLE"}, {"entity_type": "METABOLIC PATHWAY", "description": "Glycolysis is the metabolic pathway that breaks down glucose into pyruvate, producing ATP.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "GLYCOLYSIS"}, {"entity_type": "CELLULAR STRUCTURE", "description": "Lipid droplets are intracellular organelles where lipids are stored.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "LIPID DROPLETS"}, {"entity_type": "MOLECULE", "description": "siRNA (small interfering RNA) is a type of RNA molecule used to knock down gene expression.", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "id": "SIRNA"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "There is a strong positive correlation between PNPLA3 mRNA levels and SREBP1c mRNA levels in mice fed HC diets with or without LE.)", "entity_type": "UNKNOWN", "id": "PNPLA3 MRNA"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "There is a strong positive correlation between PNPLA3 mRNA levels and SREBP1c mRNA levels in mice fed HC diets with or without LE.)", "entity_type": "UNKNOWN", "id": "SREBP1C MRNA"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "There is a very strong positive correlation between PNPLA3 mRNA levels and ACC-1 mRNA levels in mice fed HC diets with or without LE.)", "entity_type": "UNKNOWN", "id": "ACC-1 MRNA"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "A high-fat diet increases hepatic triglyceride content in mice.)", "entity_type": "UNKNOWN", "id": "HEPATIC TG CONTENT"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "High-fat diet feeding does not significantly alter FAS mRNA levels compared to LF diets.)", "entity_type": "UNKNOWN", "id": "FAS MRNA"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "High-fat diet feeding does not significantly alter FAS mRNA levels compared to LF diets.)", "entity_type": "UNKNOWN", "id": "HF DIET"}, {"source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "description": "High glucose increases PNPLA3 mRNA levels in HepG2 cells.)", "entity_type": "UNKNOWN", "id": "HIGH GLUCOSE"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "High glucose levels induce PNPLA3 expression, while low glucose levels suppress it.)", "entity_type": "UNKNOWN", "id": "GLUCOSE METABOLISM"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Glucagon stimulates the expression of pyruvate carboxylase (PC), a key enzyme in gluconeogenesis.)", "entity_type": "UNKNOWN", "id": "PYRUVATE CARBOXYLASE (PC)"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Unsaturated fatty acids like OA, LA, EPA, and DHA suppress PNPLA3 gene expression.)", "entity_type": "UNKNOWN", "id": "OA, LA, EPA, DHA"}, {"source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "description": "Knockdown of PNPLA3 increases FAS expression in HepG2 cells.)", "entity_type": "UNKNOWN", "id": "PNPLA3 KNOCKDOWN"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "PNS refers to prolonged neonatal separation, which is a type of environmental stressor.<SEP>Prenatal Stress (PNS) is a type of environmental factor that can influence gene expression and pathways in the hippocampus.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf<SEP>chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "PNS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Axonal Guidance Signaling is a biological process that involves the guidance of growing axons to their targets.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "AXONAL GUIDANCE SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Protein Kinase A Signaling is a pathway involved in various cellular processes, including signal transduction and gene expression.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "PROTEIN KINASE A SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutamate Receptor Signaling is a pathway that mediates neuronal communication through glutamate receptors.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "GLUTAMATE RECEPTOR SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Wnt/\u03b2-catenin Signaling is a pathway involved in cell growth, differentiation, and development.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "WNT/\u0392-CATENIN SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CREB Signaling in Neurons is a pathway involved in neuronal plasticity and gene expression.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "CREB SIGNALING IN NEURONS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Synaptic Long Term Depression is a process that weakens synaptic connections between neurons.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "SYNAPTIC LONG TERM DEPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Synaptic Long Term Potentiation is a process that strengthens synaptic connections between neurons.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "SYNAPTIC LONG TERM POTENTIATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucocorticoid Receptor Signaling is a pathway involved in stress response and immune regulation.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "GLUCOCORTICOID RECEPTOR SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IL-8 Signaling is a pathway involved in inflammation and immune cell recruitment.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-8 SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "STAT3 Pathway is a signaling pathway involved in various cellular processes, including immune response and cell growth.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "STAT3 PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CDK5 Signaling is a pathway involved in neuronal development and function.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "CDK5 SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IL-1 Signaling is a pathway involved in inflammation and immune response.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-1 SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IL-6 Signaling is a pathway involved in inflammation and immune response.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "IL-6 SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMP signaling pathway is a pathway involved in cell growth, differentiation, and development.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "BMP SIGNALING PATHWAY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TGF-\u03b2 Signaling is a pathway involved in various cellular processes, including cell growth, differentiation, and immune regulation.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "TGF-\u0392 SIGNALING"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "The hippocampus is a brain region involved in memory and learning.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "HIPPOCAMPUS"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "The miRNome refers to the complete set of miRNAs expressed in a cell or organism.", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "id": "MIRNOME"}, {"entity_type": "GENE", "description": "ISOC1 is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "ISOCHORISMATASE DOMAIN CONTAINING 1 (ISOC1)"}, {"entity_type": "GENE", "description": "LDLRAP1 is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTER PROTEIN 1 (LDLRAP1)"}, {"entity_type": "GENE", "description": "LRRN3 is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LEUCINE-RICH REPEAT NEURONAL PROTEIN 3 (LRRN3)"}, {"entity_type": "GENE", "description": "MYO1D is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "MYOSIN ID (MYO1D)"}, {"entity_type": "GENE", "description": "PIK3C2B is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PHOSPHATIDYLINOSITOL-4-PHOSPHATE 3-KINASE, CATALYTIC SUBUNIT TYPE 2 BETA (PIK3C2B)"}, {"entity_type": "GENE", "description": "PPAP2A is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "PHOSPHATIDIC ACID PHOSPHATASE TYPE 2A (PPAP2A)"}, {"entity_type": "GENE", "description": "SAMD12 is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "STERILE ALPHA MOTIF DOMAIN CONTAINING 12 (SAMD12)"}, {"entity_type": "GENE", "description": "SERINC5 is a gene involved in a network of interacting genes potentially related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SERINE INCORPORATOR 5 (SERINC5)"}, {"entity_type": "GENE", "description": "TGF-\u03b21 is a gene modulated both in animals and humans, and involved in signaling pathways related to depression.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "TRANSFORMING GROWTH FACTOR, BETA 1 (TGF-\u03921)"}, {"entity_type": "GENE", "description": "SLC24A3 is a gene differentially expressed between rats and humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER) MEMBER 3 (SLC24A3)"}, {"entity_type": "GENE", "description": "BCL2 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "B-CELL CLL/LYMPHOMA 2 (BCL2)"}, {"entity_type": "GENE", "description": "BCL9 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "B-CELL CLL/LYMPHOMA 9 (BCL9)"}, {"entity_type": "GENE", "description": "LEF1 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1)"}, {"entity_type": "GENE", "description": "LIN54 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "LIN-54 DREAM MUVB CORE COMPLEX COMPONENT (LIN54)"}, {"entity_type": "GENE", "description": "PGAP1 is a gene down-regulated in rats and up-regulated in humans.", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "id": "POST-GPI ATTACHMENT TO PROTEINS 1 (PGAP1)"}, {"entity_type": "GENE", "description": "FoxO1 is a gene that plays a role in regulating neuronal proliferation and is activated by stress hormones like cortisol.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "FOXO1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cortisol is a human stress hormone that negatively impacts neurogenesis.<SEP>Cortisol is a stress hormone produced by the adrenal glands and plays a role in various bodily functions, including metabolism and immune response.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CORTISOL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Childhood trauma is an adverse life experience that can have lasting effects on mental health.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "CHILDHOOD TRAUMA"}, {"entity_type": "GENE", "description": "SGK-1 (Serum Glucocorticoid Kinase 1) is a stress responsive gene that mediates some of the glucocorticoid effects on brain function, including the negative effects of cortisol on neurogenesis.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "SGK-1"}, {"entity_type": "CELLULAR COMPONENT", "description": "These are cells in the hippocampus that have the potential to develop into neurons.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HIPPOCAMPAL PROGENITOR STEM CELLS"}, {"entity_type": "CELL LINE", "description": "This is an immortalized, multipotent human fetal hippocampal progenitor cell line used as a model for depression.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "HPC0A07/03C"}, {"entity_type": "CHEMICAL", "description": "BrdU is a nucleotide analog used to detect DNA replication and cell proliferation.<SEP>Bromodeoxyuridine (BrdU) is a marker of DNA synthesis and is used to detect proliferating cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "BRDU"}, {"entity_type": "DRUG", "description": "This is a cell-permeable inhibitor of FoxO1.", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "id": "AS1842856"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "miRNAs levels are investigated in the hippocampus of PNS rats.)", "entity_type": "UNKNOWN", "id": "MIRNAS"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "description": "Messenger RNA (mRNA) carries genetic information from DNA to ribosomes for protein synthesis.<SEP>Prenatal stress exposure affects mRNA expression in the hippocampus.)<SEP>mRNA is messenger RNA, a molecule that carries genetic information from DNA to the ribosomes for protein synthesis.", "entity_type": "TRANSCRIPT", "id": "MRNA"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Analysis of blood transcriptomics reveals altered gene expression in individuals exposed to early life trauma.)", "entity_type": "UNKNOWN", "id": "BLOOD TRANSCRIPTOMICS"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Analysis of blood transcriptomics reveals altered gene expression in individuals exposed to early life trauma.)", "entity_type": "UNKNOWN", "id": "EARLY LIFE TRAUMA"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of Alpha-2-Macroglobulin (A2M).)", "entity_type": "UNKNOWN", "id": "ALPHA-2-MACROGLOBULIN (A2M)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of AT-Rich Interaction Domain 5B (ARID5B).)", "entity_type": "UNKNOWN", "id": "AT-RICH INTERACTION DOMAIN 5B (ARID5B)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of Arrestin Domain Containing 4 (ARRDC4).)", "entity_type": "UNKNOWN", "id": "ARRESTIN DOMAIN CONTAINING 4 (ARRDC4)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of EPH Receptor A4 (EPHA4).)", "entity_type": "UNKNOWN", "id": "EPH RECEPTOR A4 (EPHA4)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of F-Box Protein 32 (FBXO32).)", "entity_type": "UNKNOWN", "id": "F-BOX PROTEIN 32 (FBXO32)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of Forkhead box protein O1 (FoxO1).)", "entity_type": "UNKNOWN", "id": "FORKHEAD BOX PROTEIN O1 (FOXO1)"}, {"source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "description": "Individuals exposed to early life trauma show altered expression of Heat Shock Transcription Factor 2 (HSF2).)", "entity_type": "UNKNOWN", "id": "HEAT SHOCK TRANSCRIPTION FACTOR 2 (HSF2)"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "A2M, FoxO1, and TGF-\u03b21 form a cluster of interacting genes involved in cytokine signaling, TGF-\u03b21 signaling, and glucocorticoid receptor signaling.)", "entity_type": "UNKNOWN", "id": "A2M"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "A2M, FoxO1, and TGF-\u03b21 form a cluster of interacting genes involved in cytokine signaling, TGF-\u03b21 signaling, and glucocorticoid receptor signaling.)", "entity_type": "UNKNOWN", "id": "TGF-\u03921"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both ISOC1 and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "ISOC1"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both LDLRAP1 and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "LDLRAP1"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both LRRN3 and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "LRRN3"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both MYO1D and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "MYO1D"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both PIK3C2B and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "PIK3C2B"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both PPAP2A and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "PPAP2A"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both SAMD12 and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "SAMD12"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "Both SERINC5 and FoxO1 are part of a gene network potentially related to depression.)", "entity_type": "UNKNOWN", "id": "SERINC5"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "description": "BCL2 is a gene previously associated with smoking and snoring.<SEP>BCL2 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "entity_type": "GENE", "id": "BCL2"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "BCL9 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "entity_type": "UNKNOWN", "id": "BCL9"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "LEF1 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "entity_type": "UNKNOWN", "id": "LEF1"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "LIN54 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "entity_type": "UNKNOWN", "id": "LIN54"}, {"source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "description": "PGAP1 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "entity_type": "UNKNOWN", "id": "PGAP1"}, {"source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "description": "FoxO1 mediates the negative effect of stress on neurogenesis.)", "entity_type": "UNKNOWN", "id": "NEUROGENESIS"}, {"source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "description": "AS1842856 inhibits the cortisol-induced reduction in neuronal proliferation, suggesting that FoxO1 mediates this effect.)", "entity_type": "UNKNOWN", "id": "CORTISOL-INDUCED REDUCTION IN NEURONAL PROLIFERATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant with the rs4771122 identifier.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "RS4771122"}, {"entity_type": "THERAPY", "description": "A surgical procedure to treat obesity.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "BARIATRIC SURGERY"}, {"entity_type": "DURATION", "description": "The average length of follow-up after surgery was 5.6 (2.2) years, with some individuals having as long as 9.5 years of follow up.", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "FOLLOW-UP"}, {"entity_type": "CHARACTERISTIC", "description": "81 (85%) participants were female, reflecting a typical distribution of bariatric surgery patients in the United States.<SEP>A biological characteristic distinguishing individuals as male or female.", "source_id": "chunk-055177812e320344d131432b292111b0<SEP>chunk-b3d775642c43fa3524a531a3f6ec1e41", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "GENDER"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "The SNP rs4771122 was associated with long-term weight loss, with each additional copy of the minor (G) allele linked to a larger percentage weight lost.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "LONG TERM WEIGHT LOSS"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "The association between rs4771122 and long-term weight loss was adjusted for pre-surgical BMI.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "PRE-SURGICAL BMI"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "Additional copies of the minor (G) allele were associated with increased pre-surgical weight.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "PRE-SURGICAL WEIGHT"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "rs4771122 was nominally significantly associated with trajectory group membership.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "TRAJECTORY GROUP MEMBERSHIP"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "rs4771122 was nominally significantly associated with nadir percent weight loss.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "NADIR PERCENT WEIGHT LOSS"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "rs4771122 was nominally significantly associated with 2 year percent weight loss.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 85}]", "id": "2 YEAR PERCENT WEIGHT LOSS"}, {"source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "description": "The study population included a high proportion of females, typical for bariatric surgery patients.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "BARIATRIC SURGERY PATIENTS"}, {"entity_type": "GENE", "description": "GCK is a gene associated with Maturity Onset Diabetes of the Young (MODY). Variants in this gene can lead to glucose metabolism disorders.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "GCK"}, {"entity_type": "TRANSCRIPT", "description": "The transcript of RPS19 can be affected by mutations, leading to altered protein production.<SEP>The transcript of the GCK gene contains information for producing the GCK protein.<SEP>The transcript of the SULT1A1 gene is susceptible to alterations due to detected variants, potentially affecting splicing enhancer and silencer binding sites.<SEP>The transcript of the STAT5B gene is affected by the LOF variant.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94<SEP>chunk-658df2fc2f9361a65ff1d22464744763<SEP>chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-607feda7df4db8151b99560074c91eea", "id": "TRANSCRIPT"}, {"entity_type": "PROTEIN", "description": "The GCK protein plays a role in regulating glucose metabolism.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "id": "GCK PROTEIN"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, Met210dup, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "MET210DUP"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Lys13X, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.LYS13X"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Leu185Pro, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.LEU185PRO"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Val207Leu, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.VAL207LEU"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Glu227Hisfs*47, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.GLU227HISFS*47"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Cys252Trp, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.CYS252TRP"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Arg275Leu, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.ARG275LEU"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Ser281Pro, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.SER281PRO"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Ser127Pro, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.SER127PRO"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.His141Pro, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.HIS141PRO"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, c.579+4delA, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "C.579+4DELA"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.Leu307Phe, was identified in a proband.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.LEU307PHE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific genomic variant, p.His317Gln, was identified in a proband and her mother.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 23}]", "id": "P.HIS317GLN"}, {"entity_type": "DISEASE", "description": "Maturity Onset Diabetes of the Young (MODY) is a form of diabetes caused by mutations in genes like GCK.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "MODY"}, {"entity_type": "DISEASE", "description": "Diabetes phenotype refers to the clinical manifestations of diabetes.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 127}]", "id": "DIABETES PHENOTYPE"}, {"entity_type": "DISEASE", "description": "Fasting hyperglycemia is a condition where blood sugar levels are elevated when a person has not eaten for several hours.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 127}]", "id": "FASTING HYPERGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HbA1c is a blood test that measures average blood sugar levels over the past 2-3 months.<SEP>HbA1c is a measure of average blood sugar levels over the past 2-3 months.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 127}]", "id": "HBA1C"}, {"entity_type": "DISEASE", "description": "This refers to a type of diabetes phenotype characterized by consistent but relatively low blood sugar elevations during fasting periods.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 127}]", "id": "STABLE, MILD FASTING HYPERGLYCEMIA"}, {"entity_type": "DISEASE", "description": "Co-segregation refers to the inheritance pattern of a trait or disease within a family.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "CO-SEGREGATION"}, {"entity_type": "DISEASE", "description": "A de novo mutation is a genetic change that occurs spontaneously and is not inherited from parents.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "DE NOVO"}, {"entity_type": "DISEASE", "description": "In silico tools are computer programs that predict the potential impact of genetic variants.", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "IN-SILICO TOOLS"}, {"entity_type": "INDIVIDUAL", "description": "The proband is the individual who first exhibits a particular trait or disease.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "PROBAND"}, {"entity_type": "INDIVIDUAL", "description": "The mother of the proband was also investigated for genetic variants.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "MOTHER"}, {"entity_type": "GENETIC CHANGE", "description": "A mutation is a permanent alteration in the DNA sequence.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "MUTATION"}, {"entity_type": "INDIVIDUAL", "description": "The parents of the proband were included in the genetic analysis.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "PARENTS"}, {"entity_type": "DISEASE", "description": "Clinical features are observable symptoms and signs of a disease.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "CLINICAL FEATURES"}, {"entity_type": "PROCEDURE", "description": "Genetic analysis involves examining an individual\'s DNA to identify variations.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "GENETIC ANALYSIS"}, {"entity_type": "DISEASE", "description": "Family history provides information about the occurrence of diseases in relatives.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "FAMILY HISTORY"}, {"entity_type": "PROCEDURE", "description": "Variant analysis is the process of evaluating the significance of a genetic variant.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "VARIANT ANALYSIS"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean Diet Adherence (rMED) is a measure of adherence to the Mediterranean diet, which is characterized by high consumption of fruits, vegetables, whole grains, legumes, and olive oil.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 130}]", "id": "MEDITERRANEAN DIET ADHERENCE"}, {"entity_type": "NUTRIENT", "description": "TAG refers to triglycerides, a type of fat found in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 31}]", "id": "TAG"}, {"entity_type": "NUTRIENT", "description": "HDL-C stands for high-density lipoprotein cholesterol, often considered \'good\' cholesterol.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 130}]", "id": "HDL-C"}, {"entity_type": "NUTRIENT", "description": "LDL-C stands for low-density lipoprotein cholesterol, often considered \'bad\' cholesterol.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "LDL-C"}, {"entity_type": "PROTEIN", "description": "ApoB stands for apolipoprotein B, a protein that helps transport cholesterol in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 31}]", "id": "APOB"}, {"entity_type": "PROTEIN", "description": "ApoA-1 stands for apolipoprotein A-1, a protein associated with HDL-C.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "APOA-1"}, {"entity_type": "GENE", "description": "GCKR is a gene that encodes the glucokinase regulatory protein, which plays a role in glucose metabolism.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "GLUCOKINASE REGULATORY PROTEIN (GCKR)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs780094 is a risk SNP for type 2 diabetes or hyperglycemia associated with elevated levels of BHB.<SEP>rs780094 is a specific SNP (single nucleotide polymorphism) within the GCKR gene.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-c6fdc5ed25c4e17b8c421a952bb05450", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 70}]", "id": "RS780094"}, {"entity_type": "DIETARY PATTERN", "description": "The Mediterranean Diet Adherence (rMED) is a measure of adherence to the Mediterranean diet, which is characterized by high consumption of fruits, vegetables, whole grains, legumes, and olive oil.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "id": "MEDITERRANEAN DIET ADHERENCE (RMED)"}, {"entity_type": "GENOTYPE", "description": "TC genotype refers to variations in the gene sequence.<SEP>TC stands for total cholesterol, a measure of all types of cholesterol in the blood.", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "clusters": "[{level: 0, cluster: 31}]", "id": "TC"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Smoking status is categorized as smoker or non-smoker and was analyzed to see if it influenced gene-diet interactions.<SEP>Whether or not a person currently smokes tobacco.<SEP>Smoking status refers to whether an individual smokes tobacco products.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "SMOKING STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TAG levels, which likely refer to triglyceride levels, were measured as an outcome variable in the study.", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 162}]", "id": "TAG LEVELS"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "description": "Individuals with the AA genotype of rs780094 had higher TAG concentrations.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 31}]", "id": "RS780094 (AA GENOTYPE)"}, {"source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "description": "Higher adherence to the Mediterranean diet was associated with a lower risk of hypertriacylglycerolaemia.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 130}]", "id": "HYPERTRIACYLGLYCEROLAEMIA"}, {"source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "description": "The smoking status (smoker vs. non-smoker) was examined to determine if there was a significant interaction between genes and diet in the outcomes analyzed.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "GENE\u2013DIET INTERACTION"}, {"source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "description": "Genotype refers to the specific genetic makeup of an individual.<SEP>There were differences by genotype in TAG levels observed in both smoker and non-smoker strata.)", "entity_type": "GENOMIC VARIANT", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 162}]", "id": "GENOTYPE"}, {"entity_type": "DISEASE", "description": "Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by persistent hypoglycemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CHI"}, {"entity_type": "DRUG", "description": "Diazoxide is a medication used to treat CHI by blocking calcium channels in pancreatic beta cells, inhibiting insulin secretion.<SEP>Diazoxide is a medication used to treat CHI by inhibiting insulin secretion.<SEP>Three patients were responsive to diazoxide treatment.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd<SEP>chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIAZOXIDE"}, {"entity_type": "THERAPY", "description": "Dietary treatment involves frequent feedings and/or uncooked cornstarch to manage blood glucose levels in CHI patients.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "DIETARY TREATMENT"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations in the ABCC8 gene are a common cause of CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "ABCC8 GENE MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "No KCNJ11 gene mutations were identified in this study.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "KCNJ11 GENE MUTATIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "Mutations in the GLUD1 gene can cause CHI, particularly persistent hypoglycemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GLUD1 GENE MUTATIONS"}, {"entity_type": "DISEASE", "description": "Hypoglycemia is low blood sugar, a common symptom of CHI.<SEP>Hypoglycemia refers to low blood sugar levels, a hallmark symptom of CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPOGLYCEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hyperinsulinism refers to excessive insulin production by the pancreas.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "HYPERINSULINISM"}, {"entity_type": "ORGAN", "description": "Pancreas is an organ responsible for producing insulin and other digestive enzymes.<SEP>The pancreas is an organ involved in digestion and hormone production.<SEP>The pancreas is an organ that produces insulin and other digestive enzymes.<SEP>The pancreas is an organ with both endocrine and exocrine functions, producing hormones like insulin and digestive enzymes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "PANCREAS"}, {"entity_type": "DISEASE", "description": "Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by persistent hypoglycemia.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "CONGENITAL HYPERINSULINISM (CHI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood glucose regulation is a key physiological process affected by CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "BLOOD GLUCOSE"}, {"entity_type": "CELLULAR COMPONENT", "description": "Beta cells are specialized pancreatic cells that produce and secrete insulin.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "BETA CELLS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose metabolism is a complex metabolic pathway involving various enzymes and hormones that regulates blood glucose levels.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "METABOLIC PATHWAY"}, {"entity_type": "FIELD OF STUDY", "description": "Genetic testing can identify mutations in genes like ABCC8 and GLUD1 associated with CHI.", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "id": "GENETICS"}, {"entity_type": "GENE", "description": "The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GLUD1"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Arg322 His mutation was found in patients 54, 55 and 56.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 89}]", "id": "P.ARG322 HIS"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Ser498Leu mutation was found in patient 52.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 89}]", "id": "P.SER498LEU"}, {"entity_type": "GENOMIC VARIANT", "description": "The p.Asn463Asp mutation was found in patient 53.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 89}]", "id": "P.ASN463ASP"}, {"entity_type": "DRUG", "description": "Octreotide was administered to three children who were not responsive to diazoxide.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "OCTREOTIDE"}, {"entity_type": "MEDICAL PROCEDURE", "description": "Pancreatectomy was performed in 10 patients who were unresponsive to drugs.", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "PANCREATECTOMY"}, {"entity_type": "DISEASE", "description": "Patient 7 developed diabetes mellitus at five years of age...", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "DIABETES MELLITUS"}, {"entity_type": "DISEASE", "description": "The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HYPOGLYCAEMIA"}, {"entity_type": "DISEASE", "description": "Three different heterozygous mutations in the GLUD1 gene were identified in five patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 89}]", "id": "HI/HA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gastrointestinal disturbances such as nausea, vomiting, severe gastrointestinal upset and poor appetite occurred in 69%.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "GASTROINTESTINAL DISTURBANCES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Different degrees of hypertrichosis occurred in 55% (22/40) of patients during clinical follow-up.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "HYPERTRICHOSIS"}, {"entity_type": "DISEASE", "description": "In one case (patient 43), effective diazoxide therapy had to be stopped because of thrombocytopenic purpura.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "THROMBOCYTOPENIC PURPURA"}, {"entity_type": "MEDICAL DEVICE", "description": "Six patients were fed through a nasogastric tube because of severe gastrointestinal reactions.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "NASOGASTRIC TUBE"}, {"entity_type": "DISEASE", "description": "One patient died of multiorgan failure)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "id": "MULTIORGAN FAILURE"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Diazoxide inhibits insulin production, helping to manage blood glucose levels in CHI patients.)", "entity_type": "UNKNOWN", "id": "INSULIN PRODUCTION"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Mutations in the ABCC8 gene can lead to dysfunctional ATP-sensitive potassium channels in beta cells, causing overproduction of insulin.)", "entity_type": "UNKNOWN", "id": "INSULIN OVERPRODUCTION"}, {"source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "description": "Mutations in the GLUD1 gene disrupt glutamate metabolism, contributing to CHI development.)", "entity_type": "UNKNOWN", "id": "GLUTAMATE METABOLISM"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-f921f48a406901d82ec2e32af99485bf<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "description": "Diazoxide inhibits insulin secretion by blocking calcium channels in pancreatic beta cells.)<SEP>Insulin secretion is the process by which insulin is released from pancreatic beta cells.<SEP>Insulin secretion refers to the release of insulin by the pancreas in response to elevated blood sugar levels.<SEP>Insulin secretion is the process by which insulin is released from pancreatic \u03b2 cells.", "entity_type": "PHYSIOLOGICAL PROCESS", "id": "INSULIN SECRETION"}, {"source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "description": "Patients with pancreatic disease are susceptible to developing diabetes mellitus.)", "entity_type": "UNKNOWN", "id": "PANCREATIC DISEASE"}, {"entity_type": "METABOLIC PATHWAY", "description": "AcAc (acetoacetate) is a ketone body.<SEP>AcAc is a ketone body", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "ACAC"}, {"entity_type": "METABOLIC PATHWAY", "description": "BHB (Beta-hydroxybutyrate) is a ketone body.<SEP>BHB is a ketone body", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 70}]", "id": "BHB"}, {"entity_type": "DISEASE", "description": "IFG stands for impaired fasting glucose, a condition where blood sugar levels are higher than normal but not high enough to be diagnosed as type 2 diabetes.<SEP>Impaired fasting glucose (IFG) is a condition characterized by elevated blood glucose levels after an overnight fast.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 114}]", "id": "IFG"}, {"entity_type": "DISEASE", "description": "Newly detected diabetes refers to individuals recently diagnosed with type 2 diabetes.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "NEWLY DETECTED DIABETES"}, {"entity_type": "DISEASE", "description": "IGT stands for impaired glucose tolerance, a condition where blood sugar levels are elevated after a meal but not as high as in type 2 diabetes.<SEP>Impaired glucose tolerance (IGT) is characterized by elevated blood glucose levels after consuming a sugary drink.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 114}]", "id": "IGT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "2hPG stands for 2-hour postglucose plasma glucose, a measure of blood sugar levels two hours after consuming a sugary drink.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 70}]", "id": "2HPG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose AUC (area under the curve of glucose) is a measure of blood glucose levels over time.<SEP>Glucose AUC stands for area under the curve for glucose, a measure of how much blood sugar has risen over a period of time.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "id": "GLUCOSE AUC"}, {"entity_type": "METABOLIC PATHWAY", "description": "Ketone bodies (AcAc and BHB) are produced by the liver during periods of low glucose availability.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "KETONE BODIES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glucose tolerance refers to the body\'s ability to regulate blood sugar levels. ", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "id": "GLUCOSE TOLERANCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Insulin sensitivity describes how effectively cells respond to insulin, a hormone that regulates blood sugar.", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "INSULIN SENSITIVITY"}, {"entity_type": "GENE", "description": "GCKR is a gene associated with eGFR.<SEP>GCKR is a gene associated with glucose metabolism and CRP.<SEP>GCKR is a gene associated with glucose metabolism and its variant rs780094 has been linked to elevated levels of BHB.<SEP>GCKR is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.<SEP>GCKR is a gene that encodes glucokinase regulator and has been linked to triglyceride, cholesterol synthesis, and plasma glucose concentrations.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "GCKR"}, {"entity_type": "GENE", "description": "FADS1 is a gene involved in fatty acid metabolism and its variants are nominally associated with AcAc or BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 4}]", "id": "FADS1"}, {"entity_type": "GENE", "description": "ANK1 is a gene whose variants are nominally associated with AcAc or BHB levels.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "clusters": "[{level: 0, cluster: 3}]", "id": "ANK1"}, {"entity_type": "GENE", "description": "HMGA2 is a gene associated with height and \'Age at first tooth\'.<SEP>HMGA2 is a gene whose variants are nominally associated with AcAc or BHB levels.<SEP>HMGA2 is a gene.<SEP>High Mobility Group AT-Hook 2 (HMGA2) is a gene involved in chromatin organization and transcriptional regulation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-bc2193bd869a06007022e1aa75877336<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-c63d60b991cd7442f690dcc364af47dd", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 125}]", "id": "HMGA2"}, {"entity_type": "GENE", "description": "CPT1A is a gene encoding carnitine palmitoyltransferase 1A, which regulates the binding of carnitine to long-chain fatty acids for mitochondrial oxidation.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "CPT1A"}, {"entity_type": "GENE", "description": "HMGCS1 is a gene encoding 3-hydroxy-3-methylglutaryl-CoA synthase 1, involved in ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS1"}, {"entity_type": "GENE", "description": "HMGCS2 is a gene encoding 3-hydroxy-3-methylglutaryl-CoA synthase 2, involved in ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "HMGCS2"}, {"entity_type": "GENE", "description": "ACAT1 is a gene encoding acetyl-CoA acetyltransferase 1, which catalyzes the final step in KB breakdown.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACAT1"}, {"entity_type": "GENE", "description": "BDH1 is a gene encoding BHB dehydrogenase, type 1, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "BDH1"}, {"entity_type": "GENE", "description": "OXCT1 is a gene encoding 3-oxoacid CoA transferase 1, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "OXCT1"}, {"entity_type": "GENE", "description": "ACSS2 is a gene encoding acyl-CoA synthetase short-chain family member 2, involved in ketolysis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "ACSS2"}, {"entity_type": "METABOLIC PATHWAY", "description": "FFAs are fatty acids, primarily used for energy production and involved in ketogenesis.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "FFAS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Matsuda ISI (insulin sensitivity index) measures insulin sensitivity.", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "id": "MATSUDA ISI"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f2e122f964bade37f487049bd69a3f9f", "description": "Elevated BHB levels were associated with higher glucose AUC, suggesting a role in hyperglycemia development.)<SEP>Hyperglycemia is a physiological condition characterized by elevated blood glucose levels.", "entity_type": "PHYSIOLOGICAL CONDITION", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 70}]", "id": "HYPERGLYCEMIA"}, {"source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "description": "AcAc levels were assessed across different glucose tolerance categories, including IFG, IGT, and newly diagnosed diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 110}]", "id": "GLUCOSE TOLERANCE CATEGORIES"}, {"source_id": "chunk-bc2193bd869a06007022e1aa75877336", "description": "Variants in FADS1 are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the FADS1 gene are nominally associated with AcAc and/or BHB levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 2}]", "id": "ACAC/BHB"}, {"entity_type": "GENE", "description": "APOC1 is a gene associated with cholesterol levels and CRP.<SEP>APOC1 is a gene, SNPs like rs4420638 near it are associated with type 2 diabetes (T2D).", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "APOC1"}, {"entity_type": "GENE", "description": "HNF1A is a gene associated with glucose metabolism and CRP.<SEP>HNF1A is a gene,  the rs1183910 SNP in its first intron is associated with lower risk of coronary artery disease (CAD).", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "HNF1A"}, {"entity_type": "GENE", "description": "IL6R is a gene associated with inflammation and CRP.<SEP>IL6R is a gene encoding the interleukin 6 receptor, which mediates the effects of IL-6.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "IL6R"}, {"entity_type": "GENE", "description": "PPP1R3B is a gene associated with various cellular processes and CRP.<SEP>PPP1R3B is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "PPP1R3B"}, {"entity_type": "GENE", "description": "HNF4A is a gene associated with glucose metabolism and CRP.<SEP>HNF4A is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "HNF4A"}, {"entity_type": "GENE", "description": "PABPC4 is a gene involved in mRNA processing and CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "PABPC4"}, {"entity_type": "GENE", "description": "BCL7B is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.<SEP>BCL7B is a gene involved in B cell development and CRP.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "BCL7B"}, {"entity_type": "GENE", "description": "TMEM18 is a gene with unknown function and CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "TMEM18"}, {"entity_type": "GENE", "description": "PLTP is a gene involved in lipid metabolism and CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "PLTP"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1558902 is a SNP located in the FTO gene associated with CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "RS1558902"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2867125 is a SNP located near TMEM18 associated with CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "RS2867125"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6065906 is a SNP located near PLTP and PCIF1 genes associated with CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "RS6065906"}, {"entity_type": "GENOMIC VARIANT", "description": "rs571312 is a SNP located upstream of MC4R gene associated with CRP.", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "id": "RS571312"}, {"entity_type": "GENE", "description": "IL1F10 is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.<SEP>IL1F10 is a gene, SNPs like rs6734238 near it are associated with total cholesterol levels.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "IL1F10"}, {"entity_type": "GENE", "description": "PABPC is a gene identified in the study to have pleiotropic effects on CRP and cardiometabolic phenotypes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "PABPC"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1183910 is a SNP located in the first intron of the HNF1A gene on chromosome 12, associated with CAD.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "RS1183910"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6734238 is a SNP located on chromosome 2, near the IL1F10 gene and other interleukin 1 family genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 52}]", "id": "RS6734238"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4420638 is a SNP located nearby the APOC1 gene on chromosome 19, associated with T2D.", "source_id": "chunk-372184452f1f9156514992455057f843", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "RS4420638"}, {"entity_type": "BIOMARKER", "description": "C-reactive protein (CRP) is an inflammatory marker and the focus of the study.<SEP>CRP is a gene associated with inflammation and cardiovascular disease.<SEP>CRP is a gene whose SNPs were not associated with ovarian cancer risk.<SEP>C-reactive protein (CRP) is an inflammatory marker that can be elevated in diabetes.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-372184452f1f9156514992455057f843<SEP>chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 105}]", "id": "CRP"}, {"entity_type": "DISEASE", "description": "CAD refers to Coronary Artery Disease, a cardiovascular condition.<SEP>Coronary artery disease (CAD) is a cardiovascular disease.", "source_id": "chunk-372184452f1f9156514992455057f843<SEP>chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "CAD"}, {"entity_type": "METABOLIC PATHWAY", "description": "FXR/RXR activation is a significantly enriched metabolic pathway associated with pleiotropic genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "FXR/RXR ACTIVATION"}, {"entity_type": "METABOLIC PATHWAY", "description": "LXR/RXR activation is a significantly enriched metabolic pathway associated with pleiotropic genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "LXR/RXR ACTIVATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "MODY signaling is a significantly enriched physiological process associated with pleiotropic genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "MATURITY ONSET DIABETES OF THE YOUNG (MODY) SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hepatic cholestasis is a significantly enriched physiological process associated with pleiotropic genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "HEPATIC CHOLESTASIS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Acute phase response signaling is a significantly enriched physiological process associated with pleiotropic genes.", "source_id": "chunk-372184452f1f9156514992455057f843", "id": "ACUTE PHASE RESPONSE SIGNALING"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP located in the miR-34b/c gene.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 160}]", "id": "MIR-34B/C RS4938723"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP in the TP53 gene affecting the amino acid at position 72 from Arginine to Proline.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 160}]", "id": "TP53 ARG72PRO"}, {"entity_type": "DISEASE", "description": "Iliac Aneurysm, a condition characterized by a bulge or ballooning in the aorta below the renal arteries.", "source_id": "chunk-055177812e320344d131432b292111b0", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 160}]", "id": "IA"}, {"entity_type": "GROUP", "description": "Individuals used as a comparison group to study potential associations.<SEP>Individuals without Crohn\'s Disease serving as a comparison group.<SEP>The control group served as a comparison to the CRC patients.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-055177812e320344d131432b292111b0", "id": "CONTROL GROUP"}, {"entity_type": "GROUP", "description": "Individuals with the specific condition being studied (in this case, IA).", "source_id": "chunk-055177812e320344d131432b292111b0", "id": "CASE GROUP"}, {"source_id": "chunk-055177812e320344d131432b292111b0", "description": "This SNP represents specific alleles (e.g., C and T). )", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 160}]", "id": "ALLELE"}, {"source_id": "chunk-055177812e320344d131432b292111b0", "description": "Odds Ratio measures the strength of association between a genotype and IA risk.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 138}]", "id": "STATISTICAL MEASURE"}, {"entity_type": "GENE", "description": "INADL is a gene that contains a SNP rs1056513 associated with weight, BMI, FFM, FM, trunk FM, and hip circumference.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "INADL"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1056513 is a nonsynonymous SNP in the INADL gene on chromosome 1 that is associated with weight, BMI, FFM, FM, trunk FM, and hip circumference.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RS1056513"}, {"entity_type": "GENE", "description": "COL4A1 is a gene that contains an intronic variant associated with weight z-score change.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "COL4A1"}, {"entity_type": "GENE", "description": "TSEN34 is a gene that contains a variant in the 5\u2032UTR region associated with linear growth (height change).", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TSEN34"}, {"entity_type": "GENE", "description": "MTNR1B is a gene containing an intronic variant strongly associated with fasting glucose.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MTNR1B"}, {"entity_type": "GENOMIC REGION", "description": "The APOA5-ZNF259 region on chromosome 11 contains intronic and 3\u2032UTR variants associated with triglycerides.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 49}]", "id": "APOA5-ZNF259"}, {"entity_type": "GENE", "description": "PCSK2 is a gene containing an intronic variant associated with total antioxidants.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "PCSK2"}, {"entity_type": "GENE", "description": "RNASE1 is a gene that contains a variant in the flanking 3\u2032UTR region associated with 24-h urinary nitrogen excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RNASE1"}, {"entity_type": "GENE", "description": "ASS1P11 is a gene that contains a variant in the flanking 3\u2032UTR region associated with creatinine excretion.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ASS1P11"}, {"entity_type": "GENE", "description": "GCH1 is a gene containing an intronic SNP associated with 24-h urinary dopamine: creatinine ratio.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GCH1"}, {"entity_type": "GENE", "description": "KLKB1 is a gene that contains a nonsynonymous SNP (rs3733402; S143T) associated with serum free IGF-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "KLKB1"}, {"entity_type": "GENE", "description": "MPRIP is a gene containing an intronic SNP associated with serum IGFBP-3.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "MPRIP"}, {"entity_type": "GENOMIC REGION", "description": "The flanking 5\u2032UTR region of XPA/FOXE1 (TTF-2) on chromosome 9 contains a block of twenty-three SNPs associated with serum TSH.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "XPA/FOXE1 (TTF-2)"}, {"entity_type": "GENE", "description": "DARC is a gene containing a nonsynonymous SNP (rs12075; G42D) and an intronic SNP highly associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DARC"}, {"entity_type": "GENE", "description": "GREB1 is a gene with coding variants associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "GREB1"}, {"entity_type": "GENE", "description": "DFNB31 is a gene with coding variants associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "DFNB31"}, {"entity_type": "GENE", "description": "CCR3 is a gene with variants in the 3\u2032UTR highly associated with MCP1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "CCR3"}, {"entity_type": "GENE", "description": "RASGEF1A is a gene containing an intronic SNP associated with MCP-1.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RASGEF1A"}, {"entity_type": "GENE", "description": "ABO is a gene with a variant in the intronic region strongly associated with IL-6.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "ABO"}, {"entity_type": "GENE", "description": "TMEM229B is a gene containing an intronic variant associated with ad libitum energy intake at dinner.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "TMEM229B"}, {"entity_type": "GENE", "description": "ARHGAP11A is a gene associated with sleep duration.<SEP>ARHGAP11A is a gene containing an intronic variant associated with sleep duration.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 157}]", "id": "ARHGAP11A"}, {"entity_type": "GENE", "description": "C21orf34 is a gene associated with respiratory quotient (RQ) during sleep.<SEP>C21orf34 is a gene containing a SNP in the intronic region associated with respiratory quotient (RQ) during sleep.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 113}]", "id": "C21ORF34"}, {"entity_type": "GENE", "description": "RPL is a gene with a variant associated with accelerometer-measured light activity.", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "RPL"}, {"entity_type": "GENE", "description": "PPARG is a gene containing variants associated with BMI and body fat percentage.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "PPARG"}, {"entity_type": "GENE", "description": "ADRB2 is a gene containing variants associated with weight loss response to exercise.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "id": "ADRB2"}, {"entity_type": "GENE", "description": "RPL7P3 is a gene associated with accelerometer-measured light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "RPL7P3"}, {"entity_type": "GENE", "description": "CTCFL is a gene associated with sedentary-light activity.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CTCFL"}, {"entity_type": "GENE", "description": "MATK is a gene associated with total energy expenditure.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "MATK"}, {"entity_type": "GENE", "description": "CHRNA3 is a gene associated with sleeping energy expenditure.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "CHRNA3"}, {"entity_type": "GENOMIC VARIANT", "description": "An intronic variant is a type of genomic variant found within an intron.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 157}]", "id": "INTRONIC VARIANT"}, {"entity_type": "REGULATORY ELEMENT", "description": "The 5\' untranslated region (UTR) is a regulatory element that plays a role in gene expression.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "5\' UTR REGION"}, {"entity_type": "REGULATORY ELEMENT", "description": "The 3\' untranslated region (UTR) is a regulatory element involved in mRNA stability and translation.", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "id": "3\' UTR REGION"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic variant in COL4A1 is associated with weight z-score change.)", "entity_type": "UNKNOWN", "id": "WEIGHT Z-SCORE CHANGE"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A variant in the 5\u2032UTR region of TSEN34 is associated with linear growth (height change).)", "entity_type": "UNKNOWN", "id": "LINEAR GROWTH (HEIGHT CHANGE)"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic variant in PCSK2 is associated with total antioxidants.)", "entity_type": "UNKNOWN", "id": "TOTAL ANTIOXIDANTS"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A variant in the flanking 3\u2032UTR region of RNASE1 is associated with 24-h urinary nitrogen excretion.)", "entity_type": "UNKNOWN", "id": "24-H URINARY NITROGEN EXCRETION"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A variant in the flanking 3\u2032UTR region of ASS1P11 is associated with creatinine excretion.)", "entity_type": "UNKNOWN", "id": "CREATININE EXCRETION"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in GCH1 is associated with 24-h urinary dopamine: creatinine ratio.)", "entity_type": "UNKNOWN", "id": "24-H URINARY DOPAMINE: CREATININE RATIO"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A nonsynonymous SNP (rs3733402; S143T) in KLKB1 is identified for serum free IGF-1.)", "entity_type": "UNKNOWN", "id": "SERUM FREE IGF-1"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic SNP in MPRIP is associated with serum IGFBP-3.)", "entity_type": "UNKNOWN", "id": "SERUM IGFBP-3"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A block of twenty-three SNPs in the flanking 5\u2032UTR region of XPA/FOXE1 (TTF-2) are highly associated with serum TSH.)", "entity_type": "UNKNOWN", "id": "SERUM TSH"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Highly significant associations for a nonsynonymous SNP (rs12075; G42D) and an intronic SNP in DARC are identified for MCP-1.)<SEP>MCP-1 is a chemokine that attracts monocytes and macrophages to sites of inflammation.", "entity_type": "CHEMOKINE", "id": "MCP-1"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "description": "A variant in the intronic region of ABO is strongly associated with IL-6.)<SEP>IL-6 is a cytokine involved in inflammation and immune responses.<SEP>IL-6 is a cytokine that is involved in inflammation and immune responses.<SEP>IL-6 is a pleiotropic cytokine with roles in inflammation, cell growth, and differentiation.<SEP>Interleukin-6 (IL-6) is a pro-inflammatory cytokine involved in various immune responses.<SEP>IL-6 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>IL-6 is a proinflammatory cytokine produced by adipocytes and other cells.<SEP>IL-6 is a proinflammatory cytokine produced by adipocytes.<SEP>Interleukin-6 (IL-6) is a proinflammatory cytokine involved in immune responses and metabolic regulation.", "entity_type": "CYTOKINE", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "IL-6"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "An intronic variant in TMEM229B on chromosome 14 is associated with ad libitum energy intake at dinner.)", "entity_type": "UNKNOWN", "id": "AD LIBITUM ENERGY INTAKE AT DINNER"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "description": "An intronic variant in ARHGAP11A on chromosome 15 is associated with sleep duration.)<SEP>An intronic variant in ARHGAP11A was associated with sleep duration.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 157}]", "id": "SLEEP DURATION"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A SNP in the intronic region of C21orf34 is detected for respiratory quotient (RQ) during sleep.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 113}]", "id": "RESPIRATORY QUOTIENT (RQ) DURING SLEEP"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL)", "entity_type": "UNKNOWN", "id": "ACCELEROMETER-MEASURED LIGHT ACTIVITY"}, {"source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "description": "A variant in SLC2A9 is associated with fasting glucose.)<SEP>SLC2A9 is a gene associated with uric acid levels.<SEP>SLC2A9 is a gene involved in glucose transport.", "entity_type": "GENE", "id": "SLC2A9"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants in FTO are associated with BMI and body weight.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 100}]", "id": "BMI AND BODY WEIGHT"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants in PPARG are associated with BMI and body fat percentage.)", "entity_type": "UNKNOWN", "id": "BMI AND BODY FAT PERCENTAGE"}, {"source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "description": "Variants in ADRB2 are associated with weight loss response to exercise.)", "entity_type": "UNKNOWN", "id": "WEIGHT LOSS RESPONSE TO EXERCISE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 113}]", "id": "RESPIRATORY QUOTIENT (RQ)"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL7P3.)", "entity_type": "UNKNOWN", "id": "LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "A variant was identified for sedentary-light activity in the 3\u2032UTR of CTCFL.)", "entity_type": "UNKNOWN", "id": "SEDENTARY-LIGHT ACTIVITY"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Highly significant variants were identified for total energy expenditure for MATK.)", "entity_type": "UNKNOWN", "id": "TOTAL ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Highly significant variants were identified for sleeping energy expenditure for CHRNA3.)", "entity_type": "UNKNOWN", "id": "SLEEPING ENERGY EXPENDITURE"}, {"source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "description": "Highly significant variants were identified for total energy expenditure for MATK.)", "entity_type": "UNKNOWN", "id": "VARIANT"}, {"entity_type": "GENE", "description": "APOBR is a gene associated with obesity.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "APOBR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3833080 is a deletion in the APOBR gene, associated with obesity.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "RS3833080"}, {"entity_type": "GENOMIC VARIANT", "description": "rs180743 is a SNP in the APOBR gene, associated with obesity.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 97}]", "id": "RS180743"}, {"entity_type": "GENOMIC VARIANT", "description": "rs368546180 is a deletion in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS368546180"}, {"entity_type": "GENOMIC VARIANT", "description": "rs74949322 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS74949322"}, {"entity_type": "GENOMIC VARIANT", "description": "rs151233 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS151233"}, {"entity_type": "GENOMIC VARIANT", "description": "rs149271 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS149271"}, {"entity_type": "GENOMIC VARIANT", "description": "rs180744 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS180744"}, {"entity_type": "GENOMIC VARIANT", "description": "rs151174 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS151174"}, {"entity_type": "GENOMIC VARIANT", "description": "rs40831 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS40831"}, {"entity_type": "GENOMIC VARIANT", "description": "rs61738759 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS61738759"}, {"entity_type": "GENOMIC VARIANT", "description": "rs40833 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS40833"}, {"entity_type": "GENOMIC VARIANT", "description": "rs142786317 is a variant in the APOBR gene.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "id": "RS142786317"}, {"entity_type": "GENE", "description": "SULT1A1 is a gene that encodes for sulfotransferase family 1A member 1 protein.<SEP>SULT1A1 is a gene that was analyzed for variants.", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5<SEP>chunk-607feda7df4db8151b99560074c91eea", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "SULT1A1"}, {"entity_type": "PROTEIN", "description": "RPS19 encodes a ribosomal protein essential for ribosome biogenesis.<SEP>SULT1A1 protein is encoded by the SULT1A1 gene and plays a role in sulfation reactions.", "source_id": "chunk-607feda7df4db8151b99560074c91eea<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "PROTEIN"}, {"entity_type": "GENE", "description": "SULT1A2 is a gene encoding for sulfotransferase family 1A member 2 protein.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 101}]", "id": "SULT1A2"}, {"entity_type": "GENE", "description": "TUFM is a gene involved in translation elongation.<SEP>TUFM is a gene that contains five variants affecting splicing regulator or transcription factor binding sites.<SEP>TUFM is a gene.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455<SEP>chunk-607feda7df4db8151b99560074c91eea", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 129}]", "id": "TUFM"}, {"entity_type": "OBESITY", "description": "Obesity is a complex condition influenced by genetic and environmental factors.", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "id": "ENVIRONMENTAL FACTOR"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant identified as rs61737565. It affects splicing regulator or transcription factor binding sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 129}]", "id": "RS61737565"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant identified as rs8061877. It disrupts a transcription factor binding site.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 129}]", "id": "RS8061877"}, {"entity_type": "GENOMIC VARIANT", "description": "A previously unknown variant g.28854194C/G affecting splice enhancer and silencer sites.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 129}]", "id": "G.28854194C/G"}, {"entity_type": "TABLE", "description": "S1 Table is a supplementary table containing information about the variants in TUFM.", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "id": "S1 TABLE"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "The genomic variant rs142786317 affects the transcript of the SULT1A1 gene.)", "entity_type": "UNKNOWN", "id": "SULT1A1 TRANSCRIPT"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "SNP rs145008170 is located near Lys48, which is crucial for p-nitrophenol binding in SULT1A2.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 101}]", "id": "RS145008170"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "SNP rs4987024 causes a Tyr62Phe amino acid change in the SULT1A2 protein.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 101}]", "id": "RS4987024"}, {"source_id": "chunk-607feda7df4db8151b99560074c91eea", "description": "SNP rs142241142 results in an Ala164Val amino acid change in the SULT1A2 protein.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 101}]", "id": "RS142241142"}, {"entity_type": "GENE", "description": "ALOX5 is a gene involved in arachidonate 5-lipoxygenase pathway.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "ALOX5"}, {"entity_type": "PROTEIN", "description": "Arachidonate 5-lipoxygenase is an enzyme involved in the production of leukotrienes and lipoxins, which are inflammatory mediators.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ARACHIDONATE 5-LIPOOXYGENASE"}, {"entity_type": "GENE", "description": "CCL2 is a gene that encodes for chemokine CCL2.<SEP>CCL2 is a gene whose SNPs were not associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "CCL2"}, {"entity_type": "GENE", "description": "IL18 is a gene involved in the inflammatory response.<SEP>IL18 is a gene whose SNPs were not associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL18"}, {"entity_type": "GENE", "description": "IL1A is a gene encoding for interleukin 1 alpha, a pro-inflammatory cytokine.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1A"}, {"entity_type": "GENE", "description": "IL1B is a gene encoding for interleukin 1 beta, another pro-inflammatory cytokine.<SEP>Il1b encodes interleukin 1 beta, a pro-inflammatory cytokine.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "IL1B"}, {"entity_type": "GENE", "description": "IL6 is a gene that encodes for interleukin 6, a cytokine involved in inflammation and immune response.<SEP>IL6 is a gene whose SNPs were not associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL6"}, {"entity_type": "GENE", "description": "NOS3 is a gene encoding for nitric oxide synthase 3, an enzyme that produces nitric oxide.<SEP>NOS3 is a gene involved in folate metabolism and associated with childhood ALL risk.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "NOS3"}, {"entity_type": "GENE", "description": "PTGS1 is a gene encoding prostaglandin-endoperoxide synthase 1, also known as COX-1.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "PTGS1"}, {"entity_type": "GENOMIC VARIANT", "description": "IL1A rs17561 is a missense variant in the IL1A gene that associates with decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "IL1A RS17561"}, {"entity_type": "GENOMIC VARIANT", "description": "ALOX5 rs1864414 is a SNP in the ALOX5 gene associated with decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "ALOX5 RS1864414"}, {"entity_type": "GENOMIC VARIANT", "description": "NOS3 rs743507 is a SNP in the NOS3 gene associated with decreased risk of ovarian cancer.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "NOS3 RS743507"}, {"entity_type": "GENE", "description": "POL is a gene involved in DNA replication and repair.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "POL"}, {"entity_type": "GENE", "description": "IL10 is a gene encoding for interleukin 10, an anti-inflammatory cytokine.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL10"}, {"entity_type": "GENE", "description": "IL15RA is a gene encoding the interleukin 15 receptor alpha chain, involved in immune cell development and function.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL15RA"}, {"entity_type": "GENE", "description": "IL1RN is a gene encoding for interleukin 1 receptor antagonist, which inhibits the effects of IL-1.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL1RN"}, {"entity_type": "GENE", "description": "IL4R is a gene encoding the interleukin 4 receptor, involved in immune responses and allergic reactions.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL4R"}, {"entity_type": "GENE", "description": "IL7R is a gene encoding the interleukin 7 receptor, involved in T cell development and survival.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL7R"}, {"entity_type": "GENE", "description": "IL8RA is a gene encoding the interleukin 8 receptor A, involved in inflammatory responses.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL8RA"}, {"entity_type": "GENE", "description": "IL8RB is a gene encoding the interleukin 8 receptor B, also involved in inflammatory responses.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL8RB"}, {"entity_type": "GENE", "description": "IL9 is a gene encoding interleukin 9, which plays a role in immune regulation and allergic inflammation.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "IL9"}, {"entity_type": "GENE", "description": "PTGS2 is a gene encoding prostaglandin-endoperoxide synthase 2, also known as COX-2.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "PTGS2"}, {"entity_type": "GENE", "description": "TLR2 is a gene encoding Toll-like receptor 2, involved in recognizing pathogen-associated molecular patterns.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "id": "TLR2"}, {"entity_type": "CYTOKINE", "description": "TNF is a gene encoding tumor necrosis factor, a pro-inflammatory cytokine.<SEP>TNF is a proinflammatory cytokine produced by adipocytes and other cells.", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "TNF"}, {"entity_type": "GENE", "description": "IL1B is a gene that encodes the interleukin 1, beta protein.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "IL1B (INTERLEUKIN 1, BETA)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7596684 is a genomic variant in the IL1B gene associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "RS7596684"}, {"entity_type": "GENE", "description": "PTGS1 is a gene that encodes the prostaglandin-endoperoxide synthase 1 protein.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 77}]", "id": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2282169 is a genomic variant in the PTGS1 gene associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 77}]", "id": "RS2282169"}, {"entity_type": "GENE", "description": "ALOX15 is a gene whose SNPs were not associated with ovarian cancer risk.", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "id": "ALOX15"}, {"entity_type": "DISEASE", "description": "Ovarian cancer is a malignant tumor that arises in the ovaries.<SEP>Ovarian cancer is a type of cancer affecting the ovaries.<SEP>Ovarian cancer is a type of malignant tumor that arises in the ovaries.<SEP>Ovarian cancer is a type of cancer that affects the ovaries.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "OVARIAN CANCER"}, {"entity_type": "GENE", "description": "MTHFD2 is a gene involved in folate metabolism.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "MTHFD2"}, {"entity_type": "GENE", "description": "BHMT2 is a gene involved in folate metabolism.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "BHMT2"}, {"entity_type": "GENE", "description": "SLC19A1 is a gene involved in folate metabolism and associated with childhood ALL risk.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "SLC19A1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3918186 is a SNP in the NOS3 gene, associated with increased risk of childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "RS3918186"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1051266 is a SNP in the SLC19A1 gene, associated with increased risk of childhood ALL.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "RS1051266"}, {"entity_type": "DISEASE", "description": "Childhood Acute Lymphoblastic Leukemia (ALL) is a type of cancer affecting children.", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 75}]", "id": "CHILDHOOD ALL"}, {"entity_type": "GENE", "description": "The FADS1/2 gene cluster is involved in fatty acid metabolism.<SEP>The FADS1/2 gene cluster plays a role in fatty acid metabolism.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "clusters": "[{level: 0, cluster: 30}]", "id": "FADS1/2"}, {"entity_type": "DIETARY PATTERN", "description": "Healthy Eating refers to a dietary pattern characterized by reduced intake of saturated fats and increased intake of long chain n-3 fatty acids.<SEP>The Healthy Eating diet emphasizes whole grains, fruits, vegetables, and lean protein.<SEP>The Healthy Eating diet is a dietary pattern that emphasizes whole grains, fruits, vegetables, and lean protein.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "clusters": "[{level: 0, cluster: 30}]", "id": "HEALTHY EATING"}, {"entity_type": "NUTRIENT", "description": "AA is an omega-6 fatty acid found in the blood and colonic mucosa.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "AA (ARACHIDONIC ACID)"}, {"entity_type": "NUTRIENT", "description": "EPA is an omega-3 fatty acid found in the blood and colonic mucosa.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "EPA (EICOSAPENTAENOIC ACID)"}, {"entity_type": "NUTRIENT", "description": "DHA is an omega-3 fatty acid found in the blood and colonic mucosa.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "DHA (DOCOSAHEXAENOIC ACID)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "BMI is a measure of body fat based on height and weight.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "BMI (BODY MASS INDEX)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum fatty acids are measured levels of different types of fatty acids circulating in the blood.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 162}]", "id": "SERUM FATTY ACIDS"}, {"entity_type": "NUTRIENT", "description": "Saturated fats are a type of dietary fat that is solid at room temperature.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "SATURATED FATS (SFA)"}, {"entity_type": "NUTRIENT", "description": "Monounsaturated fats are a type of dietary fat that is liquid at room temperature and generally considered heart-healthy.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "id": "MONOUNSATURATED FATS (MUFA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "This ratio is used to assess the balance between healthy and unhealthy fats in the diet.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 30}]", "id": "POLYUNSATURATED FAT: SATURATED FAT RATIO"}, {"entity_type": "NUTRIENT", "description": "n-6 Polyunsaturated fatty acids are essential fats that play a role in various bodily functions.", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "clusters": "[{level: 0, cluster: 30}]", "id": "N-6 PUFA"}, {"entity_type": "GENOMIC VARIANT", "description": "AA genotype of rs1695 polymorphism<SEP>AA refers to arachidonic acid, a polyunsaturated fatty acid.<SEP>The AA genotype of the ALDH2 rs671 variant is associated with the lowest mean daily alcohol consumption.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AA"}, {"entity_type": "METABOLIC PATHWAY", "description": "20:4 n-6 is an omega-6 fatty acid with 20 carbon atoms and 4 double bonds.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "20:4 N-6"}, {"entity_type": "BODY FLUID", "description": "Serum is the liquid portion of blood, often used in laboratory tests.<SEP>Serum refers to the liquid part of blood that carries nutrients, hormones, and other substances.<SEP>The liquid component of blood.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8<SEP>chunk-e1b4f4dac52e806f19c580640a50c729", "id": "SERUM"}, {"entity_type": "TISSUE", "description": "The colon is a part of the digestive system responsible for absorbing water and electrolytes from undigested food.<SEP>The colon is the final section of the digestive tract.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "COLON"}, {"entity_type": "NUTRIENT", "description": "Polyunsaturated fat is a type of fat that contains multiple double bonds in its fatty acid chains.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "POLYUNSATURATED FAT"}, {"entity_type": "NUTRIENT", "description": "Saturated fat is a type of fat where all carbon atoms are bonded to the maximum number of hydrogen atoms.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "SATURATED FAT"}, {"entity_type": "METABOLIC PATHWAY", "description": "MUFA refers to monounsaturated fatty acid, which has one double bond in its fatty acid chain.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "clusters": "[{level: 0, cluster: 30}]", "id": "MUFA"}, {"entity_type": "METABOLIC PATHWAY", "description": "n-3 PUFA refers to omega-3 polyunsaturated fatty acids, known for their health benefits.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "id": "N-3 PUFA"}, {"entity_type": "GENOMIC VARIANT", "description": "A minor allele is a less common variant form of a gene.<SEP>The minor allele refers to the less frequent variant of a genetic marker (like a SNP) within a population.<SEP>A minor allele is a variant form of a gene that occurs less frequently in a population.", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729<SEP>chunk-b803830d07bff8ae14550f6458048707<SEP>chunk-f05ecc979eea31a1ab844c2c7de12432", "id": "MINOR ALLELE"}, {"source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf<SEP>chunk-8b9890cf10c4a751a1d0ec7e9843002d<SEP>chunk-54c4fede216a6c4183b95ee1a2edcb17<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "description": "A principle describing the theoretical distribution of allele frequencies in a population.<SEP>Hardy-Weinberg Equilibrium is a principle in genetics that describes the theoretical distribution of allele frequencies in a population.<SEP>Hardy-Weinberg equilibrium describes the distribution of allele frequencies in a population that is not evolving.<SEP>Hardy-Weinberg equilibrium describes the expected distribution of allele frequencies in a population under specific conditions.<SEP>The genotype distribution for each SNP did not deviate from Hardy-Weinberg equilibrium.)<SEP>Hardy-Weinberg equilibrium describes the expected distribution of alleles in a population.<SEP>Hardy-Weinberg equilibrium describes the expected genotype frequencies in a population that is not evolving.", "entity_type": "STATISTICAL CONCEPT", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 161}]", "id": "HARDY-WEINBERG EQUILIBRIUM"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "The Healthy Eating group showed a significant increase in long chain n-3 PUFA intake after 6 months.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 30}]", "id": "LONG CHAIN N-3 PUFA"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "A greater number of minor alleles was significantly associated with lower AA concentration in serum.)", "entity_type": "UNKNOWN", "id": "AA CONCENTRATION"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "A greater number of minor alleles was significantly associated with lower AA concentration in serum.)", "entity_type": "UNKNOWN", "id": "NUMBER OF MINOR ALLELES"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "There was no significant association of genotype with EPA nor with long chain n-3 fatty acids (the sum of EPA and DHA).)", "entity_type": "UNKNOWN", "id": "EPA CONCENTRATION"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "There was no significant association of genotype with EPA nor with long chain n-3 fatty acids (the sum of EPA and DHA).)", "entity_type": "UNKNOWN", "id": "DHA CONCENTRATION"}, {"source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "description": "The Healthy Eating group showed a significant reduction in SFA intake after 6 months.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 30}]", "id": "SFA"}, {"entity_type": "DISEASE", "description": "A condition characterized by noisy breathing during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "SNORING"}, {"entity_type": "DISEASE", "description": "A sleep disorder characterized by repeated pauses in breathing during sleep.", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "SLEEP APNOEA"}, {"entity_type": "GENE", "description": "DLEU7 (Deleted in Liver Cancer 7) is a gene involved in cell cycle regulation and apoptosis.<SEP>DLEU7 is a gene on chromosome 13 that has been associated with snoring and other traits.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "DLEU7"}, {"entity_type": "GENE", "description": "MSRB3 is a gene on chromosome 12 that has been associated with snoring and other traits.<SEP>MSRB3 is a gene.<SEP>Methionine Sulfoxide Reductase B3 (MSRB3) is a gene involved in oxidative stress response.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MSRB3"}, {"entity_type": "GENE", "description": "BCL11B is a gene previously associated with smoking, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BCL11B"}, {"entity_type": "GENE", "description": "SMG6 is a gene previously associated with smoking and snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SMG6"}, {"entity_type": "GENE", "description": "ROBO2 is a gene previously associated with chronotype and snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ROBO2"}, {"entity_type": "GENE", "description": "NSUN3 is a gene previously associated with smoking, alcohol consumption, and snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "NSUN3"}, {"entity_type": "GENE", "description": "SNAP91 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SNAP91"}, {"entity_type": "GENE", "description": "BLC11B is a gene previously associated with smoking, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BLC11B"}, {"entity_type": "GENE", "description": "RNA5SP471 is a gene previously associated with alcohol consumption and narcolepsy.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "RNA5SP471"}, {"entity_type": "GENE", "description": "SND1 is a gene previously associated with alcohol consumption, coffee consumption, and snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SND1"}, {"entity_type": "GENE", "description": "LMO4 is a gene previously associated with insomnia.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "LMO4"}, {"entity_type": "GENE", "description": "ANAPC4 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "ANAPC4"}, {"entity_type": "GENE", "description": "SIM1 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "SIM1"}, {"entity_type": "GENE", "description": "KCNQ5 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "KCNQ5"}, {"entity_type": "GENE", "description": "CEP120 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "CEP120"}, {"entity_type": "GENE", "description": "MACF1 is a gene previously associated with musculoskeletal traits such as height and heel bone mineral density, as well as snoring.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MACF1"}, {"entity_type": "PHENOTYPE", "description": "The force exerted by circulating blood against artery walls.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "BLOOD PRESSURE"}, {"entity_type": "PHENOTYPE", "description": "The number of heartbeats per minute.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "PULSE RATE"}, {"entity_type": "PHENOTYPE", "description": "The total amount of fat in the body.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "WHOLE-BODY FAT MASS"}, {"entity_type": "DISEASE", "description": "A broad term encompassing various conditions affecting the coronary arteries.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "MAJOR CORONARY HEART DISEASE"}, {"entity_type": "DISEASE", "description": "A sudden blockage of blood flow to the heart muscle.", "source_id": "chunk-13862d7ab74f5d4fa3f2261984d15d64", "id": "HEART ATTACK"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant identified through GWAS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "RS199797821"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant identified through GWAS.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "RS200391180"}, {"entity_type": "SEX", "description": "Biological sex characterized by male chromosomes.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "MALE SEX"}, {"entity_type": "SEX", "description": "Biological sex characterized by female chromosomes.", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "FEMALE SEX"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-9977706363cc368b3be503d07ed3ef62<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "description": "Males are at a higher risk of snoring than females.)<SEP>Sex refers to biological differences between males and females.<SEP>The biological sex of an individual, typically categorized as male or female.", "entity_type": "PHYSIOLOGICAL PROCESS", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "SEX"}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Smoking frequency is positively correlated with snoring prevalence in females and to a lesser extent in males.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "SMOKING FREQUENCY"}, {"source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "description": "Alcohol consumption frequency is associated with snoring in males and to a lesser extent in females.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 104}, {level: 2, cluster: 156}]", "id": "ALCOHOL CONSUMPTION FREQUENCY"}, {"entity_type": "GENE", "description": "VDBP is a gene that encodes for Vitamin D binding protein.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VDBP"}, {"entity_type": "PROTEIN", "description": "Vitamin D binding protein is a protein that binds and transports vitamin D in the bloodstream.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "VITAMIN D BINDING PROTEIN (VDBP)"}, {"entity_type": "NUTRIENT", "description": "25-hydroxyvitamin D is a form of vitamin D found in the blood and is often used as an indicator of vitamin D status.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "25-HYDROXYVITAMIN D (25(OH)D)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2298850 is a single nucleotide polymorphism (SNP) within the VDBP gene.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "RS2298850"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4588 is a single nucleotide polymorphism (SNP) within the VDBP gene.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "RS4588"}, {"entity_type": "PHYSIOLOGICAL CHARACTERISTIC", "description": "Maternal height refers to the physical stature of the mother.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "MATERNAL HEIGHT"}, {"entity_type": "PHYSIOLOGICAL CHARACTERISTIC", "description": "Pre-pregnancy BMI is a measure of body mass index before conception.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "BMI PRE-PREGNANCY"}, {"entity_type": "PHYSIOLOGICAL CHARACTERISTIC", "description": "Terminal BMI refers to the body mass index at the end of pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "BMI TERMINAL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Ultraviolet B (UVB) radiation is a type of ultraviolet light that plays a role in vitamin D synthesis.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "UVB"}, {"entity_type": "PHYSIOLOGICAL CHARACTERISTIC", "description": "Weeks of gestation refer to the duration of pregnancy.", "source_id": "chunk-617cab4d8c10048a1335bf565693bf97", "id": "WEEKS OF GESTATION"}, {"entity_type": "GENE", "description": "VEGFA is a gene that encodes vascular endothelial growth factor.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "VEGFA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3025020 is a SNP in the VEGFA gene located at position -583.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS3025020"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2010963 is a SNP in the VEGFA gene located at position -634.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "RS2010963"}, {"entity_type": "DISEASE", "description": "Polycystic ovary syndrome (PCOS) is a hormonal disorder affecting women of reproductive age.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "PCOS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "hs-CRP is a marker of inflammation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "HS-CRP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "ESR is a measure of inflammation.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "ERYTHROCYTE SEDIMENTATION RATE (ESR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Waist-hip ratio is a measure of abdominal obesity.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "WAIST-HIP RATIO"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lipid profile refers to the levels of cholesterol, triglycerides, and other fats in the blood.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LIPID PROFILE"}, {"entity_type": "HORMONE", "description": "Total testosterone is a male sex hormone.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TOTAL TESTOSTERONE"}, {"entity_type": "HORMONE", "description": "LH is a hormone involved in ovulation and testosterone production.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "LH (LUTEINIZING HORMONE)"}, {"entity_type": "HORMONE", "description": "FSH is a hormone that stimulates the growth of ovarian follicles.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FSH (FOLLICLE-STIMULATING HORMONE)"}, {"entity_type": "HORMONE", "description": "Free testosterone refers to the unbound testosterone in the blood.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "FREE TESTOSTERONE"}, {"entity_type": "HORMONE", "description": "Bioactive testosterone refers to the active form of testosterone.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "BIOACTIVE TESTOSTERONE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Free androgen index (FAI) measures the ratio of free testosterone to total testosterone.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "ANDROGEN INDEX (FAI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HOMA-IR is an index used to estimate insulin resistance.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "HOMA-IR (HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE)"}, {"entity_type": "PROTEIN", "description": "SHBG is a protein that binds to sex hormones, such as testosterone.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "SHBG (SEX HORMONE BINDING GLOBULIN)"}, {"entity_type": "HORMONE", "description": "TSH is a hormone produced by the pituitary gland that stimulates the thyroid gland.", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "id": "TSH (THYROID STIMULATING HORMONE)"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "Carriage of the minor (C) allele of rs3025020 was associated with increased VEGF serum levels.)", "entity_type": "UNKNOWN", "id": "VEGF SERUM LEVELS"}, {"source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "description": "The presence of the minor allele (C) of rs2010963 was negatively associated with erythrocyte sedimentation rate (ESR).)", "entity_type": "UNKNOWN", "id": "ESR"}, {"entity_type": "GENOTYPE", "description": "Individuals with a val allele.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "VAL CARRIER"}, {"entity_type": "GENOTYPE", "description": "Individuals with two iso alleles.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "ISO HOMOZYGOTE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic variant called the val allele is associated with reduced response bias in a stress condition.<SEP>A variant allele associated with a specific trait or condition.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "VAL ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A common allele found in a population.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "ISO ALLELE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The tendency of participants to respond in a particular way, potentially influenced by various factors.<SEP>The tendency to favor certain responses based on learned associations with rewards and punishments.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b<SEP>chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "RESPONSE BIAS"}, {"entity_type": "STIMULUS", "description": "The strength or magnitude of an electrical shock administered.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SHOCK INTENSITY"}, {"entity_type": "PSYCHOLOGICAL MEASURE", "description": "Scores on the State-Trait Anxiety Inventory, measuring anxiety levels.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "STAI SCORES"}, {"entity_type": "PSYCHOLOGICAL MEASURE", "description": "Scores on the Positive and Negative Affect Schedule - Negative Affect subscale, measuring negative emotions.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "PANAS NA"}, {"entity_type": "BEHAVIORAL RESPONSE", "description": "Specific criterion responses, potentially indicative of physiological or psychological changes.", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "id": "SC RESPONSES"}, {"entity_type": "GENOMIC VARIANT", "description": "Individuals homozygous for the iso allele.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "ISO HOMOZYGOTES"}, {"entity_type": "EXPERIMENTAL DESIGN", "description": "A task designed to measure participants\' learning and decision-making under uncertainty.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "PROBABILISTIC REWARD TASK"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A controlled experimental condition designed to induce physiological and psychological stress.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "STRESS CONDITION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A controlled experimental condition designed to minimize physiological and psychological stress.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "NO-STRESS CONDITION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Changes in skin conductance, reflecting sympathetic nervous system activity.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "SKIN CONDUCTANCE RESPONSES"}, {"entity_type": "COGNITIVE PROCESS", "description": "The ability to differentiate between stimuli.", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "id": "DISCRIMINABILITY"}, {"source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "description": "STAI scores significantly increased over time in both the stress and no-stress conditions.)", "entity_type": "UNKNOWN", "id": "TIME"}, {"source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "description": "Discrimination was measured to control for potential confounding factors in the analysis.)", "entity_type": "UNKNOWN", "id": "CONTROL ANALYSES"}, {"entity_type": "GENE", "description": "BMP4 is a gene associated with height and \'Number of teeth\'.<SEP>BMP4 is a gene.<SEP>Bone Morphogenetic Protein 4 (BMP4) is a gene involved in growth and development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1<SEP>chunk-c63d60b991cd7442f690dcc364af47dd", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "BMP4"}, {"entity_type": "GENE", "description": "Calcium Voltage-Gated Channel Subunit Beta 2 (CACNB2) is a gene that encodes a protein involved in neuronal function.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CACNB2"}, {"entity_type": "GENE", "description": "Cell adhesion molecule with Down syndrome-related homology (CDON) is a gene involved in cell signaling.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CDON"}, {"entity_type": "GENE", "description": "Calu (CALU) and Olfactory Pigment 1 Short Wavelength (OPN1SW) are genes involved in vision and olfactory perception.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "CALU/OPN1SW"}, {"entity_type": "GENE", "description": "Ajuba (AJUBA) and Chromosome 14 Open Reading Frame 93 (C14orf93) are genes with diverse functions.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "AJUBA/C14ORF93"}, {"entity_type": "GENE", "description": "ADK is a gene.<SEP>Adenylate Kinase (ADK) is a gene involved in energy metabolism.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "ADK"}, {"entity_type": "GENE", "description": "Texin 14 (TEX14) and RAD51 Homologous Recombination Protein C (RAD51C) are genes involved in DNA repair and cell cycle regulation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "TEX14/RAD51C"}, {"entity_type": "GENE", "description": "KCNJ2 is a gene.<SEP>Potassium Voltage-Gated Channel Subfamily J Member 2 (KCNJ2) is a gene involved in regulating electrical activity of cells.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ2"}, {"entity_type": "GENE", "description": "IGF2BP1 is a gene.<SEP>Insulin-like Growth Factor 2 Binding Protein 1 (IGF2BP1) is a gene involved in mRNA stability and translation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "IGF2BP1"}, {"entity_type": "GENE", "description": "Ectodysplasin A (EDA) is a gene involved in embryonic development, particularly tooth and skin formation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "EDA"}, {"entity_type": "GENE", "description": "RAD51 Homologous Recombination Protein Like 1 (RAD51L1) is a gene involved in DNA repair.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RAD51L1"}, {"entity_type": "GENE", "description": "Paired box gene 9 (PAX9) is a transcription factor crucial for tooth development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "PAX9"}, {"entity_type": "GENE", "description": "Msx homeobox 1 (MSX1) is a gene involved in tooth development and patterning.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "MSX1"}, {"entity_type": "GENE", "description": "Runt-related transcription factor 2 (RUNX2) plays a key role in bone and tooth development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "RUNX2"}, {"entity_type": "GENE", "description": "Sonic Hedgehog (SHH) is a signaling molecule crucial for various developmental processes, including tooth formation.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "SHH"}, {"entity_type": "GENE", "description": "Wingless-type MMTV integration site family member 2B (WNT2B) is involved in cell signaling pathways essential for tooth development.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "WNT2B"}, {"entity_type": "GENE", "description": "Fibroblast growth factor 8 (FGF8) is a signaling molecule critical for tooth development and branching morphogenesis.", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "id": "FGF8"}, {"entity_type": "GENE", "description": "KCNJ160 is a gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "KCNJ160"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2520397 is a genomic variant in the FAM155E\u2013EDA gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2520397"}, {"entity_type": "GENE", "description": "FAM155E\u2013EDA is a gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "FAM155E\u2013EDA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1951867 is a genomic variant in the BMP4 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1951867"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1472259 is a genomic variant in the HMGA2 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1472259"}, {"entity_type": "GENOMIC VARIANT", "description": "rs8069452 is a genomic variant in the IGF2BP1 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS8069452"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9788982 is a genomic variant in the KCNJ2 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9788982"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2804391 is a genomic variant in the FAM155E\u2013EDA gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS2804391"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1458991 is a genomic variant in the BMP4 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1458991"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9894411 is a genomic variant in the IGF2BP1 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS9894411"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1976274 is a genomic variant in the MSRB3 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS1976274"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17101923 is a genomic variant in the HMGA2 gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 125}]", "id": "RS17101923"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7924176 is a genomic variant in the ADK gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS7924176"}, {"entity_type": "GENE", "description": "AJUBA is a gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "AJUBA"}, {"entity_type": "GENOMIC VARIANT", "description": "rs997154 is a genomic variant in the AJUBA gene.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "RS997154"}, {"entity_type": "DATASET", "description": "ALSPAC is a large-scale population-based cohort study of pregnancy and childhood development.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "ALSPAC"}, {"entity_type": "DATASET", "description": "NFBC1966 is a birth cohort study in Finland.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "NFBC1966"}, {"entity_type": "CONSORTIUM", "description": "The Lango Allen et al. Giant Consortium conducted a meta-analysis on height.", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "id": "LANGO ALLEN ET AL. GIANT CONSORTIUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Age at first tooth is a physiological process influenced by genetic variants.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "AGE AT FIRST TOOTH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Number of teeth is a physiological process influenced by genetic variants.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "NUMBER OF TEETH"}, {"entity_type": "SOFTWARE", "description": "ALLIGATOR is a software used for pathway analysis.", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "id": "ALLIGATOR"}, {"entity_type": "STUDY TYPE", "description": "A Genome-Wide Association Study (GWAS) investigates associations between genetic variations and traits.<SEP>GWAS stands for Genome-Wide Association Study.<SEP>Genome-wide association studies (GWAS) are used to identify genetic variants associated with traits.<SEP>Genome-Wide Association Study (GWAS) is a research method used to identify genetic variations associated with diseases or traits.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "GWAS"}, {"entity_type": "GENOMIC VARIANT", "description": "SNPs (Single Nucleotide Polymorphisms) are variations in a single nucleotide within a DNA sequence.<SEP>SNPs are Single Nucleotide Polymorphisms, variations in a single nucleotide of DNA.<SEP>SNPs are genetic variants that can influence the abundance of bacterial taxa in the gut.<SEP>Single Nucleotide Polymorphisms (SNPs) are common genetic variations.<SEP>Single Nucleotide Polymorphisms (SNPs) are common variations in DNA sequences.<SEP>Single Nucleotide Polymorphisms (SNPs) are variations in a single nucleotide within a DNA sequence.<SEP>Single nucleotide polymorphisms (SNPs) are variations in a single nucleotide within the DNA sequence.<SEP>SNPs are single nucleotide polymorphisms, which are variations in a single DNA building block.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-c63d60b991cd7442f690dcc364af47dd<SEP>chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-7efd4f037425eeac77e329347b16beb2", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "SNPS"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs17563 is located within the BMP4 gene.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "RS17563"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs10740993 is located within the CACNB2 gene.)", "entity_type": "UNKNOWN", "id": "RS10740993"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs4937076 is located within the CDON gene.)", "entity_type": "UNKNOWN", "id": "RS4937076"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs1799922 is located within the CALU/OPN1SW gene.)", "entity_type": "UNKNOWN", "id": "RS1799922"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs412000 is located within the TEX14/RAD51C gene.)", "entity_type": "UNKNOWN", "id": "RS412000"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs9316505 is located within the DLEU7 gene.)", "entity_type": "UNKNOWN", "id": "RS9316505"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs11077486 is located within the KCNJ2 gene.)", "entity_type": "UNKNOWN", "id": "RS11077486"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs17105278 is located within the RAD51L1 gene.)", "entity_type": "UNKNOWN", "id": "RS17105278"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs145738267 is located within the PAX9 gene.)", "entity_type": "UNKNOWN", "id": "RS145738267"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs10493984 is located within the MSX1 gene.)", "entity_type": "UNKNOWN", "id": "RS10493984"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs11706489 is located within the RUNX2 gene.)", "entity_type": "UNKNOWN", "id": "RS11706489"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs54810367 is located within the SHH gene.)", "entity_type": "UNKNOWN", "id": "RS54810367"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs10835967 is located within the WNT2B gene.)", "entity_type": "UNKNOWN", "id": "RS10835967"}, {"source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "description": "SNP rs11370467 is located within the FGF8 gene.)", "entity_type": "UNKNOWN", "id": "RS11370467"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs1351394 is a SNP in HMGA2 associated with both age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 125}]", "id": "RS1351394"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs12534093 is a SNP in IGF2BP3 associated with age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "id": "IGF2BP3"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs12534093 is a SNP in IGF2BP3 associated with age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "id": "RS12534093"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs1490384 near C6orf173 is associated with age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "id": "C6ORF173"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs1490384 near C6orf173 is associated with age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "id": "RS1490384"}, {"source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "description": "rs1570106 in RAD51L1 is associated with age at first tooth and number of teeth.)", "entity_type": "UNKNOWN", "id": "RS1570106"}, {"entity_type": "CYTOKINE", "description": "IL-10 (Interleukin 10) is an immunosuppressive cytokine.<SEP>IL-10 is a cytokine produced by various immune cells.<SEP>IL-10 is an anti-inflammatory cytokine that suppresses immune responses.<SEP>Interleukin-10 (IL-10) is a cytokine with immunosuppressive effects.<SEP>Interleukin-10 is a cytokine with immunoregulatory properties.<SEP>IL-10 is a gene that encodes for interleukin-10, an anti-inflammatory cytokine.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 163}]", "id": "IL-10"}, {"entity_type": "GENOMIC VARIANT", "description": "IL-10 receptor alpha is a gene that encodes the IL-10 receptor.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391"}, {"entity_type": "CELL TYPE", "description": "T cells are a type of immune cell that play a role in adaptive immunity.<SEP>T cells are lymphocytes involved in cell-mediated immunity.<SEP>T cells are lymphocytes that play a crucial role in adaptive immunity.<SEP>T lymphocytes, also known as T cells, are immune cells crucial for adaptive immunity.<SEP>T cells are lymphocytes involved in adaptive immunity.<SEP>T cells are immune cells that can mount a response against cancer.", "source_id": "chunk-614333487e4b92705503909d34155179<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 65}]", "id": "T CELL"}, {"entity_type": "PROTEIN", "description": "CD4+ T cells are a type of immune cell that play a role in the adaptive immune response.<SEP>CD4+ refers to a subtype of T cells that express the CD4 antigen on their surface.<SEP>CD4+ is a surface marker found on helper T cells and regulatory T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD4+"}, {"entity_type": "GENOMIC VARIANT", "description": "CD25 is a protein marker expressed by activated T cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD25\u2212"}, {"entity_type": "GENOMIC VARIANT", "description": "CD45RB is a protein found on T cells, with higher expression in naive T cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "CD45RBHI"}, {"entity_type": "GENOMIC VARIANT", "description": "Rag1 knockout mice lack functional recombination-activating genes 1 and are immunodeficient.<SEP>Rag1\u2212/\u2212 mice are genetically engineered to lack the Rag1 gene, resulting in a deficiency of T and B lymphocytes. This model is used to study immune responses.<SEP>Rag1\u2212/\u2212 mice lack functional RAG1 gene, resulting in severe combined immunodeficiency (SCID).<SEP>This refers to a genetically modified mouse model lacking the Rag1 gene, resulting in a severe immunodeficiency.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "RAG1\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "Abbreviation for macrophage used in the text.<SEP>Macrophages (M\u03a6s) are phagocytic immune cells involved in inflammation.<SEP>M\u03d5s are macrophages.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "M\u03a6"}, {"entity_type": "PROTEIN", "description": "Dendritic Cells (DCs) are antigen-presenting cells that initiate immune responses.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "DC"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice with a deletion of the IL-10 receptor alpha specifically in dendritic cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "IL-10R\u0391DCDEL"}, {"entity_type": "GENOMIC VARIANT", "description": "IL-10 receptor alpha Mdel is a variant of the IL-10 receptor gene.<SEP>IL-10R\u03b1Mdel is a genetic modification that deletes the IL-10 receptor alpha chain.<SEP>Mice with a deletion of the IL-10 receptor alpha specifically in macrophages.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "IL-10R\u0391MDEL"}, {"entity_type": "DISEASE", "description": "Dextran sodium sulfate (DSS) induced colitis is a model of acute inflammatory bowel disease.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "DSS COLITIS"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease characterized by inflammation of the colon.<SEP>Colitis is an inflammatory bowel disease affecting the colon.<SEP>Colitis is an inflammatory disease of the colon.<SEP>Inflammatory bowel disease, characterized by chronic inflammation in the colon.<SEP>Colitis is inflammation of the colon.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "COLITIS"}, {"entity_type": "DISEASE", "description": "A mouse model of colitis induced by transferring T cells from donor mice into immunodeficient recipients.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "T CELL TRANSFER COLITIS"}, {"entity_type": "PROTEIN", "description": "Helper T cells type 1 are pro-inflammatory immune cells.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "TH1"}, {"entity_type": "CELL TYPE", "description": "Helper T cells type 17 promote inflammation and tissue damage.<SEP>Th17 cells are a type of T helper cell that contribute to inflammation.<SEP>Th17 cells are a type of immune cell that play a role in autoimmune inflammation.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "TH17"}, {"entity_type": "PROTEIN", "description": "Regulatory T cells expressing Foxp3, which suppress immune responses.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "FOXP3+"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Examination of tissue samples to identify abnormalities and disease.<SEP>Examination of tissue samples under a microscope to identify abnormalities.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "HISTOPATHOLOGY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Migration of T cells into the colon, indicating immune activation.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "COLONIC T CELL INFILTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Swelling in the layer beneath the colon\'s inner lining.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "SUBMUCOSAL EDEMA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Damage to the surface lining of the colon.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "EPITHELIAL EROSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Removal of neutrophils from the body using antibodies.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "id": "NEUTROPHIL DEPLETION"}, {"entity_type": "GENOMIC VARIANT", "description": "CX3CR1 is a gene that encodes a chemokine receptor expressed on various immune cells, including macrophages.", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 88}]", "id": "CX3CR1"}, {"entity_type": "IMMUNE CELL", "description": "Neutrophils are a type of white blood cell.<SEP>Neutrophils are immune cells that fight infection.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "NEUTROPHILS"}, {"entity_type": "CELL TYPE", "description": "LPM\u03d5s (lamina propria macrophages) are a specific type of macrophage found in the lamina propria of the intestines.<SEP>LPM\u03d5s stand for lamina propria macrophages, a subtype of macrophages found in the intestinal mucosa.<SEP>Lung-resident macrophages (LPM\u03d5s) are a specialized type of macrophage found in the lungs.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "LPM\u03a6S"}, {"entity_type": "PROTEIN", "description": "CD11b is a cell surface marker typically expressed on myeloid cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD11BHI"}, {"entity_type": "PROTEIN", "description": "CD11c is a cell surface marker often found on dendritic cells and some macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD11C\u2212/LO/MOD"}, {"entity_type": "PROTEIN", "description": "F4/80 is a protein marker commonly used to identify macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "F4/80+"}, {"entity_type": "PROTEIN", "description": "Ly6G is a protein marker expressed on neutrophils.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6G\u2212/LO"}, {"entity_type": "PROTEIN", "description": "SiglecF is a protein marker typically found on eosinophils and some alveolar macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "SIGLECF\u2212"}, {"entity_type": "PROTEIN", "description": "CD64 is a cell surface receptor involved in phagocytosis, commonly expressed on macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD64+"}, {"entity_type": "PROTEIN", "description": "CX3CR1 is a chemokine receptor important for macrophage recruitment and migration.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CX3CR1+"}, {"entity_type": "GENE", "description": "CD40 is a cell surface molecule involved in antigen presentation and T cell activation.<SEP>CD40 is a gene involved in B cell activation.<SEP>CD40 is a gene located at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CD40"}, {"entity_type": "PROTEIN", "description": "CD80 is a co-stimulatory molecule expressed on antigen-presenting cells.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD80"}, {"entity_type": "PROTEIN", "description": "CD86 is another co-stimulatory molecule involved in T cell activation.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CD86"}, {"entity_type": "CELL SUBTYPE", "description": "Ly6C hi macrophages are generally considered pro-inflammatory.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6CHI"}, {"entity_type": "CELL SUBTYPE", "description": "Ly6C lo macrophages are often associated with anti-inflammatory roles.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LY6CLO"}, {"entity_type": "PROTEIN", "description": "FOXP3 is a transcription factor essential for the development and function of regulatory T cells (Tregs).<SEP>Foxp3 is a transcription factor essential for the development and function of regulatory T cells (Tregs).", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "id": "FOXP3"}, {"entity_type": "CELL TYPE", "description": "iTreg are induced regulatory T cells, generated in the periphery.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "ITREG"}, {"entity_type": "GENOMIC VARIANT", "description": "A genetic modification that combines IL-10 receptor alpha chain deletion (IL-10R\u03b1Mdel) with Rag1 deficiency (Rag1\u2212/\u2212).<SEP>IL-10R\u03b1MdelRag1\u2212/\u2212 mice are similar to Rag1\u2212/\u2212 mice but also lack the IL-10 receptor alpha chain, further compromising their immune response.<SEP>This refers to a genetically modified mouse model where the IL-10 receptor alpha chain is deleted specifically in macrophages.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 14}, {level: 1, cluster: 88}]", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"entity_type": "ANTIBODY", "description": "\u03b1Ly6G antibody is used for depletion of neutrophils.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "\u0391LY6G AB"}, {"entity_type": "ANTIBODY", "description": "A control antibody is used as a comparison to the \u03b1Ly6G antibody.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "CONTROL AB"}, {"entity_type": "EXPERIMENTAL PROCEDURE", "description": "Transferring T cells into mice is a common experimental procedure in immunology.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "T CELL TRANSFER"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice lacking the Rag1 gene, rendering them immunodeficient.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "RAG1\u2212/\u2212 RECIPIENTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Mice with deletion of the IL-10 receptor alpha chain specifically in macrophages.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 120}]", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "TISSUE", "description": "The lamina propria is a layer of connective tissue beneath the epithelium in the gastrointestinal tract.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "LAMINA PROPRIA"}, {"entity_type": "CELL TYPE", "description": "A type of T lymphocyte found in the colon.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "COLONIC CD4 T CELLS"}, {"entity_type": "CELL TYPE", "description": "Dendritic cells are antigen-presenting cells involved in immune responses.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "DCS"}, {"entity_type": "LYMPHOID TISSUE", "description": "Lymph nodes located in the mesentery, draining lymph from the intestines.", "source_id": "chunk-380a8a6e0d08cd28068a146ae5e00ce4", "id": "MESENTERIC LYMPH NODES (MLNS)"}, {"entity_type": "ORGAN", "description": "Spleen is an organ involved in filtering blood, storing white blood cells, and removing old or damaged red blood cells.<SEP>The spleen is an organ involved in filtering blood and immune responses.<SEP>The spleen is an organ involved in immune responses and blood filtration.<SEP>The spleen is an organ involved in immune responses and blood filtration.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-380a8a6e0d08cd28068a146ae5e00ce4<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "SPLEEN"}, {"entity_type": "CELL TYPE", "description": "Macrophages are immune cells involved in phagocytosis and inflammation.<SEP>Macrophages are phagocytic immune cells that play a role in inflammation and tissue repair.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 65}]", "id": "MACROPHAGE"}, {"entity_type": "IMMUNE CELL", "description": "Th17 cells are a subset of T helper cells characterized by their production of IL-17.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "TH17 CELL"}, {"entity_type": "TH17 CELL SUBTYPE", "description": "A subtype of Th17 cells identified by the expression of CD4 and IL-17A.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "CD4+IL-17A+ T CELLS"}, {"entity_type": "PROTEIN", "description": "ROR\u03b3T is a protein that is essential for the development of Th17 cells.<SEP>ROR\u03b3T is a transcription factor essential for the development and function of Th17 cells.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "ROR\u0393T"}, {"entity_type": "GENE", "description": "IL-1\u03b2 is a gene that encodes for interleukin-1 beta, another pro-inflammatory cytokine.<SEP>IL-1\u03b2 is a pro-inflammatory cytokine involved in various inflammatory responses.<SEP>IL-1\u03b2 is a proinflammatory cytokine involved in the inflammatory response.<SEP>Interleukin-1 beta (IL-1\u03b2) is a proinflammatory cytokine.<SEP>IL-1\u03b2 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>IL-1\u03b2 is a proinflammatory cytokine produced by adipocytes and other cells.<SEP>IL-1\u03b2 is a proinflammatory cytokine produced by adipocytes.<SEP>Interleukin-1 beta (IL-1\u03b2) is a proinflammatory cytokine involved in various inflammatory processes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f<SEP>chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-b971aa450a9b220806bdc000eb5efaad<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "IL-1\u0392"}, {"entity_type": "CYTOKINE", "description": "TNF-\u03b1 is a pro-inflammatory cytokine that plays a role in various inflammatory diseases.<SEP>TNF-\u03b1 is a proinflammatory cytokine elevated in SENP1-deficient mice.<SEP>TNF-\u03b1 is a proinflammatory cytokine produced by adipocytes.<SEP>Tumor necrosis factor alpha (TNF-\u03b1) is a proinflammatory cytokine that plays a role in inflammation and insulin resistance.<SEP>Tumor necrosis factor alpha (TNF-\u03b1) is a cytokine that promotes inflammation and cell death.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "TNF-\u0391"}, {"entity_type": "GENE", "description": "IFN-\u03b3 (interferon gamma) is a cytokine involved in immune responses.<SEP>IFN-\u03b3 is a cytokine produced by Th1 cells and NK cells that plays a role in cell-mediated immunity.<SEP>IFN-\u03b3 is not significantly elevated in SENP1-deficient mice.<SEP>Interferon gamma (IFN-\u03b3) is a cytokine that promotes inflammation and immune cell activation.<SEP>Interferon gamma is a cytokine with antiviral and immunomodulatory effects.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 42}]", "id": "IFN-\u0393"}, {"entity_type": "CYTOKINE", "description": "IL-17 is a pro-inflammatory cytokine produced by Th17 cells and involved in autoimmune diseases.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "IL-17"}, {"entity_type": "GENERAL TERM FOR ILLNESS", "description": "Colitis is an inflammatory bowel disease characterized by inflammation of the colon.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "DISEASE"}, {"entity_type": "TISSUE SAMPLE LOCATION", "description": "Refers to the immune cells infiltrating the colon tissue.", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "id": "COLONIC INFILTRATE"}, {"entity_type": "GENE", "description": "Rag1 gene plays a critical role in lymphocyte development.<SEP>Rag1 is a gene that is involved in the development of immune cells.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "RAG1"}, {"entity_type": "GENOMIC VARIANT", "description": "IL-10R\u03b1MdelRag1 is a genetic modification that affects the IL-10 receptor alpha chain.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "IL-10R\u0391MDELRAG1"}, {"entity_type": "PROTEIN", "description": "IL-6 receptor alpha is a gene involved in immune response.<SEP>IL-6R\u03b1 is a protein that is the receptor for IL-6.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "IL-6R\u0391"}, {"entity_type": "CELL TYPE", "description": "CD4+TCR+ T cells are a subtype of T cell that express the CD4 protein and the T-cell receptor (TCR).", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "CD4+TCR+"}, {"entity_type": "TISSUE", "description": "MLNs (mesenteric lymph nodes) are lymph nodes located in the abdomen.", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "id": "MLN"}, {"entity_type": "GENE", "description": "IL-1 receptor alpha is a gene involved in inflammatory responses.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "IL-1R\u0391"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lymphoid-resident macrophages are immune cells found in lymphoid tissues.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "LPM\u03a6"}, {"entity_type": "PROTEIN", "description": "CD11b is a cell surface marker expressed on myeloid cells, including macrophages.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 164}]", "id": "CD11B"}, {"entity_type": "PROTEIN", "description": "F4/80 is a cell surface marker specifically expressed on macrophages.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "F4/80"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Wild-type T cells are normal, unmanipulated T cells used as a control.", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "id": "WT T CELL"}, {"entity_type": "PROTEIN", "description": "Pro-IL-\u03b2 is the precursor form of interleukin-1 beta.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 163}]", "id": "PRO-IL-\u0392"}, {"entity_type": "PROTEIN", "description": "Mature IL-1\u03b2 is the active form of interleukin-1 beta, a pro-inflammatory cytokine.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 122}]", "id": "MATURE IL-1\u0392"}, {"entity_type": "CELL TYPE", "description": "Macrophages (M\u03d5s) are a type of white blood cell that play a role in innate immunity.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "M\u03a6S"}, {"entity_type": "DRUG", "description": "An antibody that blocks the IL-10 receptor, inhibiting IL-10 signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "ANTI-IL-10R ANTIBODY"}, {"entity_type": "PROTEIN", "description": "Caspase-1 is an enzyme involved in the inflammatory response and apoptosis.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "CASPASE-1"}, {"entity_type": "PROTEIN FRAGMENT", "description": "p20 is an activated fragment of caspase-1.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "P20"}, {"entity_type": "MOLECULAR SUBSTANCE", "description": "Lipopolysaccharide (LPS) is a component of bacterial cell walls that can trigger immune responses.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "LPS"}, {"entity_type": "MOLECULAR SUBSTANCE", "description": "Adenosine triphosphate (ATP) is a molecule involved in cellular energy metabolism and signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "ATP"}, {"entity_type": "CELL TYPE", "description": "Macrophages derived from IL-10R\u03b1MdelRag1\u2212/\u2212 mice.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "IL-1R\u0391MDELRAG1\u2212/\u2212 M\u03a6S"}, {"entity_type": "IMMUNE CELL", "description": "T helper 17 cells (Th17) are a subset of T lymphocytes that play a role in inflammatory responses and autoimmunity.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TH17 CELLS"}, {"entity_type": "CYTOKINE", "description": "Transforming growth factor beta (TGF\u03b2) is a cytokine involved in cell growth, differentiation, and immune regulation.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TGF\u0392"}, {"entity_type": "DRUG", "description": "An antibody that blocks the IL-6 receptor, inhibiting IL-6 signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "\u0391IL-6R\u0391 BLOCKING ANTIBODY"}, {"entity_type": "PROTEIN", "description": "The TGF\u03b2 receptor is a transmembrane protein that binds to TGF\u03b2 and initiates intracellular signaling.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "TGF\u0392 RECEPTOR"}, {"entity_type": "IMMUNE CELL", "description": "Na\u00efve T cells are T lymphocytes that have not yet encountered their specific antigen.", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "id": "NA\u00cfVE T CELLS"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "Mice lacking IL-10 receptor alpha specifically in macrophages develop more severe colitis compared to control mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "IL-10R\u0391 DELETION (M\u03a6 SPECIFIC)"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "The Lys-M-Cre transgene is expressed in granulocytes, including neutrophils.)", "entity_type": "UNKNOWN", "id": "GRANULOCYTES"}, {"source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "description": "The Lys-M-Cre transgene is expressed in granulocytes, including neutrophils.)", "entity_type": "UNKNOWN", "id": "LYS-M-CRE"}, {"source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "description": "Elevated levels of IL-1\u03b2 are associated with an intensified Th17 response.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "TH17 RESPONSE"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "Del Rag1\u2212/\u2212 mice have an increased Th17 response.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "RAG1\u2212/\u2212 MICE"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "Transfer of IL-6R\u03b1\u2212/\u2212 T cells into Rag1\u2212/\u2212 mice did not induce colitis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "IL-6R\u03b1 signaling supports but is not essential for Th17 cell formation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "TH17 CELL FORMATION"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "IL-10R\u03b1MdelRag1\u2212/\u2212 mice show a relative expansion of Th17 cells at the site of inflammation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 120}]", "id": "TH17 CELL EXPANSION"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "IL-6 is broadly necessary for T cell expansion and colitis in Rag1\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 116}]", "id": "T CELL EXPANSION"}, {"source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "description": "Transfer of IL-1R\u2212/\u2212 T cells into Rag1\u2212/\u2212 mice resulted in diminished clinical and histologic measures of colitis compared to WT T cell transfers.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "IL-1R\u2212/\u2212 T CELLS"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "IL-10 treatment suppressed caspase-1 activation, while anti-IL-10R\u03b1 Ab increased it.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 163}]", "id": "CASPASE-1 ACTIVATION"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPS and ATP stimulation induced modest activated caspase-1 levels in Rag1\u2212/\u2212 M\u03d5s.)", "entity_type": "UNKNOWN", "id": "ACTIVATED CASPASE-1"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPS and ATP stimulation induced modest activated caspase-1 levels in Rag1\u2212/\u2212 M\u03d5s.)", "entity_type": "UNKNOWN", "id": "LPS & ATP"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Caspase-1 activation was increased regardless of IL-10 or anti-IL-10R\u03b1 Ab treatment in IL-10R\u03b1MdelRag1\u2212/\u2212 M\u03d5s.)", "entity_type": "UNKNOWN", "id": "IL-10R\u0391MDELRAG1\u2212/\u2212 M\u03a6S"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPM\u03d5s from diseased IL-10R\u03b1MdelRag1\u2212/\u2212 mice promoted higher Th17 cell maturation compared to control Rag1\u2212/\u2212 LPM\u03d5s.)", "entity_type": "UNKNOWN", "id": "LPM\u03a6S FROM IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "LPM\u03d5s from diseased IL-10R\u03b1MdelRag1\u2212/\u2212 mice promoted higher Th17 cell maturation compared to control Rag1\u2212/\u2212 LPM\u03d5s.)", "entity_type": "UNKNOWN", "id": "TH17 CELL MATURATION"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Increased IL-1 and IL-6 from LPM\u03d5s promoted Th17 cell maturation.)", "entity_type": "UNKNOWN", "id": "IL-1 & IL-6 FROM LPM\u03a6S"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Blocking IL-6 signaling partially inhibited Th17 cell formation with Rag1\u2212/\u2212 LPM\u03d5s.)", "entity_type": "UNKNOWN", "id": "TH17 CELL MATURATION IN RAG1\u2212/\u2212 MICE"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Blocking IL-1 signaling substantially inhibited Th17 development in IL-10R\u03b1Mdel Rag1\u2212/\u2212-derived LPM\u03d5s.)", "entity_type": "UNKNOWN", "id": "IL-1 SIGNALING BLOCKAGE"}, {"source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "description": "Blocking IL-1 signaling substantially inhibited Th17 development in IL-10R\u03b1Mdel Rag1\u2212/\u2212-derived LPM\u03d5s.)", "entity_type": "UNKNOWN", "id": "TH17 CELL MATURATION IN IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"entity_type": "GENUS", "description": "Bacteroides is a genus of bacteria found in the human gut microbiome.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BACTEROIDES"}, {"entity_type": "GENUS", "description": "Faecalibacterium is a genus of bacteria known for its beneficial effects on gut health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "FAECALIBACTERIUM"}, {"entity_type": "GENUS", "description": "Blautia is a genus of bacteria commonly found in the human gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "BLAUTIA"}, {"entity_type": "GENUS", "description": "Alistipes is a genus of bacteria often associated with various metabolic functions in the gut.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ALISTIPES"}, {"entity_type": "GENUS", "description": "Ruminococcus is a genus of bacteria that plays a role in the fermentation of complex carbohydrates.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINOCOCCUS"}, {"entity_type": "GENUS", "description": "Lachnoclostridium is a genus of bacteria known to produce butyrate, a short-chain fatty acid beneficial for gut health.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "LACHNOCLOSTRIDIUM"}, {"entity_type": "GENUS", "description": "Genus Ruminiclostridium 9 is a bacterial taxa that was found to be associated with gut microbiome.<SEP>Ruminiclostridium 9 is a genus of bacteria with potential roles in carbohydrate metabolism and energy production.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "RUMINICLOSTRIDIUM 9"}, {"entity_type": "FAMILY", "description": "Family Peptostreptococcaeae is a bacterial taxa that was found to be associated with gut microbiome.<SEP>Peptostreptococcaeae is a family of bacteria often found in the human gut and associated with diverse metabolic activities.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "PEPTOSTREPTOCOCCAEAE"}, {"entity_type": "ETHNICITY", "description": "Middle-Eastern refers to people from the Middle East region, encompassing diverse cultures and ancestries.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "MIDDLE-EASTERN"}, {"entity_type": "ETHNICITY", "description": "American Hispanic/Latin refers to people of Hispanic or Latin American descent residing in the Americas.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "AMERICAN HISPANIC/LATIN"}, {"entity_type": "ETHNICITY", "description": "African American refers to people with ancestry tracing back to Africa, often experiencing a shared history of slavery and discrimination.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "AFRICAN AMERICAN"}, {"entity_type": "AGE GROUP", "description": "Adult refers to individuals who have reached legal maturity.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ADULT"}, {"entity_type": "AGE GROUP", "description": "Adolescent refers to individuals transitioning from childhood to adulthood.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "ADOLESCENT"}, {"entity_type": "AGE GROUP", "description": "Child refers to individuals in their early stages of development, typically under the age of 12.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "CHILD"}, {"entity_type": "MICROBIAL REGION", "description": "V4 is a specific region targeted within the 16S rRNA gene for microbial analysis.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "V4"}, {"entity_type": "MICROBIAL REGION", "description": "V3-V4 refers to a combined region of the 16S rRNA gene, encompassing both V3 and V4 regions.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "V3-V4"}, {"entity_type": "MICROBIAL REGION", "description": "V1-V2 refers to a specific region targeted within the 16S rRNA gene for microbial analysis.", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "id": "V1-V2"}, {"entity_type": "GENETIC LOCI", "description": "The LCT locus is a genetic loci associated with the abundance of Bifidobacterium.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 99}]", "id": "LCT LOCUS"}, {"entity_type": "MICROBIOME TAXA", "description": "A genus of bacteria found in the gut<SEP>Bifidobacterium is a bacterial taxa whose abundance is influenced by genetics and diet.<SEP>Bifidobacterium is a genus of bacteria belonging to the Actinobacteria class.<SEP>Bifidobacterium is a genus of bacteria found in the gut microbiome.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4<SEP>chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46<SEP>chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "BIFIDOBACTERIUM"}, {"entity_type": "GENETIC LOCI", "description": "mbQTL stands for microbiome quantitative trait loci, which are genetic loci associated with the abundance of bacterial taxa.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBQTL"}, {"entity_type": "GENETIC LOCI", "description": "mbBTL stands for microbiome binary trait loci, which are genetic loci associated with the presence or absence of bacterial taxa.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "MBBTL"}, {"entity_type": "DIVERSITY INDEX", "description": "The Simpson diversity index is a measure of species diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SIMPSON DIVERSITY INDEX"}, {"entity_type": "DIVERSITY INDEX", "description": "The inverse Simpson diversity index is a measure of species diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "INVERSE SIMPSON DIVERSITY INDEX"}, {"entity_type": "DIVERSITY INDEX", "description": "The Shannon diversity index is a measure of species diversity.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SHANNON DIVERSITY INDEX"}, {"entity_type": "MICROBIAL FEATURE", "description": "Alpha diversity refers to the diversity within a specific sample.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "ALPHA DIVERSITY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The gut microbiota is the collection of microorganisms residing in the human gastrointestinal tract.<SEP>The gut microbiota refers to the community of microorganisms residing in the gastrointestinal tract.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-af413a33fae8d27bdb15cd18447dfad4", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 99}]", "id": "GUT MICROBIOTA"}, {"entity_type": "HERITABILITY ESTIMATION", "description": "Twin-based heritability estimates the contribution of genetics to a trait.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "TWIN-BASED HERITABILITY"}, {"entity_type": "HERITABILITY ESTIMATION", "description": "SNP-based heritability estimates the contribution of genetic variants to a trait.", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "id": "SNP-BASED HERITABILITY"}, {"entity_type": "GENOMIC VARIANT", "description": "rs182549 is a genomic variant associated with the abundance of Bifidobacterium in adults.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "RS182549"}, {"entity_type": "COHORT", "description": "GEM_v12 is a cohort comprising mostly European individuals that showed an age-genotype interaction.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GEM_V12"}, {"entity_type": "COHORT", "description": "GEM_ICHIP is a cohort comprising mostly European individuals that showed an age-genotype interaction.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GEM_ICHIP"}, {"entity_type": "COHORT", "description": "GEM_v24 is a cohort mainly composed of individuals of different Israeli subethnicities who live in Israel.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GEM_V24"}, {"entity_type": "GENE", "description": "A gene associated with lactose intolerance<SEP>LCT encodes the enzyme lactase, responsible for lactose digestion.<SEP>LCT (lactase gene) plays a role in the digestion of lactose.<SEP>LCT is a gene that encodes the lactase enzyme, responsible for lactose digestion.<SEP>LCT is the gene that encodes for the lactase enzyme.<SEP>The LCT gene encodes the lactase enzyme responsible for digesting lactose.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d<SEP>chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "LCT"}, {"entity_type": "GENE", "description": "FUT2 gene encodes the enzyme alpha-1,2-fucosyltransferase, responsible for fucosylated mucus glycan secretion.<SEP>The FUT2 gene encodes an enzyme involved in fucosylation.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FUT2"}, {"entity_type": "GENE", "description": "FUT1 gene is involved in fucosylation of glycoproteins and glycolipids.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "FUT1"}, {"entity_type": "MICROBE", "description": "Ruminococcus torques is a genus of bacteria found in the gut microbiome.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS TORQUES"}, {"entity_type": "TAXON", "description": "Lachnospiraceae is a family of bacteria within the phylum Firmicutes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "LACHNOSPIRACEAE"}, {"entity_type": "MICROBE", "description": "Ruminococcus gnavus is a genus of bacteria found in the gut microbiome.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RUMINOCOCCUS GNAVUS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35866622 is a SNP associated with abundance of Ruminococcus torques group.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "RS35866622"}, {"entity_type": "GENOMIC VARIANT", "description": "rs601338 is a functional variant in the FUT2 gene that introduces a stop-codon.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RS601338"}, {"entity_type": "PROTEIN", "description": "Alpha-1,2-fucosyltransferase is an enzyme responsible for fucosylation of glycans.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "ALPHA-1,2-FUCOSYLTRANSFERASE"}, {"entity_type": "MOLECULE", "description": "ABO antigens are carbohydrate molecules found on the surface of cells.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "ABO ANTIGENS"}, {"entity_type": "MOLECULE", "description": "Mucus glycans are carbohydrates present in mucus that play a role in host-microbe interactions.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "MUCUS GLYCANS"}, {"entity_type": "GENE", "description": "PCSKS5 gene encodes a protein involved in signal transduction.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PCSKS5"}, {"entity_type": "GENE", "description": "RFK gene encodes an enzyme that phosphorylates riboflavin (vitamin B2).", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "RFK"}, {"entity_type": "GENE", "description": "GCNT1 gene encodes a glycosyltransferase involved in mucin biosynthesis.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GCNT1"}, {"entity_type": "MOLECULE", "description": "Mucin is a glycoprotein found in mucus that serves as a protective barrier.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "MUCIN"}, {"entity_type": "MICROBE", "description": "Allisonella is a genus of bacteria found in the gut microbiome.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "ALLISONELLA"}, {"entity_type": "TAXON", "description": "Peptostreptococcaceae is a family of anaerobic bacteria.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "PEPTOSTREPTOCOCCACEAE"}, {"entity_type": "GENE", "description": "CUBN gene encodes a receptor for cobalamin (vitamin B12) complexes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "CUBN"}, {"entity_type": "NUTRIENT", "description": "Cobalamin is vitamin B12, essential for various metabolic processes.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "COBALAMIN"}, {"entity_type": "PROTEIN", "description": "Gastric intrinsic factor is a protein produced in the stomach that facilitates cobalamin absorption.", "source_id": "chunk-fed46d4ab6d22b3530c4c06a4b7def46", "id": "GASTRIC INTRINSIC FACTOR"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP with strong association to Peptococcaceae family", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "RS7574352"}, {"entity_type": "PROTEIN", "description": "A gut inflammation marker", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CHROMOGRANIN A"}, {"entity_type": "PROTEIN", "description": "A gut inflammation marker", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CALPROTECTIN"}, {"entity_type": "GENE", "description": "A gene involved in insulin resistance and susceptibility to type 2 diabetes<SEP>IRF1 is a gene involved in immune response and inflammation.<SEP>IRF1 is a gene involved in interferon signaling and immune response.", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IRF1"}, {"entity_type": "GENE", "description": "A gene locus associated with blood group antigens", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "FUT1/FUT2"}, {"entity_type": "GENE", "description": "A gene associated with metabolic function", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "FNDC3B"}, {"entity_type": "GENE", "description": "A gene involved in metabolism", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "PM FBP1"}, {"entity_type": "GENE", "description": "A gene associated with polycystic kidney disease", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "PKHD1"}, {"entity_type": "DISEASE", "description": "A condition characterized by difficulty digesting lactose", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "LACTOSE INTOLERANCE"}, {"entity_type": "DISEASE", "description": "A metabolic disorder characterized by high blood sugar levels", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "TYPE 2 DIABETES MELLITUS (T2DM)"}, {"entity_type": "DIETARY PATTERN", "description": "The amount of fish consumed in a diet", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "FISH INTAKE"}, {"entity_type": "DISEASE", "description": "A condition characterized by gallstones", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "CHOLELITHIASIS"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "id": "CROHN\u2019S DISEASE"}, {"entity_type": "DISEASE", "description": "Elevated levels of cholesterol in the blood", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "HIGH CHOLESTEROL"}, {"entity_type": "PHENOTYPE", "description": "A measure of body fat distribution", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "WAIST-TO-HIP RATIO"}, {"entity_type": "PHYLUM", "description": "Actinobacteria is a class of bacteria.<SEP>Actinobacteria is a phylum of bacteria, some of which are found in the gut microbiome.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 17}]", "id": "ACTINOBACTERIA"}, {"entity_type": "DISEASE", "description": "A chronic inflammatory bowel disease that affects only the large intestine and rectum.<SEP>Ulcerative colitis is an inflammatory bowel disease.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "ULCERATIVE COLITIS"}, {"entity_type": "MICROBIOME TAXA", "description": "Oxalobacteraceae is a family of bacteria.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "OXALOBACTERACEAE"}, {"entity_type": "DISEASE", "description": "Rheumatoid arthritis is an autoimmune disease.<SEP>Rheumatoid arthritis is an autoimmune disorder affecting joints.", "source_id": "chunk-159d4c797dae6eb825c74067af703228<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RHEUMATOID ARTHRITIS"}, {"entity_type": "DISEASE", "description": "Autoimmune diseases are a group of conditions where the immune system attacks the body\'s own tissues.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "AUTOIMMUNE DISEASE"}, {"entity_type": "DISEASE", "description": "Cardiovascular diseases affect the heart and blood vessels.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "CARDIOVASCULAR DISEASE"}, {"entity_type": "DISEASE", "description": "Metabolic diseases involve problems with the body\'s ability to process nutrients.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "METABOLIC DISEASE"}, {"entity_type": "DISEASE", "description": "Psychiatric disorders affect mood, thinking, and behavior.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "PSYCHIATRIC DISEASE"}, {"entity_type": "PHENOTYPE", "description": "A nutritional phenotype refers to observable characteristics related to diet and nutrition.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "id": "NUTRITIONAL PHENOTYPE"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "Faecalibacterium was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "entity_type": "UNKNOWN", "id": "CORE MICROBIOTA"}, {"source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "description": "One cohort included samples of Middle Eastern ancestry.)", "entity_type": "UNKNOWN", "id": "COHORTS"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "Prior studies suggest that the FUT2 gene plays a role in shaping the gut microbiota.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 99}]", "id": "FUT2 GENE"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "The number of mbQTLs associated with a relaxed threshold is correlated with heritability significance.)", "entity_type": "UNKNOWN", "id": "HERITABILITY OF MICROBIAL TAXA"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "The number of mbQTLs associated with a relaxed threshold is correlated with heritability significance.)", "entity_type": "UNKNOWN", "id": "MBQTLS"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "Individuals homozygous for the low-function LCT haplotype show a positive correlation between Bifidobacterium abundance and milk product intake.)", "entity_type": "UNKNOWN", "id": "LCT GENE"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "Individuals homozygous for the low-function LCT haplotype show a positive correlation between Bifidobacterium abundance and milk product intake.)", "entity_type": "UNKNOWN", "id": "MILK PRODUCTS"}, {"source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "description": "The rs182549 SNP is strongly associated with Bifidobacterium abundance, particularly in adults.)<SEP>The rs182549 SNP is strongly associated with Bifidobacterium abundance.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "BIFIDOBACTERIUM ABUNDANCE"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs7574352 SNP is associated with the abundance of the Peptococcaceae family.)", "entity_type": "UNKNOWN", "id": "PEPTOCOCCACEAE"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs4428215 variant is associated with the FNDC3B gene.)", "entity_type": "UNKNOWN", "id": "RS4428215"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs11647069 variant is associated with the PM FBP1 gene.)", "entity_type": "UNKNOWN", "id": "RS11647069"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs9474033 variant is associated with the PKHD1 gene.)", "entity_type": "UNKNOWN", "id": "RS9474033"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs182549 variant is associated with an increased risk of type 2 diabetes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "TYPE 2 DIABETES MELLITUS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-c791a4e35844d642ba0c69774072f7cd", "description": "A chronic inflammatory bowel disease that can affect any part of the digestive tract.<SEP>The rs35866622 variant is negatively associated with the risk of Crohn\u2019s disease.)", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 28}, {level: 1, cluster: 126}]", "id": "CROHN\'S DISEASE"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "Escherichia coli is a type of bacteria commonly used in genetic engineering and protein expression.<SEP>The rs7574352 SNP is associated with altered abundance of Escherichia coli.)", "entity_type": "BACTERIA", "id": "ESCHERICHIA COLI"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs7574352 SNP is associated with altered abundance of Bacteroides fragilis.)", "entity_type": "UNKNOWN", "id": "BACTEROIDES FRAGILIS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs182549 variant is associated with Bifidobacterium adolescentis abundance.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "BIFIDOBACTERIUM ADOLESCENTIS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs7574352 SNP is associated with altered abundance of Faecalibacterium prausnitzii.)", "entity_type": "UNKNOWN", "id": "FAECALIBACTERIUM PRAUSNITZII"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs7574352 SNP is associated with levels of short-chain fatty acids.)", "entity_type": "UNKNOWN", "id": "SHORT-CHAIN FATTY ACIDS"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs7574352 SNP is associated with methane production in the gut.)", "entity_type": "UNKNOWN", "id": "METHANE"}, {"source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "description": "The rs182549 variant is associated with increased antibiotic resistance.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 98}]", "id": "ANTIBIOTIC RESISTANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4988235 is a genetic variant associated with milk intake and other dietary factors.<SEP>rs4988235 is a genomic variant associated with lactase persistence.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "RS4988235"}, {"entity_type": "NUTRIENT", "description": "Milk is a dairy product consumed as a beverage.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "MILK"}, {"entity_type": "NUTRIENT", "description": "Milk beverages are drinks made from milk.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "MILK BEVERAGES"}, {"entity_type": "NUTRIENT", "description": "Dairy products are a category of foods derived from milk.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "id": "DAIRY PRODUCTS"}, {"entity_type": "LIPID", "description": "C15:0 is a type of fatty acid found in plasma.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "C15:0"}, {"entity_type": "LIPID", "description": "C17:0 is a type of fatty acid found in plasma.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "C17:0"}, {"entity_type": "LIPID", "description": "HDL cholesterol is a type of lipoprotein associated with cardiovascular health.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "HDL CHOLESTEROL"}, {"entity_type": "FOOD", "description": "Potatoes are a starchy root vegetable.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "POTATOES"}, {"entity_type": "FOOD", "description": "Cereal products are grains processed into various forms for consumption.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "CEREAL PRODUCTS"}, {"entity_type": "FOOD", "description": "Fruits are plant-based foods containing vitamins, minerals, and fiber.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "FRUITS"}, {"entity_type": "FOOD", "description": "Poultry refers to domesticated birds raised for meat consumption.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "POULTRY"}, {"entity_type": "FOOD", "description": "Non-alcoholic beverages are drinks that do not contain alcohol.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "NON-ALCOHOLIC BEVERAGES"}, {"entity_type": "FOOD", "description": "Wine is an alcoholic beverage produced from fermented grapes.", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "clusters": "[{level: 0, cluster: 22}]", "id": "WINE"}, {"source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "description": "One additional LP allele (rs4988235) was not associated with the intake of other dairy products.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 22}]", "id": "DAIRY PRODUCTS (GENERAL)"}, {"entity_type": "NUTRIENT", "description": "A nutrient essential for various bodily functions, including cell membrane formation and neurotransmitter synthesis.<SEP>Choline is an essential nutrient important for various biological processes.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e<SEP>chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE"}, {"entity_type": "DRUG", "description": "Methamphetamine is a potent stimulant drug.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "METHAMPHETAMINE"}, {"entity_type": "DRUG", "description": "Marijuana is a psychoactive substance with varying effects.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "MARIJUANA"}, {"entity_type": "DRUG", "description": "Cocaine is a highly addictive stimulant drug.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "COCAINE"}, {"entity_type": "DRUG", "description": "Heroin is an opioid drug with strong addictive properties.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "HEROIN"}, {"entity_type": "DRUG", "description": "Methaqualone is a sedative-hypnotic drug.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "METHAQUALONE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The amount of calories consumed in the diet.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DIETARY CALORIC INTAKE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The recommended daily intake of a nutrient, in this case choline.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "AI (ADEQUATE INTAKE)"}, {"entity_type": "THERAPY", "description": "The administration of choline as a supplement.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "CHOLINE SUPPLEMENTATION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A measure of socioeconomic status.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "SOCIAL CLASS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The level of formal education completed by the mother.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "MATERNAL EDUCATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cognitive abilities, including language and problem-solving skills.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A subjective measure of stress levels.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCEIVED STRESS"}, {"entity_type": "DISEASE", "description": "A mood disorder characterized by persistent sadness and loss of interest.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "DEPRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Overall health and well-being related to nutrient intake.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "NUTRITIONAL STATUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The habitual use of alcoholic beverages.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "ALCOHOL CONSUMPTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The age of the infants at specific time points during the study.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "INFANT AGE AT ASSESSMENTS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A learning paradigm used to assess infant cognitive abilities.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "EYEBLINK CONDITIONING (EBC)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The percentage of responses that are elicited by a conditioned stimulus.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PERCENT CRS (CONDITIONED RESPONSES)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The length of time since the first day of the woman\'s last menstrual period.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "GESTATIONAL AGE (GA)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The weight of the newborn at birth.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "BIRTHWEIGHT"}, {"entity_type": "DISEASE", "description": "A condition characterized by a birthweight below 2500 grams.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "LOW BIRTHWEIGHT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The dimensions of the newborn, including length and head circumference.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "BIRTH SIZE"}, {"entity_type": "DISEASE", "description": "A condition where fetal growth is impaired due to alcohol exposure during pregnancy.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FETAL ALCOHOL GROWTH RESTRICTION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A test used to assess infant cognitive abilities, including visual recognition memory and processing speed.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAGAN TEST OF INFANT INTELLIGENCE (FTII)"}, {"entity_type": "DISEASE", "description": "A range of conditions caused by prenatal alcohol exposure.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "FAS (FETAL ALCOHOL SPECTRUM DISORDERS)"}, {"entity_type": "DISEASE", "description": "A milder form of FAS, characterized by some but not all features of FAS.", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "id": "PFAS (PARTIAL FETAL ALCOHOL SYNDROME)"}, {"entity_type": "DISEASE", "description": "Post-natal FAS-related abnormalities, also known as Fetal Alcohol Spectrum Disorders", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PFAS"}, {"entity_type": "GENE", "description": "The Phosphatidylethanolamine N-methyltransferase gene, responsible for endogenous choline synthesis.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PEMT"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the PEMT gene that reduces endogenous choline synthesis.<SEP>A specific variant of the PEMT gene that reduces its activity, leading to decreased choline synthesis.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "RS12325817"}, {"entity_type": "TREATMENT GROUP", "description": "A group of infants who received choline supplementation during the study.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "CHOLINE ARM"}, {"entity_type": "TREATMENT GROUP", "description": "A group of infants who received a placebo instead of choline supplementation.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "PLACEBO ARM"}, {"entity_type": "PHYSIOLOGICAL STATE", "description": "The level of choline intake in the mother\'s diet during pregnancy.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "DIETARY CHOLINE STATUS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The amount of choline consumed by a pregnant woman through her diet.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "MATERNAL DIETARY CHOLINE INTAKE"}, {"entity_type": "PHYSIOLOGICAL STATE", "description": "A sufficient level of choline intake during pregnancy, typically defined as greater than 450 mg/day.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "ADEQUATE CHOLINE INTAKE"}, {"entity_type": "PHYSIOLOGICAL LIMIT", "description": "The upper limit of choline intake considered safe during pregnancy, set at 3.5 g/day.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "UL OF CHOLINE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which the body produces choline internally.", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "id": "ENDOGENOUS CHOLINE SYNTHESIS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Choline supplementation may promote catch-up growth in infants, particularly in weight and head circumference.)", "entity_type": "UNKNOWN", "id": "INFANT GROWTH"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Heavy alcohol consumption during pregnancy can increase the risk of FASD.)", "entity_type": "UNKNOWN", "id": "FETAL ALCOHOL SPECTRUM DISORDER (FASD)"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Methamphetamine use during pregnancy can lead to various complications for both mother and fetus.)", "entity_type": "UNKNOWN", "id": "PREGNANCY COMPLICATIONS"}, {"source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "description": "Heroin exposure in utero can result in NAS, a withdrawal syndrome in newborns.)", "entity_type": "UNKNOWN", "id": "NEONATAL ABSTINENCE SYNDROME (NAS)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs10886471 is a single nucleotide polymorphism (SNP) that exhibits short tandem repeat (STR) variations.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "RS10886471"}, {"entity_type": "GENE", "description": "GRK5 is a gene involved in regulating blood glucose.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "GRK5"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Systolic Blood Pressure (SBP) is the pressure in the arteries when the heart beats.<SEP>Systolic Blood Pressure (SBP) is the pressure in your arteries when your heart beats.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "SBP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Diastolic Blood Pressure (DBP) is the pressure in the arteries when the heart rests between beats.<SEP>Diastolic Blood Pressure (DBP) is the pressure in your arteries when your heart rests between beats.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd<SEP>chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "DBP"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Two-hour Postprandial Glucose (2h PG) refers to the blood glucose level two hours after a meal.", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "id": "2 H PG"}, {"entity_type": "DISEASE", "description": "Type 2 Diabetes Mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and relative insulin deficiency.<SEP>Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by elevated blood glucose levels.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "T2DM"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele variation within a gene sequence, designated as (CA)15.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)15 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele variation within a gene sequence, designated as (CA)17.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)17 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele variation within a gene sequence, designated as (CA)18.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)18 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific allele variation within a gene sequence, designated as (CA)19.", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "id": "(CA)19 ALLELE"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "CA repeat sequences in introns can influence enhancer or repressor splicing during gene expression.)", "entity_type": "UNKNOWN", "id": "CA REPEAT SEQUENCES"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "CA repeat sequences in introns can influence enhancer or repressor splicing during gene expression.)", "entity_type": "UNKNOWN", "id": "GENE EXPRESSION"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9<SEP>chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "A condition in which blood sugar levels are higher than normal but not high enough to be diagnosed as type 2 diabetes.<SEP>Impaired Fasting Glucose (IFG) is a condition of prediabetes.)", "entity_type": "DISEASE", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 114}]", "id": "PREDIABETES"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) both indicate elevated blood glucose levels.)", "entity_type": "UNKNOWN", "id": "BLOOD GLUCOSE ELEVATION"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) both indicate elevated blood glucose levels.)", "entity_type": "UNKNOWN", "id": "IFG, IGT"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "These clinical parameters are associated with increased blood glucose levels in individuals with prediabetes and T2DM.)", "entity_type": "UNKNOWN", "id": "INCREASED BLOOD GLUCOSE"}, {"source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "description": "These clinical parameters are associated with increased blood glucose levels in individuals with prediabetes and T2DM.)", "entity_type": "UNKNOWN", "id": "WAIST CIRCUMFERENCE, BMI, SBP, DBP, FPG, 2 H PG"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "The (CA)16 allele was used as a reference for comparing alleles associated with T2DM.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 114}]", "id": "(CA)16 ALLELE"}, {"source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "description": "Multiple alleles including (CA)15, (CA)17, (CA)18, and (CA)19 were negatively correlated with T2DM.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 114}]", "id": "MULTIPLE ALLELES"}, {"entity_type": "STUDY", "description": "The WHI Observational Study investigates the association between serum selenium concentration and colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "WHI OBSERVATIONAL STUDY"}, {"entity_type": "GROUP", "description": "Individuals diagnosed with colorectal cancer were included as cases in the study.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "CASES"}, {"entity_type": "GROUP", "description": "Controls are individuals used for comparison in experiments, presumably healthy individuals.<SEP>Healthy individuals without colorectal cancer were included as controls in the study.<SEP>The control group consisted of individuals without the specific genetic condition being studied.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-d311ac0182b37003c75c0005b4337fa6<SEP>chunk-dcbd547f8218e7097805720fd6ea43ba", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "CONTROLS"}, {"entity_type": "DISEASE", "description": "Colorectal cancer is the primary focus of this observational study.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "COLORECTAL CANCER"}, {"entity_type": "BIOMARKER", "description": "Serum selenium concentration was measured to assess its potential association with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "SERUM SELENIUM CONCENTRATION"}, {"entity_type": "GENE", "description": "The GPX4 gene, involved in selenium metabolism, was analyzed for genetic variants associated with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "GPX4 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs8178974 is a specific SNP within the GPX4 gene found to be statistically significantly associated with colorectal cancer risk.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "id": "RS8178974"}, {"entity_type": "CHARACTERISTIC", "description": "Race/ethnicity was considered but did not differ between cases and controls due to matching criteria.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "RACE/ETHNICITY"}, {"entity_type": "MEDICATION/TREATMENT", "description": "Use of postmenopausal hormone was less frequent in cases compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "POSTMENOPAUSAL HORMONE USE"}, {"entity_type": "DRUG", "description": "Non-steroidal anti-inflammatory drugs (NSAIDs) use was similar between cases and controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "NSAIDS"}, {"entity_type": "SUPPLEMENT", "description": "Use of selenium supplements was similar between cases and controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "SELENIUM SUPPLEMENTS"}, {"entity_type": "NUTRIENT", "description": "Intake of calcium was lower in cases than controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "CALCIUM"}, {"entity_type": "NUTRIENT", "description": "Intake of dietary fiber was lower in cases compared to controls.", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 53}]", "id": "DIETARY FIBER"}, {"entity_type": "GENE", "description": "A gene involved in the immune response and signaling pathway.<SEP>CARD9 is a gene that plays a role in immune response and colitis.<SEP>Card9 is a gene involved in regulating the immune response, particularly in mucosal immunity.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 118}]", "id": "CARD9"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "DSS (dextran sulfate sodium) is an agent used to induce colitis in animal models.<SEP>Dextran sulfate sodium (DSS) is an environmental factor used to induce colitis in mice.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "DSS"}, {"entity_type": "GENOMIC VARIANT", "description": "WT refers to wild-type mice, representing a control group in experiments.<SEP>WT refers to wild-type mice, which serve as a control group in the study.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 17}]", "id": "WT"}, {"entity_type": "GENOMIC VARIANT", "description": "Card9\u2212/\u2212 refers to mice lacking the CARD9 gene, used to study its role in colitis.<SEP>Card9\u2212/\u2212 refers to mice with a knockout of the Card9 gene.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 17}]", "id": "CARD9\u2212/\u2212"}, {"entity_type": "PROTEIN", "description": "Ki67 is a protein marker for cell proliferation.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "KI67"}, {"entity_type": "PROTEIN", "description": "Cleaved caspase 3 is a protein marker for apoptosis.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CLEAVED CASPASE 3"}, {"entity_type": "GENE", "description": "Reg3g encodes REGIII-\u03b3, an antimicrobial protein produced by intestinal epithelial cells.<SEP>Reg3g encodes a protein involved in antimicrobial defense.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 119}]", "id": "REG3G"}, {"entity_type": "GENE", "description": "Reg3b encodes REGIII-\u03b2, an antimicrobial protein produced by intestinal epithelial cells.<SEP>Reg3b encodes a protein involved in antimicrobial defense.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "REG3B"}, {"entity_type": "GENE", "description": "A cytokine that can normalize AHR ligand production and colitis susceptibility.<SEP>IL-22 is a cytokine that promotes tissue repair and antimicrobial defense in the gut.<SEP>IL-22 is a gene that encodes for interleukin-22, a cytokine involved in immune responses and tissue repair.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 142}]", "id": "IL-22"}, {"entity_type": "CYTOKINE", "description": "IL-17A (interleukin-17A) is a cytokine involved in inflammatory responses.<SEP>IL-17A is a cytokine with protective effects in the context of inflammation and infection.<SEP>Interleukin 17A (IL-17A) is a cytokine that promotes inflammation and neutrophil recruitment.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL-17A"}, {"entity_type": "CELL TYPE", "description": "CD3\u2212CD4\u2212NKp46\u2212 cells are a subset of immune cells involved in gut immunity.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CD3\u2212CD4\u2212NKP46\u2212"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Fungal load refers to the amount of fungi present in a particular tissue or environment.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "FUNGAL LOAD"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A technique used to identify and characterize fungal species based on their ITS2 DNA region.<SEP>ITS2 sequencing is a technique used to identify and characterize fungal species in a sample.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ITS2 SEQUENCING"}, {"entity_type": "PHYLUM", "description": "Ascomycota is a phylum of fungi that includes many common species.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ASCOMYCOTA"}, {"entity_type": "PHYLUM", "description": "Basidiomycota is a phylum of fungi that includes mushrooms and other saprophytic species.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "BASIDIOMYCOTA"}, {"entity_type": "PHYLUM", "description": "Zygomycota is a phylum of fungi that includes molds and some parasites.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "ZYGOMYCOTA"}, {"entity_type": "DISEASE", "description": "DSS-induced colitis is a model of inflammatory bowel disease induced by dextran sulfate sodium.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "DSS-INDUCED COLITIS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Ki67 staining is used to detect the presence of proliferating cells.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "KI67 STAINING"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cleaved caspase 3 staining is used to detect apoptotic cells.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CLEAVED CASPASE 3 STAINING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Transcriptomics analysis of the colon tissue to study gene expression changes.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "COLONIC TRANSCRIPTOMES"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Using bioinformatic tools to analyze gene expression data and identify enriched pathways.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "PATHWAY ANALYSES"}, {"entity_type": "METABOLIC PATHWAY", "description": "Biological pathways involved in immune responses, such as inflammation and defense against pathogens.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "IMMUNE-RELATED PATHWAYS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Biological pathways involved in the processes of cell growth and division.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "CELL PROLIFERATION AND REPLICATION PATHWAYS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process of new epithelial cells being formed in the colon lining.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "EPITHELIAL CELL PROLIFERATION"}, {"entity_type": "PROCESS", "description": "Apoptosis is a programmed cell death process that plays a role in the destruction of \u03b2 cells in SENP1-deficient mice.<SEP>Programmed cell death, a natural process for eliminating damaged or unwanted cells.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 68}]", "id": "APOPTOSIS"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The community of fungi present in the gut.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "FUNGAL MICROBIOTA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The community of bacteria present in the gut.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "BACTERIAL MICROBIOTA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A technique used to identify and characterize bacterial species based on their 16S rRNA gene sequences.", "source_id": "chunk-4d5e7ab61a7357d5106f4a8a355f40d0", "id": "16S RDNA SEQUENCING"}, {"entity_type": "GENUS", "description": "Adlercreutzia is a genus of bacteria found in the gut microbiome.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 17}]", "id": "ADLERCREUTZIA"}, {"entity_type": "SPECIES", "description": "Lactobacillus reuteri is a species of bacteria often found in probiotics and the gut microbiome.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 17}]", "id": "LACTOBACILLUS REUTERI"}, {"entity_type": "PROTEIN", "description": "IL-22 (interleukin-22) is a cytokine involved in intestinal homeostasis and immune response.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "IL22"}, {"entity_type": "GENE", "description": "Cxcl1 encodes a chemokine involved in inflammation and immune cell recruitment.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "CXCL1"}, {"entity_type": "GENE", "description": "Cxcl5 encodes a chemokine involved in inflammation and immune cell recruitment.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "CXCL5"}, {"entity_type": "GENE", "description": "Fos is a transcription factor involved in cell proliferation and differentiation.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "FOS"}, {"entity_type": "GENE", "description": "Il17a encodes a cytokine involved in inflammatory responses.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 119}]", "id": "IL17A"}, {"entity_type": "GENE", "description": "Defb1 encodes a defensin, an antimicrobial peptide.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "DEFB1"}, {"entity_type": "GENOMIC VARIANT", "description": "Il22\u2212/\u2212 refers to mice with a knockout of the Il22 gene.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "id": "IL22\u2212/\u2212"}, {"entity_type": "GROUP", "description": "Refers to mice colonized with wild-type microbiota in experiments.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "WT\u2192GF"}, {"entity_type": "GROUP", "description": "Refers to mice colonized with Card9 knockout microbiota in experiments.", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 119}]", "id": "CARD9\u2212/\u2212\u2192GF"}, {"entity_type": "GENE", "description": "Card9 is a gene that plays a role in immune responses.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "CARD9</ENTITY>"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "IL-22 is a cytokine involved in immune responses, particularly against pathogens and inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-22</ENTITY>"}, {"entity_type": "DISEASE", "description": "DSS is a chemical used to induce colitis in animal models.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "DSS</ENTITY>"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tryptophan metabolism involves the conversion of tryptophan by bacteria and host cells into various metabolites.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "TRYPTOPHAN METABOLISM</ENTITY>"}, {"entity_type": "MOLECULAR INTERACTION", "description": "AHR (Aryl hydrocarbon receptor) is a transcription factor activated by tryptophan metabolites.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "AHR</ENTITY>"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "IAA (indole-3-acetic acid) is a tryptophan metabolite that acts as an AHR ligand.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IAA</ENTITY>"}, {"entity_type": "NUTRIENT/METABOLITE", "description": "Kyn is a tryptophan metabolite produced by host cells via IDO1.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "KYNURENINE (KYN)</ENTITY>"}, {"entity_type": "PROTEIN", "description": "IDO1 (indoleamine 2,3-dioxygenase 1) is an enzyme involved in tryptophan metabolism.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IDO1</ENTITY>"}, {"entity_type": "MICROBE/BACTERIA", "description": "Allobaculum is a genus of bacteria found in the gut microbiota.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "ALLOBACULUM SP.</ENTITY>"}, {"entity_type": "GENOMIC VARIANT", "description": "Card9\u2212/\u2212 refers to mice with a knockout of the Card9 gene.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "CARD9\u2212/\u2212</ENTITY>"}, {"entity_type": "DISEASE</ENTITY>", "description": "DSS (dextran sulfate sodium) is a chemical used to induce colitis in animal models.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "DSS </ENTITY>"}, {"entity_type": "PHYSIOLOGICAL PROCESS/CYTOKINE</ENTITY>", "description": "IL-23 is a cytokine involved in immune responses, particularly promoting inflammation.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "IL-23</ENTITY>"}, {"entity_type": "CELL TYPE/IMMUNE CELL</ENTITY>", "description": "\u03b3\u03b4 T cells are a type of immune cell involved in tissue surveillance and response to infection.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "\u0393\u0394 T CELLS</ENTITY>"}, {"entity_type": "CELL TYPE/IMMUNE CELL</ENTITY>", "description": "ILCs are a group of innate immune cells that produce cytokines like IL-22.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "ILC (INNATE LYMPHOID CELL)</ENTITY>"}, {"entity_type": "PROTEIN/CYTOKINE</ENTITY>", "description": "Reg3g and Reg3b are antimicrobial peptides involved in mucosal immunity.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "REG3G & REG3B</ENTITY>"}, {"entity_type": "MOLECULAR INTERACTION/TRANSCRIPTION FACTOR</ENTITY>", "description": "AHR is a transcription factor that regulates gene expression in response to ligands.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "AHR (ARYL HYDROCARBON RECEPTOR)</ENTITY>"}, {"entity_type": "AHR AGONIST/CHEMICAL</ENTITY>", "description": "Ficz is an AHR agonist that mimics the effects of natural ligands.", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "id": "FICZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)</ENTITY>"}, {"entity_type": "PROTEIN", "description": "An aryl hydrocarbon receptor, a transcription factor.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 142}]", "id": "AHR"}, {"entity_type": "NUTRIENT", "description": "An essential amino acid that is metabolized by the gut microbiota and AHR.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "TRYPTOPHAN"}, {"entity_type": "METABOLITE", "description": "A metabolite produced from tryptophan via IDO1.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "KYNURENINE (KYN)"}, {"entity_type": "METABOLITE", "description": "A metabolite produced by the gut microbiota.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "INDOLE-3-ACETIC ACID (IAA)"}, {"entity_type": "DISEASE", "description": "Inflammatory bowel disease, a collective term for Crohn\'s disease and ulcerative colitis.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 118}]", "id": "IBD"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "The collection of microorganisms inhabiting the gut.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 99}]", "id": "MICROBIOTA"}, {"entity_type": "PROTEIN", "description": "An enzyme that catalyzes the conversion of tryptophan to Kynurenine.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "IDO1"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Substrates that bind to and activate the AHR.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 99}]", "id": "AHR LIGANDS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the CARD9 gene associated with IBD risk.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "CARD9 GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific single-nucleotide polymorphism (SNP) in the CARD9 gene.", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "id": "RS10781499"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "Card9 knockout mice exhibited an unusual positive correlation between bacterial and fungal biodiversity.)<SEP>Card9 knockout mice show decreased biodiversity in their gut microbiome compared to wild-type mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 17}]", "id": "BIODIVERSITY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "In WT mice, there was a negative correlation between bacterial and fungal biodiversity, suggesting competition.)", "entity_type": "UNKNOWN", "id": "BACTERIAL BIODIVERSITY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "In WT mice, there was a negative correlation between bacterial and fungal biodiversity, suggesting competition.)", "entity_type": "UNKNOWN", "id": "FUNGAL BIODIVERSITY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "Decreased IL-22 expression was observed in Card9\u2212/\u2212\u2192GF mice, contributing to their impaired recovery from DSS-induced epithelial injury.)", "entity_type": "UNKNOWN", "id": "DSS-INDUCED INJURY"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "TH22 cells were found to produce less IL-22 in the colon lamina propria of Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "entity_type": "UNKNOWN", "id": "IL-22 PRODUCTION"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "TH22 cells were found to produce less IL-22 in the colon lamina propria of Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "entity_type": "UNKNOWN", "id": "TH22 CELLS"}, {"source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "description": "NKp46+ ILCs produced less IL-22 in the colon lamina propria of Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "entity_type": "UNKNOWN", "id": "NKP46+ ILCS"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "The Card9 gene is involved in the production of IL-22 by T cells and ILCs in the colon.)", "entity_type": "UNKNOWN", "id": "IL-22 PRODUCTION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Defects in the Card9 gene lead to increased susceptibility to DSS-induced colitis.)", "entity_type": "UNKNOWN", "id": "COLITIS SUSCEPTIBILITY</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Production of IL-22 is crucial for recovery from DSS-induced colitis.)", "entity_type": "UNKNOWN", "id": "COLITIS RECOVERY</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of DSS causes inflammation and damage to the colon, mimicking inflammatory bowel disease.)<SEP>Administration of DSS induces colitis in mice.)", "entity_type": "UNKNOWN", "id": "COLITIS INDUCTION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Tryptophan metabolites, such as IAA, can activate the AHR.)", "entity_type": "UNKNOWN", "id": "AHR ACTIVATION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Kyn can also modulate AHR activity.)", "entity_type": "UNKNOWN", "id": "KYNURENINE</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "IDO1 catalyzes the production of Kyn from tryptophan.)", "entity_type": "UNKNOWN", "id": "KYN PRODUCTION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Mice lacking Card9 are more susceptible to colitis compared to wild-type mice.)", "entity_type": "UNKNOWN", "id": "CARD9\u2212/\u2212 MICE</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "L. reuteri can activate AHR.)", "entity_type": "UNKNOWN", "id": "L. REUTERI</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Allobaculum sp. can activate AHR.)", "entity_type": "UNKNOWN", "id": "ALLOBACULUM</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Ficz is an agonist that activates the AHR.)", "entity_type": "UNKNOWN", "id": "AHR AGONIST</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Wild-type mice are less susceptible to colitis compared to Card9\u2212/\u2212 mice.)", "entity_type": "UNKNOWN", "id": "WT</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Germ-free mice are less susceptible to colitis compared to conventional mice with microbiota.)", "entity_type": "UNKNOWN", "id": "GF</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "IL-23 stimulates the production of IL-22 by T cells and ILCs.)", "entity_type": "UNKNOWN", "id": "IMMUNE CELL STIMULATION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "ILCs are important producers of IL-22 in the gut.)", "entity_type": "UNKNOWN", "id": "ILC</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Expression of Reg3g and Reg3b is protective against colitis by inhibiting bacterial growth.)", "entity_type": "UNKNOWN", "id": "COLITIS PROTECTION</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of Ficz reduces colitis severity by activating AHR.)", "entity_type": "UNKNOWN", "id": "COLITIS TREATMENT</ENTITY>"}, {"source_id": "chunk-29025895ac187b8e88dec5cea9478842", "description": "Administration of Ficz reduces colitis severity by activating AHR.)", "entity_type": "UNKNOWN", "id": "FICZ</ENTITY>"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Impaired tryptophan metabolism leads to defective AHR activation.)", "entity_type": "UNKNOWN", "id": "AHR ACTIVATION"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Impaired tryptophan metabolism leads to defective AHR activation.)", "entity_type": "UNKNOWN", "id": "TRYPTOPHAN METABOLISM"}, {"source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "description": "Patients with IBD have decreased levels of tryptophan and IAA, and increased levels of Kyn in fecal samples.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 118}]", "id": "TRYPTOPHAN METABOLITES"}, {"entity_type": "PROTEIN", "description": "\u03b22 microglobulin (\u03b22m) is a protein that forms part of the MHC complex.<SEP>\u03b22M is a gene associated with hypertension and whose expression is regulated by SH2B3.<SEP>\u03b22M is a gene that is associated with hypertension.<SEP>\u03b22m (beta-2 microglobulin) is a protein that associates with HLA class I molecules.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "\u03922M"}, {"entity_type": "DISEASE", "description": "Hypertension is a cardiovascular disease characterized by elevated blood pressure.<SEP>Hypertension is a cardiovascular disease characterized by elevated blood pressure.<SEP>Hypertension refers to high blood pressure, a risk factor for cardiovascular disease.<SEP>Hypertension is a condition characterized by high blood pressure.<SEP>Hypertension, or high blood pressure, is a condition where the force of blood against artery walls is consistently too high.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579<SEP>chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "HYPERTENSION"}, {"entity_type": "GENE", "description": "SH2B3 is a gene that regulates \u03b22M expression and is linked to hypertension.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "SH2B3"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3184504 is a polymorphism associated with both \u03b22M levels and SH2B3 expression.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "RS3184504"}, {"entity_type": "STATISTICAL MEASURE", "description": "Odds ratio (OR) is a statistical measure used to quantify the association between an exposure and an outcome in observational studies.<SEP>The odds ratio is a measure of association used to quantify the strength of the relationship between variables.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5<SEP>chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "ODDS RATIO (OR)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Confidence interval (CI) is a range of values within which the true population parameter is likely to fall.", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "id": "CONFIDENCE INTERVAL (CI)"}, {"source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "description": "Decreased SH2B3 expression was found to be causally related to higher \u03b22M levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "SH2B3 EXPRESSION"}, {"entity_type": "GENE", "description": "DHFR is a gene involved in folate metabolism.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "DHFR"}, {"entity_type": "GENE", "description": "MTHFD1 is a gene involved in folate metabolism.<SEP>Methylenetetrahydrofolate dehydrogenase 1 gene (MTHFD1) encodes a protein with three enzyme activities involved in one-carbon derivative metabolism.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914<SEP>chunk-382f24e5db6941e2e3db379fe499b223", "id": "MTHFD1"}, {"entity_type": "GENE", "description": "SHMT1 is a gene involved in folate metabolism.<SEP>Serine Hidroximetil Transferase 1 gene (SHMT1) is involved in pyrimidine synthesis and the reversible conversion of serine to glycine.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914<SEP>chunk-382f24e5db6941e2e3db379fe499b223", "id": "SHMT1"}, {"entity_type": "GENE", "description": "TYMS is a gene involved in folate metabolism.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "TYMS"}, {"entity_type": "NUTRIENT", "description": "A B vitamin essential for DNA synthesis, cell division, and other metabolic processes.<SEP>Folate is a crucial nutrient for cell growth and development.<SEP>Folate is a nutrient that can be measured in blood levels and is linked to various health outcomes.<SEP>Folate is a vitamin essential for various metabolic processes, particularly DNA synthesis and cell division.<SEP>Folate (Vitamin B9) is an essential nutrient involved in cell growth and DNA synthesis.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-9a35876dc1aaf7342f023cab4f5b9914<SEP>chunk-dd3c1834035af8b4436c8058609b6fd8<SEP>chunk-22216738ccbae0a6276bb4499018c434", "id": "FOLATE"}, {"entity_type": "DISEASE", "description": "NTDs are neural tube defects, birth defects that occur when the neural tube, which develops into the brain and spinal cord, does not close properly.", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "id": "NTD"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "SNP rs2236224 in the MTHFD1 gene was associated with an increased risk of NTDs in infants with low folate intake compared to those with high folate intake.)", "entity_type": "UNKNOWN", "id": "RS2236224"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914<SEP>chunk-382f24e5db6941e2e3db379fe499b223", "description": "SNP rs2236225 in the MTHFD1 gene was associated with an increased risk of NTDs in infants with low folate intake compared to those with high folate intake.)<SEP>The transition from G to A (rs2236225) in the MTHFD1 gene, resulting in ARG-653-GLN alteration, is associated with susceptibility to neural tube defects and found at increased frequencies in TMD patients.", "entity_type": "GENOMIC VARIANT", "id": "RS2236225"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "SNP rs11627387 in the MTHFD1 gene was associated with a four-fold increase in NTD risk when there was low maternal folate intake compared to infants with the GG genotype and high maternal folate intake.)", "entity_type": "UNKNOWN", "id": "RS11627387"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Heterozygous mothers carrying the MTHFR SNP rs1476413 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "entity_type": "UNKNOWN", "id": "RS1476413"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Heterozygous mothers carrying the MTHFR SNP rs1801131 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "entity_type": "UNKNOWN", "id": "RS1801131"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "Heterozygous mothers carrying the MTHFR SNP rs1801133 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "entity_type": "UNKNOWN", "id": "RS1801133"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The maternal SHMT1 SNP rs669340 CG genotype was associated with a reduced risk of an NTD-affected pregnancy compared to mothers with the CC genotype.)", "entity_type": "UNKNOWN", "id": "RS669340"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "An interaction effect was observed for risk of NTDs in infants with the SHMT1 SNP rs12939757 AG genotype that were in the low folate intake group compared to infants with the AA genotype that were in the high folate intake group.)", "entity_type": "UNKNOWN", "id": "RS12939757"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The TYMS SNP rs502396 heterozygous genotype was associated with a reduced risk of NTDs for mothers in the low folate intake group compared to the high folate intake group with the common homozygous genotype.)", "entity_type": "UNKNOWN", "id": "RS502396"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The TYMS SNP rs699517 heterozygous genotype was associated with a reduced risk of NTDs for mothers in the low folate intake group compared to the high folate intake group with the common homozygous genotype.)", "entity_type": "UNKNOWN", "id": "RS699517"}, {"source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "description": "The TYMS SNP rs2847153 AG genotype was associated with a reduced risk of NTDs in infants.)", "entity_type": "UNKNOWN", "id": "RS2847153"}, {"entity_type": "GENOMIC VARIANT", "description": "rs10399931 is a genomic variant within the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "RS10399931"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4950928 is a genomic variant within the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 47}]", "id": "RS4950928"}, {"entity_type": "GENE", "description": "CHI3LI is a gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 44}]", "id": "CHI3LI"}, {"entity_type": "DISEASE", "description": "IFG is a condition characterized by elevated blood glucose levels after fasting.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED FASTING GLUCOSE (IFG)"}, {"entity_type": "DISEASE", "description": "IGT is a condition characterized by an inability to properly regulate blood glucose levels after consuming glucose.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "IMPAIRED GLUCOSE TOLERANCE (IGT)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum C-peptide concentration is a measure of insulin secretion.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "clusters": "[{level: 0, cluster: 6}, {level: 1, cluster: 47}]", "id": "SERUM C-PEPTIDE CONCENTRATION"}, {"entity_type": "COHORT", "description": "The Inter99 cohort is a group of individuals who participated in a study.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "INTER99"}, {"entity_type": "HEALTHCARE FACILITY", "description": "Steno Diabetes Center is a healthcare facility where individuals were recruited for the study.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "STENO DIABETES CENTER"}, {"entity_type": "DISEASE GROUP", "description": "T2D patients are individuals diagnosed with Type 2 Diabetes.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "T2D PATIENTS"}, {"entity_type": "HEALTH STATUS", "description": "Individuals with normal glucose tolerance have healthy blood sugar levels.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "INDIVIDUALS WITH NORMAL GLUCOSE TOLERANCE"}, {"entity_type": "GENETIC VARIANT", "description": "tgSNPs refer to tagging SNPs, which are genetic variants used to represent other variations in a region of DNA.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "TGSNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12123883 is a specific genomic variant within the CHI3LI gene.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "RS12123883"}, {"entity_type": "TABLE", "description": "A table containing information about SNPs in CCHCR1.<SEP>Table 1 presents clinical characteristics for the Inter99 cohort and individuals from Steno Diabetes Center.", "source_id": "chunk-72f4505e43f67f3564607392cb178656<SEP>chunk-44a871da300abc9be525b468f502f5cb", "id": "TABLE 1"}, {"entity_type": "DATA TABLE", "description": "Table 2 shows the association of rs10399931, rs4950928, and other tgSNPs of CHI3LI with T2D.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "TABLE 2"}, {"entity_type": "DATA TABLES", "description": "Tables 3 and 4 present multiadjusted associations between rs10399931 and rs4950928 with BMI and other T2D-related quantitative traits.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "TABLE 3 & 4"}, {"entity_type": "DATA TABLE", "description": "Table 5 shows the association of CHI3LI haplotype blocks with T2D.", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "id": "TABLE 5"}, {"entity_type": "DISEASE", "description": "Age-Related Macular Degeneration (AMD) is a degenerative eye disease.<SEP>Age-related macular degeneration, a common eye disease.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5<SEP>chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "AMD"}, {"entity_type": "DIETARY PATTERN", "description": "Healthy Lifestyle Score, a measure of healthy dietary and lifestyle choices.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "HLS"}, {"entity_type": "GENE", "description": "Complement factor H gene, involved in regulating the complement system.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "CFH"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk allele in the CFH gene associated with increased AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "Y402H CFH RISK ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk allele in the CFH gene associated with increased AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "A69S RISK ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the CFB/C2 gene associated with increased AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "RS641153 (CFB/C2)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the CFI gene not significantly associated with AMD risk in this study.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS10033900 (CFI)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism in the C3 gene not significantly associated with AMD risk in this study.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "RS2230199 (C3)"}, {"entity_type": "GENE", "description": "ARMS2 is a gene associated with Age-Related Macular Degeneration (AMD) risk.<SEP>Age-related Macular Degeneration Susceptibility 2 gene, involved in retinal function and associated with AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5<SEP>chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "ARMS2"}, {"entity_type": "GENOMIC VARIANT", "description": "A risk allele in the ARMS2 gene associated with increased AMD risk.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "A69S ARMS2 RISK ALLELE"}, {"entity_type": "DIETARY PATTERN", "description": "Lifestyle Factors, measured by low levels of leafy greens, dietary LZ (plasma) and MPOD.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "id": "LZ"}, {"entity_type": "NUTRIENT", "description": "A type of polyunsaturated fat found in certain foods, which may have health benefits.<SEP>Omega-3 fatty acids are essential fats that may help lower triglyceride levels.", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "OMEGA-3 FATTY ACIDS"}, {"entity_type": "GENE", "description": "CFB/C2 is a gene involved in the complement pathway.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 137}]", "id": "CFB/C2"}, {"entity_type": "GENOMIC VARIANT", "description": "C3 rs2230199 is a specific variant in the C3 gene.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 137}]", "id": "C3 RS2230199"}, {"entity_type": "GENOMIC VARIANT", "description": "CFI rs10033900 is a specific variant in the CFI gene.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 137}]", "id": "CFI RS10033900"}, {"entity_type": "LIFESTYLE FACTOR", "description": "A healthy lifestyle score, reflecting factors like diet and exercise, was considered in this study.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 137}]", "id": "HEALTHY LIFESTYLE SCORE"}, {"entity_type": "DISEASE", "description": "Age-Related Macular Degeneration is a degenerative eye disease.", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "id": "AGE-RELATED MACULAR DEGENERATION (AMD)"}, {"entity_type": "STATISTICAL MEASURE", "description": "Synergy index (SI", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 137}]", "id": "SYNERGY INDEX (SI)"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Women with two copies of the Y402H CFH risk allele had 2.4 times greater odds of AMD.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "CFH Y402H RISK ALLELE"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Each additional risk CFH allele increased odds for AMD.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "CFH GENOTYPE"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "Low HLS was associated with increased odds of AMD.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "The joint effect of low HLS and high-risk CFH genotype on AMD risk was greater than the sum of their individual effects, suggesting synergy.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "CFH GENOTYPE & HLS"}, {"source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "description": "At least one ARMS2 risk allele was associated with increased odds of AMD.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 136}]", "id": "ARMS2 RISK ALLELE"}, {"entity_type": "GENE", "description": "HECTD4 is a gene located in the region associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "HECTD4"}, {"entity_type": "GENE", "description": "ACAD10 is a gene located in the region associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "ACAD10"}, {"entity_type": "GENE", "description": "CUX2 is a gene located in the region associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "CUX2"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs2074356 is located in the HECTD4 gene and is associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS2074356"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs11066015 is located in the ACAD10 gene and is associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS11066015"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs12229654 is located in the MYL2 gene and is associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS12229654"}, {"entity_type": "GENOMIC VARIANT", "description": "Imputed SNP rs11065828 is associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS11065828"}, {"entity_type": "GENOMIC VARIANT", "description": "Imputed SNP rs79105258 is associated with coffee consumption.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "RS79105258"}, {"entity_type": "DIETARY PATTERN", "description": "The regular intake of coffee beverages.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "COFFEE CONSUMPTION"}, {"entity_type": "DIETARY PATTERN", "description": "Coffee consumed without added sugar.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "BLACK COFFEE"}, {"entity_type": "DIETARY PATTERN", "description": "Coffee consumed with added sugar.", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "id": "SUGARED COFFEE"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Participants who consumed \u22652 cups/day of black coffee had a lower risk of developing prediabetes and type 2 diabetes combined.)", "entity_type": "UNKNOWN", "id": "BLACK COFFEE CONSUMPTION"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Participants who consumed \u22652 cups/day of black coffee had a lower risk of developing prediabetes and type 2 diabetes combined.)", "entity_type": "UNKNOWN", "id": "PREDIABETES AND TYPE 2 DIABETES COMBINED"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Participants who consumed sugary coffee had a lower risk of developing prediabetes and type 2 diabetes combined.)", "entity_type": "UNKNOWN", "id": "SUGARY COFFEE CONSUMPTION"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "The inverse association between black coffee consumption and the risk of prediabetes and type 2 diabetes was more pronounced among individuals with high genetic risk scores, although not statistically significant.)", "entity_type": "UNKNOWN", "id": "BLACK COFFEE CONSUMPTION EFFECT ON PREDIABETES AND TYPE 2 DIABETES"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "The inverse association between black coffee consumption and the risk of prediabetes and type 2 diabetes was more pronounced among individuals with high genetic risk scores, although not statistically significant.)", "entity_type": "UNKNOWN", "id": "HIGH GENETIC RISK SCORE"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "For each coffee-related SNP, the association between black coffee consumption and the risk of prediabetes and type 2 diabetes was inverse for the minor allele.)<SEP>Specific genetic variations (SNPs) in genes like HECTD4, ACAD10, MYL2, and CUX2 were associated with coffee consumption and potentially influence the relationship between coffee and diabetes risk.)", "entity_type": "UNKNOWN", "id": "COFFEE-RELATED SNPS"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Participants who consumed \u22652 cups/day of black coffee had a lower risk of prediabetes and type 2 diabetes compared to non-black-coffee consumers.)", "entity_type": "UNKNOWN", "id": "PREDIABETES AND TYPE 2 DIABETES RISK"}, {"source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "description": "Similar to black coffee, sugared coffee consumption was associated with a reduced risk of prediabetes and type 2 diabetes.)", "entity_type": "UNKNOWN", "id": "SUGARED COFFEE CONSUMPTION"}, {"entity_type": "GENE", "description": "SENP1 is a gene involved in regulating adipogenesis and insulin sensitivity.<SEP>SENP1 is a gene involved in the development of type 1 diabetes.<SEP>SENP1 is a gene that encodes for a protein involved in regulating NF-\u03baB activation and cytokine production in adipocytes.<SEP>SENP1 is a gene that plays a role in adipocyte function and may be involved in the pathogenesis of type 1 diabetes.<SEP>SENP1 is a gene that plays a role in immunity and potentially diabetes.<SEP>SENP1 is a gene that plays a role in regulating inflammation and adipocyte function.<SEP>SENP1 is a gene that, when deficient, leads to T1DM phenotype in mice.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-fc33d6399ec56e65d007269407f1953d<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-eaf655c4dd9244523b048a122e232be4<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "SENP1"}, {"entity_type": "GENE", "description": "Adiponectin is a gene used as a promoter for Cre recombinase in SENP1-AdipoqKO mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ADIPONECTIN"}, {"entity_type": "GENE", "description": "PdgfR\u03b1 is a gene used as a promoter for Cre recombinase in SENP1-PdgfRKO mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PDGFR\u0391"}, {"entity_type": "GENE", "description": "aP2/Fabp4 is a gene used as a promoter for Cre recombinase in SENP1-aP2KO mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "AP2/FABP4"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The mT/mG reporter system was used to visualize Cre recombination in adipocytes of aP2-Cre deleter mice.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "MT/MG REPORTER"}, {"entity_type": "GENE KNOCKOUT MODEL", "description": "A genotype representing mice with a targeted deletion of the SENP1 gene and the adiponectin (Adipoq) gene.<SEP>SENP1-AdipoqKO is a mouse model where SENP1 gene is deleted specifically in adipocytes using Adiponectin promoter driven Cre recombinase.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "id": "SENP1-ADIPOQKO"}, {"entity_type": "GENE KNOCKOUT MODEL", "description": "A genotype representing mice with a targeted deletion of the SENP1 gene and the platelet-derived growth factor receptor alpha (Pdgfr\u03b1) gene.<SEP>SENP1-PdgfRKO is a mouse model where SENP1 gene is deleted specifically in adipocytes using PdgfR\u03b1 promoter driven Cre recombinase.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "id": "SENP1-PDGFRKO"}, {"entity_type": "GENOMIC VARIANT", "description": "A genotype representing mice with a targeted deletion of the SENP1 gene in the adipose tissue (aP2 promoter) expressing adipocytes.<SEP>SENP1-aP2KO is a mouse model where SENP1 gene is deleted specifically in adipocytes using aP2/Fabp4 promoter driven Cre recombinase.<SEP>SENP1-aP2KO is a mouse model with a deletion of SENP1 in adipocytes.<SEP>SENP1-aP2KO mice are genetically modified mice with a knockout of the SENP1 gene in adipose tissue.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "SENP1-AP2KO"}, {"entity_type": "CONTROL GROUP", "description": "SENP1lox/lox mice are control mice without deletion of the SENP1 gene.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SENP1LOX/LOX"}, {"entity_type": "CELL TYPE", "description": "CD11b+F4/80+ cells are macrophages.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "CD11B+F4/80+"}, {"entity_type": "TISSUE", "description": "Pancreatic islets are clusters of endocrine cells in the pancreas responsible for insulin secretion.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PANCREATIC ISLETS"}, {"entity_type": "TISSUE", "description": "Interscapular brown adipose tissue is a type of fat tissue involved in thermogenesis.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INTERSTITIAL BROWN ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Perigonadal white adipose tissue is a type of fat tissue located around the gonads.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERIGONADAL WHITE ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Peri-pancreatic adipose tissue is a type of fat tissue surrounding the pancreas.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "PERI-PANCREATIC ADIPOSE TISSUE (PAT)"}, {"entity_type": "CELL TYPE", "description": "Smooth muscle cells and pericytes are cell types found in blood vessels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "SMOOTH MUSCLE CELLS/PERICYTES"}, {"entity_type": "CELL TYPE", "description": "Vascular endothelial cells form the lining of blood vessels.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "VASCULAR ENDOTHELIAL CELLS"}, {"entity_type": "DISEASE", "description": "An autoimmune disorder characterized by the destruction of insulin-producing cells in the pancreas.)<SEP>Type 1 diabetes mellitus is an autoimmune disease characterized by destruction of insulin-producing beta cells in the pancreas.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-a8f2b3b97a70df26efb35263714bf43c", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "TYPE 1 DIABETES MELLITUS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cre recombinase is an enzyme used to induce site-specific recombination.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "CRE RECOMBINASE"}, {"entity_type": "CELL TYPE", "description": "Adipocytes are cells specialized in fat storage and release.<SEP>Adipocytes are cells that store fat.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "id": "ADIPOCYTE"}, {"entity_type": "TISSUE", "description": "White adipose tissue is a type of fat tissue involved in energy storage.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "WHITE ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Beige adipose tissue is a type of fat tissue with features of both white and brown adipose tissue.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "BEIGE ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Brown adipose tissue is a type of fat tissue involved in thermogenesis.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "BROWN ADIPOSE TISSUE"}, {"entity_type": "CELL TYPE", "description": "Islet \u03b2 cells are endocrine cells in the pancreas responsible for insulin production.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "ISLET \u0392 CELL"}, {"entity_type": "TEST", "description": "Glucose tolerance test is a diagnostic procedure to assess glucose metabolism.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "GLUCOSE TOLERANCE TEST (GTT)"}, {"entity_type": "TEST", "description": "Insulin tolerance test is a diagnostic procedure to assess insulin sensitivity.", "source_id": "chunk-a8f2b3b97a70df26efb35263714bf43c", "id": "INSULIN TOLERANCE TEST (ITT)"}, {"entity_type": "DISEASE", "description": "Insulin-dependent diabetes mellitus is a chronic autoimmune disease characterized by destruction of insulin-producing beta cells in the pancreas.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN-DEPENDENT DIABETES MELLITUS"}, {"entity_type": "CELL TYPE", "description": "Pancreatic islet \u03b2 cells are specialized endocrine cells responsible for producing and secreting insulin.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 68}]", "id": "PANCREATIC ISLET \u0392 CELLS"}, {"entity_type": "MODEL ORGANISM", "description": "SENP1-deficient mice are genetically engineered mice lacking functional SENP1 gene, used as a model to study the role of SENP1 in diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "SENP1-DEFICIENT MICE"}, {"entity_type": "PROCESS", "description": "Immune cell invasion refers to the infiltration of immune cells into pancreatic islets, leading to inflammation and destruction of \u03b2 cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "IMMUNE CELL INVASION"}, {"entity_type": "MECHANISM", "description": "T-cell mediated destruction is a key mechanism in type 1 diabetes where cytotoxic T cells attack and kill insulin-producing \u03b2 cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "T-CELL MEDIATED DESTRUCTION"}, {"entity_type": "DISEASE", "description": "Type 1 diabetes (T1DM) is an autoimmune disease characterized by the destruction of pancreatic beta cells, leading to high blood sugar levels.<SEP>Type 1 diabetes is an autoimmune disease affecting the pancreas.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "TYPE 1 DIABETES"}, {"entity_type": "CELL", "description": "CD8+ T cells are a subtype of T lymphocyte involved in cytotoxic immunity.<SEP>CD8+ T cells are cytotoxic lymphocytes that play a crucial role in killing infected or cancerous cells, including \u03b2 cells in T1DM.<SEP>CD8+ T cells are immune cells that play a role in killing infected or cancerous cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-d3a9c93928447522ce3df4209f8ac803<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 68}]", "id": "CD8+ T CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD4+ T cells are a subtype of T lymphocyte involved in cell-mediated immunity.<SEP>CD4+ T cells are helper lymphocytes that orchestrate immune responses by releasing cytokines and activating other immune cells.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-fc33d6399ec56e65d007269407f1953d", "id": "CD4+ T CELLS"}, {"entity_type": "BIOMARKER", "description": "Insulin autoantibodies (IAA) are a specific biomarker for type 1 diabetes, indicating an autoimmune response against \u03b2 cells.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "INSULIN AUTOANTIBODY (IAA)"}, {"entity_type": "METABOLITE", "description": "\u03b2-hydroxybutyrate is a ketone body produced by the liver during periods of low glucose availability, often seen in uncontrolled diabetes.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "\u0392-HYDROXYBUTYRATE"}, {"entity_type": "SYSTEM", "description": "The immune system is a complex network of cells and tissues that protect the body from pathogens and disease.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "IMMUNE SYSTEM"}, {"entity_type": "TISSUE", "description": "Skin is an organ that acts as a protective barrier against external environment.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "SKIN"}, {"entity_type": "ORGAN", "description": "Lymph nodes are small, bean-shaped organs that filter lymph fluid and play a role in immune responses.", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "id": "LYMPH NODES"}, {"entity_type": "MOLECULAR INTERACTION", "description": "NRP-V7-positive CD8+ T cells are immune cells that target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "NRP-V7-POSITIVE CD8+ T CELLS"}, {"entity_type": "PROTEIN", "description": "Islet-specific glucose-6-phosphatase catalytic subunit-related protein is a target antigen for NRP-V7-positive CD8+ T cells.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN"}, {"entity_type": "DISEASE", "description": "T1DM stands for type 1 diabetes mellitus, an autoimmune disease that affects the pancreas and insulin production.<SEP>Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease characterized by destruction of insulin-producing cells.<SEP>Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by insulin deficiency.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "T1DM"}, {"entity_type": "CELL TYPE", "description": "\u03b2 cells are pancreatic cells that produce insulin.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "\u0392 CELLS"}, {"entity_type": "TISSUE", "description": "PATs refers to pancreatic adipose tissue.<SEP>Peri-adipose tissues (PATs) are a type of adipose tissue.<SEP>Perigonadal adipose tissue (PATs) are a type of adipose tissue that plays a role in energy storage and metabolism.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "PATS"}, {"entity_type": "DISEASE", "description": "Cardiac myocarditis is inflammation of the heart muscle.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CARDIAC MYOCARDITIS"}, {"entity_type": "IMMUNE CELL", "description": "Macrophages are immune cells involved in inflammation.<SEP>Macrophages are immune cells that engulf and destroy pathogens.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "MACROPHAGES"}, {"entity_type": "CELLULAR COMPONENT", "description": "T cells are a type of immune cell.<SEP>T cells are immune cells involved in adaptive immunity.<SEP>T cells are immune cells that play a role in both psoriasiform and eczematous reactions.<SEP>T cells are lymphocytes responsible for cell-mediated immunity.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-4389e37ac64d551cdf89e7f4230a3589<SEP>chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "id": "T CELLS"}, {"entity_type": "CYTOKINE", "description": "CCL5 is a chemokine that recruits immune cells to sites of inflammation.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CCL5 (RANTES)"}, {"entity_type": "MODEL ORGANISM", "description": "SENP1-aP2KO mice are a genetically modified mouse model used to study SENP1 function.<SEP>SENP1-aP2KO mice are genetically modified mice with a deletion of the SENP1 gene specifically in adipocytes.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "SENP1-AP2KO MICE"}, {"entity_type": "TISSUE", "description": "Pancreatic lymph nodes are lymphoid tissues that filter lymph fluid from the pancreas.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PANCREATIC LYMPH NODES"}, {"entity_type": "TISSUE", "description": "Islets of Langerhans are clusters of cells within the pancreas that produce insulin and other hormones.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "ISLETS OF LANGERHANS"}, {"entity_type": "MODEL ORGANISM", "description": "Ctrl mice are control mice used for comparison with SENP1-aP2KO mice.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "CTRL MICE"}, {"entity_type": "TISSUE", "description": "Subcutaneous adipose tissue is fat tissue located beneath the skin.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "SUBCUTANEOUS ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Inguinal adipose tissue is a type of subcutaneous adipose tissue located in the groin area.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "INGUINAL ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Gonadal adipose tissue is adipose tissue found in the reproductive organs.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "GONADAL ADIPOSE TISSUE"}, {"entity_type": "TISSUE", "description": "Peri-renal adipose tissue is adipose tissue surrounding the kidneys.", "source_id": "chunk-0c1631ae2c195cb68139ea9d75a3b433", "id": "PERI-RENAL ADIPOSE TISSUE"}, {"entity_type": "CHEMOKINE", "description": "CCL5 is a chemokine that recruits immune cells to the pancreas.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "CCL5"}, {"entity_type": "PANCREATIC BETA CELL", "description": "\u03b2 cells are insulin-producing cells in the pancreas.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "\u0392 CELL"}, {"entity_type": "PANCREATIC ORGAN", "description": "The pancreatic islet is the cluster of endocrine cells in the pancreas, including \u03b2 cells.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PANCREATIC ISLET"}, {"entity_type": "CELL SUBTYPE", "description": "Peri-pancreatic adipocytes are adipocytes located around the pancreas.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "PERI-PANCREATIC ADIPOCYTES"}, {"entity_type": "TRANSCRIPTION FACTOR", "description": "NF-\u03baB is a transcription factor that regulates inflammatory genes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "NF-\u039aB"}, {"entity_type": "PROTEIN", "description": "FABP4 is a protein marker of adipocytes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "FABP4"}, {"entity_type": "CONTROL GROUP", "description": "A control group used for comparison in experiments.<SEP>Control group refers to mice that did not have genetic modifications.<SEP>Ctrl represents a control group, often used for comparison with experimental groups.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-eaf655c4dd9244523b048a122e232be4", "clusters": "[{level: 0, cluster: 33}]", "id": "CTRL"}, {"entity_type": "CELL TYPE", "description": "Adipocytes from SENP1 knockout mice with a targeted deletion of the SENP1 gene in the adipose tissue (aP2 promoter) expressing adipocytes.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "SENP1-AP2KO ADIPOCYTES"}, {"entity_type": "CELL TYPE", "description": "Adipocytes from control mice.", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "id": "CTRL ADIPOCYTES"}, {"entity_type": "PROTEIN", "description": "IKK (I\u03baB kinase) is a key enzyme in the NF-\u03baB signaling pathway.<SEP>IKK is a protein that plays a critical role in the NF-\u03baB signaling pathway.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "IKK"}, {"entity_type": "PROTEIN", "description": "I\u03baB\u03b1 is a protein that inhibits NF-\u03baB activity.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "I\u039aB\u0391"}, {"entity_type": "PROTEIN", "description": "NF-\u03baB p65/RelA is a protein that acts as a transcription factor in the NF-\u03baB signaling pathway.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "NF-\u039aB P65/RELA"}, {"entity_type": "PROTEIN", "description": "NEMO is a subunit of IKK complex and can be SUMOylated.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 166}]", "id": "NEMO"}, {"entity_type": "PROTEIN", "description": "SUMO1 is a small ubiquitin-like modifier protein that can be attached to target proteins.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 166}]", "id": "SUMO1"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Etoposide VP16 is a DNA damaging agent that induces stress responses.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "ETOPOSIDE VP16"}, {"entity_type": "GENETIC MODIFICATION", "description": "siRNA targeting SENP1 is used to knock down its expression.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 33}]", "id": "SENP1 SIRNA"}, {"entity_type": "CELL TYPE", "description": "Adipocytes are fat cells that play a role in energy storage and metabolism.<SEP>Adipocytes are specialized cells found in adipose tissue that store fat.<SEP>Adipocytes are fat cells that store and release triglycerides.", "source_id": "chunk-174831b97ed170039b374ba254d4f506<SEP>chunk-f290cff8dac7b522b4f56d03e8df48ce<SEP>chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 33}]", "id": "ADIPOCYTES"}, {"entity_type": "PROTEIN", "description": "SENP2 is a protein that can deSUMOylate NEMO.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "SENP2"}, {"entity_type": "PROTEIN TAG", "description": "Flag-NEMO is a NEMO protein tagged with a Flag epitope for detection and purification.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 165}]", "id": "FLAG-NEMO"}, {"entity_type": "ANIMAL MODEL", "description": "NOD mice are a model for type 1 diabetes.", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "id": "NOD MICE"}, {"entity_type": "DISEASE", "description": "The NOD mouse is a model for studying type 1 diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "NOD MOUSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hyperglycaemia refers to high blood sugar levels, a characteristic of diabetes.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "HYPERGLYCAEMIA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Islet disruption involves damage to the insulin-producing beta cells in the pancreas, leading to impaired insulin production.", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "ISLET DISRUPTION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "High-fat diet (HFD) is an environmental factor that influences metabolic processes.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "HFD"}, {"entity_type": "ADIPOSE TISSUE", "description": "Epididymal fat is a type of adipose tissue located near the epididymis.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "EPIDIDYMAL FAT"}, {"entity_type": "PHYSIOLOGICAL MEASUREMENT", "description": "Body weight is a physiological measurement reflecting the mass of an organism.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "BODY WEIGHT"}, {"entity_type": "PHYSIOLOGICAL CONDITION", "description": "Insulin resistance is a physiological condition where cells become less responsive to insulin.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "INSULIN RESISTANCE"}, {"entity_type": "EXPERIMENTAL METHOD", "description": "Intravenous Glucose Tolerance Test (ITT) is an experimental method to assess insulin sensitivity.", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "id": "ITT ASSAY"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "SENP1 deficiency leads to increased production of proinflammatory cytokines by adipocytes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "CYTOKINE PRODUCTION"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "SENP1 deletion increases NF-\u03baB activation in adipocytes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 167}]", "id": "NF-\u039aB ACTIVATION"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Cytokines secreted from SENP1-deficient adipocytes induce \u03b2 cell death in pancreatic islets.)", "entity_type": "UNKNOWN", "id": "ADIPOCYTE-DERIVED CYTOKINES"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Cytokines secreted from SENP1-deficient adipocytes induce \u03b2 cell death in pancreatic islets.)", "entity_type": "UNKNOWN", "id": "\u0392 CELL DEATH"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "SENP1-deficient adipocytes have smaller cell sizes compared to control adipocytes.)", "entity_type": "UNKNOWN", "id": "SMALLER CELL SIZE"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "SENP1-deficient adipocytes produce higher levels of proinflammatory cytokines compared to control adipocytes.)", "entity_type": "UNKNOWN", "id": "PROINFLAMMATORY CYTOKINE PRODUCTION"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Deletion of SENP1 leads to increased infiltration of immune cells into the pancreas.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "IMMUNE CELL INFILTRATION"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Adipocytes from SENP1-deficient mice exhibit reduced adipogenic differentiation markers.)", "entity_type": "UNKNOWN", "id": "REDUCED ADIPOGENESIS"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Adipocytes from SENP1-deficient mice exhibit reduced adipogenic differentiation markers.)", "entity_type": "UNKNOWN", "id": "SENP1-DEFICIENT ADIPOCYTES"}, {"source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "description": "Deletion of SENP1 leads to increased NF-\u03baB activation in adipocytes.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 123}, {level: 2, cluster: 167}]", "id": "SENP1 DELETION"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The expression of proinflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2 are increased in SENP1 knockdown cells, while IFN-\u03b3 expression remains unchanged.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 42}]", "id": "IL-6, TNF-\u0391, AND IL-1\u0392"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "Expression of various SENPs, including SENP1 and SENP2, is examined in PATs.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "SENPS"}, {"source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "description": "The expression of SENP1 in adipocytes of NOD mice is investigated to determine its relevance to T1DM.)", "entity_type": "UNKNOWN", "id": "SENP1 EXPRESSION"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "Proinflammatory cytokine levels are significantly higher in human T1DM patients compared to healthy individuals.)", "entity_type": "UNKNOWN", "id": "HUMAN T1DM PATIENTS"}, {"source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "description": "Proinflammatory cytokine levels are significantly higher in human T1DM patients compared to healthy individuals.)", "entity_type": "UNKNOWN", "id": "PROINFLAMMATORY CYTOKINES"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "SENP1 knockout (KO) mice exhibited increased liver insulin resistance under HFD conditions.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 57}]", "id": "LIVER INSULIN RESISTANCE"}, {"source_id": "chunk-174831b97ed170039b374ba254d4f506", "description": "HFD further reduced insulin levels in SENP1-aP2KO mice, but not in Ctrl mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 117}]", "id": "INSULIN LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "FokI is a genomic variant with rs2228570 or rs10735810 identifier. It has been associated with an increased risk of ovarian cancer.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 76}]", "id": "FOKI"}, {"entity_type": "GENOMIC VARIANT", "description": "ApaI is a genomic variant with rs7975232 identifier. It was investigated for its association with ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "clusters": "[{level: 0, cluster: 21}]", "id": "APAI"}, {"entity_type": "GENOMIC VARIANT", "description": "BsmI is a genomic variant with rs1544410 identifier. It has been investigated for its association with ovarian cancer risk.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "clusters": "[{level: 0, cluster: 21}]", "id": "BSMI"}, {"entity_type": "GENOMIC VARIANT", "description": " rs2228570 is a specific identifier for the FokI genomic variant.<SEP>rs2228570 is a SNP in the VDR gene associated with susceptibility to infection by T. cruzi and Chagas cardiomyopathy (CCC).", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "RS2228570"}, {"entity_type": "GENOMIC VARIANT", "description": " rs10735810 is another identifier for the FokI genomic variant.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 76}]", "id": "RS10735810"}, {"entity_type": "GENOMIC VARIANT", "description": " rs7975232 is a specific identifier for the ApaI genomic variant.<SEP>rs7975232 is a SNP in the VDR gene associated with susceptibility to infection by T. cruzi.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "RS7975232"}, {"entity_type": "GENOMIC VARIANT", "description": " rs1544410 is a specific identifier for the BsmI genomic variant.<SEP>rs1544410 is a SNP in the VDR gene associated with susceptibility to infection by T. cruzi.", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "RS1544410"}, {"entity_type": "GENE", "description": "A gene is a unit of heredity which is transferred from a parent to offspring and is held to determine some characteristic of the offspring.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "GENE"}, {"entity_type": "GENE", "description": "TaqI is a gene associated with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "TAQI"}, {"entity_type": "GENE", "description": "Cdx-2 is a gene associated with ovarian cancer risk.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "clusters": "[{level: 0, cluster: 12}, {level: 1, cluster: 74}]", "id": "CDX-2"}, {"entity_type": "GENOTYPE", "description": "AA/GA genotype refers to variations in the gene sequence.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "id": "AA/GA"}, {"entity_type": "GENOMIC VARIANT", "description": "GG genotype of rs1695 polymorphism<SEP>GG genotype refers to variations in the gene sequence.<SEP>The GG genotype of the ALDH2 rs671 variant is associated with the highest mean daily alcohol consumption in both men and women.", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GG"}, {"entity_type": "GENOMIC VARIANT", "description": "CC genotype of rs1138272 polymorphism<SEP>CC genotype refers to variations in the gene sequence.<SEP>CC is a genotype associated with rs2023239, observed in individuals with potential differences in response to alcohol and medication.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CC"}, {"entity_type": "GENOMIC VARIANT", "description": "TT genotype of rs1138272 polymorphism<SEP>TT genotype refers to variations in the gene sequence.<SEP>TT is a genotype associated with rs2023239, observed in individuals with potential differences in response to alcohol and medication.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-dc5e8cc04a1b16b1e00f3a4120e004c4<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TT"}, {"source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "description": "The Odds Ratio (OR) is a measure of the strength of association between a genetic variant and an outcome, like ovarian cancer.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 37}, {level: 1, cluster: 138}]", "id": "RISK"}, {"entity_type": "GENE", "description": "The VDR gene encodes the vitamin D receptor.<SEP>VDR is a gene involved in vitamin D metabolism.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "VDR"}, {"entity_type": "GENOMIC VARIANT", "description": "rs731236 is a SNP in the VDR gene associated with susceptibility to infection by T. cruzi and Chagas cardiomyopathy (CCC).<SEP>rs731236 is a genomic variant within the VDR gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91<SEP>chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "RS731236"}, {"entity_type": "DISEASE", "description": "_Trypanosoma cruzi_ is a parasitic protozoan that causes Chagas disease (American trypanosomiasis).", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "T. CRUZI"}, {"entity_type": "DISEASE", "description": "Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease caused by the parasite _T. cruzi_. ", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "id": "CHAGAS DISEASE"}, {"entity_type": "DISEASE", "description": "Chagas cardiomyopathy (CCC) is a serious complication of Chagas disease.", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "clusters": "[{level: 0, cluster: 21}]", "id": "CCC"}, {"source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "description": "The rs2228570 variant is associated with susceptibility to T. cruzi infection.)<SEP>The rs2228570 variant may protect against _T. cruzi_ infection, as individuals with the minor allele have lower risk.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 21}]", "id": "T. CRUZI INFECTION"}, {"entity_type": "GENE", "description": "IL-1A is a gene involved in inflammation.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "IL-1A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800587 is a genomic variant within the IL-1A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "RS1800587"}, {"entity_type": "GENE", "description": "TNF-A is a gene involved in inflammation.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "TNF-A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs361525 is a genomic variant within the TNF-A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "RS361525"}, {"entity_type": "DISEASE", "description": "HNP stands for Herniated Nucleus Pulposus, a condition affecting the spinal disc.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 83}]", "id": "HNP"}, {"entity_type": "GENOMIC VARIANT", "description": "The IL-1A -889C>T is a specific genomic variant within the IL-1A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 79}]", "id": "IL-1A -889C>T"}, {"entity_type": "GENOMIC VARIANT", "description": "The TNF-A 238G>A is a specific genomic variant within the TNF-A gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 83}]", "id": "TNF-A 238G>A"}, {"entity_type": "GENOMIC VARIANT", "description": "The VDR TaqI is a specific genomic variant within the VDR gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 83}]", "id": "VDR TAQI"}, {"entity_type": "GENOMIC VARIANT", "description": "CC genotype refers to an individual having two copies of the C allele for a given genetic locus.<SEP>The CC genotype was associated with an increased risk of CRC.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 24}]", "id": "CC GENOTYPE"}, {"entity_type": "GENOTYPE", "description": "CT genotype refers to an individual having one copy of the C allele and one copy of the T allele for a given genetic locus.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 83}]", "id": "CT GENOTYPE"}, {"entity_type": "GENOTYPE", "description": "TT genotype refers to an individual having two copies of the T allele for a given genetic locus.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 79}]", "id": "TT GENOTYPE"}, {"entity_type": "GENOTYPE", "description": "GG genotype refers to an individual having two copies of the G allele for a given genetic locus.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "GG GENOTYPE"}, {"entity_type": "GENOTYPE", "description": "GA genotype refers to an individual having one copy of the G allele and one copy of the A allele for a given genetic locus.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "GA GENOTYPE"}, {"entity_type": "ALLELE", "description": "The C allele is one variant form of a gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 22}]", "id": "C ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "The T allele is one variant form of a gene.<SEP>The T allele was present at a slightly lower frequency in CRC patients compared to controls, but this difference was not statistically significant.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27<SEP>chunk-ba82b7eb40cf9eea561d839b20584f91", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 83}]", "id": "T ALLELE"}, {"entity_type": "ALLELE", "description": "The G allele is one variant form of a gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "G ALLELE"}, {"entity_type": "ALLELE", "description": "The A allele is one variant form of a gene.", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "id": "A ALLELE"}, {"entity_type": "NUTRIENT", "description": "B12 is a nutrient that can be measured in blood levels and is linked to various health outcomes.<SEP>Vitamin B12 is an essential nutrient.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "B12"}, {"entity_type": "GENE", "description": "The MMACHC gene plays a role in vitamin B12 metabolism.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "MMACHC"}, {"entity_type": "STATISTICAL ANALYSIS METHOD", "description": "Mendelian Randomization (MR) analysis is a statistical technique used to assess causal relationships.<SEP>Mendelian Randomization (MR) analysis uses genetic variants as instrumental variables to estimate causal relationships.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0<SEP>chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MR ANALYSIS"}, {"entity_type": "STATISTICAL METHOD", "description": "Inverse-variance weighted (IVW) analysis is a statistical method used in Mendelian Randomization to combine estimates from multiple SNPs.<SEP>Inverse-variance weighted (IVW) is a specific MR method for estimating causal effects.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "IVW ANALYSIS"}, {"entity_type": "BIOMARKER", "description": "The level of vitamin B12 in the blood serum.", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "SERUM B12 CONCENTRATIONS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The amount of folate present in a person\'s blood serum.<SEP>The amount of folate present in the blood serum.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45<SEP>chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "id": "SERUM FOLATE CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Gestational duration refers to the length of pregnancy.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "GESTATIONAL DURATION"}, {"entity_type": "STATISTICAL METHOD", "description": "MR Egger is a statistical method used in Mendelian Randomization to assess causal relationships.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 111}]", "id": "MR EGGER"}, {"entity_type": "STUDY DESIGN", "description": "Mendelian Randomization (MR) is a study design used to estimate causal effects by leveraging genetic variants as instrumental variables.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "MENDELIAN RANDOMIZATION"}, {"entity_type": "STATISTICAL METRIC", "description": "I2GX is a statistical metric used to assess the influence of measurement error or weak instrument bias in Mendelian Randomization analyses.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "I2GX"}, {"entity_type": "STUDY GROUP", "description": "A Danish cohort refers to a group of individuals from Denmark followed over time for research purposes.", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "id": "DANISH COHORT"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Maternal and fetal B12 levels did not significantly influence offspring birthweight according to MR analysis.)", "entity_type": "UNKNOWN", "id": "B12 LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "Maternal folate levels positively influenced offspring birthweight, while fetal folate levels negatively impacted their own birthweight.)", "entity_type": "UNKNOWN", "id": "FOLATE LEVELS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The FUT2 variant contributed to the variance in serum B12 and folate concentrations in the original GWAS.)", "entity_type": "UNKNOWN", "id": "B12 AND FOLATE CONCENTRATIONS"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The FUT2 variant contributed to the variance in serum B12 and folate concentrations in the original GWAS.)", "entity_type": "UNKNOWN", "id": "FUT2 VARIANT"}, {"source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "description": "The MMACHC variant (rs12272669) appeared to have little effect on B12 levels in pregnant women at 28 weeks of gestation.)", "entity_type": "UNKNOWN", "id": "MMACHC VARIANT"}, {"source_id": "chunk-22216738ccbae0a6276bb4499018c434", "description": "The Danish cohort studies measured maternal B12 levels in pregnant women.)", "entity_type": "UNKNOWN", "id": "MATERNAL B12 LEVELS"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the MTHFR gene, specifically at position C677T.<SEP>MTHFR C677T is a common variant in the MTHFR gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR C677T"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the MTHFR gene, specifically at position A1298C.<SEP>MTHFR A1298C is a variant in the MTHFR gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "MTHFR A1298C"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the PAI\u20101 gene, specifically at position \u2010675 4G/5G.<SEP>PAI\u20101 \u2010675 4G/5G is a polymorphism in the PAI\u20101 gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI\u20101 \u2010675 4G/5G"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the PAI\u20101 gene, specifically at position A844G.<SEP>PAI\u20101 A844G is a polymorphism in the PAI\u20101 gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PAI\u20101 A844G"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the Prothrombin gene, specifically at position G20210A.<SEP>Prothrombin G20210A is a variant in the Prothrombin gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "PROTHROMBIN G20210A"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant in the Factor V gene, specifically at position G1691A.<SEP>Factor V G1691A is a variant in the Factor V gene.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "FACTOR V G1691A"}, {"entity_type": "DISEASE", "description": "A condition affecting left ventricle function, studied in the context of genetic variants.<SEP>LV Patients is a term used to describe individuals with left ventricular hypertrophy.", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "id": "LV PATIENTS"}, {"entity_type": "COMPOUND", "description": "A B vitamin crucial for various biological processes, including DNA synthesis and cell division.<SEP>Folic acid is a synthetic form of folate often used as a dietary supplement.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8<SEP>chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "FOLIC ACID"}, {"entity_type": "DIETARY PATTERN", "description": "The practice of regularly consuming supplements containing vitamins and minerals.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "VITAMIN SUPPLEMENTATION"}, {"entity_type": "DISEASE", "description": "The inability to conceive a child after a year or more of unprotected intercourse.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "INFERTILITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Refers to the characteristics of semen, including concentration, motility, and morphology of sperm.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SEMEN QUALITY"}, {"entity_type": "METABOLIC PATHWAY", "description": "A sulfur-containing amino acid whose levels are influenced by folate and vitamin B12 metabolism.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "HOMOCYSTEINE CONCENTRATION (THCY)"}, {"entity_type": "GENE", "description": "A gene involved in the synthesis of phosphatidylcholine, a major component of cell membranes.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "CHOLINE PATHWAY ENZYME GENE PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE (PEMT)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the PEMT gene associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "PEMT M175V MINOR V ALLELE"}, {"entity_type": "GENE", "description": "A gene encoding a receptor responsible for binding vitamin B12.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "B12 TRANSCOBALAMIN RECEPTOR GENE TCBLR (ALSO KNOWN AS CD320)"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the TCblR gene associated with male infertility.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "TCBLR RS173665"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the MTHFR gene involved in folate metabolism.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MTHFR 1298A>C MINOR C ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant of the MTHFR gene involved in folate metabolism.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MTHFR 677C>T"}, {"entity_type": "NUTRIENT", "description": "A water-soluble vitamin crucial for red blood cell formation, nerve function, and DNA synthesis.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "VITAMIN B12"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The percentage of sperm that are moving in a straight line.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "TOTAL PROGRESSIVE SPERM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The proportion of sperm with a normal shape and size.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "NORMAL SPERM MORPHOLOGY"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process where DNA within sperm cells is broken.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "DNA FRAGMENTATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The number of sperm per unit volume of semen.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SEMEN CONCENTRATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The total number of sperm in a given volume of semen.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SPERM NUMBER"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The percentage of sperm that are not moving.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "NON-MOTILE SPERM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The amount of fluid ejaculated during sexual intercourse.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "SEMEN VOLUME"}, {"entity_type": "SOCIAL FACTOR", "description": "A person\'s level of formal schooling.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "EDUCATION LEVEL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The period of time a person refrains from sexual intercourse.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "ABSTINENCE TIME"}, {"entity_type": "DISEASE", "description": "The inability of a male to father a child due to factors related to his reproductive system.", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "id": "MALE INFERTILITY"}, {"entity_type": "GENOMIC VARIANT", "description": "The polymorphism rs1979277 (Leu435Phe) in the SHMT1 gene has a significant association with TMD, with an increased frequency of the G allele in patients.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1979277"}, {"entity_type": "GENOMIC VARIANT", "description": "The polymorphism SHMT1 rs638416 located in the promoter region (5\'-UTR) of SHMT1 is associated with TMD, showing an increased frequency of the C allele and CC genotype.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS638416"}, {"entity_type": "GENE", "description": "Glutathione S-transferase mu 1 (GSTM1) gene encodes mu-class glutathione S-transferase involved in detoxification of electrophilic compounds.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1"}, {"entity_type": "GENOMIC VARIANT", "description": "The GSTM1-null polymorphism, a deletion of the GSTM1 gene, is associated with increased cancer and male infertility risk.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GSTM1-NULL POLYMORPHISM"}, {"entity_type": "GENE", "description": "Methionine Synthase Reductase (MTRR) gene is responsible for regenerating Methionine Synthase (MTR).", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "MTRR"}, {"entity_type": "GENOMIC VARIANT", "description": "The substitution of A by G (rs1801394) in the MTRR gene, leading to Ile22Met alteration, is associated with reduced enzyme affinity for the substrate and found at increased frequencies in TMD patients.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "RS1801394"}, {"entity_type": "GENE", "description": "Dopamine receptor D4 (DRD4) gene encodes a dopamine receptor with polymorphisms affecting its function.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4"}, {"entity_type": "GENOMIC VARIANT", "description": "DRD4-48bptr, a 48-bp VNTR in exon 3 of the DRD4 gene, shows variations in allele lengths (S-DRD4 and L-DRD4) associated with behavioral traits.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "DRD4-48BPTR"}, {"entity_type": "NUTRIENT", "description": "Serine is an amino acid and a precursor for glycine.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "SERINE"}, {"entity_type": "AMINO ACID", "description": "Glycine is an amino acid.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GLYCINE"}, {"entity_type": "MOLECULE", "description": "Tetrahydrofolate is a coenzyme involved in one-carbon metabolism.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "TETRAHYDROFOLATE (THF)"}, {"entity_type": "MOLECULE", "description": "5,10-methylenetetrahydrofolate is a form of tetrahydrofolate involved in nucleotide synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "5,10-METHYLENETETRAHYDROFOLATE (5,10-CH2-THF)"}, {"entity_type": "NUCLEOTIDE", "description": "Pyrimidines are nitrogenous bases found in DNA and RNA.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "PYRIMIDINE"}, {"entity_type": "AMINO ACID", "description": "Methionine is an essential amino acid.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "METHIONINE"}, {"entity_type": "NUCLEOTIDE", "description": "Thymidylate is a nucleotide involved in DNA synthesis.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "THYMIDYLATE"}, {"entity_type": "NUCLEOTIDES", "description": "Purines are nitrogenous bases found in DNA and RNA.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "PURINES"}, {"entity_type": "AMINO ACID RESIDUES", "description": "Arginine (ARG) at position 653 is a protein residue within MTHFD1.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "ARG-653"}, {"entity_type": "AMINO ACID RESIDUES", "description": "Glutamine (GLN) is an amino acid.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GLUTAMINE (GLN)"}, {"entity_type": "DISEASE", "description": "Neural tube defects are birth defects that occur when the neural tube does not close properly during fetal development.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "NEURAL TUBE DEFECTS (NTDS)"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Environmental toxins are harmful substances present in the environment.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "ENVIRONMENTAL TOXINS"}, {"entity_type": "CHEMICAL", "description": "Carcinogens are agents that can cause cancer.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "CARCINOGENS"}, {"entity_type": "MOLECULE", "description": "Glutathione is a tripeptide involved in antioxidant defense.", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "id": "GLUTATHIONE"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The SHMT1 enzyme catalyzes reactions essential for pyrimidine synthesis.)", "entity_type": "UNKNOWN", "id": "PYRIMIDINE SYNTHESIS"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "Polymorphisms in the SHMT1 gene, rs1979277 and rs638416, are significantly associated with TMD.)", "entity_type": "UNKNOWN", "id": "TMD"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The MTHFD1 protein has three enzyme activities involved in the interconversion reactions of one-carbon derivatives of THF.)", "entity_type": "UNKNOWN", "id": "ONE-CARBON METABOLISM"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "Mutations in MTHFD1 are clinically associated with susceptibility to neural tube defects sensitive to folates.)", "entity_type": "UNKNOWN", "id": "NTDS"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The GSTM1 enzyme is involved in detoxifying electrophilic compounds, including carcinogens and toxins.)", "entity_type": "UNKNOWN", "id": "DETOXIFICATION"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The deletion of the GSTM1 gene is associated with an increased risk of cancer.)", "entity_type": "UNKNOWN", "id": "INCREASED CANCER RISK"}, {"source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "description": "The MTRR protein regenerates Methionine Synthase (MTR) by reductive methylation.)", "entity_type": "UNKNOWN", "id": "METHIONINE SYNTHASE REGENERATION"}, {"entity_type": "METHOD", "description": "CDC Microbiological Assay (MBA) is a method used to measure serum folate concentrations.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC MBA"}, {"entity_type": "METHOD", "description": "High-Performance Liquid Chromatography coupled with Tandem Mass Spectrometry (HPLC-MS/MS) is a method used to measure serum folate concentrations.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC HPLC-MS/MS"}, {"entity_type": "COMPOUND", "description": "5-methyltetrahydrofolate is the active form of folate used in metabolic processes.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "5-METHYLTHF"}, {"entity_type": "BIOFLUID", "description": "Hemolysate is the liquid obtained after red blood cells are broken down.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "WHOLE-BLOOD HEMOLYSATE"}, {"entity_type": "ORGANIZATION", "description": "Laboratories are facilities equipped for scientific research and analysis.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "LABATORIES"}, {"entity_type": "CALIBRATOR", "description": "IH-CAL is a calibrator for measuring folate levels.<SEP>International Harmonization - Calibrator refers to a standardized material used to calibrate instruments or methods.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8<SEP>chunk-257a38a8ce6582c434f31b023b4a9704", "id": "IH-CAL"}, {"entity_type": "CONDITION", "description": "Using both CDC reagents (Microorganism and Calibrator) in an assay.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "CDC-MO & CDC-CAL"}, {"entity_type": "CONDITION", "description": "Using both International Harmonization reagents (Microorganism and Calibrator) in an assay.", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "id": "IH-MO & IH-CAL"}, {"entity_type": "NUTRIENT", "description": "S-FOL is a form of folate measured in serum.<SEP>S-FOL refers to a specific type of folate measurement.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "S-FOL"}, {"entity_type": "NUTRIENT", "description": "WB-FOL is a form of folate measured in whole blood.<SEP>WB-FOL refers to a specific type of folate measurement.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "WB-FOL"}, {"entity_type": "CALIBRATOR", "description": "CDC-CAL is a calibrator for measuring folate levels.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "CDC-CAL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Days represent the different time points at which samples were analyzed.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "DAY"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A microorganism is provided in the CDC round-robin kit.<SEP>Microorganisms are used in the assay for measuring folate levels.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704<SEP>chunk-7c25217961fba65d15f20beda8a58f1c", "id": "MICROORGANISM"}, {"entity_type": "ORGANIZATION", "description": "Laboratories perform the assay for measuring folate levels.", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "id": "LABORATORY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The CDC MBA target value represents the desired outcome or reference standard for S-FOL and WB-FOL measurements.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC MBA TARGET VALUE"}, {"entity_type": "REAGENT", "description": "IH reagents are used in the analysis of S-FOL and WB-FOL. ", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "IH REAGENTS"}, {"entity_type": "REAGENT", "description": "CDC reagents are used in the analysis of S-FOL and WB-FOL.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CDC REAGENTS"}, {"entity_type": "STANDARD", "description": "A calibrator, such as the Folic Acid Calibrator, is used for standardizing measurements of S-FOL and WB-FOL.", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "id": "CALIBRATOR"}, {"source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "description": "5-methylTHF and Folic Acid are both forms of the essential nutrient folate.)", "entity_type": "UNKNOWN", "id": "NUTRIENT"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1695 is a genetic polymorphism associated with an increased risk of breast cancer.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1695"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1138272 is a genetic polymorphism not significantly associated with breast cancer risk.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1138272"}, {"entity_type": "GENOMIC VARIANT", "description": "AG genotype of rs1695 polymorphism", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "AG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CT genotype of rs1138272 polymorphism<SEP>CT is a genotype associated with rs2023239, observed in individuals with potential differences in response to alcohol and medication.<SEP>CT likely refers to Cholesterol levels, as it is often analyzed alongside AC t1/2 and GC24 in this context.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-5c78814fb7c198ee95071ee5a8462070<SEP>chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "CT"}, {"entity_type": "DISEASE", "description": "Breast cancer is a type of cancer that affects the breast tissue.<SEP>Breast cancer is a type of cancer that affects the breast.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "BREAST CANCER"}, {"entity_type": "GENETIC VARIANT", "description": "The Ile105Val SNP is a single nucleotide polymorphism in the GSTP1 gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL"}, {"entity_type": "GENE", "description": "GSTP1 is a gene that encodes for glutathione S-transferase P1, an enzyme involved in detoxification.<SEP>GSTP1 is a gene that encodes glutathione S-transferase pi, an enzyme involved in detoxification.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "GSTP1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1695 is a genetic polymorphism.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "RS1695 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele G refers to one variant form of the rs1695 gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE G"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele A refers to one variant form of the rs1695 gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1138272 is a genetic polymorphism.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 161}]", "id": "RS1138272 POLYMORPHISM"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele T refers to one variant form of the rs1138272 gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE T"}, {"entity_type": "GENOMIC VARIANT", "description": "Allele C refers to one variant form of the rs1138272 gene.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ALLELE C"}, {"entity_type": "SOFTWARE", "description": "SNPeffects is an online tool used for predicting the effects of genetic variants.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "SNPEFFECTS"}, {"entity_type": "ALGORITHM", "description": "TANGO model predicts protein aggregation tendency.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "TANGO MODEL"}, {"entity_type": "ALGORITHM", "description": "LIMBO analysis assesses chaperone binding tendency.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "LIMBO ANALYSIS"}, {"entity_type": "ALGORITHM", "description": "WALTZ algorithm predicts amyloid-forming areas in protein sequences.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "WALTZ ALGORITHM"}, {"entity_type": "PROTEIN", "description": "Glutathione S-transferase P1 (GSTP1) is an enzyme involved in detoxification.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "GSTP1 PROTEIN"}, {"entity_type": "GENETIC VARIANT", "description": "Ile105Val SNP refers to a specific mutation at position 105 of the GSTP1 gene, changing isoleucine to valine.", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "id": "ILE105VAL SNP"}, {"source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "description": "The Ile105Val SNP does not influence the aggregation tendency or chaperone binding tendency of GSTP1 protein.)", "entity_type": "UNKNOWN", "id": "GSTP1 FUNCTION"}, {"source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "description": "The Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme.)", "entity_type": "UNKNOWN", "id": "AMYLOID PROPENSITY"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant found in the population.<SEP>A pathogenic variant located at codon position 778, resulting in an arginine to leucine substitution.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.R778L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant found in the population.<SEP>A pathogenic variant located at codon position 992, resulting in a proline to leucine substitution.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.P992L"}, {"entity_type": "GENOMIC VARIANT", "description": "A pathogenic variant found in the population.<SEP>A pathogenic variant located at codon position 935, resulting in a threonine to methionine substitution.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "P.T935M"}, {"entity_type": "MICROSATELLITE MARKER", "description": "A microsatellite marker located on chromosome 13.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S314"}, {"entity_type": "MICROSATELLITE MARKER", "description": "A microsatellite marker located on chromosome 13.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S301"}, {"entity_type": "MICROSATELLITE MARKER", "description": "A microsatellite marker located on chromosome 13.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "D13S316"}, {"entity_type": "GENOMIC VARIANT", "description": "A group of linked alleles at three microsatellite markers (D13S314, D13S301, D13S316) strongly associated with the p.R778L variant.<SEP>A haplogroup characterized by specific genetic variations.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1<SEP>chunk-047f259db19cbb4de945706a1bd1b450", "id": "HAPLOGROUP A"}, {"entity_type": "GENETIC HAPLOTYPE", "description": "A group of linked alleles at three microsatellite markers (D13S314, D13S301, D13S316) associated with the p.R778L variant.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "HAPLOGROUP B"}, {"entity_type": "GENETIC HAPLOTYPE", "description": "A group of linked alleles at three microsatellite markers (D13S314, D13S301, D13S316) associated with the p.R778L variant.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "HAPLOGROUP C"}, {"entity_type": "DISEASE", "description": "Wilson\'s Disease is a rare genetic disorder that affects copper metabolism.", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "id": "WD"}, {"entity_type": "GENOMIC VARIANT", "description": "A haplogroup characterized by specific genetic variations.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "HAPLOGROUP E"}, {"entity_type": "GENOMIC VARIANT", "description": "Chromosomes carrying the specific genetic variation under study.", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "id": "WD CHROMOSOMES"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.T935M variant is associated with a uniform haplogroup J, which is significantly more common on WD chromosomes compared to control chromosomes.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP J"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.R778L variant is strongly associated with Haplogroup A1, a subvariant of Haplogroup A.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP A1"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.P992L variant is more strongly associated with Haplogroup E1, a subvariant of Haplogroup E.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP E1"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.P992L variant is weakly associated with Haplogroup E2.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP E2"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.P992L variant shows sporadic association with Haplogroups D, F, G, H, and I.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP D, F, G, H, I"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.T935M variant is strongly associated with Haplogroup J1, a subvariant of Haplogroup J.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP J1"}, {"source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "description": "The p.T935M variant shows weaker association with Haplogroup J2.)", "entity_type": "UNKNOWN", "id": "HAPLOGROUP J2"}, {"entity_type": "GENOMIC VARIANT", "description": "CYP2C9*2 is a genomic variant that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*2"}, {"entity_type": "GENOMIC VARIANT", "description": "CYP2C9*3 is a genomic variant that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*3"}, {"entity_type": "GENOMIC VARIANT", "description": "CYP2C9*5 is a genomic variant that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*5"}, {"entity_type": "GENOMIC VARIANT", "description": "CYP2C9*8 is a genomic variant that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*8"}, {"entity_type": "GENOMIC VARIANT", "description": "CYP2C9*11 is a genomic variant that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "CYP2C9*11"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1799853 is a SNP that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1799853"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1057910 is a SNP that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS1057910"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28371686 is a SNP that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371686"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7900194 is a SNP that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS7900194"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28371685 is a SNP that reduces CYP2C9 activity.", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "id": "RS28371685"}, {"entity_type": "ALGORITHM", "description": "A novel algorithm designed to predict appropriate drug doses based on genetic information.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "AA ALGORITHM"}, {"entity_type": "ALGORITHM", "description": "Algorithms developed by IWPC for pharmacogenomic prediction of drug doses.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC ALGORITHMS"}, {"entity_type": "GROUP", "description": "Patients receiving a high dose of medication.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "HIGH DOSE GROUP"}, {"entity_type": "FIELD", "description": "The study of how genes influence an individual\'s response to drugs.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PHARMACOGENOMICS"}, {"entity_type": "DOSE", "description": "The calculated amount of medication prescribed for a patient.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PREDICTED DOSE"}, {"entity_type": "DOSE", "description": "The actual amount of medication administered to a patient.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "OBSERVED DOSE"}, {"entity_type": "ALGORITHM", "description": "An algorithm developed by IWPC that uses clinical data to predict drug doses.)  (entity", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "IWPC CLINICAL ALGORITHM"}, {"entity_type": "METRIC", "description": "Mean Absolute Error, a measure of the difference between predicted and observed doses.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "MAE"}, {"entity_type": "METRIC", "description": "Percentage of West African Ancestry in an individual\'s genetic background.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "PERCENT WAA"}, {"entity_type": "STATISTICAL METHOD", "description": "A method used to examine the relationship between variables, such as percent WAA and predicted dose.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "LINEAR REGRESSION ANALYSIS"}, {"entity_type": "DATA", "description": "Genetic or demographic information specific to a particular population.", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "id": "POPULATION-SPECIFIC VARIABLES"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "The SNPs rs1799853, rs1057910, and rs9923231 are combined into a CYP2C9 star variant group due to low frequency.)", "entity_type": "UNKNOWN", "id": "CYP2C9 STAR VARIANT GROUP"}, {"source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "description": "The CYP2C9 star variant group is associated with an increased risk of DVT/PE.)", "entity_type": "UNKNOWN", "id": "DVT/PE"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "The IWPC pharmacogenomics algorithm predicts drug doses based on genetic information.)", "entity_type": "UNKNOWN", "id": "IWPC PHARMACOGENOMICS ALGORITHM"}, {"source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "description": "A NNG of approximately three patients genotyped was estimated to prevent one predicted dose from being outside the 20% therapeutic dose range.)", "entity_type": "UNKNOWN", "id": "NNG"}, {"entity_type": "GENE", "description": "CYP27B1 is a gene involved in vitamin D metabolism.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "CYP27B1"}, {"entity_type": "GENE", "description": "CYP24A1 is a gene involved in vitamin D metabolism.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a<SEP>chunk-1327975b50e4a0aac1792cb595041ee5", "id": "CYP24A1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs927650 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS927650"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35051736 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS35051736"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2296241 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS2296241"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2762939 is a SNP located in the CYP24A1 gene.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "RS2762939"}, {"entity_type": "NUTRIENT", "description": "25-hydroxyvitamin D (25(OH)D) is a vitamin D metabolite.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "25(OH)D"}, {"entity_type": "NUTRIENT", "description": "1,25-dihydroxyvitamin D (1,25(OH)2D) is an active form of vitamin D.", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "id": "1,25(OH)2D"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant association between the CYP24A1 SNP rs927650 and odds for any adenoma recurrence.)", "entity_type": "UNKNOWN", "id": "ADENOMA RECURRENCE"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant association between the CYP24A1 SNP rs927650 and odds for any adenoma recurrence.)", "entity_type": "UNKNOWN", "id": "CYP24A1 SNP RS927650"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "The minor allele (A) of rs35051736 was completely absent in individuals with advanced lesions.)", "entity_type": "UNKNOWN", "id": "ADVANCED ADENOMA"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant association between increasing number of copies of the G allele in CYP24A1 rs2296241 and higher odds for recurrent adenomas with villous histology.)", "entity_type": "UNKNOWN", "id": "CYP24A1 RS2296241"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant association between increasing number of copies of the G allele in CYP24A1 rs2296241 and higher odds for recurrent adenomas with villous histology.)", "entity_type": "UNKNOWN", "id": "VILLOUS HISTOLOGY"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant interaction between CYP24A1 SNP rs2296241 and 25(OH)D.)", "entity_type": "UNKNOWN", "id": "CYP24A1 SNP RS2296241"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "There was a nominally statistically significant interaction between CYP24A1 SNP rs2762939 and 1,25(OH)2D.)", "entity_type": "UNKNOWN", "id": "CYP24A1 RS2762939"}, {"source_id": "chunk-2fb95100a1290b27baae869c6560419a", "description": "The minor allele (A) was completely absent in individuals with advanced lesions.)", "entity_type": "UNKNOWN", "id": "CYP24A1 RS35051736"}, {"entity_type": "GENOMIC VARIANT", "description": "c.428_430delAAG is a variant in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.428_430DELAAG"}, {"entity_type": "GENOMIC VARIANT", "description": "c.1186C\u2009>\u2009T is a variant in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "C.1186C\u2009>\u2009T"}, {"entity_type": "GENOMIC VARIANT", "description": "rs777676129 is a SNP in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "RS777676129"}, {"entity_type": "GENOMIC VARIANT", "description": "rs114368325 is a SNP in the CYP24A1 gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "RS114368325"}, {"entity_type": "METHOD", "description": "HRMA is a method for genotyping DNA variations based on melting temperature differences.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "HRMA"}, {"entity_type": "PHYSICAL PROPERTY", "description": "Melting temperature is a measure of thermal stability, used in HRMA analysis.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "MELTING TEMPERATURE (TM)"}, {"entity_type": "GENE TYPE", "description": "Wild-type refers to the normal, non-variant form of a gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "WILD-TYPE (WT)"}, {"entity_type": "GENOTYPE", "description": "Heterozygous refers to having two different alleles for a specific gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "HETEROZYGOUS"}, {"entity_type": "GENOTYPE", "description": "A homozygous individual carries two copies of the mutated LPL gene.<SEP>Homozygous refers to having two identical alleles for a specific gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HOMOZYGOUS"}, {"entity_type": "GENOTYPE", "description": "Compound heterozygous refers to having two different variants in a gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "COMPOUND HETEROZYGOUS"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Genotype assignment refers to determining the specific combination of alleles an individual possesses for a particular gene.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "GENOTYPE ASSIGNMENT"}, {"entity_type": "METHOD", "description": "Direct DNA sequencing is a technique for determining the order of nucleotides in DNA.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "DIRECT DNA SEQUENCING"}, {"entity_type": "MEASUREMENT", "description": "Inter-assay precision refers to the reproducibility of results between different experiments.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "INTER-ASSAY PRECISION"}, {"entity_type": "MEASUREMENT", "description": "Intra-assay precision refers to the reproducibility of results within a single experiment.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "INTRA-ASSAY PRECISION"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "Serial dilutions involve progressively reducing the concentration of a solution.", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "id": "SERIAL DILUTIONS"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "description": "The compound heterozygous sample carries both the c.428_430delAAG and c.1186C\u2009>\u2009T variants in the CYP24A1 gene.)", "entity_type": "UNKNOWN", "id": "COMPOUND HETEROZYGOUS SAMPLE"}, {"source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "description": "Sanger sequencing was used to confirm genotypes of the CYP24A1 gene.)", "entity_type": "UNKNOWN", "id": "SANGER SEQUENCING"}, {"entity_type": "GENOMIC VARIANT", "description": "A novel P1001L mutation in the ATP7A gene.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "P1001L"}, {"entity_type": "GENE", "description": "ATP7A is a gene involved in copper transport and metabolism.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATP7A"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Copper overload refers to an excessive accumulation of copper in the body.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "COPPER OVERLOAD"}, {"entity_type": "PROTEIN", "description": "b2-microglobulin is a protein marker for renal tubular injury, often elevated in Menkes disease due to copper overload.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "B2-MICROGLOBULIN"}, {"entity_type": "PROTEIN", "description": "Dopamine-\u03b2-hydroxylase is a copper-dependent enzyme involved in catecholamine synthesis.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DOPAMINE-\u0392-HYDROXYLASE"}, {"entity_type": "NUTRIENT", "description": "Cerebrospinal fluid copper levels are elevated in classical Menkes disease.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CEREBROSPINAL FLUID COPPER"}, {"entity_type": "CELL TYPE", "description": "Fibroblasts are cells found in connective tissues and are used in tissue culture studies.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "FIBROBLAST"}, {"entity_type": "GENETIC MATERIAL", "description": "Blood DNA is used for genetic testing and analysis.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BLOOD DNA"}, {"entity_type": "CELL CULTURE", "description": "Primary fibroblast cultures are obtained from skin biopsies and used for research purposes.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "PRIMARY FIBROBLAST CULTURE"}, {"entity_type": "TECHNIQUE", "description": "Quantitative real-time PCR (Q-RT-PCR) is a technique used to measure gene expression levels.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "Q-RT-PCR"}, {"entity_type": "DIAGNOSTIC TOOL", "description": "The Denver Developmental Screening Test II is a tool used to assess developmental milestones in infants.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DENVER DEVELOPMENTAL SCREENING TEST II"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The median nerve compound motor action potential is a measurement of the electrical activity in the median nerve.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIAL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The median nerve conduction velocity is a measure of the speed at which electrical signals travel along the median nerve.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "MEDIAN NERVE CONDUCTION VELOCITY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "A sensory action potential is an electrical signal transmitted by sensory neurons.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "SENSORY ACTION POTENTIAL"}, {"entity_type": "DIAGNOSTIC TEST", "description": "A brain MRI (magnetic resonance imaging) is a medical imaging technique that provides detailed images of the brain.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "BRAIN MRI"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Atrophy is a decrease in the size of tissues or organs due to cell death.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "ATROPHY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Myelination is the process by which nerve fibers are coated with myelin, a fatty substance that speeds up signal transmission.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "DELAYED MYELINATION"}, {"entity_type": "DIAGNOSTIC TEST", "description": "Clinical neurophysiology studies are tests that evaluate the electrical activity of the nervous system.", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "id": "CLINICAL NEUROPHYSIOLOGY STUDIES"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "The P1001L mutation is associated with Menkes disease.)", "entity_type": "UNKNOWN", "id": "MENKES DISEASE"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Tissue-specific mosaicism was observed for the P1001L mutation, with different levels of mutant allele expression in fibroblasts compared to blood DNA.)", "entity_type": "UNKNOWN", "id": "ATP7A MOSAICISM"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "The patient\'s performance on the Denver Developmental Screening Test II indicated delays in gross motor, fine motor, language, and personal-social development.)", "entity_type": "UNKNOWN", "id": "DEVELOPMENTAL DELAY"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Abnormalities in median nerve compound motor action potentials can indicate neurological dysfunction.)", "entity_type": "UNKNOWN", "id": "NEUROLOGICAL FUNCTION"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Brain MRI results can reveal structural abnormalities in the brain, such as atrophy and delayed myelination.)", "entity_type": "UNKNOWN", "id": "NEUROLOGICAL EXAMINATION"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Brain atrophy can be a sign of neurological disorders.)", "entity_type": "UNKNOWN", "id": "NEUROLOGICAL DISORDER"}, {"source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "description": "Delayed myelination can affect neurological development.)", "entity_type": "UNKNOWN", "id": "NEUROLOGICAL DEVELOPMENT"}, {"entity_type": "GENE", "description": "IDI is a gene that codes for deiodinase.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "IDI"}, {"entity_type": "PROTEIN", "description": "GPX4 is a gene that codes for the antioxidant enzyme glutathione peroxidase 4.<SEP>GPx4 is a selenoprotein enzyme that protects cells from oxidative stress.<SEP>GPx4 is a selenoprotein involved in antioxidant defense.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 152}]", "id": "GPX4"}, {"entity_type": "CELL LINE", "description": "IDI-T is a cell line used in experiments.<SEP>IDI-T is a transcript of the IDI gene with the T variant in its 3\'UTR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 152}]", "id": "IDI-T"}, {"entity_type": "TRANSCRIPT", "description": "IDI-C is a cell line used in experiments.<SEP>IDI-C is a transcript of the IDI gene with the C variant in its 3\'UTR.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 151}]", "id": "IDI-C"}, {"entity_type": "PROTEIN", "description": "Deiodinase is an enzyme that regulates thyroid hormone metabolism.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "DEIODINASE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "tert-butylhydroperoxide is an oxidative stress inducer used to challenge cells in this study.<SEP>tert-butylhydroperoxide is an oxidizing agent used to challenge cells.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TERT-BUTYLHYDROPEROXIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Oxidative stress is a state of imbalance between reactive oxygen species production and the body\'s antioxidant defenses.<SEP>Oxidative stress refers to an imbalance between the production of reactive oxygen species (ROS) and the body\'s ability to detoxify them.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e<SEP>chunk-c7872499c2a84b16c506a135d8033bb7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "OXIDATIVE STRESS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "ROS, or Reactive Oxygen Species, are molecules that can cause cellular damage if not properly regulated.<SEP>Reactive Oxygen Species are molecules that can damage cellular components.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 151}]", "id": "ROS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Glutathione peroxidase activity is a measure of the cell\'s ability to detoxify reactive oxygen species.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "GPX ACTIVITY"}, {"entity_type": "PROTEIN", "description": "TR1 is a selenoprotein involved in thyroid hormone metabolism.<SEP>TR1 is a transcript encoding for an unknown protein.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "TR1"}, {"entity_type": "NUTRIENT", "description": "Selenocysteine is an amino acid incorporated into selenoproteins and essential for their function.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SELENOCYSTEINE"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A medium lacking sufficient selenium, leading to reduced selenoprotein synthesis.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SE-DEPLETED MEDIUM"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "A medium enriched with selenium, allowing for normal selenoprotein synthesis.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7", "id": "SE-SUPPLEMENTED MEDIUM"}, {"entity_type": "GENE", "description": "GPX1 is a gene that codes for glutathione peroxidase 1.<SEP>GPx1 is a selenoprotein enzyme that protects cells from oxidative stress.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX1"}, {"entity_type": "PROTEIN", "description": "Selenoprotein H is a selenoprotein with unknown function.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SELENOPROTEIN H"}, {"entity_type": "GENE", "description": "GAPDH is a gene that codes for glyceraldehyde-3-phosphate dehydrogenase, a housekeeping enzyme used as a control for RNA expression.<SEP>GAPDH is a housekeeping protein used as a control for gene expression studies.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 152}]", "id": "GAPDH"}, {"entity_type": "NUTRIENT", "description": "Se, or Selenium, is an essential nutrient for the proper functioning of selenoproteins.<SEP>Selenium is an essential trace element required for the synthesis of selenoproteins.", "source_id": "chunk-c7872499c2a84b16c506a135d8033bb7<SEP>chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE"}, {"entity_type": "TRANSCRIPT", "description": "GPx4 mRNA is the messenger RNA molecule that codes for the GPx4 protein.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "GPX4 MRNA"}, {"entity_type": "TRANSCRIPT", "description": "The IDI transcript is a genetic construct expressed in experimental cell lines.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 152}]", "id": "IDI TRANSCRIPT"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Se concentration refers to the level of selenium present in the growth medium.", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "id": "SE CONCENTRATION"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "The levels of selenoprotein H mRNA were significantly lower in IDI-C cells compared with IDI-T whether the cells were grown in either Se-depleted or supplemented medium.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 151}]", "id": "SELENOPROTEIN H MRNA"}, {"source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "description": "Higher concentrations of Se led to greater GPx4 activity in IDI-C cells.)", "entity_type": "UNKNOWN", "id": "GPX4 ACTIVITY"}, {"entity_type": "GENE", "description": "CHAT is a gene that encodes choline acetyltransferase, an enzyme involved in acetylcholine synthesis.<SEP>ChAT is the protein product of the CHAT gene; it catalyzes acetylcholine synthesis.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "CHAT"}, {"entity_type": "CELL LINE", "description": "Bosc 23 is a commonly used insect cell line for expression studies.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "BOSC 23 CELLS"}, {"entity_type": "BACTERIA", "description": "E. coli is a common bacterium used in molecular biology for protein purification.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "E. COLI"}, {"entity_type": "BIOMOLECULE PURIFICATION TOOL", "description": "A Ni-NTA column is used for purification of histidine-tagged proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "NI-NTA COLUMN"}, {"entity_type": "BIOMOLECULE PURIFICATION TOOL", "description": "Fast protein liquid chromatography (FPLC) is used for further purification of proteins.", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "id": "FAST PROTEIN LIQUID CHROMATOGRAPHY"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The p.Thr553Asn mutation affects the ChAT protein.)<SEP>p.Thr553Asn is a missense mutation in the CHAT gene.)", "entity_type": "UNKNOWN", "id": "P.THR553ASN"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The p.Ser704Pro mutation affects the ChAT protein.)<SEP>p.Ser704Pro is a missense mutation in the CHAT gene.)", "entity_type": "UNKNOWN", "id": "P.SER704PRO"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The p.Ala557Thr mutation affects the ChAT protein.)<SEP>p.Ala557Thr is a missense mutation in the CHAT gene.)", "entity_type": "UNKNOWN", "id": "P.ALA557THR"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The p.Val136Met mutation affects the ChAT protein.)<SEP>p.Val136Met is a missense mutation in the CHAT gene.)", "entity_type": "UNKNOWN", "id": "P.VAL136MET"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "The p.Ile689Ser mutation affects the ChAT protein.)<SEP>p.Ile689Ser is a missense mutation in the CHAT gene.)", "entity_type": "UNKNOWN", "id": "P.ILE689SER"}, {"source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "description": "ChAT cDNAs were genetically engineered into Bosc 23 cells to study mutant and wild-type protein expression.)", "entity_type": "UNKNOWN", "id": "CHAT CDNAS"}, {"entity_type": "NUTRIENT", "description": "TGSH is a marker of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TGSH"}, {"entity_type": "NUTRIENT", "description": "GSH is a reduced form of glutathione and a marker of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "GSH"}, {"entity_type": "NUTRIENT", "description": "GSSG is an oxidized form of glutathione and a marker of oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "GSSG"}, {"entity_type": "NUTRIENT", "description": "HCY is homocysteine, an amino acid associated with oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "HCY"}, {"entity_type": "DISEASE", "description": "oxLDL stands for oxidized low-density lipoprotein, a marker of lipid peroxidation and oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "OXLDL"}, {"entity_type": "DISEASE", "description": "An inflammatory bowel disease characterized by chronic inflammation of the digestive tract.<SEP>CD is a marker of lipid peroxidation.<SEP>Crohn\'s Disease, an inflammatory bowel disease.<SEP>CD refers to Crohn\'s Disease, an inflammatory bowel disease.<SEP>Crohn\'s disease (CD) is an inflammatory bowel disease.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc<SEP>chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-6a657cd0a000b6df4db8f1305b795021<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "CD"}, {"entity_type": "DISEASE", "description": "BCD-LDL is a marker of lipid peroxidation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "BCD-LDL"}, {"entity_type": "DISEASE", "description": "TAOC represents total antioxidant capacity, reflecting the body\'s ability to neutralize free radicals and oxidative stress.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 60}, {level: 2, cluster: 150}]", "id": "TAOC"}, {"entity_type": "GENE", "description": "BCL2-like 11 is a gene associated with apoptosis.<SEP>BCL2L11 is a gene that has been associated with methylation at CpG sites.<SEP>BCL2L11 is a gene whose methylation at cg07547695 site is associated with both TGSH and GSH levels.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e<SEP>chunk-491fec1ffc43ca0e67c1080702f038a7<SEP>chunk-b05610f4a9a1033449b92655bfb67b28", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 61}]", "id": "BCL2L11"}, {"entity_type": "GENE", "description": "NDUFS7 encodes NADH dehydrogenase [ubiquinone] Fe-S protein 7, involved in mitochondrial oxidative phosphorylation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "NDUFS7"}, {"entity_type": "GENE", "description": "EIF3J encodes eukaryotic translation initiation factor 3, subunit J, important for protein synthesis.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "EIF3J"}, {"entity_type": "GENE", "description": "ZNF761 encodes zinc finger protein 761, with potential roles in transcription regulation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ZNF761"}, {"entity_type": "GENE", "description": "PSMG3 encodes proteasome assembly chaperone 3, involved in protein degradation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "PSMG3"}, {"entity_type": "GENE", "description": "ENTHD1 is involved in signal transduction and purine metabolism.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ENTHD1"}, {"entity_type": "GENE", "description": "LRIG1 plays a role in cell signaling and tumor suppression.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "LRIG1"}, {"entity_type": "GENE", "description": "RIPK3 encodes receptor-interacting serine/threonine-protein kinase 3, involved in programmed cell death.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RIPK3"}, {"entity_type": "GENE", "description": "RPS6KC1 is involved in signal transduction and ribosomal protein synthesis.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RPS6KC1"}, {"entity_type": "GENE", "description": "ATP2B4 encodes a plasma membrane calcium ATPase, regulating intracellular calcium levels.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "ATP2B4"}, {"entity_type": "GENE", "description": "SEMA6A encodes sema domain, transmembrane domain [TM], and cytoplasmic domain, [semaphorin] 6A, with anti-angiogenic properties.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "SEMA6A"}, {"entity_type": "GENE", "description": "TAPBP encodes TAP binding protein [tapasin], involved in antigen processing.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TAPBP"}, {"entity_type": "GENE", "description": "RGL2 encodes ral guanine nucleotide dissociation stimulator-like 2, involved in cellular signaling.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "RGL2"}, {"entity_type": "GENE", "description": "CKAP5 encodes cytoskeleton associated protein 5, involved in cell structure and signaling.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CKAP5"}, {"entity_type": "GENE", "description": "FOSL2 encodes FOS-like antigen 2, a transcription factor involved in cell proliferation and differentiation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FOSL2"}, {"entity_type": "GENE", "description": "FAM20C encodes family with sequence similarity 20, member C, with roles in bone development and mineralization.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FAM20C"}, {"entity_type": "GENE", "description": "FRMD6 encodes FERM Domain containing 6, involved in cell adhesion and signaling.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "FRMD6"}, {"entity_type": "MOLECULAR INTERACTION", "description": "CpG sites are regions of DNA where a cytosine nucleotide is followed by a guanine nucleotide, often involved in gene regulation and interactions.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CPGS"}, {"entity_type": "GENE REGION", "description": "5\'-UTR stands for 5\' untranslated region, a section of mRNA before the coding sequence.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "5\'-UTR"}, {"entity_type": "GENE REGION", "description": "3\'-UTR stands for 3\' untranslated region, a section of mRNA after the coding sequence.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "3\'-UTR"}, {"entity_type": "GENE REGION", "description": "TSS1500 refers to the transcription start site 1500 base pairs upstream, a regulatory region involved in gene expression.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "TSS1500"}, {"entity_type": "REGULATORY ELEMENT", "description": "CpG islands are regions with a higher than average density of CpG sites, often associated with gene regulation.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "CPG ISLAND"}, {"entity_type": "GENE REGION", "description": "Shore refers to the regions flanking CpG islands, potentially involved in regulating gene expression.", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "id": "SHORE"}, {"entity_type": "GENE", "description": "E2F1 is a gene/protein with a potential role in atherosclerosis and coronary heart disease (CHD).", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 61}]", "id": "E2F1"}, {"entity_type": "DISEASE", "description": "Coronary heart disease (CHD) is a cardiovascular disease.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 61}]", "id": "CHD"}, {"entity_type": "GENOMIC VARIANT", "description": "CpGs are cytosine-guanine dinucleotides in DNA sequences where methylation can occur.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "CPG"}, {"entity_type": "REGULATORY ELEMENT", "description": "Promoters are DNA regions upstream of genes that regulate transcription.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PROMOTER"}, {"entity_type": "DATABASE", "description": "RegulomeDB is a database that identifies functional regulatory elements in the genome.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "REGULOMEDB"}, {"entity_type": "REGULATORY ELEMENT", "description": "Transcription factor (TF) binding sites are DNA sequences that TFs recognize and bind to, regulating gene expression.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "TF BINDING SITE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Phosphorylation is a cellular process where phosphate groups are added to proteins, influencing their function.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PHOSPHORYLATION"}, {"entity_type": "PROTEIN STRUCTURAL FEATURE", "description": "Pleckstrin domains are protein regions involved in protein-protein interactions and signal transduction.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "PLECKSTRIN DOMAIN"}, {"entity_type": "GENETIC VARIANT", "description": "meQTLs (methylation quantitative trait loci) are genetic variants that influence DNA methylation levels.", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "id": "MEQTL"}, {"entity_type": "GENE", "description": "CEP55 is a gene that has been associated with methylation at CpG sites.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CEP55"}, {"entity_type": "GENE", "description": "CPB1 is a gene that has been associated with methylation at CpG sites.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CPB1"}, {"entity_type": "GENE", "description": "HIST1H4D is a gene that encodes histone cluster 1, H4d and its 3\'-UTR was associated with T2D.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HIST1H4D"}, {"entity_type": "GENE", "description": "DVL1 is a gene that encodes dishevelled-1 and its body was associated with T2D.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "DVL1"}, {"entity_type": "GENE", "description": "ZNF341 is a gene involved in transcriptional regulation, and methylation at CpG sites within it were associated with heart failure.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ZNF341"}, {"entity_type": "DISEASE", "description": "CVD stands for Cardiovascular Disease, which encompasses a range of conditions affecting the heart and blood vessels.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "CVD"}, {"entity_type": "DISEASE", "description": "Myocardial infarction is another term for a heart attack, caused by blockage of blood flow to the heart muscle.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "MYOCARDIAL INFARCTION"}, {"entity_type": "DISEASE", "description": "Heart failure is a condition where the heart can\'t pump blood effectively.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "HEART FAILURE"}, {"entity_type": "DISEASE", "description": "Ischaemic stroke occurs when blood supply to part of the brain is blocked.", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "id": "ISCHAEMIC STROKE"}, {"source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "description": "SEMA6A is involved in inhibiting angiogenesis, a process often associated with tumor growth and oxidative stress.)", "entity_type": "UNKNOWN", "id": "ANTI-ANGIOGENIC FUNCTION"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "E2F1 has been implicated in the development of atherosclerosis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 61}]", "id": "ATHEROSCLEROSIS"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "CpGs associated with oxidative stress markers show altered methylation patterns.)", "entity_type": "UNKNOWN", "id": "OXIDATIVE STRESS MARKERS"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "A higher proportion of phenotype-associated CpGs were located in promoters compared to all CpGs.)", "entity_type": "UNKNOWN", "id": "PHENOTYPE-ASSOCIATED CPGS"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "The analysis identified significant enrichment of E2F1 binding sites among phenotype-associated CpGs.)", "entity_type": "UNKNOWN", "id": "E2F1 BINDING SITE"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "Gene set enrichment analysis revealed that genes associated with oxidative stress-linked CpGs were enriched for terms related to phosphorylation and phosphate metabolism.)", "entity_type": "UNKNOWN", "id": "GENES ANNOTATED TO CPGS"}, {"source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "description": "A significant proportion of CpGs associated with oxidative stress had corresponding meQTL SNPs.)", "entity_type": "UNKNOWN", "id": "CPG SITES"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The BCL2L11 gene has a CpG site annotated to cg07547695, which was associated with methylation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 61}]", "id": "CPG SITE CG07547695"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The CEP55 gene has a CpG site annotated to cg24371383, which was associated with methylation.)", "entity_type": "UNKNOWN", "id": "CPG SITE CG24371383"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The CPB1 gene has a CpG site annotated to cg04072156, which was associated with methylation.)", "entity_type": "UNKNOWN", "id": "CPG SITE CG04072156"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The HIST1H4D gene had a CpG site in its 3\'-UTR annotated to cg08170869, which was associated with T2D.)", "entity_type": "UNKNOWN", "id": "CPG SITE CG08170869"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The DVL1 gene had a CpG site in its body annotated to cg03465880, which was associated with T2D.)", "entity_type": "UNKNOWN", "id": "CPG SITE CG03465880"}, {"source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "description": "The ZNF341 gene had a CpG site annotated to cg11842944, which was associated with heart failure.)", "entity_type": "UNKNOWN", "id": "CPG SITE CG11842944"}, {"entity_type": "GENE", "description": "The MT-ATP6 gene encodes a subunit of ATP synthase 6, which is a component of the electron transport chain in mitochondria.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MT-ATP6"}, {"entity_type": "PROTEIN", "description": "ATP synthase 6 is a protein that is part of the mitochondrial respiratory chain and plays a role in ATP production.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ATP SYNTHASE 6"}, {"entity_type": "DISEASE", "description": "Leigh syndrome is a mitochondrial disorder characterized by progressive neurological damage.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "LEIGH SYNDROME"}, {"entity_type": "GENOMIC VARIANT", "description": "The 8993T>G variant is a substitution in the MT-ATP6 gene that results in an amino acid change from Leucine to Arginine.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "8993T>G"}, {"entity_type": "INDIVIDUAL", "description": "An individual whose exome was sequenced.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000067"}, {"entity_type": "INDIVIDUAL", "description": "A healthy parent of CMH000067.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000068"}, {"entity_type": "INDIVIDUAL", "description": "A healthy parent of CMH000067.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "CMH000069"}, {"entity_type": "SEQUENCING PLATFORM", "description": "An Illumina sequencing platform used for exome enrichment and sequencing.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ILLUMINA HISEQ 2000"}, {"entity_type": "ALIGNMENT SOFTWARE", "description": "A software tool used to align sequencing reads.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "GSNAP"}, {"entity_type": "BIOLOGICAL PROCESS", "description": "The process of capturing DNA regions corresponding to protein-coding genes for sequencing.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "EXOME ENRICHMENT"}, {"entity_type": "GENOME", "description": "The genome of mitochondria, separate from the nuclear genome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MITOCHONDRIAL GENOME"}, {"entity_type": "GENOMIC REGION", "description": "The region of the genome containing protein-coding genes.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "NUCLEAR EXOME"}, {"entity_type": "GENOMIC VARIANT", "description": "A variant present in one copy of a chromosome.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "HETEROZYGOUS VARIANT"}, {"entity_type": "GENOMIC VARIANT", "description": "Variants located within the mitochondrial DNA.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "MTDNA VARIANTS"}, {"entity_type": "MOLECULAR COMPLEX", "description": "A multi-protein complex involved in ATP production.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "id": "ATP SYNTHASE COMPLEX V"}, {"entity_type": "METABOLIC PATHWAY", "description": "A series of protein complexes that transfer electrons and generate a proton gradient for ATP synthesis.<SEP>The electron transport chain is a series of protein complexes that transfer electrons, ultimately leading to ATP synthesis.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d<SEP>chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "ELECTRON TRANSPORT CHAIN"}, {"entity_type": "MOLECULAR COMPLEX", "description": "Complex I, also known as NADH dehydrogenase, is a protein complex involved in the electron transport chain.<SEP>The first enzyme complex in the electron transport chain responsible for transferring electrons from NADH to ubiquinone.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d<SEP>chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COMPLEX I"}, {"entity_type": "MOLECULE", "description": "A molecule that carries high-energy electrons.<SEP>NADH is a molecule that carries electrons during cellular respiration.", "source_id": "chunk-b930cdd3706af881cfa771b341af097d<SEP>chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH"}, {"entity_type": "GENE", "description": "NADH Dehydrogenase Subunit 1 is a protein subunit of respiratory complex I.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "NADH DEHYDROGENASE SUBUNIT 1"}, {"entity_type": "GENOMIC VARIANT", "description": "3754C>A is a novel variant in the MT-ND1 gene, causing an arginine to change to a premature stop codon at amino acid position 387 (Arg387X).", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "MT-ND1"}, {"entity_type": "GENE", "description": "COQ2  is a gene that encodes coenzyme Q2 homolog, prenyltransferase.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COQ2"}, {"entity_type": "DISEASE", "description": "Coenzyme Q10 deficiency is a disorder caused by mutations in COQ2.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "COENZYME Q10 DEFICIENCY"}, {"entity_type": "NUTRIENT", "description": "Ubiquinone, also known as coenzyme Q, is a lipid-soluble molecule involved in electron transfer within the mitochondria.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "UBIQUINONE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Flavin mononucleotide (FMN) is a cofactor for Complex I and plays a role in electron transfer.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "FMN"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Iron-sulfur clusters are protein cofactors involved in electron transfer.", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "id": "IRON\u2013SULFUR CLUSTER"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "Exome sequencing identifies genetic variants.)", "entity_type": "UNKNOWN", "id": "EXOME SEQUENCING"}, {"source_id": "chunk-b930cdd3706af881cfa771b341af097d", "description": "Exome sequencing identifies genetic variants.)", "entity_type": "UNKNOWN", "id": "VARIANTS"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "Mutations in MT-ND1 can cause Leber optic atrophy.)", "entity_type": "UNKNOWN", "id": "LEBER OPTIC ATROPHY"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "Mutations in MT-ND1 can cause mitochondrial complex I deficiency.)", "entity_type": "UNKNOWN", "id": "MITOCHONDRIAL COMPLEX I DEFICIENCY"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "Mutations in MT-ND1 can cause MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes).)", "entity_type": "UNKNOWN", "id": "MELAS"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "Subunit 1 is one of seven mtDNA encoded subunits included among the approximately 41 polypeptides of respiratory complex I.)", "entity_type": "UNKNOWN", "id": "RESPIRATORY COMPLEX I"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "The NADH dehydrogenase subunit 1 protein contains an FMN binding site.)", "entity_type": "UNKNOWN", "id": "FMN BINDING SITE"}, {"source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "description": "The NADH dehydrogenase subunit 1 protein is predicted to contain iron-sulfur cluster binding sites.)", "entity_type": "UNKNOWN", "id": "IRON\u2013SULFUR CLUSTER BINDING SITE"}, {"entity_type": "GENE", "description": "OPRM1 is a gene that encodes an opioid receptor.<SEP>OPRM1 is a gene that influences alcohol self-administration.<SEP>The OPRM1 gene is involved in opioid receptor function and has been linked to alcohol dependence.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "OPRM1"}, {"entity_type": "DRUG", "description": "Naltrexone is a medication used to reduce alcohol consumption.<SEP>Naltrexone is an opioid antagonist used as a medication for alcohol use disorder.", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544<SEP>chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "NALTREXONE"}, {"entity_type": "GENE", "description": "ALDH2 is a gene that significantly affects alcohol metabolism.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "ALDH2"}, {"entity_type": "GENOMIC VARIANT", "description": "Asn40 is a specific variant of the OPRM1 gene.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 145}]", "id": "ASN40"}, {"entity_type": "GENOMIC VARIANT", "description": "Asp40 is a specific variant of the OPRM1 gene.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 144}]", "id": "ASP40"}, {"entity_type": "NUTRIENT", "description": "Alcohol is consumed as \'drinks\' in this study.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "id": "DRINKS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Time it takes for an individual to consume their first drink after a session begins.", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 145}]", "id": "LATENCY TO FIRST DRINK"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The OPRM1 gene was not found to have a simple effect on alcohol craving, but there were significant interactions with other factors.)", "entity_type": "UNKNOWN", "id": "ALCOHOL CRAVING"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "There was no significant simple effect of the OPRM1 gene on sedation response to alcohol.)", "entity_type": "UNKNOWN", "id": "SUBJECTIVE RESPONSE TO ALCOHOL (SEDATION)"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "There was a significant three-way interaction between medication, genotype, and BrAC for stimulation response, suggesting a complex relationship.)", "entity_type": "UNKNOWN", "id": "SUBJECTIVE RESPONSE TO ALCOHOL (STIMULATION)"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "The ADH1B genotype significantly affected sedation response to alcohol.)", "entity_type": "UNKNOWN", "id": "ADH1B"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Participants reported significantly more drowsiness on naltrexone compared to placebo.)", "entity_type": "UNKNOWN", "id": "SUBJECTIVE RESPONSE TO ALCOHOL (DROWSINESS)"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Participants reported significantly more ringing in the ears on naltrexone compared to placebo.)", "entity_type": "UNKNOWN", "id": "SUBJECTIVE RESPONSE TO ALCOHOL (RINGING IN THE EARS)"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Differences in AUDIT scores were observed across OPRM1 genotype groups.)", "entity_type": "UNKNOWN", "id": "AUDIT"}, {"source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "description": "Differences in AUDIT scores were observed across OPRM1 genotype groups.)", "entity_type": "UNKNOWN", "id": "DRINKING VARIABLES"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "Asp40 is a specific variant of the OPRM1 gene.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 144}]", "id": "OPRM1 GENE"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "Individuals with Asn40 variant consume significantly fewer drinks compared to those with Asp40.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 144}]", "id": "ALCOHOL SELF-ADMINISTRATION"}, {"source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "description": "ALDH2 genotype significantly influences alcohol consumption.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 144}]", "id": "ALDH2 GENOTYPE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant within the ALDH2 gene, specifically rs671, influences alcohol metabolism and has different genotypes (GG, GA, AA) associated with varying levels of alcohol consumption.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "ALDH2 RS671"}, {"entity_type": "GENOMIC VARIANT", "description": "The GA genotype of the ALDH2 rs671 variant is associated with intermediate levels of daily alcohol consumption.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "GA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Education status refers to an individual\'s highest level of formal schooling.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "EDUCATION STATUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Blood cortisol levels are a measure of the amount of the stress hormone cortisol circulating in the blood.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "BLOOD CORTISOL LEVELS"}, {"entity_type": "STATISTICAL ANALYSIS METHOD", "description": "A statistical analysis method used to examine the association between two variables without controlling for other factors.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "UNIVARIATE MODEL"}, {"entity_type": "STATISTICAL ANALYSIS METHOD", "description": "A statistical analysis method used to examine the association between two variables while controlling for other factors.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "MULTIVARIATE MODEL"}, {"entity_type": "STATISTICAL ANALYSIS METHOD", "description": "A statistical method used to assess the robustness of findings by examining different assumptions or scenarios.", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "id": "SENSITIVITY ANALYSIS"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "BMI differed significantly according to the rs671 polymorphism in men.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "RS671 POLYMORPHISM"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 54}]", "id": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "The ALDH2 rs671 genotypes had different distributions and impacts on alcohol consumption in men compared to women.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 52}]", "id": "ALDH2 RS671 GENOTYPES"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "After adjusting for various covariates, the multivariate model revealed a stronger association between daily alcohol consumption and blood cortisol levels in women compared to men.)<SEP>Higher daily alcohol consumption was associated with elevated blood cortisol levels in both men and women.)<SEP>In both sexes, a univariate model showed a positive association between daily alcohol consumption and blood cortisol levels.)", "entity_type": "UNKNOWN", "id": "DAILY ALCOHOL CONSUMPTION"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "Sensitivity analysis was performed to evaluate the reliability of the association between genetically predicted alcohol consumption and cortisol levels.)<SEP>The MR analysis showed a positive association between genetically predicted daily alcohol consumption and cortisol levels in men.)", "entity_type": "UNKNOWN", "id": "CORTISOL LEVELS"}, {"source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "description": "Sensitivity analysis was performed to evaluate the reliability of the association between genetically predicted alcohol consumption and cortisol levels.)<SEP>The MR analysis showed a positive association between genetically predicted daily alcohol consumption and cortisol levels in men.)", "entity_type": "UNKNOWN", "id": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"entity_type": "GENE", "description": "ABCG2 is a gene associated with uric acid levels.<SEP>ABCG2 is a gene that encodes an ABC transporter.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "ABCG2"}, {"entity_type": "GENE", "description": "SLC22A12 is a gene associated with uric acid levels.<SEP>SLC22A12 is a gene that encodes a solute carrier family member.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "id": "SLC22A12"}, {"entity_type": "DISEASE", "description": "Hyperuricemia (HUA) is a condition characterized by elevated levels of serum uric acid.<SEP>Hyperuricemia (HUA) is a condition characterized by elevated uric acid levels in the blood.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 35}]", "id": "HUA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum Uric Acid (sUA) refers to the level of uric acid in the blood serum.<SEP>Serum uric acid (sUA) level is a measure of uric acid concentration in blood.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "SUA"}, {"entity_type": "PROTEIN", "description": "Low-density lipoprotein (LDL) is a type of cholesterol that can contribute to plaque buildup in arteries.<SEP>Low-density lipoprotein cholesterol (LDL) is a type of cholesterol associated with increased risk of heart disease.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "LDL"}, {"entity_type": "PROTEIN", "description": "High-density lipoprotein (HDL) is a type of cholesterol that helps remove LDL from the arteries.<SEP>High-density lipoprotein cholesterol (HDL) is a type of cholesterol that helps remove LDL from the bloodstream.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-befd5ea20007b1d02d987897c798dadd", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "HDL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Serum creatinine is a waste product filtered by the kidneys, and elevated levels can indicate kidney damage.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "SERUM CREATININE"}, {"entity_type": "DRUG", "description": "Diuretics are medications that help remove excess fluid from the body by increasing urine production.", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "id": "DIURETICS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3733951 is a single nucleotide polymorphism in the SLC2A9 gene.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "RS3733951"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2231142 is a genomic variant associated with increased systolic uric acid (sUA) levels and higher uric acid level-associated hypertension risk.<SEP>rs2231142 is a single nucleotide polymorphism in the ABCG2 gene.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00<SEP>chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 35}]", "id": "RS2231142"}, {"entity_type": "GENOMIC VARIANT", "description": "rs893006 is a single nucleotide polymorphism in the SLC22A12 gene.", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 55}]", "id": "RS893006"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Systolic uric acid (sUA) is a measure of uric acid levels in the blood.", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "clusters": "[{level: 0, cluster: 35}]", "id": "SYSTOLIC URIC ACID"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "The ABCG2 rs2231142 polymorphism is associated with serum uric acid (sUA) levels.)", "entity_type": "UNKNOWN", "id": "SUA LEVEL"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "Individuals carrying the risk allele of the ABCG2 rs2231142 SNP have a higher risk of HUA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 35}]", "id": "RS2231142 ABCG2"}, {"source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "description": "Individuals carrying the risk allele of the SLC2A9 rs3733591 SNP have a higher risk of HUA.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 35}]", "id": "RS3733591 SLC2A9"}, {"source_id": "chunk-7091ed039203b69ad83d281b22c89579", "description": "Carriers of the rs2231142 T allele have a significantly increased risk of developing hypertension associated with high uric acid levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 35}]", "id": "HYPERTENSION RISK"}, {"source_id": "chunk-7091ed039203b69ad83d281b22c89579", "description": "Carriers of the rs2231142 T allele have a significantly increased risk of developing hypertension associated with high uric acid levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 35}]", "id": "URIC ACID LEVEL-ASSOCIATED HYPERTENSION"}, {"entity_type": "GENE", "description": "LRP2 is a gene that has been associated with kidney function.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "LRP2"}, {"entity_type": "GENE", "description": "NFATC1 gene plays a role in kidney function.<SEP>NFATC1 is a gene that has been associated with kidney function.<SEP>NFATC1 is a gene that plays a central role in inducible gene transcription during immune response and is a downstream target of the transplant immunosuppression drug cyclosporine A.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 72}]", "id": "NFATC1"}, {"entity_type": "GENE", "description": "UNCX is a gene associated with increased risk of CKD.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "UNCX"}, {"entity_type": "GENE", "description": "ALMS1 is a gene associated with increased risk of CKD.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "ALMS1"}, {"entity_type": "GENE", "description": "PDILT-UMOD is a gene associated with kidney function and CKD, specifically the variants rs77924615.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "PDILT-UMOD"}, {"entity_type": "GENE", "description": "PRKAG2 is a gene associated with eGFR in individuals with diabetes.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "PRKAG2"}, {"entity_type": "GENE", "description": "DCDC5-MPPED2 is a gene associated with kidney function.<SEP>DCDC5-MPPED2 is a gene locus involved in the development of cognitive function and synaptic plasticity.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "DCDC5-MPPED2"}, {"entity_type": "GENE", "description": "SLC34A1 is a gene associated with kidney function.<SEP>SLC34A1 is a gene involved in phosphate transport.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "SLC34A1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "eGFR (estimated glomerular filtration rate) is a measure of kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "EGFR"}, {"entity_type": "DISEASE", "description": "CKD (Chronic Kidney Disease) is a condition characterized by the progressive loss of kidney function.<SEP>Chronic Kidney Disease (CKD) is a progressive loss of kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-3edc72730d68b4c7fd6ba397aa087391<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "CKD"}, {"entity_type": "DISEASE", "description": "ESRD (End-Stage Renal Disease) is the final stage of CKD, requiring dialysis or transplantation.", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "id": "ESRD"}, {"entity_type": "GENE", "description": "PIP5K1B encodes phosphatidylinositol phosphate kinase 1 beta, which plays a role in cell signaling and membrane trafficking.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "PIP5K1B"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1260326 is a missense variant in the GCKR gene that results in increased de novo triglyceride and cholesterol synthesis, decreased plasma glucose concentrations.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "RS1260326"}, {"entity_type": "PROTEIN", "description": "HDAC8 is a histone deacetylase involved in kidney function and development.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 73}]", "id": "HDAC8"}, {"entity_type": "DRUG", "description": "Cyclosporine A is an immunosuppressant drug that targets NFATC1.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 72}]", "id": "CYCLOSPORINE A"}, {"entity_type": "GENE", "description": "Loco is the closest ortholog of RGS14 in Drosophila melanogaster and has a role in lifespan and stress resistance.<SEP>The loco gene plays a role in resistance to salt stress.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCO"}, {"entity_type": "GENE", "description": "RGS14 encodes a member of the regulator of G protein signaling family, which modulates downstream effects of G\u03b1 subunits and has unknown function in kidneys.<SEP>RGS14 gene plays a role in kidney function.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083<SEP>chunk-5ac437b050552f5db2abf19f1bf897cf", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 72}]", "id": "RGS14"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Phosphate transport is the process by which phosphate ions are moved across cell membranes.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "PHOSPHATE TRANSPORT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Immune response is a coordinated defense mechanism against infection and disease.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 72}]", "id": "IMMUNE RESPONSE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Lifespan refers to the length of time an organism lives.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "LIFESPAN"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Stress resistance is the ability of an organism to withstand adverse environmental conditions.", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "id": "STRESS RESISTANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant is present in the y1w1 strain.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "Y1W1"}, {"entity_type": "GENOMIC VARIANT", "description": "The locoEY-P283 genetic modification is used to investigate the role of the loco gene.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "LOCOEY-P283"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "NaCl, or sodium chloride, is added to the diet in experiments to induce salt stress.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "NACL"}, {"entity_type": "DISEASE", "description": "Salt stress is a condition that causes physiological challenges in organisms.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "SALT STRESS"}, {"entity_type": "DISEASE", "description": "Glomerulosclerosis is a disease affecting the kidneys, characterized by scarring of glomeruli.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "GLOMERULOSCLEROSIS"}, {"entity_type": "ORGAN", "description": "The kidney is an organ responsible for filtering waste products from the blood.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "KIDNEY"}, {"entity_type": "ANATOMICAL STRUCTURE", "description": "A glomerulus is a small network of capillaries in the kidney responsible for filtration.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "GLOMERULUS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The expression levels of mRNA within the kidneys reflect gene activity.", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "id": "RENAL MRNA EXPRESSION"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "NFATC1 plays a role in kidney function.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 72}]", "id": "KIDNEY FUNCTION"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "High-salt diet exposure significantly decreases renal mRNA expression of Rgs14.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "HIGH-SALT DIET"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "High-salt diet exposure significantly decreases renal mRNA expression of Rgs14.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "RENAL MRNA EXPRESSION OF RGS14"}, {"source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "description": "High-salt diet exposure significantly decreases renal mRNA expression of Nfatc1.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 11}, {level: 1, cluster: 71}]", "id": "RENAL MRNA EXPRESSION OF NFATC1"}, {"entity_type": "DISEASE", "description": "Campylobacter infections are a bacterial illness that can be associated with various symptoms.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "CAMPYLOBACTER INFECTIONS"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in Campylobacter bacteria that confers resistance to quinolone antibiotics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "QUINOLONE-RESISTANT CAMPYLOBACTER"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in Campylobacter bacteria that confers resistance to erythromycin antibiotics.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "ERYTHROMYCIN-RESISTANT CAMPYLOBACTER"}, {"entity_type": "MICROORGANISM", "description": "C. coli is a species of Campylobacter bacteria commonly associated with foodborne illness.<SEP>Campylobacter coli is a bacterium that can cause illness in humans.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c<SEP>chunk-0d155c005072e55d94179ce7952bf5a9", "id": "C. COLI"}, {"entity_type": "MICROORGANISM", "description": "C. jejuni is a species of Campylobacter bacteria commonly associated with foodborne illness.<SEP>Campylobacter jejuni is a bacterium that causes campylobacteriosis.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c<SEP>chunk-0d155c005072e55d94179ce7952bf5a9", "id": "C. JEJUNI"}, {"entity_type": "LOCATION", "description": "Denmark is the country where the study on Campylobacter infections was conducted.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "DENMARK"}, {"entity_type": "LOCATION", "description": "Spain is a country mentioned as a potential source of travel-associated quinolone-resistant Campylobacter infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "SPAIN"}, {"entity_type": "LOCATION", "description": "Portugal is a country mentioned as a potential source of travel-associated quinolone-resistant Campylobacter infections.", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "id": "PORTUGAL"}, {"entity_type": "DRUG", "description": "Fluoroquinolones are a class of antibiotics used to treat bacterial infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "FLUOROQUINOLONES"}, {"entity_type": "DRUG", "description": "Macrolides are another class of antibiotics used to treat bacterial infections.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "MACROLIDES"}, {"entity_type": "STUDY SAMPLE", "description": "A sample of Campylobacter isolates collected from retail food products and broiler chickens.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CAMPYLOBACTERISOLATES FROM RETAIL FOOD PRODUCTS AND BROILER CHICKENS"}, {"entity_type": "FOOD", "description": "Chicken is a type of poultry that can be a source of Campylobacter infection.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "CHICKEN"}, {"entity_type": "FOOD", "description": "Turkey is a type of poultry that can be a source of Campylobacter infection.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "TURKEY"}, {"entity_type": "FOOD", "description": "Pork is a type of meat that can be contaminated with Campylobacter.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "PORK"}, {"entity_type": "ANIMAL", "description": "Broiler chickens are specifically raised for meat production and can be a source of Campylobacter.", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "id": "BROILER CHICKENS"}, {"source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "description": "Traveling abroad, particularly to regions in Southern Europe and Southeast Asia, was significantly associated with a higher proportion of quinolone-resistant Campylobacter infections.)", "entity_type": "UNKNOWN", "id": "FOREIGN TRAVEL"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "C. jejuni infection leads to the disease campylobacteriosis.)", "entity_type": "UNKNOWN", "id": "CAMPYLOBACTERIOSIS"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "This is the data source used in the study.)", "entity_type": "UNKNOWN", "id": "CAMPYLOBACTER ISOLATES FROM RETAIL FOOD PRODUCTS AND BROILER CHICKENS"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "This is the data source used in the study.)", "entity_type": "UNKNOWN", "id": "STUDY SAMPLE"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Certain strains of C. jejuni are resistant to nalidixic acid, an antibiotic.)", "entity_type": "UNKNOWN", "id": "NALIDIXIC ACID RESISTANCE"}, {"source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "description": "Some strains of C. coli exhibit resistance to erythromycin.)", "entity_type": "UNKNOWN", "id": "ERYTHROMYCIN RESISTANCE"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs9534511) is associated with increased social disinhibition score.<SEP>rs9534511 is a SNP located on the HTR2A gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "RS9534511"}, {"entity_type": "GENE", "description": "HTR2A is a gene that plays a role in serotonin signaling.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "HTR2A"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs4938056) is associated with increased social disinhibition score.<SEP>rs4938056 is a SNP located on the HTR3B gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "RS4938056"}, {"entity_type": "GENE", "description": "HTR3B is a gene that encodes a serotonin receptor.<SEP>HTR3B is a gene that plays a role in serotonin signaling.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HTR3B"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs1998220) is associated with increased social disinhibition score.<SEP>rs1998220 is a SNP located in an intronic region of the OPRM1 gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "RS1998220"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs1003921) is associated with a protective effect against increased social disinhibition score.<SEP>rs1003921 is a SNP located in an intronic region of the KCNC1 gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "RS1003921"}, {"entity_type": "GENE", "description": "KCNC1 is a gene that encodes a voltage-gated potassium channel.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "KCNC1"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs16116) is associated with a protective effect against increased social disinhibition score.<SEP>rs16116 is a SNP located in an intergenic region downstream of the NPY gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "RS16116"}, {"entity_type": "GENE", "description": "NPY is a gene that encodes neuropeptide Y, involved in various physiological processes.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "NPY"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (rs16870286) is associated with a protective effect against increased social disinhibition score.<SEP>rs16870286 is a SNP located within the LINC00518 gene and is associated with increased risk of social disinhibition.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1<SEP>chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "RS16870286"}, {"entity_type": "GENE", "description": "LINC00518 is a miscellaneous RNA gene that codes for an uncharacterized protein.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "id": "LINC00518"}, {"entity_type": "SOCIAL BEHAVIOR", "description": "A measure of impulsivity and tendency to engage in risky behaviors.", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "SOCIAL DISINHIBITION"}, {"entity_type": "DISEASE", "description": "Social disinhibition score is a measure of behavioral tendencies.", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 141}]", "id": "SOCIAL DISINHIBITION SCORE"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "Higher linguistic acculturation scores were associated with higher mean social disinhibition scores.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "LINGUISTIC ACCULTURATION"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "A higher TAS score is associated with increased risk of social disinhibition.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "TAS (TEMPERAMENT AND CHARACTER INVENTORY - REWARD DEPENDENCE SCALE)"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "A higher DAS score is associated with increased risk of social disinhibition.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "DAS (DIFFICULTIES AT SCHOOL SCALE)"}, {"source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "description": "Youth with at least one parent who had completed high school or attained additional education reported higher mean social disinhibition scores compared to those whose parents did not graduate high school.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 38}, {level: 1, cluster: 140}]", "id": "PARENTAL EDUCATION"}, {"entity_type": "GENE", "description": "CNR1 is a gene that encodes the CB1 receptor, involved in the mesocorticolimbic neurocircuitry.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CNR1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2023239 is a genetic variant located upstream of exon 3 of the CNR1 gene and acts as an alternative promoter.<SEP>rs2023239 is a genomic variant that has been investigated for its interaction with alcohol consumption and medication effects.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59<SEP>chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "RS2023239"}, {"entity_type": "PROTEIN", "description": "The CB1 receptor is a protein that binds to cannabinoids and modulates neurotransmission in various brain regions.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "CB1 RECEPTOR"}, {"entity_type": "ANATOMICAL REGION", "description": "Prefrontal cortex (PFC) is a region of the brain involved in higher-order cognitive functions.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "PFC"}, {"entity_type": "ANATOMICAL REGION", "description": "Brodmann areas 9 and 10 are specific regions within the PFC.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "BRODMANN AREAS 9 AND 10"}, {"entity_type": "ANATOMICAL REGION", "description": "Nucleus accumbens (NAcc) is a brain region involved in reward and motivation.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "NACC"}, {"entity_type": "ANATOMICAL REGION", "description": "Ventrolateral prefrontal cortex (VMPFC) is a region of the PFC involved in decision-making and impulse control.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VMPFC"}, {"entity_type": "ANATOMICAL REGION", "description": "Ventral tegmental area (VTA) is a brain region that produces dopamine and plays a role in reward.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "VTA"}, {"entity_type": "ANATOMICAL REGION", "description": "Orbitofrontal cortex (OFC) is a region of the PFC involved in evaluating rewards and making decisions.", "source_id": "chunk-27c6611dceafae880176ce8a7e7fc07e", "id": "OFC"}, {"entity_type": "DRUG", "description": "Olanzapine is a medication that targets the dopamine system and has been studied for its interaction with alcohol consumption and rs2023239.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "OLANZAPINE"}, {"entity_type": "DRUG", "description": "Cyproheptadine hydrochloride is an active control medication used in comparison to olanzapine.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CYPROHEPTADINE HYDROCHLORIDE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Reward is a physiological process that involves feelings of pleasure and satisfaction.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "REWARD"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Positive affect is a physiological state characterized by feelings of happiness and well-being.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "POSITIVE AFFECT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "High refers to a subjective feeling of euphoria or intoxication.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "HIGH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Craving refers to a strong desire or urge for something, in this case, alcohol.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "CRAVING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Drinks per drinking day is a measure of alcohol consumption frequency.", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "id": "DRINKS PER DRINKING DAY"}, {"entity_type": "GENE", "description": "The LPL gene encodes lipoprotein lipase, an enzyme involved in lipid metabolism.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 33}]", "id": "LPL"}, {"entity_type": "PROTEIN", "description": "Lipoprotein lipase is an enzyme that breaks down fats in the blood.<SEP>Lipoprotein lipase is an enzyme that hydrolyzes chylomicrons.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 132}]", "id": "LIPOPROTEIN LIPASE"}, {"entity_type": "DISEASE", "description": "LPL deficiency is a rare autosomal recessive disorder characterized by decreased LPL activity due to mutations in the LPL gene.<SEP>Patients with LPL deficiency can present with marked hypertriglyceridemia.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "LPL DEFICIENCY"}, {"entity_type": "DIETARY FAT", "description": "Chylomicrons are lipoprotein particles that transport dietary fat in the bloodstream.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 132}]", "id": "CHYLOMICRON"}, {"entity_type": "ENDOGENOUS LIPID METABOLISM", "description": "Exogenous lipid metabolism involves the digestion and absorption of dietary fat, while endogenous lipid metabolism involves the synthesis and mobilization of lipids within the body.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 132}]", "id": "EXOGENOUS LIPID METABOLISM"}, {"entity_type": "DISEASE", "description": "Eruptive xanthomas are skin lesions characterized by yellow papules that often appear after meals.<SEP>Eruptive xanthomas are skin lesions that can appear when triglyceride levels are high.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "ERUPTIVE XANTHOMAS"}, {"entity_type": "DISEASE", "description": "Melena is a medical condition characterized by the passage of dark, tarry stools due to bleeding in the gastrointestinal tract.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "MELENA"}, {"entity_type": "DISEASE", "description": "Hemochromatosis is a disorder characterized by excessive iron accumulation in the body.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "HEMATOCHROMATOSIS"}, {"entity_type": "DISEASE", "description": "A papular rash is a skin condition characterized by small, raised bumps that are often itchy.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "PAPULAR RASH"}, {"entity_type": "DISEASE", "description": "Lipemia retinalis is a condition characterized by the appearance of fat deposits in the retina.<SEP>Lipemia retinalis is a condition in which fats build up in the blood vessels of the retina.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "LIPEMIA RETINALIS"}, {"entity_type": "DISEASE", "description": "Pancreatitis is an inflammation of the pancreas.<SEP>Pancreatitis is inflammation of the pancreas, which can be caused by high triglyceride levels.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63<SEP>chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "PANCREATITIS"}, {"entity_type": "DISEASE", "description": "Gastrointestinal bleeding is bleeding from any part of the digestive tract.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "GASTROINTESTINAL BLEEDING"}, {"entity_type": "CELL TYPE", "description": "Myocytes are muscle cells that contract and generate force.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 33}]", "id": "MYOCYTES"}, {"entity_type": "PROTEIN", "description": "GPIHBP1 is a glycoprotein that binds to lipoprotein lipase and transports it to the capillary lumen.", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 132}]", "id": "GPIHBP1"}, {"entity_type": "GENETIC LOCATION", "description": "The LPL gene is located on chromosome 8p21.3.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "id": "CHROMOSOME 8P21.3"}, {"entity_type": "GENE", "description": "The LPL gene provides instructions for making lipoprotein lipase, an enzyme that breaks down fats in the blood.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "LPL GENE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Lipoprotein lipase interacts with triglyceride-rich lipoproteins to break them down.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 132}]", "id": "TRIGLYCERIDE-RICH LIPOPROTEINS"}, {"entity_type": "DISEASE", "description": "Hypertriglyceridemia is a condition characterized by elevated levels of triglycerides in the blood.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "HYPERTRIGLYCERIDEMIA"}, {"entity_type": "DIETARY PATTERN", "description": "Limiting dietary fat intake is a key treatment strategy for LPL deficiency.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "DIETARY FAT RESTRICTION"}, {"entity_type": "NUTRIENT", "description": "Medium-chain triglycerides (MCTs) are fats that can be absorbed directly into the bloodstream.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "MCT SUPPLEMENTS"}, {"entity_type": "DRUG", "description": "Gemfibrozil is a medication that can help lower triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "GEMFIBROZIL"}, {"entity_type": "DRUG", "description": "Orlistat is a medication that blocks the absorption of fat from food.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 133}]", "id": "ORLISTAT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Amino acid residue 240 plays a functional role in lipolysis of triglyceride-rich lipoproteins.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "AMINO ACID RESIDUE 240"}, {"entity_type": "PROTEIN REGION", "description": "The local domain containing amino acid residue 240 is important for the function of lipoprotein lipase.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LOCAL DOMAIN"}, {"entity_type": "GENOTYPE", "description": "A heterozygous individual carries one normal copy and one mutated copy of the LPL gene.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HETEROZYGOTE"}, {"entity_type": "GENOTYPE", "description": "A compound heterozygote has two different mutations in the LPL gene.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "COMPOUND HETEROZYGOTE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Triglyceride (TG) levels are a measure of fat concentration in the blood.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "TG LEVELS"}, {"entity_type": "METABOLIC PATHWAY", "description": "Lipid metabolism encompasses the processes involved in the synthesis, breakdown, and transport of lipids.<SEP>Lipid metabolism encompasses the processes involved in the synthesis, transport, and breakdown of lipids.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86<SEP>chunk-dcbd547f8218e7097805720fd6ea43ba", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "LIPID METABOLISM"}, {"entity_type": "DISEASE", "description": "Lipoprotein lipase deficiency is a genetic disorder characterized by impaired lipid metabolism.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "LIPOPROTEIN LIPASE DEFICIENCY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hyperviscosity refers to an increased thickness of the blood, which can occur with elevated triglyceride levels.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "HYPERVISCOSITY"}, {"entity_type": "DISEASE", "description": "Gastrointestinal hemorrhage is bleeding in the digestive tract.", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "id": "GASTROINTESTINAL HEMORRHAGE"}, {"source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "description": "Lipoprotein lipase deficiency can lead to hemochromatosis due to impaired lipid metabolism.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 32}, {level: 1, cluster: 131}]", "id": "HEMOCHROMATOSIS"}, {"entity_type": "DRUG", "description": "Topiramate is a medication used to treat alcohol dependence.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "TOPIRAMATE"}, {"entity_type": "EVENT", "description": "Adverse events are unwanted side effects that can occur as a result of taking medication.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "ADVERSE EVENTS"}, {"entity_type": "METRIC", "description": "NNT (Number Needed to Treat) is a measure of treatment effectiveness, indicating the number of patients who need to be treated to prevent one HDD.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "NNT"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2832407 is a specific genetic variation that was found to influence the effect of topiramate.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "RS2832407"}, {"entity_type": "EVENT", "description": "Heavy Drinking Days (HDDs) are a measure of alcohol consumption.", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "HDDS"}, {"entity_type": "METRIC", "description": "NNT-AEmod+ (Number Needed to Treat - Adverse Event Modified) is a measure of treatment effectiveness considering the severity of adverse events.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "NNT-AEMOD+"}, {"entity_type": "METRIC", "description": "NNT-AEsev+ (Number Needed to Treat - Adverse Event Severe) is a measure of treatment effectiveness considering severe adverse events.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "NNT-AESEV+"}, {"entity_type": "DEMOGRAPHIC GROUP", "description": "The European-American subgroup is a specific population group within the study.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "id": "EUROPEAN-AMERICAN SUBGROUP (EA)"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "Individuals homozygous for the rs2832407*C allele experienced a greater benefit from topiramate in reducing HDDs compared to placebo.)", "entity_type": "UNKNOWN", "id": "RS2832407*C-HOMOZYGOTES"}, {"source_id": "chunk-0c7ab28db433187759e760725a105836", "description": "For individuals carrying the A allele of rs2832407, topiramate had no significant effect on reducing HDDs.)", "entity_type": "UNKNOWN", "id": "RS2832407*A-ALLELE CARRIERS"}, {"entity_type": "GENE", "description": "ABCB1 is a gene that encodes an ATP-binding cassette transporter protein.<SEP>ABCB1 is a gene that plays a role in drug transport and metabolism.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCB1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1045642 is a single nucleotide polymorphism (SNP) in the ABCB1 gene.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "RS1045642"}, {"entity_type": "GENE", "description": "CYP2D6 is a gene that encodes an enzyme involved in drug metabolism.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CYP2D6"}, {"entity_type": "DISEASE", "description": "CINV stands for Chemotherapy-Induced Nausea and Vomiting, a common adverse effect of chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CINV"}, {"entity_type": "DISEASE", "description": "The Common Toxicity Criteria for Adverse Events (CTCAE) is a standardized system for grading the severity of adverse events associated with cancer treatment, including nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "CTCAE"}, {"entity_type": "DRUG", "description": "Palonosetron is an antiemetic medication commonly used to prevent and treat nausea and vomiting associated with chemotherapy.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PALONOSETRON"}, {"entity_type": "DRUG", "description": "Dexamethasone is a corticosteroid medication often used in combination with other antiemetics to manage nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "DEXAMETHASONE"}, {"entity_type": "DRUG", "description": "Prochlorperazine is an antipsychotic medication that can also be used as an antiemetic.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "PROCHLORPERAZINE"}, {"entity_type": "DRUG", "description": "Ondansetron is a serotonin receptor antagonist commonly used to prevent and treat nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ONDANSETRON"}, {"entity_type": "DRUG", "description": "Fosaprepitant is a neurokinin-1 receptor antagonist used to prevent and treat nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "FOSAPREPITANT"}, {"entity_type": "DISEASE", "description": "Gastrointestinal cancer is a type of cancer that affects the digestive system.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "GASTROINTESTINAL CANCER"}, {"entity_type": "DISEASE", "description": "Thoracic cancer is a type of cancer that affects the chest region.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "THORACIC CANCER"}, {"entity_type": "DISEASE", "description": "Malignancy refers to the presence of a cancerous tumor or growth.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "MALIGNANCY"}, {"entity_type": "DISEASE", "description": "Advanced stage disease refers to cancer that has spread to other parts of the body.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "ADVANCED STAGE DISEASE"}, {"entity_type": "DISEASE", "description": "Highly emetogenic chemotherapy regimens are treatments that have a high likelihood of causing nausea and vomiting.", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "id": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Heterozygotes for the ABCB1 (rs1045642) variant reported more severe acute nausea compared to individuals with homozygous wild type or homozygous variant genotypes.)", "entity_type": "UNKNOWN", "id": "ACUTE NAUSEA"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "CYP2D6 phenotype was not associated with acute or delayed CINV, suggesting no direct link between CYP2D6 and nausea severity.)", "entity_type": "UNKNOWN", "id": "PATIENT-REPORTED ACUTE NAUSEA"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "Patients reported their level of acute nausea as part of the CINV assessment.)", "entity_type": "UNKNOWN", "id": "PATIENT REPORTED ACUTE NAUSEA"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "The CTCAE grade was used to assess the severity of CINV.)", "entity_type": "UNKNOWN", "id": "CTCAE GRADE OF NAUSEA"}, {"source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "description": "The majority of patients had gastrointestinal malignancies.)", "entity_type": "UNKNOWN", "id": "PATIENT CHARACTERISTIC"}, {"entity_type": "GENE", "description": "MCM6 is a gene associated with lactase persistence.<SEP>MCM6 is a gene involved in DNA replication and repair.<SEP>MCM6 is a gene located on chromosome 2, near LCT.<SEP>The MCM6 gene plays a role in DNA replication and cell cycle progression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-ec104044b3aa65560be8d81dbb3940d6<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6"}, {"entity_type": "EPIGENETIC MODIFICATION", "description": "Changes in DNA modification patterns can affect gene expression, including that of LCT.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 84}]", "id": "DNA MODIFICATION"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The mTAG-click method is a technique used to enrich unmodified DNA fragments for analysis.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "MTAG-CLICK METHOD"}, {"entity_type": "MOLECULAR INTERACTION", "description": "These arrays are used to interrogate DNA modification patterns across chromosomes.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "AFFYMETRIX HIGH DENSITY HUMAN TILING ARRAYS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Microarrays containing probes that span the entire length of a chromosome can be used to analyze DNA modification patterns.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "TILING MICROARRAYS"}, {"entity_type": "CELL", "description": "Enterocytes are intestinal epithelial cells responsible for nutrient absorption.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 84}]", "id": "ENTEROCYTES"}, {"entity_type": "TISSUE", "description": "The jejunum is a part of the small intestine involved in digestion and nutrient absorption.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "JEJUNUM"}, {"entity_type": "CHROMOSOME", "description": "Chromosome 2 contains the LCT gene and other genes related to lactase regulation.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "CHROMOSOME 2"}, {"entity_type": "CHROMOSOME", "description": "Chromosome 9 was included in some arrays for control purposes.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "CHROMOSOME 9"}, {"entity_type": "CHROMOSOME", "description": "Chromosome 19 was included in some arrays for control purposes.", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "id": "CHROMOSOME 19"}, {"entity_type": "DNA FEATURE", "description": "A CpG site is a location in DNA where a cytosine nucleotide is followed by a guanine nucleotide.<SEP>CpG sites are regions of the genome where a cytosine nucleotide is followed by a guanine nucleotide.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "CPG SITE"}, {"entity_type": "REGION OF GENE", "description": "Intron 5 is a non-coding region within the LCT gene.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 5"}, {"entity_type": "REGION OF GENE", "description": "Intron 3 is a non-coding region within the LCT gene.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 3"}, {"entity_type": "REGION OF GENE", "description": "Intron 2 is a non-coding region within the LCT gene.<SEP>Intron 2 is a non-coding region within the Lct gene.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTRON 2"}, {"entity_type": "REGION OF GENE", "description": "Exon 1 is a coding region within the LCT gene.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EXON 1"}, {"entity_type": "DATABASE", "description": "The Epigenomics Roadmap is a database of human epigenomic data.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "EPIGENOMICS ROADMAP"}, {"entity_type": "REGULATORY ELEMENT", "description": "DNase I hypersensitivity sites are regions of DNA that are more accessible to DNase I enzyme.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "DNASE I HYPERSENSITIVITY SITES"}, {"entity_type": "HISTONE MARK", "description": "H3K4me1 is a histone modification associated with active enhancers.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "H3K4ME1"}, {"entity_type": "HISTONE MARK", "description": "H3K27ac is a histone modification associated with active enhancers.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "H3K27AC"}, {"entity_type": "HISTONE MARK", "description": "H3K4me3 is a histone modification associated with active promoters.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "H3K4ME3"}, {"entity_type": "LONG NON-CODING RNA", "description": "LOCN100507600 is a long non-coding RNA.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "LOCN100507600"}, {"entity_type": "REGION OF GENE", "description": "Intron 13 is a non-coding region within the MCM6 gene.<SEP>MCM6 intron 13 contains a genomic variant associated with lactase persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 84}]", "id": "MCM6 INTRON 13"}, {"entity_type": "REGION OF GENE", "description": "Exon 16 is a coding region within the MCM6 gene.<SEP>Exon 16 of the MCM6 gene shows significant differences in DNA modification between haplotypes.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1<SEP>chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6 EXON 16"}, {"entity_type": "REGION OF GENE", "description": "The 3\u2032UTR is a non-coding region at the end of the MCM6 gene.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "MCM6 3\u2032UTR"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "A biological sample collected from sperm.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "SPERM SAMPLE"}, {"entity_type": "BIOLOGICAL SAMPLE", "description": "Samples taken from the intestines.", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "id": "INTESTINE SAMPLES"}, {"entity_type": "GENOMIC VARIANT", "description": "C-13910 is a genomic variant within the MCM6 gene that influences lactase persistence.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "C-13910"}, {"entity_type": "TRANSCRIPT", "description": "LCT mRNA is the messenger RNA transcript produced by the LCT gene.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 82}]", "id": "LCT MRNA"}, {"entity_type": "PROMOTER REGION", "description": "The LCT promoter region is active and involved in gene expression.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LCT PROMOTER"}, {"entity_type": "LONG NON-CODING RNA", "description": "LOC100507600 is a long non-coding RNA that regulates LCT mRNA levels.", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "id": "LNCRNA LOC100507600"}, {"entity_type": "CELL LINE", "description": "Caco-2 is a human intestinal epithelial cell line.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CACO-2"}, {"entity_type": "LNCRNA", "description": "LOC100507600 is a long non-coding RNA (lncRNA) that regulates LCT expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 102}]", "id": "LOC100507600"}, {"entity_type": "PROTEIN", "description": "CTCF is a protein that binds to insulator sites and regulates gene expression.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CTCF"}, {"entity_type": "MOLECULAR INTERACTION", "description": "DNA methylation is a process that involves adding a methyl group to DNA, which can affect gene expression.<SEP>DNA methylation is an epigenetic modification that can inhibit CTCF binding.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "id": "DNA METHYLATION"}, {"entity_type": "PHENOTYPE", "description": "Lactase persistence is the ability to digest lactose in adulthood.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 79}]", "id": "LACTASE PERSISTENCE"}, {"entity_type": "GENETIC FEATURE", "description": "An intron is a non-coding sequence within a gene.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "INTRON"}, {"entity_type": "REGION", "description": "An exon is a coding sequence within a gene.<SEP>An exon is a segment of a gene that codes for a protein.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-512b044cf65a4e519d519c6239959c6c", "id": "EXON"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP -13910 is a single nucleotide polymorphism located at position -13910 of the LOC100507600 gene.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "SNP -13910"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Small interfering RNAs are RNA molecules that can silence gene expression through RNA interference.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "clusters": "[{level: 0, cluster: 18}, {level: 1, cluster: 102}]", "id": "SMALL-INTERFERING RNAS"}, {"entity_type": "GENETIC FEATURE", "description": "Intron 1 is a non-coding region within the Lct gene.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "LNTRON 1"}, {"entity_type": "GENETIC FEATURE", "description": "Intron 13 is a non-coding region within the Mcm6 gene.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "INTRON 13"}, {"entity_type": "MOLECULAR INTERACTION", "description": "CRISPR-Cas9 is a genome editing technology that can be used to introduce specific modifications into DNA.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "CRISPR-CAS9"}, {"entity_type": "DATABASE", "description": "ENCODE datasets are public repositories of genomic data.", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "id": "ENCODE DATASETS"}, {"source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "description": "Epigenetic modifications within the MCM6 gene, particularly intron 13-exon 13 and exon 16, are correlated with inter-individual differences in LCT mRNA levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 82}]", "id": "MCM6 REGION"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The LCT intron 5 region maps to the promoter of the lncRNA LOCN100507600.)", "entity_type": "UNKNOWN", "id": "LCT INTRON 5"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The MCM6 exon 17 region maps to the 3\u2032 untranslated region (3\u2032-UTR) of MCM6.)", "entity_type": "UNKNOWN", "id": "MCM6 EXON 17"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "LCT exon 1 had an abundance of H3K4me3 and H3K27ac, indicative of an active promoter.)", "entity_type": "UNKNOWN", "id": "ACTIVE PROMOTER"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "LCT exon 1 had an abundance of H3K4me3 and H3K27ac, indicative of an active promoter.)", "entity_type": "UNKNOWN", "id": "LCT EXON 1"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers, H3K4me1 and H3K27ac were detected at LCT introns 2 and 3.)", "entity_type": "UNKNOWN", "id": "ACTIVE ENHANCER"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers, H3K4me1 and H3K27ac were detected at LCT introns 2 and 3.)", "entity_type": "UNKNOWN", "id": "LCT INTRON 2 & 3"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "Histone marks characteristic of active enhancers, H3K4me1 and H3K27ac were detected at MCM6 intron 13 and exon 16 to 3\u2032-UTR.)", "entity_type": "UNKNOWN", "id": "MCM6 INTRON 13 & EXON 16"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The seven LCT\u2013MCM6 regions facilitate the cell-type specificity of LCT modification.)", "entity_type": "UNKNOWN", "id": "CELL-TYPE SPECIFIC EXPRESSION"}, {"source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "description": "The seven LCT\u2013MCM6 regions facilitate the cell-type specificity of LCT modification.)", "entity_type": "UNKNOWN", "id": "LCT\u2013MCM6 REGIONS"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "Different C-13910 haplotypes result in distinct levels of LCT mRNA expression with age.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 82}]", "id": "C-13910 HAPLOTYPE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "Individuals with the CC genotype at the C-13910 locus exhibit lactase non-persistence.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}]", "id": "LACTASE NON-PERSISTENCE"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "In lactase non-persistent individuals, DNA modifications increase with age, while in lactase persistent individuals they tend to decrease.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "DNA MODIFICATION CHANGES"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The LOC100507600 lncRNA negatively regulates LCT mRNA levels.)<SEP>The expression level of LOC100507600 lncRNA is positively correlated with LCT mRNA levels.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 82}]", "id": "LOC100507600 LNCRNA"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modifications in MCM6 exon 16 change gradually with age.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "MCM6 EXON 16 DNA MODIFICATION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modifications increase in LCT intron 2 with age in mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 84}]", "id": "LCT INTRON 2"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "Changes at MCM6 intron 13 are observed after conception.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "MCM6 INTEIN 13 DNA MODIFICATION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "DNA modifications increase in LCT intron 8 with age in mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 48}]", "id": "LCT INTRON 8 DNA MODIFICATION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The presence of H3K27ac marks identifies an enhancer element within the LCT intron 2 region.)", "entity_type": "UNKNOWN", "id": "ENHANCER ELEMENT"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The presence of H3K4me3 marks indicates a promoter region within the LCT exon 1-intron 1 region.)", "entity_type": "UNKNOWN", "id": "PROMOTER REGION"}, {"source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "description": "The presence of POLR2A indicates an active promoter region within the LCT exon 1-intron 1 region.)", "entity_type": "UNKNOWN", "id": "POLR2A"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion of Lct introns 1 and 2 causes widespread downregulation of Lct mRNA throughout the duodenum and jejunum.)", "entity_type": "UNKNOWN", "id": "LCT DELETION"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deletion of Lct introns 1 and 2 causes widespread downregulation of Lct mRNA throughout the duodenum and jejunum.)", "entity_type": "UNKNOWN", "id": "LCT MRNA LEVELS"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Caco-2 cells in an undifferentiated state resemble cancer-like cells.)", "entity_type": "UNKNOWN", "id": "UNDIFFERENTIATED STATE"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Caco-2 cells in a differentiated state resemble enterocyte-like cells of the small intestine.)", "entity_type": "UNKNOWN", "id": "DIFFERENTIATED STATE"}, {"source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "description": "Deleting regions within the Lct gene, including introns 1 and 2, leads to a reduction in Lct mRNA levels.)", "entity_type": "UNKNOWN", "id": "CRISPR-CAS9 DELETION"}, {"entity_type": "GENOMIC VARIANT", "description": "T is the minor allele at rs4988235 associated with lactase persistence.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "T"}, {"entity_type": "GENOMIC VARIANT", "description": "C is the minor allele at rs4988235 associated with lactase non-persistence.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "id": "C"}, {"entity_type": "DIETARY PATTERN", "description": "Milk drinking is a dietary pattern analyzed in relation to lactase persistence.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 79}]", "id": "MILK DRINKING"}, {"entity_type": "DISEASE", "description": "RCC (Renal Cell Carcinoma) is a disease studied in relation to milk consumption.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "RCC"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Education level is an environmental factor potentially associated with both milk consumption and other health outcomes.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "EDUCATION"}, {"entity_type": "COUNTRY", "description": "Romania is a country where milk consumption and genetic data were collected.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "ROMANIA"}, {"entity_type": "COUNTRY", "description": "Poland is a country where milk consumption and genetic data were collected.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "POLAND"}, {"entity_type": "COUNTRY", "description": "Russia is a country where milk consumption and genetic data were collected.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "RUSSIA"}, {"entity_type": "COUNTRY", "description": "The Czech Republic is a country where milk consumption and genetic data were collected.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "CZECH REPUBLIC"}, {"entity_type": "COUNTRY", "description": "The UK is a country mentioned in comparison to other European regions.", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 79}]", "id": "UK"}, {"source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "description": "A higher risk of RCC was observed among individuals who consumed milk.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 8}, {level: 1, cluster: 56}, {level: 2, cluster: 146}]", "id": "MILK CONSUMPTION"}, {"source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "description": "Observed genotype frequencies deviated from Hardy-Weinberg equilibrium in Romania (p=0.02), suggesting genetic influences on allele distribution.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 161}]", "id": "GENOTYPE FREQUENCIES"}, {"entity_type": "THERAPY", "description": "Hydroxyurea treatment, often abbreviated as HU treatment, is a therapy used to increase fetal hemoglobin (HbF) levels in patients with sickle cell disease.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 91}]", "id": "HYDROXYUREA TREATMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Baseline HbF refers to the level of fetal hemoglobin present before hydroxyurea treatment begins.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 90}]", "id": "BASELINE HBF"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "MTD HbF refers to Mean Target HbF, a physiological measure reflecting hemoglobin F levels in adults.<SEP>MTD HbF stands for Maximum Tolerated Dose HbF, which represents the highest level of fetal hemoglobin achieved during hydroxyurea treatment.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 91}]", "id": "MTD HBF"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Delta HbF refers to the change in fetal hemoglobin levels after starting hydroxyurea treatment, calculated as MTD HbF minus Baseline HbF.<SEP>Delta HbF represents the change in hemoglobin F levels.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce<SEP>chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "DELTA HBF"}, {"entity_type": "GENOMIC VARIANT", "description": "HBG2-Xmn1-rs7482144 is a single nucleotide polymorphism (SNP) within the HBG2 gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HBG2-XMN1-RS7482144"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1427407 is a single nucleotide polymorphism (SNP) within the BCL11A gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 90}]", "id": "BCL11A RS1427407"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4671393 is a single nucleotide polymorphism (SNP) within the BCL11A gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 91}]", "id": "BCL11A RS4671393"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11886868 is a single nucleotide polymorphism (SNP) within the BCL11A gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 92}]", "id": "BCL11A RS11886868"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9399137 is a single nucleotide polymorphism (SNP) within the HMIP-2 gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 90}]", "id": "HMIP-2 RS9399137"}, {"entity_type": "GENOMIC VARIANT", "description": "rs9402686 is a single nucleotide polymorphism (SNP) within the HMIP-2 gene.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 91}]", "id": "HMIP-2 RS9402686"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "HbF, or fetal hemoglobin, is an important type of hemoglobin produced during fetal development.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HBF"}, {"entity_type": "DISEASE", "description": "Sickle cell disease is a genetic blood disorder that affects the shape of red blood cells.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "clusters": "[{level: 0, cluster: 15}, {level: 1, cluster: 91}]", "id": "SICKLE CELL DISEASE"}, {"entity_type": "GROUP", "description": "The Brazilian cohort refers to the group of patients participating in the study from Brazil.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "BRAZILIAN COHORT"}, {"entity_type": "STATISTICAL METHOD", "description": "Regression analysis is a statistical method used to examine the relationship between variables.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "REGRESSION ANALYSIS"}, {"entity_type": "GENETIC CONCEPT", "description": "A haplotype is a specific combination of alleles at different loci on a chromosome that are inherited together.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "HAPLOTYPE"}, {"entity_type": "STATISTICAL CONCEPT", "description": "Linkage disequilibrium refers to the non-random association of alleles at different loci on a chromosome.", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "id": "LINKAGE DISEQUILIBRIUM"}, {"entity_type": "GENE", "description": "HMIP-2 is a gene whose SNPs are being studied for their association with MTD HbF and delta HbF.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "id": "HMIP-2"}, {"entity_type": "GENOMIC VARIANT", "description": "The C-A haplotype of the HMIP-2 gene was associated with MTD HbF but lost significance after correcting for baseline HbF. <SEP>The C-A haplotype of the HMIP-2 gene was associated with MTD HbF but lost significance after correcting for baseline HbF.", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "C-A HAPLOTYPE"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "This SNP had a very low allele frequency in the Brazilian cohort and was excluded from further analysis.)", "entity_type": "UNKNOWN", "id": "STUDY EXCLUSION"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "The five candidate SNPs used in the study were all found to be in agreement with Hardy-Weinberg Equilibrium.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 108}, {level: 2, cluster: 161}]", "id": "FIVE CANDIDATE SNPS"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Regression analysis was used to evaluate the association between SNPs and various HbF measurements.)", "entity_type": "UNKNOWN", "id": "BASELINE HBF, MTD HBF, DELTA HBF"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Haplotype analysis was performed to assess the combined effect of BCL11A and HMIP-2 SNPs.)", "entity_type": "UNKNOWN", "id": "BCL11A SNPS, HMIP-2 SNPS"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Haplotype analysis was performed to assess the combined effect of BCL11A and HMIP-2 SNPs.)", "entity_type": "UNKNOWN", "id": "HAPLOTYPE ANALYSIS"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Linkage disequilibrium testing revealed that HMIP-2 rs9399137 and rs9402686 are in strong linkage.)", "entity_type": "UNKNOWN", "id": "HMIP-2 RS9399137, HMIP-2 RS9402686"}, {"source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "description": "Linkage disequilibrium testing revealed that HMIP-2 rs9399137 and rs9402686 are in strong linkage.)", "entity_type": "UNKNOWN", "id": "LINKAGE DISEQUILIBRIUM TESTING"}, {"source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "description": "The HMIP-2 gene is being investigated for its role in regulating or influencing Mean Target HbF and Delta HbF.)", "entity_type": "UNKNOWN", "id": "PHYSIOLOGICAL PROCESS"}, {"entity_type": "DISEASE", "description": "Fanconi anemia (FA) is a rare genetic disorder characterized by bone marrow failure, congenital abnormalities, and increased chromosomal breakage.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCONI ANEMIA"}, {"entity_type": "DISEASE", "description": "Radial aplasia is a birth defect characterized by the absence or incomplete development of the radius bone in the forearm.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "RADIAL APLASIA"}, {"entity_type": "DISEASE", "description": "Microcephaly is a birth defect characterized by an abnormally small head size.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "MICROCEPHALY"}, {"entity_type": "DISEASE", "description": "Micrognathia is a birth defect characterized by an abnormally small jaw.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "MICROGNATHIA"}, {"entity_type": "DISEASE", "description": "Caf\u00e9 au lait spots are flat, light-brown patches of skin that appear at birth or shortly after. ", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "CAF\u00c9 AU LAIT SPOTS"}, {"entity_type": "DISEASE", "description": "Absent left kidney is a congenital anomaly where the left kidney fails to develop.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "ABSENT LEFT KIDNEY"}, {"entity_type": "DISEASE", "description": "Bone marrow failure is a condition in which the bone marrow doesn\'t produce enough blood cells.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "BONE MARROW FAILURE"}, {"entity_type": "DISEASE", "description": "Chromosomal breakage refers to damage or breaks in chromosomes, which can lead to genetic disorders.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "CHROMOSOMAL BREAKAGE"}, {"entity_type": "CELLULAR COMPONENT", "description": "Lymphoblastoid cell lines are derived from lymphocytes and are commonly used for research.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "LYMPHOBLASTOID CELL LINE (LCLS)"}, {"entity_type": "CELLULAR COMPONENT", "description": "Fibroblasts are cells responsible for producing collagen and other extracellular matrix components.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FIBROBLASTS"}, {"entity_type": "PROTEIN", "description": "FANCD2 is a protein involved in the DNA repair pathway.<SEP>FANCD2 is a protein that interacts with URD and FANCI.<SEP>FANCD2 is another substrate of the FANCL complex involved in DNA repair.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f", "id": "FANCD2"}, {"entity_type": "PROTEIN", "description": "FANCA is a protein essential for DNA repair and is mutated in Fanconi anemia type A.<SEP>FANCA is a protein that interacts with FAAP20 through the N-terminal region of FAAP20.", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f<SEP>chunk-cc528af98598e1adb4684c0166430cf4", "id": "FANCA"}, {"entity_type": "PROTEIN", "description": "UBE2T is a gene.<SEP>UBE2T is a ubiquitin-conjugating enzyme involved in the ubiquitination of FANCD2.<SEP>Ube2T is a member of the E2 UBC enzyme family and plays a role in ubiquitination.<SEP>Ube2T is an E2 ubiquitin-conjugating enzyme that binds to the RING domain of FANCL.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-b3b792ab4e6f6251de68ef6e959aee1f<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8<SEP>chunk-ffd1276c89bcac745a7e58082e97236f", "id": "UBE2T"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Fibroblasts derived from the subject (RA2627) are hypersensitive to crosslinking agents and display elevated chromosomal breakage levels.)", "entity_type": "UNKNOWN", "id": "FIBROBLASTS FROM SUBJECT RA2627"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The subject\'s fibroblasts (RA2627) are deficient in FANCD2 monoubiquitination.)", "entity_type": "UNKNOWN", "id": "FANCD2 MONOUBIQUITINATION"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The subject\'s fibroblasts (RA2627) are deficient in FANCD2 monoubiquitination.)", "entity_type": "UNKNOWN", "id": "SUBJECT\'S FIBROBLASTS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The subject\u2019s lymphoblastoid cell line (LCLs) carry a FANCA mutation, but normal levels of FANCA protein are detected.)", "entity_type": "UNKNOWN", "id": "FANCA MUTATION C.2574C>G/P.SER858ARG"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "The subject\u2019s lymphoblastoid cell line (LCLs) carry a FANCA mutation, but normal levels of FANCA protein are detected.)", "entity_type": "UNKNOWN", "id": "SUBJECT\'S LCLS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Markedly reduced UBE2T transcript levels were detected in RA2627 fibroblasts compared to non-FA patient cell line (RA3380).)", "entity_type": "UNKNOWN", "id": "RA2627 FIBROBLASTS"}, {"source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "description": "Markedly reduced UBE2T transcript levels were detected in RA2627 fibroblasts compared to non-FA patient cell line (RA3380).)", "entity_type": "UNKNOWN", "id": "UBE2T TRANSCRIPT LEVELS"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Overexpression of UBE2T rescued cellular defects in RA2627 cells.)<SEP>Overexpression of UBE2T rescued cellular hypersensitivity to crosslinking agents MMC, DEB and cisplatin in RA2627 fibroblasts.)", "entity_type": "UNKNOWN", "id": "RA2627 CELLULAR DEFECTS"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "RA2627 cells exhibit hypersensitivity to MMC.)", "entity_type": "UNKNOWN", "id": "MMC"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "RA2627 cells exhibit hypersensitivity to DEB.)", "entity_type": "UNKNOWN", "id": "DEB"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "RA2627 cells exhibit hypersensitivity to cisplatin.)", "entity_type": "UNKNOWN", "id": "CISPLATIN"}, {"source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac<SEP>chunk-ffd1276c89bcac745a7e58082e97236f", "description": "FANCI is a protein that interacts with URD and FANCD2.<SEP>FANCI is a substrate of the FANCL complex, which plays a role in DNA repair.<SEP>Overexpression of UBE2T restored monoubiquitination of FANCI.)", "entity_type": "PROTEIN", "id": "FANCI"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "Analysis of cell cycle distribution following treatment with MMC revealed an accumulation of RA2627 cells in G2 that was rescued by UBE2T overexpression to the levels observed in wild type BJ cells.)", "entity_type": "UNKNOWN", "id": "G2"}, {"source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "description": "The cell cycle distribution of RA2627 cells after MMC treatment was similar to that of wild type BJ cells after UBE2T overexpression.)", "entity_type": "UNKNOWN", "id": "WILD TYPE BJ CELLS"}, {"entity_type": "GENE", "description": "RPS19 is a gene that is mutated in Diamond Blackfan Anemia (DBA).", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "clusters": "[{level: 0, cluster: 29}, {level: 1, cluster: 128}]", "id": "RPS19"}, {"entity_type": "PROTEIN", "description": "LARS is an aminoacyl-tRNA synthetase that plays a role in protein synthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "LARS"}, {"entity_type": "PROTEIN", "description": "WARS is a gene involved in amino acid synthesis and is down-regulated in DBA patients.<SEP>WARS is an aminoacyl-tRNA synthetase involved in protein synthesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "WARS"}, {"entity_type": "PROTEIN", "description": "GARS is an aminoacyl-tRNA synthetase that catalyzes the attachment of glycine to tRNA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "GARS"}, {"entity_type": "PROTEIN", "description": "SARS is an aminoacyl-tRNA synthetase involved in protein synthesis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "SARS"}, {"entity_type": "PROTEIN", "description": "QARS is an aminoacyl-tRNA synthetase that adds glutamine to tRNA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "QARS"}, {"entity_type": "PROTEIN", "description": "EPRS is an aminoacyl-tRNA synthetase that adds proline to tRNA.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "EPRS"}, {"entity_type": "PROTEIN", "description": "PSAT1 is involved in the metabolism of glycine, serine and threonine.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PSAT1"}, {"entity_type": "PROTEIN", "description": "PHGDH catalyzes a key step in the synthesis of serine.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PHGDH"}, {"entity_type": "PROTEIN", "description": "CTH is involved in the conversion of cysteine to taurine.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "CTH"}, {"entity_type": "PROTEIN", "description": "CASP9 is a caspase involved in apoptosis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "CASP9"}, {"entity_type": "PROTEIN", "description": "NFKBIA is an inhibitor of NF-\u03baB, a transcription factor involved in inflammation.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKBIA"}, {"entity_type": "PROTEIN", "description": "NFKBIE is another inhibitor of NF-\u03baB.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKBIE"}, {"entity_type": "PROTEIN", "description": "APAF1 is a component of the apoptosome, a complex that activates caspase 9.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "APAF1"}, {"entity_type": "PROTEIN", "description": "NFKB2 is a subunit of NF-\u03baB.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKB2"}, {"entity_type": "PROTEIN", "description": "NFKB1 is another subunit of NF-\u03baB.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "NFKB1"}, {"entity_type": "PROTEIN", "description": "BIRC3 is an inhibitor of apoptosis.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "BIRC3"}, {"entity_type": "PROTEIN", "description": "PRMT2 is a methyltransferase involved in various cellular processes, including gene expression.", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "id": "PRMT2"}, {"entity_type": "PROTEIN", "description": "RPL27A is a ribosomal protein essential for ribosome assembly.<SEP>RPL27A is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL27A"}, {"entity_type": "PROTEIN", "description": "RPL29 is a ribosomal protein gene.<SEP>RPL29 is a ribosomal protein involved in ribosome biogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL29"}, {"entity_type": "PROTEIN", "description": "RPL31 is a ribosomal protein gene.<SEP>RPL31 is a ribosomal protein involved in ribosome function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL31"}, {"entity_type": "PROTEIN", "description": "RPL14 is a ribosomal protein essential for ribosome assembly.<SEP>RPL14 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL14"}, {"entity_type": "PROTEIN", "description": "RPL18A is a ribosomal protein gene.<SEP>RPL18A is a ribosomal protein involved in ribosome biogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL18A"}, {"entity_type": "PROTEIN", "description": "RPS3 is a ribosomal protein essential for ribosome assembly.<SEP>RPS3 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS3"}, {"entity_type": "PROTEIN", "description": "RPL18 is a ribosomal protein gene.<SEP>RPL18 is a ribosomal protein involved in ribosome biogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL18"}, {"entity_type": "PROTEIN", "description": "RPL13 is a ribosomal protein gene.<SEP>RPL13 is a ribosomal protein involved in ribosome function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL13"}, {"entity_type": "PROTEIN", "description": "RPL3 is a ribosomal protein essential for ribosome assembly.<SEP>RPL3 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL3"}, {"entity_type": "PROTEIN", "description": "RPL34 is a ribosomal protein gene.<SEP>RPL34 is a ribosomal protein involved in ribosome biogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL34"}, {"entity_type": "PROTEIN", "description": "RPS2 is a ribosomal protein essential for ribosome assembly.<SEP>RPS2 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS2"}, {"entity_type": "PROTEIN", "description": "RPS12 is a ribosomal protein gene.<SEP>RPS12 is a ribosomal protein involved in ribosome biogenesis.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPS12"}, {"entity_type": "PROTEIN", "description": "RPL15 is a ribosomal protein gene.<SEP>RPL15 is a ribosomal protein involved in ribosome function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL15"}, {"entity_type": "PROTEIN", "description": "RPL28 is a ribosomal protein essential for ribosome assembly.<SEP>RPL28 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba<SEP>chunk-34ffb077c584b98555081f882f8f8b94", "id": "RPL28"}, {"entity_type": "GENE", "description": "RPL22 is a ribosomal protein gene.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RPL22"}, {"entity_type": "GENE", "description": "AMPD3 is a gene involved in energy metabolism and is up-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "AMPD3"}, {"entity_type": "GENE", "description": "CCND2 is a cell cycle regulator and is up-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CCND2"}, {"entity_type": "GENE", "description": "SOD2 encodes superoxide dismutase, an antioxidant enzyme, and is up-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SOD2"}, {"entity_type": "GENE", "description": "TNFAIP3 is involved in inflammation and is up-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "TNFAIP3"}, {"entity_type": "GENE", "description": "COMP encodes a proteoglycan involved in extracellular matrix formation and is down-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "COMP"}, {"entity_type": "GENE", "description": "ZIC1 is a transcription factor involved in development and is down-regulated in DBA patients.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "ZIC1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cell death is a biological process observed in the context of disease.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CELL DEATH"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Cellular development is a complex process essential for organismal growth and function.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CELLULAR DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Molecular transport refers to the movement of molecules within and between cells.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "MOLECULAR TRANSPORT"}, {"entity_type": "DISEASE", "description": "Cancer is a group of diseases characterized by uncontrolled cell growth and proliferation.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CANCER"}, {"entity_type": "DISEASE", "description": "Haematological disorders affect the blood, bone marrow, and lymphatic system.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "HAEMATOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Immunological disorders involve dysfunction of the immune system.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "IMMUNOLOGICAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Renal disorders affect the kidneys.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "RENAL DISORDERS"}, {"entity_type": "DISEASE", "description": "Skeletal disorders affect the bones and joints.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SKELETAL DISORDERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Embryonic development encompasses the processes involved in the formation of an embryo from a fertilized egg.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "EMBRYONIC DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Skeletal tissue development involves the formation and growth of bones.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "SKELETAL TISSUE DEVELOPMENT"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Connective tissue development encompasses the formation and maintenance of tissues that support and connect other tissues.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "CONNECTIVE TISSUE DEVELOPMENT"}, {"entity_type": "DISEASE", "description": "DBA refers to a specific disease condition, likely Dubowitz Muscular Dystrophy.", "source_id": "chunk-dcbd547f8218e7097805720fd6ea43ba", "id": "DBA"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in the RPS19 gene are found in individuals with DBA.)", "entity_type": "UNKNOWN", "id": "DBA PATIENTS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in the RPS19 gene are found in individuals with DBA.)", "entity_type": "UNKNOWN", "id": "RPS19 GENE"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "The RPS19 protein is involved in ribosome biogenesis, a crucial cellular process.)", "entity_type": "UNKNOWN", "id": "RIBOSOME BIOGENESIS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "The RPS19 protein is involved in ribosome biogenesis, a crucial cellular process.)", "entity_type": "UNKNOWN", "id": "RPS19 PROTEIN"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in aminoacyl-tRNA biosynthesis are differentially expressed in DBA patients.)", "entity_type": "UNKNOWN", "id": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in glycine, serine and threonine metabolism are differentially expressed in DBA patients.)", "entity_type": "UNKNOWN", "id": "GLYCINE, SERINE AND THREONINE METABOLISM PATHWAY"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in death receptor signaling are differentially expressed in DBA patients.)", "entity_type": "UNKNOWN", "id": "DEATH RECEPTOR SIGNALING PATHWAY"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in the role of PKR in interferon induction and antiviral response are differentially expressed in DBA patients.)", "entity_type": "UNKNOWN", "id": "ROLE OF PKR IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Genes involved in RAR activation are differentially expressed in DBA patients.)", "entity_type": "UNKNOWN", "id": "RAR ACTIVATION PATHWAY"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in RPS19, particularly c.1-1G>A, can lead to exon skipping and activation of Nonsense-mediated decay (NMD).)", "entity_type": "UNKNOWN", "id": "NMD"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "Mutations in RPS19, particularly c.1-1G>A, can lead to exon skipping and activation of Nonsense-mediated decay (NMD).)", "entity_type": "UNKNOWN", "id": "RPS19 MUTATIONS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "These proteins are all essential components of the aminoacyl-tRNA biosynthesis pathway.)", "entity_type": "UNKNOWN", "id": "LARS, WARS, GARS, SARS, QARS, EPRS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "These proteins participate in the metabolism of glycine, serine and threonine.)", "entity_type": "UNKNOWN", "id": "PSAT1, PHGDH, GARS, CTH, SARS, SHMT2"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "These proteins are involved in the death receptor signaling pathway, which regulates cell death.)", "entity_type": "UNKNOWN", "id": "CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "These proteins are all ribosomal proteins.)", "entity_type": "UNKNOWN", "id": "RIBOSOMAL PROTEINS"}, {"source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "description": "These proteins are all ribosomal proteins.)", "entity_type": "UNKNOWN", "id": "RPL22, RPL27A, RPL29, RPL31, RPL14, RPL18A, RPS3, RPL18, RPL13, RPL3, RPL34, RPS2, RPS12, RPL15, RPL28"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism (G/A) in the BDNF gene.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF RS6265 (G/A)"}, {"entity_type": "GENOMIC VARIANT", "description": "A polymorphism (A/T) in the BDNF gene.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "BDNF RS2049046 (A/T)"}, {"entity_type": "DISEASE", "description": "A neurological disorder characterized by recurrent headaches.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "MIGRAINE"}, {"entity_type": "STATISTICAL MODEL", "description": "A statistical model used to analyze the association between a genetic variant and a disease, comparing the frequency of alleles in cases and controls.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "ALLELE MODEL"}, {"entity_type": "STATISTICAL MODEL", "description": "A statistical model used to analyze the association between a genetic variant and a disease, considering individuals with two copies of the risk allele.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "RECESSIVE MODEL"}, {"entity_type": "STATISTICAL MODEL", "description": "A statistical model used to analyze the association between a genetic variant and a disease, considering the number of risk alleles present.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "ADDITIVE MODEL"}, {"entity_type": "STATISTICAL MODEL", "description": "A statistical model used to analyze the association between a genetic variant and a disease, considering individuals with at least one copy of the risk allele.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "DOMINANT MODEL"}, {"entity_type": "STATISTICAL MEASURE", "description": "A measure of the strength of association between a genetic variant and a disease, indicating the odds of developing the disease in individuals with the variant compared to those without.<SEP>The odds ratio measures the association between an exposure and an outcome.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-814fe155e9cb953da61f6a79d1d25784", "id": "OR (ODDS RATIO)"}, {"entity_type": "STATISTIC", "description": "A range of values within which the true population parameter is likely to fall.", "source_id": "chunk-814fe155e9cb953da61f6a79d1d25784", "id": "95%CI (CONFIDENCE INTERVAL)"}, {"entity_type": "DRUG", "description": "Adalimumab is a biologic drug used to treat various inflammatory conditions.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "ADALIMUMAB"}, {"entity_type": "PATIENT", "description": "A 48-year-old Caucasian woman with severe HS who developed paradoxical psoriasis after adalimumab treatment.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 1"}, {"entity_type": "PATIENT", "description": "A 40-year-old Caucasian man with severe HS who developed paradoxical psoriasis after adalimumab treatment.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 2"}, {"entity_type": "PATIENT", "description": "A 27-year-old Caucasian man with severe HS who developed paradoxical psoriasis after biological therapy.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PATIENT 3"}, {"entity_type": "DISEASE", "description": "Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "HS"}, {"entity_type": "DISEASE", "description": "Psoriasis is a chronic autoimmune disease characterized by red, itchy, and scaly patches on the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PSORIASIS"}, {"entity_type": "DISEASE", "description": "Paradoxical psoriasis is a paradoxical reaction where treatment for one condition leads to the development of another.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "PARADOXICAL PSORIASIS"}, {"entity_type": "DISEASE SEVERITY SCORING", "description": "The Sartorius score is a tool for assessing the severity of HS.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "SARTORIUS SCORE"}, {"entity_type": "SKIN LESION", "description": "Nodules are solid, raised bumps on the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "NODULES"}, {"entity_type": "SKIN LESION", "description": "Fistulas are abnormal tunnels that connect different parts of the body.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "FISTULAS"}, {"entity_type": "SKIN LESION", "description": "Sinus tracts are narrow channels in the skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "SINUS TRACTS"}, {"entity_type": "DISEASE", "description": "Psoriasiform dermatitis is a skin condition that resembles psoriasis.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "PSORIASIFORM DERMATITIS"}, {"entity_type": "SKIN LESION", "description": "Eczematous-like skin lesions are red, itchy, and inflamed patches of skin.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "id": "ECZEMATOUS-LIKE SKIN LESIONS"}, {"entity_type": "IMMUNE CELL", "description": "Mast cells are immune cells that release histamine and other inflammatory mediators.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "MAST CELLS"}, {"entity_type": "CYTOKINE", "description": "Interleukin-36 gamma (IL-36\u03b3) is a cytokine that promotes inflammation.", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL-36\u0393"}, {"entity_type": "CELL", "description": "CD3+ cells are a type of immune cell found in skin biopsies of HS patients.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD3+ CELLS"}, {"entity_type": "CELL", "description": "CD4+ cells are a type of immune cell found in skin biopsies.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "CD4+"}, {"entity_type": "CELL", "description": "Keratinocytes are epithelial cells that make up the epidermis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 43}]", "id": "KERATINOCYTES"}, {"entity_type": "CYTOKINE", "description": "Type I IFN\u2010\u03b2 is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 43}]", "id": "TYPE I IFN\u2010\u0392"}, {"entity_type": "CYTOKINE", "description": "IFN\u2010\u03ba is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IFN\u2010\u039a"}, {"entity_type": "DISEASE", "description": "Paradoxical psoriasis is a skin condition that resembles acute psoriasis.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 43}]", "id": "PARADOXICALLY PSORIASIS"}, {"entity_type": "CYTOKINE", "description": "LL\u201037 is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "LL\u201037"}, {"entity_type": "CYTOKINE", "description": "LT\u2010\u03b1 is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "LT\u2010\u0391"}, {"entity_type": "CYTOKINE", "description": "LT\u2010\u03b2 is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "LT\u2010\u0392"}, {"entity_type": "GENE", "description": "HLA\u2010C is a gene that encodes for HLA-C protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "HLA\u2010C"}, {"entity_type": "GENE", "description": "ERAP1 is a gene that encodes for ERAp1 protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "id": "ERAP1"}, {"entity_type": "CYTOKINE", "description": "TNF\u2010\u03b1 is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "TNF\u2010\u0391"}, {"entity_type": "CYTOKINE", "description": "IL\u201017F is a cytokine involved in immune responses.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL\u201017F"}, {"entity_type": "GENE", "description": "IL\u201023R is a gene that encodes for IL\u201023 receptor.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL\u201023R"}, {"entity_type": "CELL", "description": "Dendritic cells are antigen-presenting immune cells.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "DENDRITIC CELLS"}, {"entity_type": "GENE", "description": "IL\u201012B is a gene that encodes for IL-12b protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL\u201012B"}, {"entity_type": "GENE", "description": "IKB\u03b6 is a gene that encodes for I\u03baB\u03b6 protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IKB\u0396"}, {"entity_type": "GENE", "description": "A20 is a gene that encodes for A20 protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "A20"}, {"entity_type": "PROTEIN", "description": "A20 binding protein interacts with A20.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "A20 BINDING PROTEIN"}, {"entity_type": "GENE", "description": "Tyk2 is a gene that encodes for Tyk2 protein.", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "TYK2"}, {"entity_type": "GENE", "description": "CCHCR1 is a gene with three SNPs (rs1576/rs130079/rs746647) mentioned in Table 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "CCHCR1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1576 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS1576"}, {"entity_type": "GENOMIC VARIANT", "description": "rs130079 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS130079"}, {"entity_type": "GENOMIC VARIANT", "description": "rs746647 is a SNP located within the CCHCR1 gene.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS746647"}, {"entity_type": "GENE", "description": "IL23R is a gene mentioned in the context of paradoxical psoriasiform reactions to anti-TNFs.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "IL23R"}, {"entity_type": "GENOMIC VARIANT", "description": "rs11209026 is a SNP in the IL23R gene previously associated with paradoxical psoriasiform reactions.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS11209026"}, {"entity_type": "GENOMIC VARIANT", "description": "rs72676067 is a SNP detected in patient 2.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS72676067"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1004819 is a SNP detected in patient 1.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "RS1004819"}, {"entity_type": "PATIENT GROUP", "description": "Patients suffering from a condition that may be related to IL23R gene variants, specifically paradoxical psoriasiform reactions to anti-TNFs.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "HS PATIENTS"}, {"entity_type": "DISEASE", "description": "A skin reaction characterized by inflammation and resembling psoriasis that occurs as a response to TNF inhibitors (anti-TNFs).", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "PARADOXICAL PSORIASIFORM REACTIONS"}, {"entity_type": "THERAPY", "description": "Tumor necrosis factor inhibitor drugs used to treat inflammatory conditions.", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "id": "ANTI\u2010TNFS"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Paradoxical psoriasis manifested as psoriasiform eruptions, pustular lesions, and erythemato-scaly plaques.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "SKIN LESIONS"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Patient 1 had HS classified as Hurley III.)", "entity_type": "UNKNOWN", "id": "HURLEY III"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Patient 1\'s PASI score was 6.8.)", "entity_type": "UNKNOWN", "id": "PASI"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Patient 1 and Patient 2 developed erythematous-pustular lesions as part of their paradoxical psoriasis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "ERYTHEMATOUS-PUSTULAR LESIONS"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "Patient 2 developed alopecia areata.)", "entity_type": "UNKNOWN", "id": "ALOPECIA AREATA"}, {"source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "description": "A decrease in IFN-\u03b3+ CD3+ cells was observed in paradoxical skin reactions compared to classical psoriasis.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "T LYMPHOCYTES"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "IL\u201022 was similar in T cells of psoriasiform lesions and classical psoriasis.)", "entity_type": "UNKNOWN", "id": "IL\u201022"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "CD3+ skin T cells from HS patients were enriched in CD8+, but not in CD4+ cells, when compared to PBMC isolated from the same patients.)", "entity_type": "UNKNOWN", "id": "CD8+"}, {"source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "IL\u201017RA"}, {"entity_type": "GENE", "description": "FANCL is a gene that encodes for a protein involved in DNA repair.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "FANCL"}, {"entity_type": "PROTEIN", "description": "DmFANCL is the Drosophila homolog of human FANCL, used as a structural comparison.<SEP>DmFANCL is the Drosophila homolog of the human FANCL protein.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DMFANCL"}, {"entity_type": "PROTEIN DOMAIN", "description": "The DRWD domain is a protein domain found in FANCL and related proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "DRWD DOMAIN"}, {"entity_type": "SECONDARY STRUCTURE ELEMENT", "description": "A \u03b2-meander is a type of secondary structure element consisting of a series of \u03b2-strands arranged in a curved pattern.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0392-MEANDER"}, {"entity_type": "SECONDARY STRUCTURE ELEMENT", "description": "A \u03b2-element is a short segment of polypeptide chain characterized by a beta sheet conformation.<SEP>A \u03b2-element is a structural component within proteins.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0392-ELEMENT"}, {"entity_type": "SECONDARY STRUCTURE ELEMENT", "description": "An \u03b1-helix is a common secondary structure element in proteins, forming a spiral shape.<SEP>An \u03b1-helix is another common secondary structure element in proteins, characterized by a helical conformation.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "\u0391-HELIX"}, {"entity_type": "PROTEIN FOLD", "description": "The RWD fold is a common protein fold found in various proteins involved in DNA repair and ubiquitination.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "RWD FOLD"}, {"entity_type": "PROTEIN FAMILY", "description": "E2 UBC enzymes are a family of proteins that catalyze the transfer of ubiquitin to target proteins.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "E2 UBC ENZYMES"}, {"entity_type": "AMINO ACID MOTIF", "description": "The YPXXXP motif is a short amino acid sequence found in some proteins, including FANCL, and is involved in protein-protein interactions.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "YPXXXP MOTIF"}, {"entity_type": "AMINO ACID MOTIF", "description": "The HPXXXP motif is similar to the YPXXXP motif and may also play a role in protein-protein interactions.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HPXXXP MOTIF"}, {"entity_type": "PROTEIN", "description": "Ubiquitin is a small protein that can be attached to other proteins, marking them for degradation or other cellular processes.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "UBIQUITIN"}, {"entity_type": "AMINO ACID", "description": "Cysteine is an amino acid with a thiol group (-SH) which can form disulfide bonds and participate in enzymatic reactions.", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "CYSTEINE"}, {"entity_type": "PROTEIN SURFACE FEATURE", "description": "A hydrophobic patch is a region on a protein surface that is composed of hydrophobic amino acids, which tend to interact with each other and avoid water.<SEP>A hydrophobic patch refers to a region on a protein surface enriched with nonpolar amino acids, often involved in interactions.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6b6599f2e169a7aa2a4822b71605cbc8", "id": "HYDROPHOBIC PATCH"}, {"entity_type": "PROTEIN", "description": "The URD (Ubiquitin-like protein) is a domain found in FANCL and interacts with other proteins like Ube2T and FANCI/FANCD2.<SEP>URD is a protein that interacts with FANCI and FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9<SEP>chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "URD"}, {"entity_type": "PROTEIN", "description": "DmDRWD is the Drosophila ortholog of the human FANCL protein.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "DMDRWD"}, {"entity_type": "PROTEIN", "description": "The RING domain of FANCL is responsible for binding Ube2T and mediating its interaction with substrates.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "RING"}, {"entity_type": "MOLECULAR STRUCTURE", "description": "A \u03b2-strand is a common secondary structure element in proteins.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "\u0392-STRAND"}, {"entity_type": "MOLECULAR STRUCTURE", "description": "A four-stranded \u03b2-meander is a specific arrangement of \u03b2-strands.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "FOUR-STRANDED \u0392-MEANDER"}, {"entity_type": "MOLECULAR STRUCTURE", "description": "A kinked helix is a type of \u03b1-helix with a bend or kink in its structure.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "KINKED HELIX"}, {"entity_type": "MOLECULAR FEATURE", "description": "A hydrophobic groove is a depression or cleft on the protein surface that favors interaction with hydrophobic molecules.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HYDROPHOBIC GROOVE"}, {"entity_type": "INTERACTION", "description": "This describes an experimentally observed interaction between the human RING domain and Ube2T.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HUMAN RING DOMAIN BINDS UBE2T"}, {"entity_type": "INTERACTION", "description": "This refers to the binding of the central domain of FANCL to FANCI and FANCD2.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "THE HUMAN CENTRAL DOMAIN BINDS FANCI AND FANCD2"}, {"entity_type": "DOMAIN", "description": "The ELF domain is a region within FANCL, shown in Drosophila studies not to be essential for substrate binding.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ELF DOMAIN"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These specific amino acids are part of the hydrophobic patch on the N-terminal lobe of URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-149, TYR-165, PHE-166, AND VAL-167"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These amino acids form another hydrophobic patch between \u03b1-helix 1 and the N-terminal region of the large kinked helix.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-121, ALA-140, ILE-184, TYR-187, AND LEU-191"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These residues are part of a conserved region on the N-terminal region in DmDRWD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "TYR-112, TYR-113, AND LEU-116"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These residues are found in the more extensively conserved region on human URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ILE-115, TRP-123, LEU-126, VAL-127, TYR-128, ALA-129, AND PHE-133"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These amino acids constitute a hydrophobic groove in the C-terminal domain of DmDRWD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "ILE-243, MET-246, LEU-248, LEU-264, LEU-268, AND TRP-271"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These residues form a hydrophobic groove on human URD.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "PHE-253, VAL-260, AND LEU-268"}, {"entity_type": "AMINO ACID RESIDUES", "description": "These residues extend the hydrophobic groove in the human URD compared to DmFANCL.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "LEU-248, PHE-252, LEU-254, ILE-265, AND ILE-271"}, {"entity_type": "AMINO ACID RESIDUES", "description": "This residue in Ube2T is predicted to interact with the RING domain.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "HIS-63"}, {"entity_type": "AMINO ACID RESIDUES", "description": "Phenylalanine at position 63 in Ube2T.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "PHE-63"}, {"entity_type": "MUTANT PROTEIN", "description": "Mutated Ube2T protein with Phe63 replaced by alanine.", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "id": "UBE2T-F63A"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant of URD, L248A/F252A/L254A/I265A, reduces binding with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "L248A/F252A/L254A/I265A"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant of URD, W212A/L214A, reduces binding with FANCI and FANCD2.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "W212A/L214A"}, {"entity_type": "PROTEIN PART", "description": "The C-terminal lobe of URD is involved in substrate binding.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "C-TERMINAL LOBE"}, {"entity_type": "PROTEIN PART", "description": "The N-terminal lobe of URD does not appear to be critical for substrate binding.", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "id": "N-TERMINAL LOBE"}, {"entity_type": "GENE", "description": "FGFR4 is a gene that encodes the fibroblast growth factor receptor 4.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4"}, {"entity_type": "GENOMIC VARIANT", "description": "FGFR4 rs376618 is a genomic variant in the FGFR4 gene that did not show significant differential treatment effects.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 RS376618"}, {"entity_type": "GENOMIC VARIANT", "description": "FGFR4 rs351855 (Gly388Arg) is a functional genetic variant associated with differential colesevelam treatment effects on AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "FGFR4 RS351855"}, {"entity_type": "DRUG", "description": "Colesevelam is a drug used to treat hypercholesterolemia.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "COLESEVELAM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "AC t1/2 refers to the terminal half-life of atorvastatin in circulation.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "AC T1/2"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "GC24 refers to the area under the curve of drug concentration versus time over 24 hours.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GC24"}, {"entity_type": "GENOMIC VARIANT", "description": "KLB rs4975017 is a genomic variant in the KLB gene associated with differential colesevelam treatment effects on CT.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS4975017"}, {"entity_type": "GENOMIC VARIANT", "description": "KLB rs17618244 (Arg728Gln) is a functional variant in the KLB gene associated with modest colesevelam treatment effects on AC t1/2 and GC24.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "KLB RS17618244"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Hardy-Weinberg equilibrium describes a state of genetic balance within a population.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "HARDY\u2013WEINBERG EQUILIBRIUM (HWE)"}, {"entity_type": "DISEASE", "description": "Healthy control patients are individuals without the disease being studied.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "CONTROL PATIENTS"}, {"entity_type": "GENOMIC VARIANT", "description": "Gly388Arg is a specific type of mutation in FGFR4 affecting amino acid Glycine at position 388 to Arginine.", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "id": "GLY388ARG"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Diarrhea", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 153}]", "id": "IBS-D"}, {"entity_type": "DISEASE", "description": "Irritable Bowel Syndrome with Constipation", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 155}]", "id": "IBS-C"}, {"entity_type": "DISEASE", "description": "Healthy Volunteers", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 153}]", "id": "HV"}, {"entity_type": "PROTEIN", "description": "Fibroblast Growth Factor 19, involved in regulating bile acid metabolism.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 154}]", "id": "FGF19"}, {"entity_type": "METABOLIC PATHWAY", "description": "The metabolic pathway for the synthesis of bile acids.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 153}]", "id": "BA SYNTHESIS"}, {"entity_type": "PROTEIN", "description": "Complement Component 4, a protein involved in the immune response.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "C4"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Bile Acid Excretion in Stool", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 155}]", "id": "STOOL BA"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The concentration of Complement Component 4 in serum.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 154}]", "id": "SERUM C4"}, {"entity_type": "MEDICAL INTERVENTION", "description": "Surgical removal of the gallbladder.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 154}]", "id": "CHOLECYSTECTOMY"}, {"entity_type": "BIOMOLECULE", "description": "Bile Acid", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "BA"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Quantitative measure of fecal output over a 48 hour period", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "48-HOUR STOOL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The mass of feces excreted in a given time period.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 155}]", "id": "STOOL WEIGHT"}, {"entity_type": "DIETARY PATTERN", "description": "The amount of fat consumed in the diet.", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "id": "FAT INTAKE"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "A moderate positive correlation was observed between total stool bile acid excretion and stool fat content.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 103}, {level: 2, cluster: 155}]", "id": "STOOL FAT"}, {"source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "description": "There was a significant positive correlation between BMI and total stool bile acid excretion.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 19}, {level: 1, cluster: 106}, {level: 2, cluster: 158}]", "id": "TOTAL STOOL BA"}, {"entity_type": "GENE", "description": "FAAP20 is a gene that encodes a 20 kDa protein involved in binding to FANCA through its N-terminal region and containing a conserved UBZ domain in its C terminal extremity.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20"}, {"entity_type": "PROTEIN", "description": "FAAP20-UBZ is a gene that encodes a protein involved in ubiquitin binding.<SEP>FAAP20-UBZ is a protein domain that binds to ubiquitin (Ub). It plays a role in DNA damage repair.<SEP>FAAP20-UBZ is the UBZ domain of the FAAP20 protein, which binds to ubiquitin chains.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-cc528af98598e1adb4684c0166430cf4", "id": "FAAP20-UBZ"}, {"entity_type": "GENOMIC VARIANT", "description": "K63-Ub2 refers to a linked ubiquitin chain where lysine 63 of one ubiquitin molecule is connected to another ubiquitin molecule.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "K63-UB2"}, {"entity_type": "AMINO ACID", "description": "Cys147 is a cysteine residue in the FAAP20-UBZ domain that coordinates with zinc ions.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS147"}, {"entity_type": "AMINO ACID", "description": "Cys150 is a cysteine residue in the FAAP20-UBZ domain that coordinates with zinc ions.<SEP>Cys150 is an amino acid residue in FAAP20-UBZ that is important for ubiquitin binding.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2<SEP>chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS150"}, {"entity_type": "AMINO ACID", "description": "His166 is a histidine residue in the FAAP20-UBZ domain that coordinates with zinc ions.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "HIS166"}, {"entity_type": "AMINO ACID", "description": "Cys170 is a cysteine residue in the FAAP20-UBZ domain that coordinates with zinc ions.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "CYS170"}, {"entity_type": "AMINO ACID", "description": "Leu71 is an amino acid residue in ubiquitin that interacts with neighboring ubiquitin molecules.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "LEU71"}, {"entity_type": "AMINO ACID", "description": "Lys63 is an amino acid residue on ubiquitin that is involved in forming K63-linked chains.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "LYS63"}, {"entity_type": "AMINO ACID", "description": "Gly76 is an amino acid residue on ubiquitin that links two ubiquitins in a K63-linked chain.", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "id": "GLY76"}, {"entity_type": "PROTEIN", "description": "Ubiquitin (Ub) is a small protein involved in various cellular processes, including protein degradation and signal transduction.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "UBIQUITIN (UB)"}, {"entity_type": "AMINO ACID", "description": "Leu8 is an amino acid residue located on ubiquitin (Ub).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "LEU8"}, {"entity_type": "AMINO ACID", "description": "Ile44 is a hydrophobic patch on ubiquitin (Ub) that interacts with FAAP20-UBZ.<SEP>Ile44 is an amino acid residue on ubiquitin that interacts with UBZ domains.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ILE44"}, {"entity_type": "AMINO ACID", "description": "Val70 is an amino acid residue located on ubiquitin (Ub).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "VAL70"}, {"entity_type": "AMINO ACID", "description": "Thr66 is an amino acid residue located on ubiquitin (Ub).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "THR66"}, {"entity_type": "AMINO ACID", "description": "His68 is an amino acid residue located on ubiquitin (Ub).", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "HIS68"}, {"entity_type": "AMINO ACID", "description": "Ala46 is an amino acid residue on ubiquitin (Ub) that interacts with FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ALA46"}, {"entity_type": "AMINO ACID", "description": "Gly47 is an amino acid residue on ubiquitin (Ub) that interacts with FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "GLY47"}, {"entity_type": "AMINO ACID", "description": "Trp180 is an amino acid residue located in FAAP20-UBZ and interacts with Ile44 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "TRP180"}, {"entity_type": "AMINO ACID", "description": "Asp164 is an amino acid residue in FAAP20-UBZ that forms a hydrogen bond with Gly47 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ASP164"}, {"entity_type": "AMINO ACID", "description": "Leu171 is an amino acid residue in FAAP20-UBZ that interacts with Arg72 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "LEU171"}, {"entity_type": "AMINO ACID", "description": "Ser174 is an amino acid residue in FAAP20-UBZ that interacts with Arg72 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "SER174"}, {"entity_type": "AMINO ACID", "description": "Thr175 is an amino acid residue in FAAP20-UBZ that interacts with Arg72 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "THR175"}, {"entity_type": "AMINO ACID", "description": "Asp177 is an amino acid residue in FAAP20-UBZ that interacts with Arg42 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ASP177"}, {"entity_type": "AMINO ACID", "description": "Val178 is an amino acid residue in FAAP20-UBZ that interacts with Gln49 of Ub.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "VAL178"}, {"entity_type": "AMINO ACID", "description": "Arg72 is an amino acid residue on ubiquitin (Ub) that interacts with several residues in FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ARG72"}, {"entity_type": "AMINO ACID", "description": "Arg42 is an amino acid residue on ubiquitin (Ub) that interacts with Asp177 of FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "ARG42"}, {"entity_type": "AMINO ACID", "description": "Qln49 is an amino acid residue on ubiquitin (Ub) that interacts with Val178 of FAAP20-UBZ.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "GLN49"}, {"entity_type": "MUTATION", "description": "C150S is a mutation that substitutes cysteine with serine at position 150 in FAAP20-UBZ, disrupting ubiquitin binding.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "C150S"}, {"entity_type": "MUTATION", "description": "D164A is a mutation that substitutes aspartic acid with alanine at position 164 in FAAP20-UBZ, disrupting ubiquitin binding.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "D164A"}, {"entity_type": "MUTATION", "description": "A168L is a mutation that substitutes alanine with leucine at position 168 in FAAP20-UBZ, disrupting ubiquitin binding.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "A168L"}, {"entity_type": "MUTATION", "description": "W180A is a mutation that substitutes tryptophan with alanine at position 180 in FAAP20-UBZ, disrupting ubiquitin binding.", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "W180A"}, {"entity_type": "PROTEIN", "description": "WRNIP1-UBZ is a gene that encodes a protein involved in ubiquitin binding.<SEP>WRNIP1-UBZ is a ubiquitin-binding domain from the protein WRNIP1.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "WRNIP1-UBZ"}, {"entity_type": "PROTEIN", "description": "RAD18-UBZ is a gene that encodes a protein involved in ubiquitin binding.<SEP>RAD18-UBZ is a ubiquitin-binding domain from the protein RAD18.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "RAD18-UBZ"}, {"entity_type": "PROTEIN", "description": "Pol\u03b7-UBZ is a gene that encodes a protein involved in ubiquitin binding.<SEP>Pol\u03b7-UBZ is a ubiquitin-binding domain from the protein Pol\u03b7.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "POL\u0397-UBZ"}, {"entity_type": "PROTEIN", "description": "NEMO-UBZ is a gene that encodes a protein involved in ubiquitin binding.<SEP>NEMO-UBZ is a ubiquitin-binding domain from the protein NEMO.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591<SEP>chunk-fa32a208a2f004c10c1b6777c3be13f2", "id": "NEMO-UBZ"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Pro21-Val22 is a sequence of amino acids in the \u03b2-loop of WRNIP1.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "PRO21-VAL22"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Pro398-Lys399 is a sequence of amino acids in the \u03b2-loop of NEMO-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "PRO398-LYS399"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Glu636-Lys637 is a sequence of amino acids in the \u03b2-loop of Pol\u03b7-UBZ.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "GLU636-LYS637"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Asp164, Leu167, Ala168 and Leu171 are amino acids in FAAP20-UBZ that interact with ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ASP164, LEU167, ALA168 AND LEU171"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Asp652, Phe655, Ala656 and Leu659 are amino acids in Pol\u03b7-UBZ that interact with ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ASP652, PHE655, ALA656 AND LEU659"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Gln411, Val414, Met415 and Ile418 are amino acids in NEMO-UBZ that interact with ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "GLN411, VAL414, MET415 AND ILE418"}, {"entity_type": "AMINO ACID", "description": "Ala168 is an amino acid in FAAP20-UBZ that interacts with ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "ALA168"}, {"entity_type": "AMINO ACID", "description": "Met415 is an amino acid in NEMO-UBZ that interacts with ubiquitin.", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "id": "MET415"}, {"entity_type": "GENOMIC VARIANT", "description": "Specific Single Nucleotide Polymorphisms (SNPs) within the HLA gene region used to identify disease association.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA TAG SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific combination of HLA genes associated with disease risk.", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "id": "HLA-DQ HAPLOTYPE"}, {"entity_type": "DISEASE", "description": "An autoimmune disorder where the immune system attacks the thyroid gland.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "AUTOIMMUNE THYROIDITIS"}, {"entity_type": "DISEASE", "description": "An autoimmune disease that can affect various organs and tissues.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "SYSTEMIC LUPUS ERYTHEMATOSUS"}, {"entity_type": "DISEASE", "description": "A bone disease characterized by softening of the bones due to vitamin D deficiency.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "OSTEOMALACIA"}, {"entity_type": "DISEASE", "description": "A neurological condition characterized by recurrent episodes of abnormal electrical activity in the brain.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "SEIZURE DISORDERS"}, {"entity_type": "DISEASE", "description": "A genetic disorder caused by an extra copy of chromosome 21.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "DOWN SYNDROME"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Patients with CD experience chronic diarrhea, abdominal pain, anorexia and abdominal distension.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "CLINICAL SYMPTOMS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Autoimmune manifestations in CD patients include type 1 diabetes mellitus, autoimmune thyroiditis, and systemic lupus erythematosus.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "AUTOIMMUNE MANIFESTATIONS"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Non-autoimmune disease manifestations in CD patients include osteomalacia, seizure disorders, and Down syndrome.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "NON-AUTOIMMUNE DISEASE MANIFESTATIONS"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Minor \'G\' allele of rs2395182 is more prevalent in healthy controls compared to CD patients.)<SEP>rs2395182 is a SNP located in the HLA-DQB1 gene.", "entity_type": "GENOMIC VARIANT", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "RS2395182"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2<SEP>chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Minor \'C\' allele of rs7775228 is more frequent in controls compared to CD patients.)<SEP>rs7775228 is a SNP located in the HLA-DQB1 gene.", "entity_type": "GENOMIC VARIANT", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 149}]", "id": "RS7775228"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Minor \'T\' allele of rs2187668 is more prevalent in CD patients compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "RS2187668"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "Homozygous DQ2.5 haplotype is significantly higher in CD patients compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "HLA-DQ2.5"}, {"source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "description": "DQ8/DQX haplotype is more frequent among CD patients compared to controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 59}]", "id": "HLA-DQ8/DQX"}, {"entity_type": "GENE", "description": "ABCC1 is a gene that encodes an ATP-binding cassette transporter protein.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC1"}, {"entity_type": "GENE", "description": "ABCC2 is a gene that encodes an ATP-binding cassette transporter protein.<SEP>ABCC2 is a gene that has been linked to patient survival in ovarian cancer.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCC2"}, {"entity_type": "GENE", "description": "ABCA1 is a gene that encodes an ATP-binding cassette transporter protein.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ABCA1"}, {"entity_type": "GENE", "description": "ERCC1 is a gene involved in DNA repair.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC1"}, {"entity_type": "GENE", "description": "CYP3A4 is a gene that encodes a cytochrome P450 enzyme.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "CYP3A4"}, {"entity_type": "GENE", "description": "ERCC2 is a gene involved in DNA repair.<SEP>ERCC2 is a gene that has been linked to patient survival in ovarian cancer.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3<SEP>chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERCC2"}, {"entity_type": "DRUG", "description": "Paclitaxel is a chemotherapy drug.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "PACLITAXEL"}, {"entity_type": "DRUG", "description": "Carboplatin is a chemotherapy drug.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "CARBOPLATIN"}, {"entity_type": "DISEASE", "description": "Anemia is a condition characterized by a deficiency of red blood cells or hemoglobin, leading to reduced oxygen-carrying capacity.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ANEMIA"}, {"entity_type": "DISEASE", "description": "Thrombocytopenia is a condition characterized by a low platelet count.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "THROMBOCYTOPENIA"}, {"entity_type": "DISEASE", "description": "Neutropenia is a condition characterized by a low neutrophil count, increasing the risk of infection.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "NEUTROPENIA"}, {"entity_type": "DISEASE", "description": "Febrile neutropenia is a serious complication of chemotherapy characterized by fever and neutropenia.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "FEBRILE NEUTROPENIA"}, {"entity_type": "DISEASE", "description": "Sensory neuropathy is a type of nerve damage that affects the ability to feel touch, temperature, pain, or vibration.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "SENSORY NEUROPATHY"}, {"entity_type": "DISEASE", "description": "Motor neuropathy is a type of nerve damage that affects the muscles, leading to weakness and difficulty with movement.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "MOTOR NEUROPATHY"}, {"entity_type": "PROTEIN", "description": "Growth factors are proteins that stimulate cell growth, division, and differentiation.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "GROWTH FACTORS"}, {"entity_type": "DRUG", "description": "Erythropoiesis-stimulating agents (ESAs) are medications used to increase red blood cell production.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "ERYTHROPOIESIS-STIMULATING AGENTS (ESAS)"}, {"entity_type": "PROTEIN", "description": "Colony-stimulating factors (CSFs) are proteins that stimulate the production of white blood cells.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "COLONY-STIMULATING FACTORS (CSFS)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Progression free interval (PFI) is a measure of time from the start of treatment to the occurrence of disease progression.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "PROGRESSION FREE INTERVAL (PFI)"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Overall survival (OS) is a measure of the time from the start of treatment to death from any cause.", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "id": "OVERALL SURVIVAL (OS)"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1799793 is a genomic variant within the ERCC2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS1799793"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12762549 is a genomic variant within the ABCC2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS12762549"}, {"entity_type": "GENE", "description": "SERPINB2 is a gene that has been linked to patient survival in ovarian cancer.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "SERPINB2"}, {"entity_type": "GENOMIC VARIANT", "description": "rs6104 is a genomic variant within the SERPINB2 gene.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RS6104"}, {"entity_type": "CHEMICAL", "description": "Platinum is a metal used in chemotherapy drugs, specifically platinum-based regimens.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "PLATINUM"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FIGO stage refers to the staging system for ovarian cancer based on tumor spread and other factors.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "FIGO STAGE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tumor grade describes the aggressiveness of ovarian cancer cells based on their appearance under a microscope.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR GRADE"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Tumor histology refers to the examination of the microscopic structure of ovarian cancer tissues.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "TUMOR HISTOLOGY"}, {"entity_type": "DISEASE", "description": "Residual disease refers to any remaining cancer cells after debulking surgery.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "RESIDUAL DISEASE"}, {"entity_type": "THERAPY", "description": "Debulking surgery is a surgical procedure to remove as much of the ovarian cancer tumor as possible.", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "id": "DEBULKING SURGERY"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1128503 variant in the ABCB1 gene was significantly associated with grade 3\u20134 anemia.)", "entity_type": "UNKNOWN", "id": "RS1128503"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs363717 variant in the ABCA1 gene was significantly associated with grade 3\u20134 anemia.)", "entity_type": "UNKNOWN", "id": "RS363717"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs11615 variant in the ERCC1 gene was significantly associated with grade 3\u20134 anemia.)", "entity_type": "UNKNOWN", "id": "RS11615"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs4986910 variant in the CYP3A4 gene was significantly associated with grade 3\u20134 thrombocytopenia.)", "entity_type": "UNKNOWN", "id": "RS4986910"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2074087 variant in the ABCC1 gene was associated with an increased risk of using erythropoiesis-stimulating agents (ESAs).)", "entity_type": "UNKNOWN", "id": "ESA USE"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2074087 variant in the ABCC1 gene was associated with an increased risk of using erythropoiesis-stimulating agents (ESAs).)", "entity_type": "UNKNOWN", "id": "RS2074087"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2073337 variant in the ABCC2 gene was associated with a reduced risk of using colony-stimulating factors (CSFs).)", "entity_type": "UNKNOWN", "id": "CSF USE"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs2073337 variant in the ABCC2 gene was associated with a reduced risk of using colony-stimulating factors (CSFs).)", "entity_type": "UNKNOWN", "id": "RS2073337"}, {"source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "description": "The rs1799793 variant in the ERCC2 gene was significantly associated with a longer progression-free interval.)", "entity_type": "UNKNOWN", "id": "PROGRESSION FREE INTERVAL"}, {"source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "description": "The rs1799793 variant in the ERCC2 gene was significantly associated with improved patient survival (PFI).>", "entity_type": "UNKNOWN", "id": "PATIENT SURVIVAL (PFI)"}, {"entity_type": "GENE", "description": "UMPS is a gene located on chromosome 3 that encodes for uridine monophosphate synthase. It plays a role in pyrimidine biosynthesis.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "UMPS"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant, found in individual I4, leads to a frameshift and premature stop codon in the UMPS gene.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.302DELA (P.LYS101ARGFS*9)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant, found in I3 and his mother M3, is predicted to result in an amino acid change from arginine to glycine at position 96.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.286A>G (P.ARG96GLY)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant was detected in individual I5, leading to an amino acid change from glycine to arginine at position 104.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.310G>A (P.GLY104ARG)"}, {"entity_type": "GENOMIC VARIANT", "description": "This variant, found in individual I9, leads to a change from isoleucine to asparagine at position 286.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.857T>A (P.ILE286ASN)"}, {"entity_type": "GENOMIC VARIANT", "description": "This synonymous change, found in I6, does not alter the amino acid sequence of UMPS.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C.360A>G (P.LEU120LEU)"}, {"entity_type": "SPECIES", "description": "Homo sapiens is the scientific name for humans.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "H. SAPIENS"}, {"entity_type": "SPECIES", "description": "Drosophila melanogaster is a species of fruit fly often used in genetic research.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "D. MELANOGASTER"}, {"entity_type": "SPECIES", "description": "Caenorhabditis elegans is a nematode worm commonly used as a model organism in biological research.", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "id": "C. ELEGANS"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "A de novo 6.4 Mb deletion on chromosome 3 was found in individual I1, encompassing the UMPS gene.)", "entity_type": "UNKNOWN", "id": "DELETION ON CHROMOSOME 3"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "Heterozygous alterations in UMPS were found in several individuals, predicted to lead to premature stop codons and subsequent protein truncation or NMD.)", "entity_type": "UNKNOWN", "id": "PROTEIN TRUNCATION/NONSENSE-MEDIATED MRNA DECAY (NMD)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "The 6.4 Mb deletion containing UMPS did not include genes known to cause agenesis of the corpus callosum when deleted.)", "entity_type": "UNKNOWN", "id": "AGENESIS OF THE CORPUS CALLOSUM"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "Seven different heterozygous missense alterations were detected in UMPS across several individuals.)", "entity_type": "UNKNOWN", "id": "MISSENSE ALTERATIONS"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "Individual I7 harbored this maternally inherited variant in UMPS which is predicted to lead to a premature stop codon.)", "entity_type": "UNKNOWN", "id": "UMPS C.385G>T (P.GLY129*)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was found in both individuals I10 and I11, maternally inherited in I10 and paternally in I11.)", "entity_type": "UNKNOWN", "id": "UMPS C.889G>T (P.GLU297*)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was detected in twelve family members within pedigree 2, with both maternal and paternal inheritance patterns observed.)", "entity_type": "UNKNOWN", "id": "C.224C>A (P.PRO75HIS)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was found in I3 along with c.286A>G (p.Arg96Gly), suggesting they are on the same allele.)", "entity_type": "UNKNOWN", "id": "C.1285G>C (P.GLY429ARG)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was found in I6 and is maternally inherited.)", "entity_type": "UNKNOWN", "id": "C.689G>A (P.ARG230HIS)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was detected in I7 and is maternally inherited.)", "entity_type": "UNKNOWN", "id": "C.688C>T (P.ARG230CYS)"}, {"source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "description": "This variant was detected in I11 and both parents were not tested.)", "entity_type": "UNKNOWN", "id": "C.451G>A (P.VAL151MET)"}, {"entity_type": "GENE", "description": "TGF-\u00df1 is a gene that plays a role in various cellular processes.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TGF-SS1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800469 C/T is a specific genomic variant within the TGF-\u00df1 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS1800469 C/T"}, {"entity_type": "GENE", "description": "IL-8 is a gene that encodes a protein involved in inflammation and immune responses.<SEP>IL-8 is a gene that encodes for interleukin-8, a cytokine involved in inflammatory responses.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68<SEP>chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-8"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4073 T/A is a specific genomic variant within the IL-8 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS4073 T/A"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800896 A/G is a specific genomic variant within the IL-10 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 115}, {level: 2, cluster: 163}]", "id": "RS1800896 A/G"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1179251 C/G is a specific genomic variant within the IL-22 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 142}]", "id": "RS1179251 C/G"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2227485 C/T is a specific genomic variant within the IL-22 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 142}]", "id": "RS2227485 C/T"}, {"entity_type": "GENE", "description": "IL-27 is a gene that encodes for interleukin-27, a cytokine involved in immune responses.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "IL-27"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17855750 T/G is a specific genomic variant within the IL-27 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS17855750T/G"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1800629 C/G is a specific genomic variant within the TNF-\u03b1 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 1}, {level: 1, cluster: 41}, {level: 2, cluster: 143}]", "id": "RS1800629 C/G"}, {"entity_type": "GENOMIC VARIANT", "description": "rs16944 is a specific genomic variant within the IL-1\u03b2 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "clusters": "[{level: 0, cluster: 26}, {level: 1, cluster: 121}]", "id": "RS16944"}, {"entity_type": "GENE", "description": "TLR4 is a gene that encodes for Toll-like receptor 4, involved in recognizing pathogen-associated molecular patterns.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "TLR4"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4986790 A/G is a specific genomic variant within the TLR4 gene.", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "id": "RS4986790 A/G"}, {"entity_type": "DISEASE", "description": "CRC stands for Colorectal Cancer, a type of cancer affecting the colon and rectum.", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "clusters": "[{level: 0, cluster: 24}]", "id": "CRC"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The heterozygous AG genotype of the IL-10 (rs1800896 A/G) polymorphism was significantly decreased among patients with CRC.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}]", "id": "IL-10 RS1800896 A/G POLYMORPHISM"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "The G allele frequency of the IL-22 (rs1179251 C/G) polymorphism was significantly decreased in patients with CRC.)<SEP>The homozygous GG genotype of the IL-22 (rs1179251 C/G) polymorphism was decreased among patients with CRC, although it did not reach significance.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}]", "id": "IL-22 RS1179251 C/G POLYMORPHISM"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "A decrease in the GG genotype of the IL-27 (rs17855750 T/G) polymorphism was observed in patients with CRC, suggesting a potential protective effect.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}]", "id": "IL-27 RS17855750T/G POLYMORPHISM"}, {"source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "description": "A clear tendency for a decrease in the CT genotype of the TGF-\u00df1 (rs1800469 C/T) polymorphism was observed in patients with CRC.)<SEP>The TT genotype was significantly decreased in the patients with CRC, suggesting a potential association.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 24}]", "id": "TGF-SS1 RS1800469 C/T POLYMORPHISM"}, {"source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "description": "The control group was used to compare the frequency of the T allele in individuals with CRC.)", "entity_type": "UNKNOWN", "id": "CRC PATIENTS"}, {"entity_type": "GENE", "description": "TSLP is a gene involved in asthma susceptibility.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "id": "TSLP"}, {"entity_type": "DISEASE", "description": "Asthma is a chronic inflammatory disease of the airways.<SEP>Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-3c66ee37333cba1e51a2bdc729038b68", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 81}]", "id": "ASTHMA"}, {"entity_type": "LIFESTYLE FACTOR", "description": "Ex-smokers are individuals who have previously smoked but have quit.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 78}]", "id": "EX-SMOKERS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FEV1 stands for forced expiratory volume in 1 second, a measure of lung function.<SEP>FEV1, or forced expiratory volume in 1 second, measures lung function.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FEV1"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FVC stands for forced vital capacity, a measure of the maximum amount of air that can be exhaled from the lungs.<SEP>FVC, or forced vital capacity, measures the total amount of air that can be exhaled after a deep breath.", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c<SEP>chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FVC"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "SNP rs1898671 was nominally associated with asthma susceptibility.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 80}]", "id": "ASTHMA SUSCEPTIBILITY"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "SNP rs1898671 was nominally associated with asthma susceptibility.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 78}]", "id": "RS1898671"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "SNP rs1898671 did not show significant association with the risk of asthma in the subgroup of never-smokers.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 78}]", "id": "NEVER-SMOKERS"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "The second most frequent haplotype (GAGGGCAAAG) showed a significant increased risk with asthma after adjusting age, BMI and population stratification.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 80}]", "id": "TSLP HAPLOTYPE (GAGGGCAAAG)"}, {"source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "description": "Never-smokers were a control group in the study.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 78}]", "id": "ASTHMA RISK"}, {"entity_type": "GENE", "description": "PTPN2 is a gene associated with autoimmune diseases.<SEP>PTPN2 is a gene involved in immune regulation.<SEP>PTPN2 is a gene involved in various cellular processes.<SEP>PTPN2 is a gene that plays a role in immune regulation.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTPN2"}, {"entity_type": "GENE", "description": "PTPN2/22 refers to the combined PTPN2 and PTPN22 genes.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "PTPN2/22"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP (single nucleotide polymorphism) within the PTPN2 gene at position rs1893217.<SEP>rs1893217 is a genomic variant mapped to the PTPN2 gene.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS1893217"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN2 gene at position rs2542151.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2542151"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN2 gene at position rs7234029.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS7234029"}, {"entity_type": "GENOMIC VARIANT", "description": "A significant SNP (single nucleotide polymorphism) within the PTPN2 gene at position rs478582, associated with an increased risk of CD.<SEP>rs478582 is a genomic variant within the PTPN2 gene associated with susceptibility to MAPbacteremia.<SEP>rs478582 is a single nucleotide polymorphism (SNP) located in the PTPN2 gene.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "RS478582"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN22 gene at position rs2476601, previously linked to inflammatory autoimmune diseases.<SEP>rs2476601 is a genomic variant within the PTPN22 gene associated with susceptibility to MAPbacteremia.<SEP>rs2476601 is a single nucleotide polymorphism (SNP) located in the PTPN22 gene.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-84ec948f22126cef7d93b1d7465b79db<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "RS2476601"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN22 gene at position rs2488457.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2488457"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN22 gene at position rs33996649.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS33996649"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN22 gene at position rs34209542.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS34209542"}, {"entity_type": "GENOMIC VARIANT", "description": "A SNP within the PTPN22 gene at position rs2476599.", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "id": "RS2476599"}, {"entity_type": "GENE", "description": "PTPN22 is a gene that encodes for the protein LYP.<SEP>PTPN22 is a gene that plays a role in immune regulation.", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 135}]", "id": "PTPN22"}, {"entity_type": "DISEASE", "description": "A group of individuals without a specific disease for comparison in research studies.<SEP>Individuals without asthma serving as a comparison group.<SEP>Individuals who are not infected with HIV.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-6cb127717713bd0ab5be9436fc0c7568<SEP>chunk-3c66ee37333cba1e51a2bdc729038b68", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "HEALTHY CONTROLS"}, {"entity_type": "GENOMIC VARIANT", "description": "PTP N22 is a risk variant associated with autoimmune disorders.<SEP>PTPN22 is a gene involved in immune regulation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "id": "PTP N22"}, {"entity_type": "DISEASE", "description": "MAPbacteremia is a bacterial infection.<SEP>Mycobacterium avium complex (MAC) bacteremia is a serious infection.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0<SEP>chunk-6a657cd0a000b6df4db8f1305b795021", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "MAPBACTEREMIA"}, {"entity_type": "GENE", "description": "The PTPN22 gene plays a role in immune regulation and the presence of rs2476601 variant was associated with IFN-\u03b3 expression.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "clusters": "[{level: 0, cluster: 25}]", "id": "PTPN22:RS2476601"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Phytohemagglutinin (PHA) is a plant lectin used as a mitogen to stimulate T-cell proliferation.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 63}]", "id": "PHA"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Purified protein derivative (PPD) from Mycobacterium avium complex (MAC) is used to assess immune response.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 63}]", "id": "MAP PPD-LIKE"}, {"entity_type": "CELLULAR COMPONENT", "description": "T lymphocytes, a type of white blood cell crucial for immune responses.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 63}]", "id": "T-CELLS"}, {"entity_type": "SUBJECT GROUP", "description": "Individuals without Crohn\'s disease, used as a comparison group.", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 63}]", "id": "HEALTHY CONTROL"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Purified protein derivative (PPD), a common allergen derived from Mycobacterium tuberculosis, used to assess immune response. This text refers to it as \'MAP PPD-like\' which is specific to Mycobacterium avium complex.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "id": "PPD-LIKE"}, {"source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "description": "The presence of specific alleles (TC or CC) in the PTPN2:rs478582 SNP was significantly associated with an increased risk of CD compared to healthy controls. The odds ratio for CD patients carrying these alleles was 3.03.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 25}]", "id": "PTPN2:RS478582"}, {"source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "description": "This SNP has been previously linked to various inflammatory autoimmune diseases.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 25}]", "id": "INFLAMMATORY AUTOIMMUNE DISEASES"}, {"source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "description": "The T-G haplotype, which combines the major alleles of both PTPN2:rs478582 and PTPN22:rs2476601, was more prevalent in healthy controls compared to CD patients.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "T-G HAPLOTYPE"}, {"source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "description": "The C-G haplotype, which combines a minor allele of PTPN2:rs478582 with a major allele of PTPN22:rs2476601, was more prevalent in CD patients compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "C-G HAPLOTYPE"}, {"source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "description": "Subjects with heterozygous or homozygous alleles of PTPN2:rs478582 had significantly lower CD average relative gene expression compared to healthy controls with similar SNPs.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 25}]", "id": "CD AVERAGE RELATIVE GENE EXPRESSION"}, {"source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "description": "Subjects with heterozygous or minor alleles of PTPN2:rs478582 had significantly higher IFN-\u03b3 relative gene expression in CD subjects compared to those with normal alleles.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 25}]", "id": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "description": "Subjects with heterozygous or minor alleles of PTPN2:rs478582 had a significantly higher presence of MAPbacteremia compared to healthy controls with similar SNPs.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 25}]", "id": "MAP INFECTION"}, {"source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "description": "CD subjects with the T-A haplotype had a higher prevalence of MAPbacteremia compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 62}]", "id": "T-A HAPLOTYPE"}, {"source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "description": "T-cell proliferation in CD subjects with MAPbacteremia was higher when stimulated with both PHA and MAP PPD-like compared to those without MAPbacteremia.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 63}]", "id": "CD SUBJECTS WITH MAPBACTEREMIA"}, {"entity_type": "PROTEIN", "description": "LYP-620R is a protein encoded by the PTPN22 gene and associated with the non-risk allele.<SEP>LYP-620R is a variant of the LYP gene associated with loss-of-function.<SEP>LYP-620R is a variant of the protein LYP.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "LYP-620R"}, {"entity_type": "PROTEIN", "description": "LYP-620W is a protein encoded by the PTPN22 gene and associated with the risk allele.<SEP>LYP-620W is a variant of the LYP gene with a potential impact on function.<SEP>LYP-620W is a variant of the protein LYP.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 135}]", "id": "LYP-620W"}, {"entity_type": "CELL TYPE", "description": "Na\u00efve Tconv are a subset of CD4+ T cells that have not encountered their specific antigen.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "NA\u00cfVE TCONV"}, {"entity_type": "CELL TYPE", "description": "Memory Tconv are a subset of CD4+ T cells that have previously encountered their specific antigen.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "MEMORY TCONV"}, {"entity_type": "CELL TYPE", "description": "Treg are regulatory T cells.<SEP>Tregs are a subset of CD4+ T cells that suppress immune responses.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 135}]", "id": "TREG"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "TCR signaling is a process initiated by the binding of T cell receptor to its antigen.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "TCR SIGNALING"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Ca2+ flux is an important signal transduction event involved in T cell activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "CA2+ FLUX"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "pERK signaling is a downstream pathway activated by TCR stimulation and involved in T cell activation.", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "PERK SIGNALING"}, {"entity_type": "PROTEIN", "description": "An early activation marker expressed on activated T cells.<SEP>CD69 is an activation marker expressed on T cells upon stimulation.<SEP>CD69 is an activation marker expressed on T cells.<SEP>CD69 is an early activation marker expressed on lymphocytes upon stimulation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CD69"}, {"entity_type": "PROTEIN", "description": "ICOS is an activation marker expressed on T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 27}]", "id": "ICOS"}, {"entity_type": "PROTEIN", "description": "CD25 is the IL-2 receptor alpha chain, an activation marker expressed on activated T cells.<SEP>CD25 is the alpha chain of the interleukin-2 receptor, expressed on activated T cells, including Tregs.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 27}]", "id": "CD25"}, {"entity_type": "PROTEIN", "description": "CD226 is an activation marker expressed on T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 27}]", "id": "CD226"}, {"entity_type": "PROTEIN", "description": "PD-1 is an inhibitory receptor expressed on activated T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "clusters": "[{level: 0, cluster: 27}]", "id": "PD-1"}, {"entity_type": "PROTEIN", "description": "CTLA-4 is an inhibitory receptor expressed on activated T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "CTLA-4"}, {"entity_type": "CELL TYPE", "description": "Tconv are conventional T cells.<SEP>Tconv refers to conventional T cells, a subset of T lymphocytes.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-dee0a8a550579bff19f48d41446e842d", "id": "TCONV"}, {"entity_type": "DISEASE", "description": "Tregs refers to regulatory T cells, a subset of T lymphocytes.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "TREGS"}, {"entity_type": "GENE", "description": "eGFP (Enhanced Green Fluorescent Protein) is a gene used as a reporter to track cell location and activity.<SEP>eGFP is a green fluorescent protein used as a reporter gene.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "EGFP"}, {"entity_type": "CELLULAR COMPONENT", "description": "APCs are Antigen Presenting Cells that activate T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "APCS"}, {"entity_type": "CELL LINE", "description": "K562 is a human myelogenous leukemia cell line often used in research.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "K562"}, {"entity_type": "CELLULAR COMPONENT", "description": "aAPCs are antigen-presenting cells loaded with antibodies for activation studies.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "AAPCS"}, {"entity_type": "ANTIBODY", "description": "Anti-CD3 is an antibody that binds to the CD3 receptor on T cells, activating them.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "ANTI-CD3"}, {"entity_type": "ANTIBODY", "description": "Anti-CD28 is an antibody that binds to the CD28 receptor on T cells, enhancing activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "ANTI-CD28"}, {"entity_type": "CHEMICAL", "description": "PMA (phorbol 12-myristate 13-acetate) is a chemical activator of protein kinase C.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "PMA"}, {"entity_type": "CHEMICAL", "description": "Ionomycin is a calcium ionophore that increases intracellular calcium levels.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IONOMYCIN"}, {"entity_type": "CYTOKINE", "description": "A cytokine involved in T cell proliferation and survival.<SEP>IL-2 (Interleukin 2) is a cytokine important for T cell proliferation and survival.<SEP>IL-2 (Interleukin-2) is a cytokine that promotes the proliferation and survival of T cells.<SEP>Interleukin-2 (IL-2) is a cytokine involved in T cell proliferation and differentiation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "IL-2"}, {"entity_type": "CYTOKINE", "description": "IL-4 (Interleukin 4) is a cytokine involved in Th2 immune responses.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-4"}, {"entity_type": "CYTOKINE", "description": "IL-5 (Interleukin 5) is a cytokine that promotes eosinophil differentiation and activation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-5"}, {"entity_type": "CYTOKINE", "description": "IL-9 (Interleukin 9) is a cytokine involved in Th9 cell development and function.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-9"}, {"entity_type": "CYTOKINE", "description": "IL-13 (Interleukin 13) is a cytokine involved in Th2 responses and allergic inflammation.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "id": "IL-13"}, {"entity_type": "CYTOKINE", "description": "A pro-inflammatory cytokine produced by activated T cells.<SEP>IFN\u03b3 (Interferon gamma) is a cytokine produced by Th1 cells and important for antiviral immunity.<SEP>IFN\u03b3 (Interferon-gamma) is a cytokine produced by activated immune cells, including CAR T cells.", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7<SEP>chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "IFN\u0393"}, {"entity_type": "CELL TYPE", "description": "Autologous antigen-presenting cells (APCs) are used in the suppression assays.", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "id": "AUTOLOGOUS APCS"}, {"source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "description": "The LYP variants impact the kinetics of CD69 and other activation markers on T cells.)", "entity_type": "UNKNOWN", "id": "CD69 EXPRESSION"}, {"source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "description": "The LYP variants impact the kinetics of CD69 and other activation markers on T cells.)", "entity_type": "UNKNOWN", "id": "LYP VARIANT"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "CD69 is expressed following Tconv activation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 27}]", "id": "TCONV ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "CTLA-4 is expressed following Treg activation.)", "entity_type": "UNKNOWN", "id": "TREGS ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "Overexpression of LYP-620R blunts T cell activation marker kinetics and proliferation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 134}]", "id": "T CELL ACTIVATION"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "The PTPN22 risk variant permits proliferation in Tconv but not in Tregs.)", "entity_type": "UNKNOWN", "id": "PTP N22 RISK VARIANT"}, {"source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "description": "The PTPN22 risk variant permits proliferation in Tconv but not in Tregs.)", "entity_type": "UNKNOWN", "id": "TCONV PROLIFERATION"}, {"source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "description": "Overexpression of LYP-620R in Treg cells suppresses the proliferation of Tresp cells.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 36}, {level: 1, cluster: 135}]", "id": "TRESP"}, {"entity_type": "MOLECULAR INTERACTION", "description": "A genetically engineered type of T cell that expresses a chimeric antigen receptor (CAR) targeting TAG72.<SEP>TAG72-BB\u03b6 CAR T cells are engineered immune cells designed to target TAG72 protein on tumor cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "TAG72-BB\u0396 CAR T CELLS"}, {"entity_type": "GENE", "description": "A gene encoding a signaling molecule that enhances T cell activation and persistence.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN"}, {"entity_type": "GENE", "description": "A gene encoding a signaling molecule involved in T cell cytotoxicity.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CD3\u0396 CYTOLYTIC DOMAIN"}, {"entity_type": "GENE", "description": "A modified version of the CD19 gene used as a marker for tracking CAR T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "TRUNCATED CD19 (CD19T)"}, {"entity_type": "GENE", "description": "A gene encoding an antibody fragment that specifically binds to TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CC49"}, {"entity_type": "GENE", "description": "A modified version of the human IgG4 antibody constant region that lacks a CH2 domain, used to enhance CAR stability and function.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "HUMAN IGG4 FC EXTRACELLULAR SPACER LACKING A CH2 DOMAIN (\u0394CH2)"}, {"entity_type": "GENE", "description": "A gene encoding a membrane protein involved in T cell signaling and interactions.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CD4 TRANSMEMBRANE DOMAIN"}, {"entity_type": "CELL", "description": "Immune cells isolated from peripheral blood.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "HUMAN HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS"}, {"entity_type": "CELL", "description": "Peripheral blood mononuclear cells depleted of CD14+ and CD25+ cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "DPBMC"}, {"entity_type": "CELL", "description": "T cells that have not been genetically modified.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "MOCK (UNTRANSDUCED) T CELLS"}, {"entity_type": "PROTEIN", "description": "A co-stimulatory receptor expressed on activated T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CD137"}, {"entity_type": "PROTEIN", "description": "A cell surface protein overexpressed on some ovarian cancer cells.<SEP>TAG72 is a gene encoding a protein targeted by the CAR T cells used in this study.<SEP>TAG72 is a protein expressed by ovarian cancer cells and used as a target for CAR T cell therapy.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "TAG72"}, {"entity_type": "CELL", "description": "A human colorectal cancer cell line that expresses TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "LS174T"}, {"entity_type": "CELL", "description": "A human ovarian cancer cell line that expresses TAG72.<SEP>OVCAR3 is a human ovarian cancer cell line used in the study.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0<SEP>chunk-bdeb2c0c1ba80048874f6dedb2c2b619<SEP>chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "OVCAR3"}, {"entity_type": "CELL", "description": "A human ovarian cancer cell line that expresses TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "OV90"}, {"entity_type": "CELL", "description": "A human ovarian cancer cell line that does not express TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "SKOV3"}, {"entity_type": "CELL", "description": "A human ovarian cancer cell line that does not express TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "OVCAR8"}, {"entity_type": "CELL", "description": "A human ovarian cancer cell line that expresses low levels of TAG72.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "COV362.4"}, {"entity_type": "PROTEIN", "description": "A cell surface protein overexpressed on prostate cancer cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "PSCA"}, {"entity_type": "GENE", "description": "A gene encoding a cell surface protein typically expressed on B cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "CD19"}, {"entity_type": "PROTEIN", "description": "A monoclonal antibody that binds to the human CD3 receptor on T cells.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "ANTI-HUMAN CD3 ANTIBODY (E.G., OKT3)"}, {"entity_type": "PROTEIN", "description": "A cytokine that promotes T cell survival, proliferation, and memory formation.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "IL-15"}, {"entity_type": "PROTEIN", "description": "A monoclonal antibody that specifically binds to the TAG72 protein.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "ANTI-TAG72 ANTIBODY (E.G., 8H9)"}, {"entity_type": "METHOD", "description": "Experiments performed outside a living organism.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "IN VITRO"}, {"entity_type": "METHOD", "description": "Experiments performed within a living organism.", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "IN VIVO"}, {"entity_type": "DISEASE", "description": "OAS3 refers to patient-derived ovarian ascites sample from a specific individual.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "OAS3"}, {"entity_type": "DISEASE", "description": "OAS4 refers to patient-derived ovarian ascites sample from a specific individual.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "OAS4"}, {"entity_type": "DISEASE", "description": "OAS7 refers to patient-derived ovarian ascites sample from a specific individual.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "OAS7"}, {"entity_type": "DISEASE", "description": "NSG mice are immunodeficient mice used as models for human disease.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "id": "NSG MICE"}, {"entity_type": "CELL TYPE", "description": "CAR T cells are genetically engineered T lymphocytes designed to target specific antigens.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "CAR T CELLS"}, {"entity_type": "GENE", "description": "ffluc (Firefly Luciferase) is a gene encoding an enzyme that produces light, allowing for non-invasive imaging of cells.", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "FFLUC"}, {"entity_type": "DISEASE MODEL", "description": "OV90 is an ovarian cancer xenograft model used in the study.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "OV90 MODEL"}, {"entity_type": "CONTROL GROUP", "description": "Mice that received no treatment served as controls.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "id": "MOCK-TREATED MICE"}, {"entity_type": "DISEASE PROCESS", "description": "Tumor recurrence refers to the reappearance of tumor growth after initial treatment.", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "TUMOR RECURRENCE"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "i.p. (intraperitoneal) delivery is a regional therapeutic approach for treating tumors in the abdomen.)", "entity_type": "UNKNOWN", "id": "I.P. DELIVERY"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "i.p. (intraperitoneal) delivery is a regional therapeutic approach for treating tumors in the abdomen.)", "entity_type": "UNKNOWN", "id": "REGIONAL TREATMENT"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "i.v. (intravenous) delivery is a systemic therapeutic approach that delivers medication throughout the body.)", "entity_type": "UNKNOWN", "id": "I.V. DELIVERY"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "i.v. (intravenous) delivery is a systemic therapeutic approach that delivers medication throughout the body.)", "entity_type": "UNKNOWN", "id": "SYSTEMIC TREATMENT"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "TAG72-BB\u03b6 CAR T cells effectively control and reduce the growth of OVCAR3 tumors in mice.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 39}]", "id": "OVCAR3 TUMOR"}, {"source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "description": "Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells is more effective than intravenous delivery in controlling tumor growth and extending survival in mice.)", "entity_type": "UNKNOWN", "id": "MORE EFFECTIVE THAN I.V. "}, {"source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "description": "Repeat dosing of TAG72-BB\u03b6 CAR T cells led to more durable anti-tumor responses compared with single dosing.)", "entity_type": "UNKNOWN", "id": "IMPROVED THERAPEUTIC RESPONSES"}, {"source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "description": "Repeat dosing of TAG72-BB\u03b6 CAR T cells led to more durable anti-tumor responses compared with single dosing.)", "entity_type": "UNKNOWN", "id": "REPEAT DOSING"}, {"source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "description": "Tumor recurrences were associated with reduced TAG72 expression, suggesting antigen escape as a resistance mechanism.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 0}, {level: 1, cluster: 40}]", "id": "ANTIGEN ESCAPE"}, {"entity_type": "GENE", "description": "THSD4 is a gene located at the THSD4-UACA-TLE3 locus on chromosome 15q23 and has been associated with FEV1/FVC in the Hutterite population.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "THSD4"}, {"entity_type": "GENE", "description": "UACA is a gene located at the THSD4-UACA-TLE3 locus on chromosome 15q23 and has been associated with FEV1/FVC in the Hutterite population.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "UACA"}, {"entity_type": "GENE", "description": "TLE3 is a gene located at the THSD4-UACA-TLE3 locus on chromosome 15q23 and has been associated with FEV1/FVC in the Hutterite population.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "TLE3"}, {"entity_type": "GENOMIC VARIANT", "description": "rs12441227 is a SNP located at the THSD4-UACA-TLE3 locus on chromosome 15q23 and was found to be the most significant SNP associated with FEV1/FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "RS12441227"}, {"entity_type": "GENE", "description": "C10orf11 is a gene located on chromosome 10q22.3 and has been associated with FEV1 in previous meta-analyses of lung function GWAS.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "C10ORF11"}, {"entity_type": "GENE", "description": "CCL23 is a gene located on chromosome 17q12 and was associated with FEV1/FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CCL23"}, {"entity_type": "GENE", "description": "CCL18 is a gene located on chromosome 17q12 and was associated with FEV1/FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CCL18"}, {"entity_type": "GENE", "description": "PITPNC1 is a gene located on chromosome 17q24.2 and was associated with FEV1/FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "PITPNC1"}, {"entity_type": "GENE", "description": "CHAF1B is a gene located on chromosome 21q22.13 and was associated with FEV1/FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "CHAF1B"}, {"entity_type": "GENE", "description": "IL37 is a gene located on chromosome 2q13 and has been associated with FEV1 in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "IL37"}, {"entity_type": "GENE", "description": "ASXL3 is a gene located on chromosome 18q12.1 and has been associated with FVC in the Hutterites.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "ASXL3"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "FEV1/FVC is a physiological process that measures forced expiratory volume in one second divided by forced vital capacity.<SEP>FEV1/FVC is the ratio of FEV1 to FVC and reflects how efficiently the lungs are able to exhale air.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2<SEP>chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "FEV1/FVC"}, {"entity_type": "HERITABILITY MEASURE", "description": "H2 represents broad-sense heritability, which encompasses both additive and non-additive genetic variance.<SEP>h2 represents narrow-sense heritability, which accounts only for additive genetic variance.", "source_id": "chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a", "id": "H2"}, {"entity_type": "GROUP", "description": "Hutterites are a religious group of people who are known to have low FEV1/FVC values.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "HUTTERITES"}, {"entity_type": "ALGORITHM", "description": "GRAIL algorithm is used to identify functional connections between genes.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "GRAIL ALGORITHM"}, {"entity_type": "GENOMIC VARIANT", "description": "Low FEV1/FVC alleles refer to genetic variants associated with lower forced expiratory volume in one second divided by forced vital capacity.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "LOW FEV1/FVC ALLELES"}, {"entity_type": "GENETIC LOCUS", "description": "THSD4-UACA-TLE3 locus is a chromosomal region containing genes THSD4, UACA, and TLE3.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "THSD4-UACA-TLE3 LOCUS"}, {"entity_type": "GENETIC LOCUS", "description": "C10orf11 locus is a chromosomal region containing the gene C10orf11.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "id": "C10ORF11 LOCUS"}, {"entity_type": "GENOMIC VARIANT", "description": "GWAS SNPs are Single Nucleotide Polymorphisms identified through Genome-Wide Association Studies.<SEP>Genome-wide significant SNPs (P-value < 5x10-8) from the GWAS catalog.", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GWAS SNPS"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "The \u03b2-defensin genes are functionally connected to chemokine genes (CCL18 and CXCL12).)", "entity_type": "UNKNOWN", "id": "CHEMOKINE GENES (CCL18 AND CXCL12)"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "The \u03b2-defensin genes are functionally connected to chemokine genes (CCL18 and CXCL12).)", "entity_type": "UNKNOWN", "id": "\u0392-DEFENSIN GENES"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "TNFRSF13B is functionally connected to the \u03b2-defensin genes.)", "entity_type": "UNKNOWN", "id": "TNFRSF13B"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "The CCL23-CCL18 locus is functionally connected to the \u03b2-defensin genes.)", "entity_type": "UNKNOWN", "id": "CCL23-CCL18 LOCUS"}, {"source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "description": "The CCL23-CCL18 locus is functionally connected to CXCL12.)", "entity_type": "UNKNOWN", "id": "CXCL12"}, {"entity_type": "GENE", "description": "CTLA4 is a gene involved in T cell regulation.<SEP>CTLA4 is a gene that plays a role in T cell regulation.<SEP>CTLA4 is a gene.<SEP>The CTLA4 gene encodes a protein involved in immune checkpoint regulation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-f02653cb486dbf68cc259f74ea8b2b2e<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CTLA4"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs231775 in the CTLA4 gene was associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231775"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs231725 in the CTLA4 gene was associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS231725"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs3087243 in the CTLA4 gene was not associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS3087243"}, {"entity_type": "GENOMIC VARIANT", "description": "SNP rs5742909 in the CTLA4 gene was not associated with PBC susceptibility.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "RS5742909"}, {"entity_type": "DISEASE", "description": "Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "PBC"}, {"entity_type": "POPULATION GROUP", "description": "Asians are an ethnic group.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "ASIANS"}, {"entity_type": "POPULATION GROUP", "description": "Caucasians are an ethnic group.", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "id": "CAUCASIANS"}, {"entity_type": "CELL TYPE", "description": "CD8+ T cells are a type of immune cell that play a role in the cytotoxic immune response.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "CD8+"}, {"entity_type": "CELL TYPE", "description": "Peripheral blood mononuclear cells are a heterogeneous population of white blood cells, including lymphocytes, monocytes, and macrophages.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS)"}, {"entity_type": "REFERENCE PANEL", "description": "The 1000 Genomes Project is a reference panel of human genomes that provides information about genetic variation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "1000 GENOMES"}, {"entity_type": "GENE", "description": "Genes are segments of DNA that encode proteins or functional RNA molecules.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "GENES"}, {"entity_type": "MEASUREMENT", "description": "Probes are sequences of DNA used to detect specific genes or genetic variants.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "PROBE"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Expression quantitative trait loci (eQTLs) are genetic variants associated with changes in gene expression.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "EQTLS"}, {"entity_type": "GENE", "description": "The IKBKE gene encodes a protein involved in regulating inflammatory responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IBKBKE"}, {"entity_type": "GENE", "description": "The STAT6 gene encodes a transcription factor involved in T cell differentiation.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STAT6"}, {"entity_type": "GENE", "description": "The STX2 gene encodes syntaxin 2, a protein involved in intracellular transport of vesicles.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "STX2"}, {"entity_type": "TRANSCRIPT", "description": "RP11\u2212534L20.5 is a long coding RNA located downstream of the IKBKE gene.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RP11\u2212534L20.5"}, {"entity_type": "DISEASE", "description": "T1D is Type 1 Diabetes, an autoimmune disease.<SEP>Type 1 Diabetes, a complex autoimmune disease.<SEP>Type 1 diabetes (T1D) is an autoimmune disease characterized by destruction of insulin-producing beta cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "T1D"}, {"entity_type": "DISEASE", "description": "Rheumatoid arthritis (RA) is an autoimmune disease that affects the joints.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "RA"}, {"entity_type": "GENE", "description": "The IKBKE gene encodes a protein involved in regulating inflammatory responses.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "IKBKE"}, {"entity_type": "REGION", "description": "3\' untranslated region (UTR) is a section of mRNA found after the coding sequence.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "3\'UTR"}, {"entity_type": "GENETIC VARIANT", "description": "An AT repeat is a type of genetic polymorphism consisting of tandem repeats of the dinucleotide adenine-thymine.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "ATN REPEAT"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The process of adding a methyl group to a molecule, often DNA or histones. Can affect gene expression.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "METHYLATION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "The process by which naive T cells develop into effector or memory T cells.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "T CELL DIFFERENTIATION"}, {"entity_type": "DISEASE", "description": "A disease caused by a virus.", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "id": "VIRAL INFECTION"}, {"entity_type": "GENOMIC VARIANT", "description": "cg26091609 is a genomic variant associated with CTLA4 expression.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CG26091609"}, {"entity_type": "GENE", "description": "RPS26 is a gene encoding a ribosomal protein and located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RPS26"}, {"entity_type": "GENE", "description": "CDK2 is a gene involved in cell cycle regulation, located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CDK2"}, {"entity_type": "GENE", "description": "RAB5B is a gene encoding a GTPase involved in intracellular trafficking, located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "RAB5B"}, {"entity_type": "GENE", "description": "SUOX is a gene involved in sulfur metabolism, located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "SUOX"}, {"entity_type": "GENE", "description": "IKZF4 is a gene encoding a transcription factor involved in immune cell development, located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IKZF4"}, {"entity_type": "GENE", "description": "ERBB3 is a gene encoding a receptor tyrosine kinase involved in cell growth and survival, located in the trans-acting regulatory locus on chromosome 12q13.2.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "ERBB3"}, {"entity_type": "GENE", "description": "GZMA is a gene encoding a cytotoxic protein, highly expressed in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GZMA"}, {"entity_type": "GENE", "description": "GZMB is a gene encoding a cytotoxic protein, highly expressed in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GZMB"}, {"entity_type": "GENE", "description": "GZMH is a gene encoding a cytotoxic protein, highly expressed in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GZMH"}, {"entity_type": "GENE", "description": "GNLY is a gene encoding a cytotoxic protein, highly expressed in T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "GNLY"}, {"entity_type": "GENE", "description": "CD8A is a gene encoding a cell surface marker for cytotoxic T cells.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "CD8A"}, {"entity_type": "GENE", "description": "IL-27 is a cytokine produced by innate immune cells that interacts with its receptor to activate STAT1/STAT3 signaling.<SEP>IL27 is a cytokine gene associated with immune regulation.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "IL27"}, {"entity_type": "GENE", "description": "STAT1 is a gene encoding a transcription factor involved in interferon signaling.<SEP>STAT1 is a gene that encodes a protein involved in the interferon signaling pathway.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "STAT1"}, {"entity_type": "GENE", "description": "REC8 is a gene involved in DNA recombination.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "REC8"}, {"entity_type": "METABOLIC PATHWAY", "description": "The mTOR signaling pathway is involved in cell growth, proliferation, and metabolism.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "MTOR SIGNALING"}, {"entity_type": "IMMUNE CELL", "description": "B cells are a type of white blood cell important for humoral immunity.<SEP>B cells are a type of white blood cell involved in the immune response.<SEP>B cells are lymphocytes responsible for producing antibodies.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-5b68770e1b446d6cba0d4e1ecabf497b<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "B CELLS"}, {"entity_type": "DISEASE", "description": "Vitiligo is an autoimmune disease characterized by loss of skin pigmentation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "VITILIGO"}, {"entity_type": "DISEASE CATEGORY", "description": "A group of disorders characterized by the immune system attacking the body\'s own tissues.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "AUTOIMMUNE DISEASES"}, {"entity_type": "DISEASE CATEGORY", "description": "Diseases involving inflammation, often caused by immune system dysregulation.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "INFLAMMATORY DISEASES"}, {"entity_type": "POPULATION", "description": "Refers to individuals with genetic origins in Europe.", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "id": "EUROPEAN ANCESTRY"}, {"entity_type": "GENOMIC VARIANT", "description": "rs181206[G] is a missense SNP associated with T1D susceptibility and changes in IRF1 and STAT1 expression.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "RS181206[G]"}, {"entity_type": "GENE", "description": "IL27RA is a gene encoding the IL-27 receptor alpha chain.<SEP>IL27RA is the gene encoding the IL-27 receptor alpha chain.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL27RA"}, {"entity_type": "GENE", "description": "IL6ST encodes the gp130 protein, a subunit of the IL-27 receptor.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "IL6ST (GP130)"}, {"entity_type": "PROTEIN", "description": "EBI3 is a protein that forms a heterodimer with IL-27.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "EBI3"}, {"entity_type": "DNA SEQUENCE", "description": "ISRE stands for Interferon Stimulated Response Element, a DNA sequence recognized by STAT proteins.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "ISRE"}, {"entity_type": "GENOMIC VARIANT", "description": "Pro119 is a missense variant in the IL-27 gene resulting from the rs181206[G] SNP.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "PRO119"}, {"entity_type": "AMINO ACID SEQUENCE", "description": "Leu119 is the wild-type amino acid sequence at position 119 in the IL-27 protein.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "LEU119"}, {"entity_type": "CELL LINE", "description": "HEK293 cells are a human embryonic kidney cell line commonly used for molecular biology research.", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "id": "HEK293 CELLS"}, {"entity_type": "CELL", "description": "PBMCs stand for Peripheral Blood Mononuclear Cells, which include lymphocytes, monocytes, and macrophages.<SEP>Peripheral blood mononuclear cells (PBMCs) are a type of white blood cell.<SEP>Peripheral blood mononuclear cells (PBMCs) are a mixture of immune cells isolated from blood.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68<SEP>chunk-1b40d071abac0ba432a9fb0096796f45<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 68}]", "id": "PBMCS"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The IKBKE gene plays a role in regulating inflammatory responses to viral infections.)", "entity_type": "UNKNOWN", "id": "INFLAMMATORY RESPONSES"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The STX2 gene encodes syntaxin 2, which is involved in intracellular transport of vesicles.)", "entity_type": "UNKNOWN", "id": "INTRACELLULAR TRANSPORT"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The CTLA4 gene encodes a protein involved in immune checkpoint regulation.)", "entity_type": "UNKNOWN", "id": "IMMUNE CHECKPOINT REGULATION"}, {"source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "description": "The expression levels of CTLA4 are inversely correlated with DNA methylation at a CpG site near its second exon.)", "entity_type": "UNKNOWN", "id": "EXPRESSION LEVELS"}, {"source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "description": "The rs1131017 SNP is located in the 5\'UTR of the RPS26 gene and acts as a lead trans-acting regulatory locus influencing hundreds of genes.)", "entity_type": "UNKNOWN", "id": "RS1131017"}, {"source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "description": "These genes are located in the trans-acting regulatory locus on chromosome 12q13.2 influenced by rs1131017.)", "entity_type": "UNKNOWN", "id": "CDK2, RAB5B, SUOX, IKZF4, ERBB3"}, {"source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "description": "The missense variant rs181206 is located within the IL27 gene.)", "entity_type": "UNKNOWN", "id": "RS181206"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4073 is a single nucleotide polymorphism (SNP) in the IL-8 gene.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 80}]", "id": "RS4073"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2227306 is a single nucleotide polymorphism (SNP) in the IL-8 gene.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 80}]", "id": "RS2227306"}, {"entity_type": "PROTEIN", "description": "IL-8 protein is a chemokine that attracts immune cells to sites of inflammation.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "IL-8 PROTEIN"}, {"entity_type": "PROTEIN", "description": "Serum concentration of IL-8 protein.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 81}]", "id": "IL-8 SERUM"}, {"entity_type": "GROUP", "description": "Individuals diagnosed with asthma.", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "id": "PATIENT GROUP"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "Increased IL-8 mRNA expression is observed in patients with asthma compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 81}]", "id": "IL-8 MRNA"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "The rs4073 TT genotype is associated with an increased risk of atopic asthma.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 13}, {level: 1, cluster: 80}]", "id": "ATOPIC ASTHMA"}, {"source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "description": "IL-8 protein plays a role in inflammation and immune responses.)", "entity_type": "UNKNOWN", "id": "INFLAMMATION"}, {"entity_type": "GENE", "description": "ASAH1 is a gene being studied in the context of IBS and epistasis.<SEP>The ASAH1 gene is located on 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "ASAH1"}, {"entity_type": "GENE", "description": "The NAT2 gene lies on 8p22 and has 22 HapMap SNPs and only 4 typed SNPs from the transcription start to end of the gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "NAT2"}, {"entity_type": "GENE", "description": "FGFR2 is a much larger gene with regions of high LD where the kernel machine method outperforms the min test.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "FGFR2"}, {"entity_type": "GENE", "description": "The HLA-B gene is a part of the human leukocyte antigen (HLA) complex and lies on 6p21.3.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HLA-B"}, {"entity_type": "GENE", "description": "The ASAH1 gene is located on 8p22-p21.3 and consists of 86 HapMap SNPs and 14 typed SNPs on the Illumina HumanHap550 array.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "ASAH1 GENE"}, {"entity_type": "GENE", "description": "The NAT2 gene lies on 8p22 and has 22 HapMap SNPs and only 4 typed SNPs from the transcription start to end of the gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "NAT2 GENE"}, {"entity_type": "GENE", "description": "FGFR2 is a much larger gene with regions of high LD where the kernel machine method outperforms the min test.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "FGFR2 GENE"}, {"entity_type": "GENE", "description": "The HLA-B gene is a part of the human leukocyte antigen (HLA) complex and lies on 6p21.3.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HLA-B GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "HapMap SNPs are genetic variations identified by the HapMap project and are used in genetic studies.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "HAPMAP SNPS"}, {"entity_type": "GENOMIC VARIANT", "description": "Typed SNPs are specific SNPs that have been genotyped and are included in a particular study.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "TYPED SNPS"}, {"entity_type": "MOLECULAR INTERACTION", "description": "The Illumina HumanHap550 array is a genotyping platform that measures genetic variations, including SNPs.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "ILLUMINA HUMANHAP550 ARRAY"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1390358 is a specific SNP in the NAT2 gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "RS1390358"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1112005 is a specific SNP in the NAT2 gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "RS1112005"}, {"entity_type": "GENOMIC VARIANT", "description": "rs7832071 is a specific SNP in the NAT2 gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "RS7832071"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1208 is a specific SNP in the NAT2 gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "RS1208"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1058026 is a specific SNP in the HLA-B gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "id": "RS1058026"}, {"entity_type": "GENOMIC VARIANT", "description": "rs2523608 is a SNP mentioned as potentially causal.<SEP>rs2523608 is a specific SNP in the HLA-B gene.", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0<SEP>chunk-076f6aeeb369546413bc63c9f305553a", "id": "RS2523608"}, {"entity_type": "DISEASE", "description": "IBS refers to Irritable Bowel Syndrome.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "IBS"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Epistasis is a phenomenon where the effect of one gene depends on another.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "EPISTASIS"}, {"entity_type": "ALGORITHM", "description": "The linear kernel is a type of algorithm used in machine learning.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LINEAR KERNEL"}, {"entity_type": "ALGORITHM", "description": "The IBS kernel is a type of algorithm used in machine learning that considers the similarity between individuals based on their genotypes.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "IBS KERNEL"}, {"entity_type": "ALGORITHM", "description": "The weighted IBS kernel is a type of algorithm that incorporates weights to prioritize rare variants.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "WEIGHTED IBS KERNEL"}, {"entity_type": "ALGORITHM", "description": "The min test is an algorithm used in genetic association studies.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "MIN TEST"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "LDs refers to Linkage Disequilibrium, which describes the non-random association of alleles at different loci.", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "id": "LDS"}, {"source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "description": "In regions of high LD, the kernel machine method outperforms the min test for the FGFR2 gene.)", "entity_type": "UNKNOWN", "id": "HIGH LD REGIONS"}, {"source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "description": "The weighted IBS kernel upweights rare alleles, as shown by its higher power when the causal SNP with a lower MAF (rs1058026) was simulated.)", "entity_type": "UNKNOWN", "id": "MAF"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The kernel machine SNP-set test was used to evaluate the overall effect of the ASAH1 gene.)<SEP>The kernel machine SNP-set test was used to study the overall effect of the ASAH1 gene.)", "entity_type": "UNKNOWN", "id": "KERNEL MACHINE SNP-SET TEST"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "For simulations with imputed data, the linear kernel had an empirical Type 1 error rate of 0.0566.)", "entity_type": "UNKNOWN", "id": "IMPUTED DATA"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The ASAH1 gene is described as having a good LD structure.)", "entity_type": "UNKNOWN", "id": "GOOD LD STRUCTURE"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The weighted IBS kernel incorporates information about rare variants.)", "entity_type": "UNKNOWN", "id": "RARE VARIANTS"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "When a common allele is causal, the linear kernel may be more powerful than the weighted IBS kernel.)", "entity_type": "UNKNOWN", "id": "COMMON ALLELE"}, {"source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "description": "The IBS kernel measures the similarity between individuals based on their genotypes.)", "entity_type": "UNKNOWN", "id": "GENOTYPE SIMILARITY"}, {"entity_type": "TREATMENT", "description": "Anti-CTLA-4 is a type of immunotherapy drug.<SEP>Anti-CTLA-4 is a type of immunotherapy treatment for metastatic melanoma.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 112}]", "id": "ANTI-CTLA-4"}, {"entity_type": "TREATMENT", "description": "Anti-PD-1 is a type of immunotherapy drug.<SEP>Anti-PD-1 is a type of immunotherapy treatment for metastatic melanoma.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 112}]", "id": "ANTI-PD-1"}, {"entity_type": "TREATMENT", "description": "Combination therapy involves both anti-CTLA-4 and anti-PD-1 immunotherapies.<SEP>Combination therapy involves the use of multiple immunotherapy drugs, such as anti-CTLA-4 and anti-PD-1.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8<SEP>chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 112}]", "id": "COMBINATION THERAPY"}, {"entity_type": "DISEASE", "description": "Metastatic melanoma is a type of skin cancer that has spread to other parts of the body.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 112}]", "id": "METASTATIC MELANOMA"}, {"entity_type": "DRUG", "description": "Ipilimumab is an anti-CTLA-4 immunotherapy drug.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IPILIMUMAB"}, {"entity_type": "DRUG", "description": "Tremelimumab is an anti-CTLA-4 immunotherapy drug.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "TREMELIMUMAB"}, {"entity_type": "DRUG", "description": "Nivolumab is an anti-PD-1 immunotherapy drug.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "NIVOLUMAB"}, {"entity_type": "DRUG", "description": "Pembrolizumab is an anti-PD-1 immunotherapy drug.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "PEMBROLIZUMAB"}, {"entity_type": "DISEASE", "description": "Celiac disease is an autoimmune disorder affecting the small intestine.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "CELIAC DISEASE"}, {"entity_type": "DISEASE", "description": "Inflammatory bowel disease is a group of disorders causing inflammation in the digestive tract.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "INFLAMMATORY BOWEL DISEASE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs17388568 is a genomic variant mapped to the IL2, ADAD1 and IL21 region.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "RS17388568"}, {"entity_type": "GENE", "description": "IL2 is a gene involved in immune response.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IL2"}, {"entity_type": "GENE", "description": "ADAD1 is a gene with unknown function.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ADAD1"}, {"entity_type": "GENE", "description": "IL21 is a gene involved in immune response.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "IL21"}, {"entity_type": "DISEASE", "description": "Allergy is an immune system reaction to substances.", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "id": "ALLERGY"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Treatment response refers to the body\'s reaction and change in condition following treatment.", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "clusters": "[{level: 0, cluster: 20}, {level: 1, cluster: 112}]", "id": "TREATMENT RESPONSE"}, {"entity_type": "GENE", "description": "EBNA2 is a gene that binds to chromatin at MS risk loci dependent on the risk allele.<SEP>EBNA2 is a viral protein that binds to DNA and regulates gene expression.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "EBNA2"}, {"entity_type": "GENOMIC VARIANT", "description": "MS risk loci are genomic variants associated with multiple sclerosis (MS).<SEP>MS risk loci refer to specific regions on chromosomes associated with an increased risk of multiple sclerosis.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "MS RISK LOCI"}, {"entity_type": "GENE", "description": "TRAF3/RCOR1 is a gene located at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "TRAF3/RCOR1"}, {"entity_type": "GENE", "description": "TNFAIP8 is a gene involved in regulating inflammation.<SEP>TNFAIP8 is a gene located at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFAIP8"}, {"entity_type": "GENE", "description": "TNFRSF1A is a gene encoding the TNFR1 receptor, involved in immune signaling.<SEP>TNFRSF1A is a gene located at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TNFRSF1A"}, {"entity_type": "GENE", "description": "TBX6 is a gene involved in development and cell fate.<SEP>TBX6 is a gene located at a MS risk locus.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TBX6"}, {"entity_type": "PROTEIN", "description": "EBNA2-TAT is a protein that inhibits the EBV latency III growth program.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "EBNA2-TAT"}, {"entity_type": "GENE", "description": "LMP1 is a gene regulated by EBNA2 and involved in the EBV latency III growth program.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "LMP1"}, {"entity_type": "PROTEIN", "description": "RBP-J\u03ba is a protein that interacts with EBNA2.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "id": "RBP-J\u039a"}, {"entity_type": "GENE", "description": "CLECL1 is a gene associated with multiple sclerosis (MS).<SEP>CLECL1 is a gene involved in immune signaling.", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "CLECL1"}, {"entity_type": "GENE", "description": "TRAF3 is a gene involved in immune signaling.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "TRAF3"}, {"entity_type": "GENE", "description": "RCOR1 is a gene involved in transcriptional regulation.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "RCOR1"}, {"entity_type": "CELLULAR COMPONENT", "description": "Lymphoblastoid cell lines (LCLs) are immortalized B cells.", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "id": "LCLS"}, {"source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "description": "EBNA2-TAT inhibits the EBV latency III growth program.)", "entity_type": "UNKNOWN", "id": "EBV LATENCY III GROWTH PROGRAM"}, {"entity_type": "GENE", "description": "The COX-2 gene is involved in inflammation and pain.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "COX-2 GENE"}, {"entity_type": "GENE", "description": "The ITGA2 gene plays a role in platelet function and aggregation.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ITGA2 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs3842787 is a polymorphism in the COX-1 gene associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS3842787"}, {"entity_type": "GENOMIC VARIANT", "description": "rs20417 is a genomic variant associated with differences in CAD percentage between patients and controls.<SEP>rs20417 is a polymorphism in the COX-2 gene associated with aspirin insensitivity.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea<SEP>chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS20417"}, {"entity_type": "GENOMIC VARIANT", "description": "rs201184269 is a polymorphism in the ITGA2B gene, but it wasn\'t significantly associated with aspirin insensitivity.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS201184269"}, {"entity_type": "GENOMIC VARIANT", "description": "rs1126643 is a genomic variant associated with variations in averaged platelet number.<SEP>rs1126643 is a polymorphism in the ITGA2 gene associated with aspirin insensitivity.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea<SEP>chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "RS1126643"}, {"entity_type": "DISEASE", "description": "A condition where individuals do not respond adequately to aspirin\'s effects.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "ASPIRIN INSENSITIVITY"}, {"entity_type": "DISEASE", "description": "A disease characterized by narrowing or blockage of the coronary arteries, reducing blood flow to the heart.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "CORONARY ARTERY DISEASE (CAD)"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Cellular components involved in blood clotting.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "PLATELET"}, {"entity_type": "RESEARCH METHODOLOGICAL ISSUE", "description": "A tendency for studies with statistically significant results to be published more frequently than those with non-significant results.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "PUBLICATION BIAS"}, {"entity_type": "STATISTICAL TEST", "description": "Used to detect publication bias in meta-analyses.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "EGGER\'S TEST"}, {"entity_type": "STATISTICAL METHOD", "description": "A statistical technique used to examine the relationship between multiple variables and an outcome.", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "id": "META-REGRESSION"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "Platelet number represents the quantity of platelets circulating in the blood.", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "id": "PLATELET NUMBER"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "Association Strength", "entity_type": "UNKNOWN", "id": "CHINESE POPULATION"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "Heterogeneity", "entity_type": "UNKNOWN", "id": "PERCENTAGE OF CAD"}, {"source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "description": "Heterogeneity", "entity_type": "UNKNOWN", "id": "AVERAGED PLATELET NUMBER"}, {"entity_type": "GENE", "description": "STAT5B is a gene involved in T cell activation and homeostasis.<SEP>STAT5B is a gene that plays a critical role in immune system function.<SEP>STAT5B is a gene that plays a crucial role in growth and immune function. A homozygous nonsense mutation in STAT5B was identified in three siblings with severe short stature.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589<SEP>chunk-e323b0d4f82733a78f687e51f47b500a<SEP>chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "STAT5B"}, {"entity_type": "GENOMIC VARIANT", "description": "This genomic variant, c.1892G>A, results in a nonsense mutation in the STAT5B gene.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "C.1892G>A"}, {"entity_type": "GENOMIC VARIANT", "description": "This specific mutation converts tryptophan at position 631 to a premature stop codon, leading to a truncated protein.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "P.W631* "}, {"entity_type": "DISEASE", "description": "A condition characterized by normal serum growth hormone levels but impaired responsiveness to it.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "GROWTH HORMONE INSENSITIVITY (GHI)"}, {"entity_type": "DISEASE", "description": "A condition characterized by reduced height compared to average.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "SHORT STATURE"}, {"entity_type": "PHENOTYPE", "description": "The parents of the affected siblings were consanguineous, meaning they were related.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "CONSANGUINITY"}, {"entity_type": "DISEASE", "description": "A respiratory infection causing inflammation of the lungs.", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "id": "PNEUMONIA"}, {"entity_type": "GENOMIC VARIANT", "description": "A loss-of-function (LOF) STAT5B variant, specifically the p.W631* variant, was identified in the patients.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "P.W631* VARIANT"}, {"entity_type": "PROTEIN", "description": "The STAT5B protein is involved in various immune functions, including T cell development and regulation.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "STAT5B PROTEIN"}, {"entity_type": "IMMUNE CELL", "description": "Natural Killer (NK) cells are lymphocytes that play a role in the innate immune system.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "NK CELLS"}, {"entity_type": "PROTEIN", "description": "Immunoglobulins are antibodies produced by B cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IMMUNOGLOBULIN"}, {"entity_type": "ANTIBODY", "description": "IgE is a type of antibody associated with allergic reactions and atopy.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "IGE"}, {"entity_type": "DISEASE", "description": "Chronic eczema is a skin condition characterized by persistent inflammation and dryness.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CHRONIC ECZEMA"}, {"entity_type": "DISEASE", "description": "Reactive airway disease refers to conditions like asthma, where airways become inflamed and constricted.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "REACTIVE AIRWAY DISEASE"}, {"entity_type": "CONDITION", "description": "Autoimmunity is when the immune system attacks the body\'s own tissues.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "AUTOIMMUNITY"}, {"entity_type": "PROTEIN", "description": "Thyroglobulin is a protein found in the thyroid gland.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYROGLOBULIN"}, {"entity_type": "ENZYME", "description": "Thyroid peroxidase is an enzyme involved in thyroid hormone production.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYROID PEROXIDASE"}, {"entity_type": "PRECURSOR CELL", "description": "Thymocytes are immature T cells that develop in the thymus.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "THYMOCYTES"}, {"entity_type": "IMMUNE CELL", "description": "Splenocytes are immune cells found in the spleen.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "SPLENOCYTES"}, {"entity_type": "IMMATURE IMMUNE CELL", "description": "Recent thymic emigrants (RTEs) are newly matured T cells that have recently emigrated from the thymus.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "RECENT THYMIC EMIGRANTS (RTES)"}, {"entity_type": "CONDITION", "description": "T cell lymphopenia is a condition characterized by a reduced number of T cells in the blood.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "T CELL LYMPHOPENIA"}, {"entity_type": "IMMUNE CELL", "description": "Regulatory T cells (Tregs) are a specialized subset of T cells that suppress immune responses.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "REGULATORY T CELLS (TREGS)"}, {"entity_type": "PROTEIN", "description": "CD127 is a subunit of the interleukin-7 receptor, expressed on na\u00efve and memory T cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CD127"}, {"entity_type": "IMMUNE CELL", "description": "Memory T cells are long-lived T cells that provide rapid responses to previously encountered antigens.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "MEMORY T CELLS"}, {"entity_type": "T CELL SUBSET", "description": "Central memory T cells reside in lymphoid organs and can differentiate into effector T cells upon re-exposure to antigen.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CENTRAL MEMORY (TCM)"}, {"entity_type": "T CELL SUBSET", "description": "Effector memory T cells circulate in peripheral tissues and are able to rapidly respond to infection at sites of inflammation.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "EFFECTOR MEMORY (TEM)"}, {"entity_type": "T CELL SUBSET", "description": "Effector memory cells that have re-expressed the CD45RA marker, indicating a state of exhaustion or senescence.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "EFFECTOR MEMORY CELLS RE-EXPRESSING CD45RA (TEMRA)"}, {"entity_type": "PROTEIN", "description": "GH stands for growth hormone, a peptide hormone that stimulates growth and cell reproduction.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "GH"}, {"entity_type": "PROTEIN", "description": "CD71, also known as Transferrin Receptor 1, is involved in iron uptake by cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CD71"}, {"entity_type": "PROTEIN", "description": "CD40 Ligand (CD40L) is a protein expressed on activated T cells that interacts with CD40 on antigen-presenting cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CD40L"}, {"entity_type": "PROTEIN", "description": "CD134, also known as 4-1BB, is a co-stimulatory receptor involved in T cell activation and survival.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CD134"}, {"entity_type": "PROTEIN", "description": "Human Leukocyte Antigen (HLA) molecules are involved in presenting antigens to T cells.", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "HLA"}, {"entity_type": "PROTEIN", "description": "CD95, also known as Fas, is a receptor involved in apoptosis (programmed cell death).", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "id": "CD95"}, {"entity_type": "CELLULAR COMPONENT", "description": "TCM cells are a type of cellular component that remained within normal ranges.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "TCM CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD4+ TEM cells are a type of immune cell subset that were not significantly altered in proportion.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ TEM CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD8+ TEM cells are a type of immune cell subset that increased in proportion with age.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEM CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD8+ TEMRA cells are a type of memory T cell subset that were elevated in infancy but normalized around age 4.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ TEMRA CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD4+ memory T cells are a subset of T cells that remained normal in proportion.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD4+ MEMORY T CELLS"}, {"entity_type": "CELLULAR COMPONENT", "description": "CD8+ memory T cells are a subset of T cells that were elevated in proportion in patients with STAT5B deficiency.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "CD8+ MEMORY T CELLS"}, {"entity_type": "INDIVIDUAL", "description": "Siblings are individuals related by blood or genetics.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "SIBLING"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Infancy is the period of early childhood development.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "INFANCY"}, {"entity_type": "DEVELOPMENTAL STAGE", "description": "Age 4 refers to a specific developmental stage in childhood.", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "id": "AGE 4"}, {"source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "description": "Patient 1 experienced recurrent urinary tract, pulmonary infections requiring antibiotics.)  (relationship", "entity_type": "UNKNOWN", "id": "RECURRENT INFECTIONS"}, {"source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "description": "STAT5B deficiency leads to increased proportions of memory CD8+ T cells over time.)", "entity_type": "UNKNOWN", "id": "MEMORY CD8+ T CELLS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "The STAT5B gene plays a critical role in CD8+ T cell activation and homeostasis, as evidenced by the elevation of CD8+ memory T cells in patients with STAT5B deficiency.)", "entity_type": "UNKNOWN", "id": "CD8+ T CELL ACTIVATION AND HOMEOSTASIS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Patients with STAT5B deficiency carried elevated proportions of CD8+ memory T cells from infancy, suggesting a role for this variant in T cell development and function.)", "entity_type": "UNKNOWN", "id": "CD8+ MEMORY T CELL PROPORTIONS"}, {"source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "description": "Patients with STAT5B deficiency carried elevated proportions of CD8+ memory T cells from infancy, suggesting a role for this variant in T cell development and function.)", "entity_type": "UNKNOWN", "id": "STAT5B VARIANT"}, {"entity_type": "GENE", "description": "The HLA-DRB1 gene is a gene that plays a role in immune response.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA\u2010DRB1 GENE"}, {"entity_type": "GENE", "description": "The HLA-DQB1 gene is a gene that plays a role in immune response.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HLA\u2010DQB1 GENE"}, {"entity_type": "GENOMIC VARIANT", "description": "rs28383172 is a SNP located in the HLA\u2010DRB1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 149}]", "id": "RS28383172"}, {"entity_type": "GENOMIC VARIANT", "description": "rs4713586 is a SNP located in the HLA-DQB1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "RS4713586"}, {"entity_type": "DISEASE", "description": "ALL (acute lymphoblastic leukemia) is a type of blood cancer.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "ALL"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "ASP hypersensitivity refers to an abnormal immune response to aspirin or other NSAIDs.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "ASP HYPERSENSITIVITY"}, {"entity_type": "GENOMIC VARIANT", "description": "HLA-DRB1*07:01 is a specific variant of the HLA-DRB1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 149}]", "id": "HLA\u2010DRB1*07:01 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "DQA1*02:01 is a specific variant of the DQA1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "DQA1*02:01 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "DQB1*02:02 is a specific variant of the DQB1 gene.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "DQB1*02:02 ALLELE"}, {"entity_type": "GENOMIC VARIANT", "description": "A haplotype consisting of the HLA-DRB1*07:01, DQA1*02:01, and DQB1*02:02 alleles.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 149}]", "id": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"entity_type": "POPULATION", "description": "Refers to a group of people from Hungary.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "HUNGARIAN POPULATION"}, {"entity_type": "POPULATION", "description": "A large population group representing individuals of European ancestry.<SEP>A specific population group with European ancestry.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62<SEP>chunk-0dd0781947ec4a92007eb1736b1888c2", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 147}]", "id": "EUR SUPER POPULATION"}, {"entity_type": "POPULATION", "description": "A large population group representing individuals of African or American descent.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "AMR SUPER POPULATION"}, {"entity_type": "POPULATION", "description": "A large population group representing individuals of East Asian descent.", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "id": "EAS SUPER POPULATION"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the HLA-DRB1 gene.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "HLA-DRB1*07:01"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the DQA1 gene.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQA1*02:01"}, {"entity_type": "GENOMIC VARIANT", "description": "A specific variant within the DQB1 gene.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "DQB1*02:02"}, {"entity_type": "GENETIC HAPLOTYPE", "description": "A combination of three specific genetic variants, HLA-DRB1*07:01, DQA1*02:01, and DQB1*02:02.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 148}]", "id": "HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02"}, {"entity_type": "DISEASE", "description": "An allergic reaction to Escherichia coli derived antigens.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 148}]", "id": "E. COLI ASP HYPERSENSITIVITY"}, {"entity_type": "ALGORITHM", "description": "A specific algorithm used for genotyping.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM II"}, {"entity_type": "ALGORITHM", "description": "A specific algorithm used for genotyping.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM III"}, {"entity_type": "ALGORITHM", "description": "A specific algorithm used for genotyping.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "ALGORITHM IV"}, {"entity_type": "ALGORITHM", "description": "A specific algorithm used for genotyping, particularly effective at tagging the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 147}]", "id": "ALGORITHM V"}, {"entity_type": "DATASET", "description": "A large-scale dataset of human genomic sequences.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "1000 GENOMES DATASET"}, {"entity_type": "PERFORMANCE METRIC", "description": "The proportion of true positives correctly identified by a test.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "id": "SENSITIVITY"}, {"entity_type": "PERFORMANCE METRIC", "description": "The proportion of true negatives correctly identified by a test.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 147}]", "id": "SPECIFICITY"}, {"entity_type": "PERFORMANCE METRIC", "description": "The probability that a negative test result is truly negative.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 147}]", "id": "NEGATIVE PREDICTIVE VALUE"}, {"entity_type": "PERFORMANCE METRIC", "description": "The probability that a positive test result is truly positive.", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 147}]", "id": "POSITIVE PREDICTIVE VALUE"}, {"source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "description": "Algorithms III and IV were designed to identify the same group of patients who are HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carriers.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 9}, {level: 1, cluster: 58}, {level: 2, cluster: 149}]", "id": "RS2395182, RS4713586 AND RS7775228"}, {"entity_type": "GENE", "description": "TLR7 is a gene that encodes a protein involved in the immune response.<SEP>TLR7 is a gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TLR7"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179008 is a polymorphism in the TLR7 gene.<SEP>rs179008 is a single nucleotide polymorphism (SNP) located in the TLR7 gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179008"}, {"entity_type": "GENOMIC VARIANT", "description": "rs179009 is a polymorphism in the TLR7 gene.<SEP>rs179009 is a single nucleotide polymorphism (SNP) located in the TLR7 gene.", "source_id": "chunk-05d583f893b703816ad8de9561aa5292<SEP>chunk-2c91cdebb36ef064eb01a7021a961302", "id": "RS179009"}, {"entity_type": "DISEASE", "description": "Individuals infected with the Human Immunodeficiency Virus (HIV).", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "HIV-INFECTED INDIVIDUALS"}, {"entity_type": "DISEASE", "description": "HIV disease progression is a medical condition.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "HIV DISEASE PROGRESSION"}, {"entity_type": "ENVIRONMENTAL FACTOR", "description": "Tobacco use is a known risk factor for various diseases.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "TOBACCO"}, {"entity_type": "PHYSIOLOGICAL PROCESS", "description": "CD4 counts refer to the number of CD4+ T cells in the blood, which are important for immune function.", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "id": "CD4 COUNTS"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The rs179008 SNP is located within the TLR7 gene.)", "entity_type": "UNKNOWN", "id": "TLR7 GENE"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "Individuals infected with HIV showed a significantly reduced frequency of the rs179009 AG genotype compared to healthy controls.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "RS179009 AG GENOTYPE"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "The frequency of the rs179009 AG genotype decreased as HIV disease progressed from early to advanced stages.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 7}, {level: 1, cluster: 51}]", "id": "HIV DISEASE STAGES"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "There was a trend towards a higher prevalence of the TLR7 rs179009AG genotype among tobacco-consuming HIV-infected individuals compared to nonusers, although this did not reach statistical significance.)", "entity_type": "UNKNOWN", "id": "TLR7 RS179009AG GENOTYPE"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "There was a trend towards a higher prevalence of the TLR7 rs179009AG genotype among tobacco-consuming HIV-infected individuals compared to nonusers, although this did not reach statistical significance.)", "entity_type": "UNKNOWN", "id": "TOBACCO CONSUMPTION"}, {"source_id": "chunk-05d583f893b703816ad8de9561aa5292", "description": "There were no significant differences in the distribution of TLR7 rs179008 and rs179009 genotypes between HIV-infected individuals who consumed alcohol and those who did not.)", "entity_type": "UNKNOWN", "id": "TLR7 RS179008/RS179009 GENOTYPES"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the ALK gene, specifically at codon 1275 resulting in a substitution of glutamine (Q) with arginine (R), is found in some NBL tumor samples.<SEP>ALK R1275Q is a neoepitope resulting from a genomic variant in the ALK gene.<SEP>ALK R1275Q is a neoepitope, which is a novel antigenic determinant that arises from mutations in tumor cells.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-614333487e4b92705503909d34155179<SEP>chunk-de413ae6100407d8dadd5bdee87c1074", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "ALK R1275Q"}, {"entity_type": "GENE", "description": "ALK is a gene involved in cell signaling and can be mutated to create neoepitopes.<SEP>ALK is a gene that encodes an enzyme involved in cell signaling.<SEP>ALK is a gene that encodes for a protein involved in cell signaling and growth. Mutations in this gene, particularly R1275Q, can contribute to neuroblastoma development.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 66}]", "id": "ALK"}, {"entity_type": "GENOMIC VARIANT", "description": "A genomic variant in the NRAS gene, specifically at codon 61 resulting in a substitution of glutamine (Q) with lysine (K), is found in some melanoma, thyroid, and colorectal cancers.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "NRAS Q61K"}, {"entity_type": "GENE", "description": "ZNF717 is a gene that encodes for a zinc finger protein involved in transcriptional regulation.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "ZNF717"}, {"entity_type": "SOFTWARE", "description": "ProTECT is a software program designed to predict neoepitopes, which are peptides derived from tumor-specific mutations that can be recognized by the immune system.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "PROTECT"}, {"entity_type": "COHORT", "description": "The TARGET cohort is a collection of patient samples and clinical data used in cancer research.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "TARGET"}, {"entity_type": "PROTEIN", "description": "HLA-B*15:01 is a HLA allele used as a template for modeling peptide/HLA interactions.<SEP>HLA-B*15:01 is a gene that codes for HLA-B*15:01 protein.<SEP>HLA-B*15:01 is a major histocompatibility complex class I protein.<SEP>HLA-B*15:01 is a specific type of Major Histocompatibility Complex (MHC) molecule that presents peptides to T cells.<SEP>HLA-B*15:01 is a specific type of human leukocyte antigen, which plays a role in presenting antigens to T cells.", "source_id": "chunk-614333487e4b92705503909d34155179<SEP>chunk-de413ae6100407d8dadd5bdee87c1074<SEP>chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "HLA-B*15:01"}, {"entity_type": "PEPTIDE", "description": "AQDIYRASY is a nonamer neoepitope derived from the ALK R1275Q mutation.<SEP>AQDIYRASY is a nonamer peptide neoepitope derived from the ALK gene.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-830d8819004960d1d149ac70149c72a0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "AQDIYRASY"}, {"entity_type": "PEPTIDE", "description": "AQDIYRASYY is a decamer neoepitope derived from the ALK R1275Q mutation.<SEP>AQDIYRASYY is a decamer peptide neoepitope derived from the ALK gene.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2<SEP>chunk-830d8819004960d1d149ac70149c72a0", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "AQDIYRASYY"}, {"entity_type": "TECHNIQUE", "description": "SEC is a chromatography technique used to separate molecules based on their size.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "SIZE EXCLUSION CHROMATOGRAPHY (SEC)"}, {"entity_type": "TECHNIQUE", "description": "LC\u2013MS is a technique used to identify and quantify molecules based on their mass-to-charge ratio.", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "id": "LIQUID CHROMATOGRAPHY\u2013MASS SPECTROSCOPY (LC\u2013MS)"}, {"entity_type": "TECHNIQUE", "description": "LC\u2013MS is a technique used to identify and quantify molecules in a sample.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "LIQUID CHROMATOGRAPHY\u2013MASS SPECTROMETRY (LC\u2013MS)"}, {"entity_type": "TECHNIQUE", "description": "DSF is a technique used to measure the stability of proteins.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "DIFFERENTIAL SCANNING FLUORIMETRY (DSF)"}, {"entity_type": "TECHNIQUE", "description": "X-ray crystallography is a technique used to determine the three-dimensional structure of molecules.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "id": "X-RAY CRYSTALLOGRAPHY"}, {"entity_type": "STRUCTURAL DATA", "description": "PDB ID 5TXS refers to the structural data for the nonamer complex (HLA-B*15:01/\u03b22m/AQDIYRASY) in the Protein Data Bank.", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "PDB ID 5TXS"}, {"entity_type": "STRUCTURAL DATA", "description": "PDB ID 5VZ5 refers to the structural data for the decamer complex (HLA-B*15:01/\u03b22m/AQDIYRASYY) in the Protein Data Bank.)  (relationship", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "id": "PDB ID 5VZ5"}, {"entity_type": "SELF-ANTIGEN", "description": "ARDIYRASY is the self-peptide sequence derived from ALK protein, typically recognized by immune system as self.<SEP>ARDIYRASY is the self-peptide sequence derived from ALK protein, typically recognized by immune system as \'self\'.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "ARDIYRASY"}, {"entity_type": "PROTEIN", "description": "T cell receptor (TCR) is a protein on the surface of T cells that recognizes neoepitopes presented by MHC molecules.<SEP>TCRs are T cell receptors that recognize peptide-HLA complexes.<SEP>TCRs are receptors on the surface of T cells that recognize and bind to antigens presented by MHC molecules.", "source_id": "chunk-614333487e4b92705503909d34155179<SEP>chunk-de413ae6100407d8dadd5bdee87c1074<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 65}]", "id": "TCR"}, {"entity_type": "AMINO ACID", "description": "Arginine 151 is an amino acid residue in the HLA-B*15:01 molecule.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "ARG151"}, {"entity_type": "AMINO ACID", "description": "Tyrosine 9 is an amino acid residue within the peptide epitope, involved in interactions with HLA.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "TYR9"}, {"entity_type": "PROTEIN STRUCTURE", "description": "A 310 helix is a secondary structure motif found in proteins. It plays a role in protein stability and interaction.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "310 HELIX"}, {"entity_type": "PEPTIDE", "description": "A nonamer peptide is a peptide composed of nine amino acids.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "id": "NONAMER"}, {"entity_type": "PEPTIDE", "description": "A decamer peptide is a peptide composed of ten amino acids.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "DECAMER"}, {"entity_type": "PROTEIN STRUCTURE", "description": "The peptide-binding groove is the region on an MHC molecule where peptides bind.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "PEPTIDE-BINDING GROOVE"}, {"entity_type": "INTERMOLECULAR FORCE", "description": "Hydrophobic interactions are attractive forces between nonpolar molecules.", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "HYDROPHOBIC INTERACTIONS"}, {"entity_type": "INTERMOLECULAR FORCE", "description": "Hydrogen bonds are weak attractions between a hydrogen atom and an electronegative atom (like oxygen or nitrogen).", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "id": "HYDROGEN BONDS"}, {"entity_type": "PEPTIDE", "description": "ALK peptides are derived from the ALK protein and are recognized by HLA molecules.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ALK PEPTIDE"}, {"entity_type": "PROTEIN", "description": "HLA-A*01:01 is a HLA allele frequently found in populations and known to form stable p/MHC complexes.<SEP>HLA-A*01:01 is a gene that codes for HLA-A*01:01 protein.", "source_id": "chunk-614333487e4b92705503909d34155179<SEP>chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "HLA-A*01:01"}, {"entity_type": "DATABASE", "description": "The EMBL-EBI database provides information about HLA alleles.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "EMBL-EBI DATABASE"}, {"entity_type": "SOFTWARE TOOL", "description": "Rosetta is a software tool used for protein modeling and structure prediction.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "ROSETTA"}, {"entity_type": "DATABASE", "description": "The PDB (Protein Data Bank) contains experimentally determined protein structures.", "source_id": "chunk-614333487e4b92705503909d34155179", "id": "PDB"}, {"entity_type": "MOLECULAR INTERACTION", "description": "Neoepitopes are molecular fragments derived from mutated proteins that can be recognized by the immune system.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 66}]", "id": "NEOEPITOPE"}, {"entity_type": "PROTEIN", "description": "MHC tetramers are protein complexes used to identify T cells that recognize specific neoepitopes.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 66}]", "id": "MHC TETRAMER"}, {"entity_type": "VIRUS", "description": "SARS coronavirus is a virus responsible for Severe Acute Respiratory Syndrome.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 66}]", "id": "SARS CORONAVIRUS"}, {"entity_type": "COMPLEX", "description": "A p/MHC complex is a complex formed between a major histocompatibility complex (MHC) molecule and a peptide.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "P/MHC COMPLEX"}, {"entity_type": "PEPTIDE", "description": "A peptide is a short chain of amino acids.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 69}]", "id": "PEPTIDE"}, {"entity_type": "PEPTIDE", "description": "A decamer peptide is a peptide composed of ten amino acids.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "DECAME"}, {"entity_type": "STRUCTURE", "description": "The X-ray structure refers to the three-dimensional arrangement of atoms in a molecule.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "STRUCTURE"}, {"entity_type": "PROPERTY", "description": "Thermal stability refers to the temperature at which a protein or complex begins to unfold.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "THERMAL STABILITY"}, {"entity_type": "ANALYSIS", "description": "Binding energy calculations are computational methods used to predict the strength of interactions between molecules.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "BINDING ENERGY CALCULATIONS"}, {"entity_type": "MODEL", "description": "The Rosetta model is a computational model of a molecular structure.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "ROSETTA MODEL"}, {"entity_type": "METRIC", "description": "RMSD (root mean square deviation) is a metric used to compare two structures.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "RMSD"}, {"entity_type": "INTERACTION", "description": "Contact refers to a close interaction between atoms in molecules.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "CONTACT"}, {"entity_type": "REGION", "description": "The A-pocket is a region within the MHC groove where peptide residues can bind.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "A-POCKET"}, {"entity_type": "REGION", "description": "The F-pocket is a region within the MHC groove where peptide residues can bind.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "F-POCKET"}, {"entity_type": "PART OF MOLECULE", "description": "A side chain is the part of an amino acid that extends from the backbone.", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "id": "SIDE-CHAIN"}, {"entity_type": "MOLECULAR INTERACTION", "description": "An immunodominant epitope is a part of an antigen that is preferentially recognized by the immune system.", "source_id": "chunk-41c7131af28e2a745ef6b88b8601860f", "id": "IMMUNODOMINANT EPITOPE"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ALK R1275Q mutation is found in some patients with Neuroblastoma (NBL).)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 64}]", "id": "NEUROBLASTOMA"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The NRAS Q61K mutation is frequently found in these cancer types.)", "entity_type": "UNKNOWN", "id": "MELANOMA, THYROID, COLORECTAL CANCERS"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "A mutation in the ZNF717 gene, specifically at codon 716, is found in some NBL samples.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 64}]", "id": "ZNF717 Q716"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The ProTECT software is used to predict neoepitopes arising from tumor mutations.)", "entity_type": "UNKNOWN", "id": "NEOEPITOPE PREDICTION"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The TARGET cohort includes neuroblastoma (NBL) samples used in the study.)", "entity_type": "UNKNOWN", "id": "NEUROBLASTOMA SAMPLES"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The HLA-B*15:01 allele binds to neoepitopes derived from the ALK R1275Q mutation.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "NEOEPITOPE BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "The AQDIYRASY neoepitope binds to HLA-B*15:01 with a high affinity.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 67}]", "id": "HLA-B*15:01 BINDING"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "E. coli was used to produce recombinant HLA-B*15:01 molecules for binding studies.)", "entity_type": "UNKNOWN", "id": "PROTEIN PRODUCTION"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "SEC was used to purify the recombinant HLA-B*15:01/neoepitope complexes.)", "entity_type": "UNKNOWN", "id": "PROTEIN PURIFICATION"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "SEC was used to purify the recombinant HLA-B*15:01/neoepitope complexes.)", "entity_type": "UNKNOWN", "id": "SEC"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "LC\u2013MS was used to confirm the presence of the neoepitopes in the MHC complexes.)", "entity_type": "UNKNOWN", "id": "LC\u2013MS"}, {"source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "description": "LC\u2013MS was used to confirm the presence of the neoepitopes in the MHC complexes.)", "entity_type": "UNKNOWN", "id": "PEPTIDE IDENTIFICATION"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The nonamer peptide AQDIYRASY is a shorter version of the decamer peptide AQDIYRASYY.)", "entity_type": "UNKNOWN", "id": "DECAMER PEPTIDE"}, {"source_id": "chunk-830d8819004960d1d149ac70149c72a0", "description": "The nonamer peptide AQDIYRASY is a shorter version of the decamer peptide AQDIYRASYY.)", "entity_type": "UNKNOWN", "id": "NONAMER PEPTIDE"}, {"source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "description": "Neoepitopes are novel antigens arising from mutations, while self-antigens are typically recognized as \'self\' by the immune system.)", "entity_type": "UNKNOWN", "clusters": "[{level: 0, cluster: 10}, {level: 1, cluster: 66}]", "id": "SELF-ANTIGEN"}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "Researchers used the EMBL-EBI database to select HLA alleles for their study.)", "entity_type": "UNKNOWN", "id": "DATA SOURCE"}, {"source_id": "chunk-614333487e4b92705503909d34155179", "description": "Researchers used the EMBL-EBI database to select HLA alleles for their study.)", "entity_type": "UNKNOWN", "id": "RESEARCHERS"}, {"entity_type": "GENOMIC VARIANT", "description": "rs74420772 is a single nucleotide polymorphism (SNP) that achieved genome-wide significance in the TwinGene GWAS.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS74420772"}, {"entity_type": "GENOMIC VARIANT", "description": "1p31.3 is a chromosomal region containing two SNPs associated with IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "1P31.3"}, {"entity_type": "GENOMIC VARIANT", "description": "11q24.1 is a chromosomal region containing six SNPs associated with IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "11Q24.1"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35923643-G is the leading SNP in 11q24.1, with a significant allelic effect size for IgM anti-PC levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS35923643-G"}, {"entity_type": "GENE", "description": "The GRAM domain containing 1B (GRAMD1B) gene is located within the LD block associated with rs35923643.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "GRAMD1B"}, {"entity_type": "GENOMIC VARIANT", "description": "rs735665-A is a proxy SNP for rs35923643-G, in strong linkage disequilibrium.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "RS735665-A"}, {"entity_type": "DISEASE", "description": "Chronic lymphocytic leukemia (CLL) is a type of cancer associated with genetic variants affecting IgM levels.<SEP>Chronic lymphocytic leukemia (CLL) is a type of cancer that affects white blood cells.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CLL"}, {"entity_type": "DISEASE", "description": "Anti-Phosphocholine immunoglobulin M (IgM anti-PC) is an immune marker implicated in various diseases, including CLL.<SEP>IgM anti-PC is an antibody.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "IGM ANTI-PC"}, {"entity_type": "PROTEIN", "description": "Immunoglobulin M (IgM) is a type of antibody associated with the immune response.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "IGM"}, {"entity_type": "OTHER", "description": "A polygenic risk score (PRS) combines genetic variants to estimate an individual\'s risk for a particular disease.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "POLYGENIC RISK SCORE"}, {"entity_type": "STUDY", "description": "TwinGene is a GWAS study that identified rs74420772 as genome-wide significant for IgM anti-PC.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "TWINGENE"}, {"entity_type": "ORGANIZATION", "description": "The InterLymph consortium is a group of researchers who conducted a GWAS on CLL.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "INTERLYMPH CONSORTIUM"}, {"entity_type": "STUDY/AUTHOR", "description": "Jonsson et al. conducted a GWAS on general immunoglobulin levels.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "id": "JONSSON ET AL. "}, {"entity_type": "CELL LINE", "description": "GM12878 is a human lymphoblastoid cell line used in genomic studies.<SEP>GM12878 is an immortalized human B-cell line used in research.", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a<SEP>chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "GM12878"}, {"entity_type": "GENOMIC VARIANT", "description": "rs35923643 is a genomic variant located at 11q24.1.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RS35923643"}, {"entity_type": "PROTEIN", "description": "RUNX3 is a Runt-related transcription factor that binds to the region around rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "RUNX3"}, {"entity_type": "PROTEIN", "description": "SPI1 is a transcription factor identified by ChIP-seq experiments as potentially binding near rs35923643.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "SPI1"}, {"entity_type": "DISEASE", "description": "Incident CLL cases are individuals newly diagnosed with chronic lymphocytic leukemia.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "INCIDENT CLL CASES"}, {"entity_type": "CONTROL GROUP", "description": "Matched controls are healthy individuals who were age- and sex-matched with the CLL cases.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "MATCHED CONTROLS"}, {"entity_type": "CELL TYPE", "description": "CD34+ cells are hematopoietic stem cells.", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "id": "CD34+"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "The SNP rs35923643 overlaps with the binding motif of RUNX3, and switching from the major allele T/A to the minor C/G allele impedes RUNX3 binding affinity.)", "entity_type": "UNKNOWN", "id": "RUNX3 BINDING"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "Regulatory marks such as H3K4Me1 and DNaseI hypersensitivity were found at rs35923643 in immune cell lines like GM12878, CD34+ cells, and GM12865.)", "entity_type": "UNKNOWN", "id": "IMMUNE-CELL LINES"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "The difference in IgM anti-PC levels between CLL cases and matched controls showed a declining trend over time.)", "entity_type": "UNKNOWN", "id": "TIME BETWEEN SAMPLING AND DIAGNOSIS"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "Levels of IgM anti-PC were lower in prevalent CLL cases compared to matched controls.)", "entity_type": "UNKNOWN", "id": "PREVALENT CLL CASES"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "DNaseI hypersensitivity was found at rs35923643 in CD34+ cells.)", "entity_type": "UNKNOWN", "id": "DNASEI HYPERSENSITIVITY"}, {"source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "description": "DNaseI hypersensitivity was found at rs35923643 in GM12865.)", "entity_type": "UNKNOWN", "id": "GM12865"}], "links": [{"weight": 2.0, "description": "SNPs in the SEC16B gene are associated with an increased risk of obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "SEC16 HOMOLOG B", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "SNPs in the DNAJC27 gene are associated with an increased risk of obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "DNAJ HEAT SHOCK PROTEIN FAMILY (HSP40) MEMBER C27", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "SNPs in the CDKAL1 gene are associated with an increased risk of obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "CDK5 REGULATORY SUBUNIT-ASSOCIATED PROTEIN 1-LIKE 1", "target": "OBESITY RISK"}, {"weight": 2.0, "description": "SNPs in the TFAP2B gene are associated with an increased risk of obesity.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "TRANSCRIPTION FACTOR AP-2 BETA", "target": "OBESITY RISK"}, {"weight": 9.0, "description": "The incidence of metabolic syndrome was much higher in the obese groups in both genders, and the risk increased 5.86-fold in the obese group.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESITY RISK", "target": "METABOLIC SYNDROME"}, {"weight": 1.0, "description": "Variations in SEC16B are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "SEC16B"}, {"weight": 2.0, "description": "Variations in DNAJC27 are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "DNAJC27"}, {"weight": 3.0, "description": "Variations in CDKAL1 are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "CDKAL1"}, {"weight": 4.0, "description": "Variations in TFAP2B are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "TFAP2B"}, {"weight": 5.0, "description": "Variations in BDNF are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "BDNF"}, {"weight": 6.0, "description": "Variations in MYL2 are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "MYL2"}, {"weight": 7.0, "description": "Variations in OLFM4 are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "OLFM4"}, {"weight": 8.0, "description": "FTO gene is known to be a major genetic contributor to obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "FTO"}, {"weight": 9.0, "description": "MC4R gene plays a role in regulating appetite and energy expenditure, and variations are associated with obesity risk.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "MC4R"}, {"weight": 10.0, "description": "Variations in GIPR are associated with an increased risk of obesity.)", "source_id": "chunk-eec0b4c60ebeb28599428b3552de2d1b", "order": 1, "source": "OBESITY RISK", "target": "GIPR"}, {"weight": 5.0, "description": "The FTO rs9939609 polymorphism increases the risk of obesity, particularly in individuals without university education.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY RISK", "target": "FTO RS9939609 POLYMORPHISM"}, {"weight": 21.0, "description": "Variations in the CDKAL1 gene are associated with an increased risk of T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "CDKAL1", "target": "T2D RISK"}, {"weight": 3.0, "description": "The rs10946398 variant is located in the CDKAL1 gene and is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CDKAL1", "target": "RS10946398"}, {"weight": 19.0, "description": "Variations in the BDNF gene have been linked to an increased risk of depression and other mental health disorders.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "BDNF", "target": "MENTAL HEALTH"}, {"weight": 18.0, "description": "Genetic variants in the FTO gene are associated with increased body mass index (BMI) and obesity risk.)<SEP>The FTO gene is associated with an increased risk of obesity.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FTO", "target": "OBESITY"}, {"weight": 1.0, "description": "rs9939609 is a SNP located in the FTO gene, and it is associated with an increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "FTO", "target": "RS9939609"}, {"weight": 18.0, "description": "The FTO gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "FTO", "target": "CRP"}, {"weight": 27.0, "description": "Variants in FTO are associated with BMI and body weight.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "FTO", "target": "BMI AND BODY WEIGHT"}, {"weight": 17.0, "description": "Mutations in the MC4R gene can lead to severe obesity.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "MC4R", "target": "OBESITY"}, {"weight": 4.0, "description": "The MC4R gene may influence susceptibility to type 2 diabetes, and its interaction with weight loss interventions warrants further investigation.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "MC4R", "target": "T2D"}, {"weight": 24.0, "description": "The MC4R gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "MC4R", "target": "CRP"}, {"weight": 29.0, "description": "Variants in MC4R are associated with BMI.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "MC4R", "target": "BMI"}, {"weight": 8.0, "description": "Interaction of carbohydrates and total fat was reported with the GIPR rs10423928 by MDCS.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "GIPR", "target": "CARBOHYDRATES & FAT"}, {"weight": 0.0, "description": "Variants in GIPR are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the GIPR gene are nominally associated with AcAc and/or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GIPR", "target": "ACAC/BHB"}, {"weight": 5.0, "description": "The average BMI of the obese group was approximately 27.1 kg/m2, higher than the nonobese group.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "BMI", "target": "OBESE GROUP"}, {"weight": 6.0, "description": "The average BMI of the nonobese group was approximately 22.5 kg/m2 in both gender groups.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "BMI", "target": "NONOBESE GROUP"}, {"weight": 4.0, "description": "PRS had a stronger impact on BMI in individuals with early menarche.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "BMI", "target": "PRS"}, {"weight": 1.0, "description": "The FTO rs9939609 polymorphism is associated with higher BMI in individuals.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "BMI", "target": "FTO RS9939609 POLYMORPHISM"}, {"weight": 25.0, "description": "Higher BMI is a significant risk factor for developing T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "BMI", "target": "T2D RISK"}, {"weight": 3.0, "description": "Mean BMI was not significantly different between T2D-ESRD case and nondiabetic control subjects.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "BMI", "target": "T2D-ESRD CASE AND NONDIABETIC CONTROL SUBJECTS"}, {"weight": 4.0, "description": "IFG/IGT status was positively associated with BMI at baseline compared to NGT subjects.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "IFG/IGT"}, {"weight": 6.0, "description": "T2D status was positively associated with BMI at baseline compared to NGT subjects.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "T2D"}, {"weight": 8.0, "description": "Baseline FPG levels were positively associated with BMI at baseline.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "FASTING PLASMA GLUCOSE (FPG)"}, {"weight": 10.0, "description": "Baseline 2hPG levels were positively associated with BMI at baseline.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI", "target": "TWO-HOUR PLASMA GLUCOSE (2HPG)"}, {"weight": 1.0, "description": "The rs9939609 SNP is associated with an increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS9939609"}, {"weight": 2.0, "description": "The rs2984618 SNP is associated with an increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS2984618"}, {"weight": 3.0, "description": "The rs7903146 SNP is associated with an increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "BMI", "target": "RS7903146"}, {"weight": 0.6, "description": "Pre-surgical BMI was adjusted for in the analysis.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "BMI", "target": "PRE-SURGICAL WEIGHT"}, {"weight": 16.0, "description": "Carriers of any minor alleles in the FADS gene cluster had a lower BMI compared to those with all major alleles.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "BMI", "target": "GENOTYPE"}, {"weight": 16.0, "description": "Higher BMI is associated with increased snoring prevalence in both males and females.)<SEP>Higher BMI was associated with increased snoring risk in sensitivity analyses.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83<SEP>chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "BMI", "target": "SNORING"}, {"weight": 8.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "BMI", "target": "CASES"}, {"weight": 9.0, "description": "BMI differed significantly according to the rs671 polymorphism in men.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BMI", "target": "RS671 POLYMORPHISM"}, {"weight": 7.0, "description": "Higher BMI is associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "BMI", "target": "SUA"}, {"weight": 1.0, "description": "Higher BMI was observed in the IBS-D subgroup compared to IBS-C and HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "IBS-D"}, {"weight": 9.0, "description": "There was a significant positive correlation between BMI and serum C4 concentrations.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "SERUM C4"}, {"weight": 10.0, "description": "There was a significant positive correlation between BMI and total stool bile acid excretion.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "BMI", "target": "TOTAL STOOL BA"}, {"weight": 7.0, "description": "The waist circumferences were higher in the obese group than the nonobese group in both genders.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "OBESE GROUP"}, {"weight": 2.0, "description": "The FTO rs9939609 polymorphism is associated with greater waist circumference.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "WAIST CIRCUMFERENCE", "target": "FTO RS9939609 POLYMORPHISM"}, {"weight": 2.0, "description": "Early menarche age interacted with PRS for the obesity risk.  )", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "MENARCHE AGE"}, {"weight": 6.0, "description": "High PRS was associated with higher BMI in those with low plant-based diet intake, but protected against obesity risk in those with high plant-based diet intake.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "PLANT-BASED DIET"}, {"weight": 8.0, "description": "High fried-food intake partially offset the impact of PRS on BMI.)", "source_id": "chunk-3ad8ef794841d749e48b3223741e91d3", "order": 1, "source": "PRS", "target": "FRIED-FOOD INTAKE"}, {"weight": 2.0, "description": "Men were older than women in the study group.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "AGE", "target": "MEN"}, {"weight": 3.0, "description": "Obese women were older than nonobese women in the study group.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "AGE", "target": "WOMEN"}, {"weight": 26.0, "description": "Increasing age is a known risk factor for T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "AGE", "target": "T2D RISK"}, {"weight": 2.0, "description": "Age is a significant risk factor for snoring, with the odds of snoring increasing with each year.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "AGE", "target": "SNORING"}, {"weight": 7.0, "description": "There\'s a significant SNP-age interaction on the level of Bifidobacterium abundance.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "AGE", "target": "BIFIDOBACTERIUM ABUNDANCE"}, {"weight": 6.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "AGE", "target": "CASES"}, {"weight": 9.0, "description": "Older age and increased body mass index are often associated with a higher BMI.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "AGE", "target": "BODY MASS INDEX (BMI)"}, {"weight": 8.0, "description": "The GA genotype group was older than other genotypes in both sexes.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "AGE", "target": "GA GENOTYPE"}, {"weight": 7.0, "description": "Older youth (\u226514 years) had higher mean social disinhibition scores compared to younger youth.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "AGE", "target": "SOCIAL DISINHIBITION"}, {"weight": 5.0, "description": "In lactase non-persistent individuals, DNA modifications increase with age, while in lactase persistent individuals they tend to decrease.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "DNA MODIFICATION CHANGES"}, {"weight": 1.0, "description": "DNA modifications in MCM6 exon 16 change gradually with age.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "MCM6 EXON 16 DNA MODIFICATION"}, {"weight": 3.0, "description": "Changes at MCM6 intron 13 are observed after conception.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "MCM6 INTEIN 13 DNA MODIFICATION"}, {"weight": 4.0, "description": "DNA modifications increase in LCT intron 8 with age in mice.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "AGE", "target": "LCT INTRON 8 DNA MODIFICATION"}, {"weight": 8.0, "description": "The average age of HIV-infected individuals in the study was...)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "AGE", "target": "HIV-INFECTED INDIVIDUALS"}, {"weight": 11.0, "description": "Serum triglyceride concentrations were higher in men than women.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "MEN", "target": "TRIGLYCERIDES"}, {"weight": 1.0, "description": "The ALDH2 rs671 genotypes had different distributions and impacts on alcohol consumption in men compared to women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "MEN", "target": "ALDH2 RS671 GENOTYPES"}, {"weight": 10.0, "description": "Serum total cholesterol and LDL concentrations were much higher in women than men.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "WOMEN", "target": "TOTAL CHOLESTEROL"}, {"weight": 2.0, "description": "The ALDH2 rs671 genotypes had different distributions and impacts on alcohol consumption in women compared to men.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "WOMEN", "target": "ALDH2 RS671 GENOTYPES"}, {"weight": 4.0, "description": "Obese women were shorter than nonobese women in the study group.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "HEIGHT", "target": "NONOBESE WOMEN"}, {"weight": 1.0, "description": "Variants in HMGA2 are associated with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "HEIGHT", "target": "HMGA2"}, {"weight": 15.0, "description": "The rs35866622 variant is positively associated with height.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "HEIGHT", "target": "RS35866622"}, {"weight": 8.0, "description": "Skeletal muscle and fat mass were higher in the obese group than the nonobese group for both genders.)", "source_id": "chunk-fa6293a0a10f175b4aebac8e885c0d20", "order": 1, "source": "OBESE GROUP", "target": "SKELETAL MUSCLE MASS"}, {"weight": 0.8, "description": "The rs6734238 SNP near the IL1F10 gene is associated with total cholesterol levels.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "TOTAL CHOLESTEROL", "target": "RS6734238"}, {"weight": 6.0, "description": "Intronic and 3\u2032UTR variants in the APOA5-ZNF259 region are associated with triglycerides.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "TRIGLYCERIDES", "target": "APOA5-ZNF259"}, {"weight": 8.0, "description": "The FTO rs1558902 genotype interacts with a high-protein diet, leading to greater weight loss, fat reduction, and changes in fat distribution compared to those not carrying the risk allele.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "HIGH-PROTEIN DIET"}, {"weight": 6.0, "description": "The FTO rs1558902 genotype interacts with a low-protein diet, resulting in less weight loss and altered fat distribution compared to those not carrying the risk allele.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "LOW-PROTEIN DIET"}, {"weight": 11.0, "description": "The FTO rs1558902 genotype influences an individual\'s susceptibility to weight gain or loss.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "WEIGHT"}, {"weight": 12.0, "description": "The FTO rs1558902 genotype interacts with dietary interventions to influence changes in body composition.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "BODY COMPOSITION"}, {"weight": 13.0, "description": "Individuals carrying the FTO rs1558902 risk allele exhibit greater reductions in total fat when on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "TOTAL FAT"}, {"weight": 14.0, "description": "The FTO rs1558902 genotype influences changes in FM% when combined with different dietary interventions.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "FAT MASS PERCENTAGE (FM%)"}, {"weight": 15.0, "description": "Individuals carrying the FTO rs1558902 risk allele experience greater reductions in trunk fat when on a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "TRUNK FAT"}, {"weight": 16.0, "description": "The FTO rs1558902 genotype interacts with protein intake, leading to changes in VAT reduction.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "VISCERAL ADIPOSE TISSUE (VAT)"}, {"weight": 17.0, "description": "The FTO rs1558902 genotype influences changes in SAT reduction, particularly when combined with different dietary interventions.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "FTO RS1558902", "target": "SUBCUTANEOUS ADIPOSE TISSUE (SAT)"}, {"weight": 10.0, "description": "A high-protein diet can lead to greater weight loss when combined with the FTO rs1558902 risk allele.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "WEIGHT LOSS"}, {"weight": 14.0, "description": "Individuals carrying the FTO rs1558902 risk allele experience greater fat reduction when following a high-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "FAT REDUCTION"}, {"weight": 18.0, "description": "A high-protein diet, especially for those with the FTO rs1558902 risk allele, can lead to significant changes in body fat distribution.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "CHANGES IN FAT DISTRIBUTION"}, {"weight": 2.0, "description": "Individuals with the AA genotype experienced a greater decrease in fat distribution when following a high-protein diet.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "HIGH-PROTEIN DIET", "target": "AA GENOTYPE"}, {"weight": 12.0, "description": "A low-protein diet may result in less weight loss when combined with the FTO rs1558902 risk allele.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "LOW-PROTEIN DIET", "target": "WEIGHT LOSS"}, {"weight": 16.0, "description": "Individuals carrying the FTO rs1558902 risk allele may experience less fat reduction when following a low-protein diet.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "LOW-PROTEIN DIET", "target": "FAT REDUCTION"}, {"weight": 20.0, "description": "A low-protein diet may result in less significant changes in fat distribution for individuals with the FTO rs1558902 risk allele.)", "source_id": "chunk-2926e6216bf945b12ea4daa6345cad1f", "order": 1, "source": "LOW-PROTEIN DIET", "target": "CHANGES IN FAT DISTRIBUTION"}, {"weight": 4.0, "description": "Individuals with the AA genotype had less loss in TAT and SAT while following a low-protein diet.)", "source_id": "chunk-a321a6d63755366a1fc3eafbd9fbce83", "order": 1, "source": "LOW-PROTEIN DIET", "target": "AA GENOTYPE"}, {"weight": 10.0, "description": "A low-protein diet is a treatment strategy for HI/HA syndrome.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "LOW-PROTEIN DIET", "target": "HI/HA"}, {"weight": 3.0, "description": "The FTO rs9939609 polymorphism is associated with higher weight.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "WEIGHT", "target": "FTO RS9939609 POLYMORPHISM"}, {"weight": 0.9, "description": "Long-term weight loss is determined by changes in weight over time.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "WEIGHT", "target": "LONG TERM WEIGHT LOSS"}, {"weight": 4.0, "description": "Mice with deletion of IL-10 receptor alpha specifically in macrophages exhibit accelerated weight loss during colitis.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "WEIGHT LOSS", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"weight": 4.0, "description": "Higher educational level is associated with a lower risk of obesity.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "OBESITY", "target": "EDUCATIONAL LEVEL"}, {"weight": 4.0, "description": "Individuals carrying the A-allele of the FTO SNP have a higher risk of developing obesity.)", "source_id": "chunk-63d0b5be485a69f44e2799ccc9510487", "order": 1, "source": "OBESITY", "target": "A-ALLELE"}, {"weight": 18.0, "description": "Mutations in the LEPR gene can cause leptin resistance and obesity.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "OBESITY", "target": "LEPR"}, {"weight": 2.0, "description": "The rs3833080 deletion in APOBR is nominally associated with obesity.)", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "RS3833080"}, {"weight": 4.0, "description": "The rs180743 SNP in APOBR is nominally associated with obesity.)", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "RS180743"}, {"weight": 6.0, "description": "Genetic variation in the APOBR gene is associated with obesity.)", "source_id": "chunk-7ca64f92964b051cfb1c43f967f243a5", "order": 1, "source": "OBESITY", "target": "APOBR"}, {"weight": 8.0, "description": "Some SNPs in the SULT1A2 gene have been associated with obesity risk.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "OBESITY", "target": "SULT1A2"}, {"weight": 13.0, "description": "The rs182549 variant is negatively associated with obesity.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "OBESITY", "target": "RS182549"}, {"weight": 8.0, "description": "Obesity is associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "OBESITY", "target": "SUA"}, {"weight": 12.0, "description": "High levels of \u03b2-hydroxybutyrate indicate uncontrolled diabetes and impaired glucose metabolism.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "DIABETES", "target": "\u0392-HYDROXYBUTYRATE"}, {"weight": 4.0, "description": "SENP1-aP2KO mice developed diabetes earlier than Ctrl mice under HFD conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "DIABETES", "target": "SENP1-AP2KO"}, {"weight": 13.0, "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "DIABETES", "target": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"weight": 10.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "SMOKING", "target": "CASES"}, {"weight": 12.0, "description": "Smokers consume more drinks compared to non-smokers, although this relationship is not strong.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "SMOKING", "target": "ALCOHOL SELF-ADMINISTRATION"}, {"weight": 5.0, "description": "In the Czech Republic, smoking was associated with milk consumption.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "SMOKING", "target": "MILK CONSUMPTION"}, {"weight": 2.0, "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "SNP", "target": "C21ORF34"}, {"weight": 1.0, "description": "Several SNPs were identified as reaching genome-wide significance for association with \'age at first tooth\'.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "SNP", "target": "AGE AT FIRST TOOTH"}, {"weight": 2.0, "description": "Many SNPs were found to be associated with \'number of teeth\' at genome-wide significance.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "SNP", "target": "NUMBER OF TEETH"}, {"weight": 2.0, "description": "The minor allele of each SNP was inversely associated with the risk of type 2 diabetes.)", "source_id": "chunk-b803830d07bff8ae14550f6458048707", "order": 1, "source": "SNP", "target": "TYPE 2 DIABETES"}, {"weight": 3.0, "description": "Genetic variation can occur due to SNPs, which are variations in a single nucleotide within the DNA sequence.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "SNP", "target": "GENOMIC VARIANT"}, {"weight": 3.0, "description": "The odds ratio quantifies the association between risk alleles and disease.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "OR", "target": "RISK ALLELE"}, {"weight": 4.0, "description": "Confidence intervals provide a measure of uncertainty around the odds ratio.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "OR", "target": "CI"}, {"weight": 5.0, "description": "A low p-value suggests a statistically significant association between risk alleles and disease.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "OR", "target": "P-VALUE"}, {"weight": 1.0, "description": "Odds Ratio measures the strength of association between a genotype and IA risk.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "OR", "target": "STATISTICAL MEASURE"}, {"weight": 0.8, "description": "The odds ratio (OR) was used to quantify the association between healthy lifestyle score and AMD risk.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "OR", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 1.0, "description": "The Odds Ratio (OR) is a measure of the strength of association between a genetic variant and an outcome, like ovarian cancer.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OR", "target": "RISK"}, {"weight": 2.0, "description": "A higher OR was observed for milk drinking in individuals carrying the lactase persistence genotype.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "OR", "target": "MILK CONSUMPTION"}, {"weight": 0.6, "description": "The OR indicates that the odds of having CRC were 0.68 times lower for individuals with the T allele compared to those without it.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "OR", "target": "T ALLELE"}, {"weight": 14.0, "description": "The protective effect of PA on T2D risk was weaker among individuals with high adherence to a T2D-GRS compared to those with low adherence.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PA", "target": "T2D\u2010GRS"}, {"weight": 15.0, "description": "The minor HNF1B rs4430796 A-allele weakened and potentially reversed the protective effect of higher PA on T2D incidence in persons with the GG genotype.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PA", "target": "HNF1B RS4430796"}, {"weight": 16.0, "description": "In NHS, women with the IRS1 rs1522813 A-allele and low levels of PA had a higher risk to develop T2D compared with those with the GG genotype.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PA", "target": "IRS1 RS1522813"}, {"weight": 1.0, "description": "The FTO rs9939609 polymorphism is associated with increased BMI in the General Practice population.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "BMI IN GP"}, {"weight": 2.0, "description": "The FTO rs9939609 polymorphism exhibits a recessive association with BMI in the Overweight/Obese Hypertensive Population.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "BMI IN OHP"}, {"weight": 3.0, "description": "No significant association was observed between the FTO rs9939609 polymorphism and BMI in the Healthy, Controlled Risk population.)", "source_id": "chunk-3135befd0c3140ad097d96ace6de86a1", "order": 1, "source": "FTO RS9939609 POLYMORPHISM", "target": "BMI IN HCR"}, {"weight": 1.0, "description": "Studies have shown interactions between TCF7L2 gene variants and fiber intake on the risk of type 2 diabetes.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2", "target": "FIBER"}, {"weight": 1.0, "description": "Research suggests that variations in the TCF7L2 gene may interact with whole grain consumption to influence type 2 diabetes risk.)", "source_id": "chunk-0d8bc9a093c56fefc8b7af3fb9bc2862", "order": 1, "source": "TCF7L2", "target": "WHOLE GRAIN"}, {"weight": 7.0, "description": "The rs7903146 variant is located in the TCF7L2 gene and is associated with an increased risk of type 2 diabetes.)<SEP>The rs7903146 variant within the TCF7L2 gene modifies the effect of incretins on insulin secretion.)<SEP>rs7903146 is a risk variant located within the TCF7L2 gene.)<SEP>rs7903146 is a SNP located in the TCF7L2 gene, and it is associated with an increased BMI at baseline.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4<SEP>chunk-ab449d4ec9f3baa290d63f09fdbd3fbc<SEP>chunk-1fde08e52a188ac6a549e7c11d59a092<SEP>chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "TCF7L2", "target": "RS7903146"}, {"weight": 19.0, "description": "Variations in the TCF7L2 gene are strongly linked to an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "TCF7L2", "target": "T2D RISK"}, {"weight": 2.0, "description": "The TCF7L2 gene variant rs12255372 is associated with a reduced risk of developing type 2 diabetes in individuals who participate in weight loss interventions.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "TCF7L2", "target": "T2D"}, {"weight": 2.0, "description": "The TCF7L2 gene has been linked to risk alleles, particularly rs7903146.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "TCF7L2", "target": "RISK ALLELE"}, {"weight": 3.0, "description": "Increased fiber intake was associated with lower T2D incidence among individuals with the rs7903146 CC genotype, but not among those with the risk T allele.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER", "target": "RS7903146"}, {"weight": 5.0, "description": "In MDCS, fiber intake showed an interaction with the rs10923931 variant in the NOTCH2 gene.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER", "target": "NOTCH2"}, {"weight": 6.0, "description": "In MDCS, fiber intake showed an interaction with the rs4457053 variant in the ZBED3 gene.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FIBER", "target": "ZBED3"}, {"weight": 4.0, "description": "Higher whole-grain intake was associated with lower T2D incidence among individuals with the rs7903146 CC genotype, but not among those with the risk T allele.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "WHOLE GRAIN", "target": "RS7903146"}, {"weight": 3.0, "description": "Higher AcAc levels predicted an increased risk of developing type 2 diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "TYPE 2 DIABETES", "target": "ACAC"}, {"weight": 6.0, "description": "Lifestyle intervention led to a significant decrease in proinsulin levels compared to placebo.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "LIFESTYLE INTERVENTION", "target": "PROINSULIN"}, {"weight": 8.0, "description": "Metformin treatment led to a decrease in proinsulin levels.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "METFORMIN", "target": "PROINSULIN"}, {"weight": 8.0, "description": "A marginally nonsignificant interaction (P = .05) was observed between olive oil intake and the GIPR variant rs10423928 in EPIC-InterAct.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "OLIVE OIL", "target": "GIPR VARIANT RS10423928"}, {"weight": 13.0, "description": "In PREDIMED, a borderline significant interaction between the CLOCK variant rs4580704 and the Mediterranean diet was observed.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "MEDITERRANEAN DIET", "target": "CLOCK VARIANT RS4580704"}, {"weight": 8.0, "description": "The Mediterranean group also showed a significant increase in long chain n-3 PUFA intake after 6 months.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "MEDITERRANEAN DIET", "target": "LONG CHAIN N-3 PUFA"}, {"weight": 13.0, "description": "The Mediterranean group showed a significant decrease in n-6 PUFA intake after 6 months.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "MEDITERRANEAN DIET", "target": "N-6 PUFA"}, {"weight": 2.0, "description": "Individuals with no minor alleles in the FADS1/2 gene cluster showed a lower concentration of AA in their colon after following the Mediterranean diet compared to the Healthy Eating diet.)", "source_id": "chunk-e1b4f4dac52e806f19c580640a50c729", "order": 1, "source": "MEDITERRANEAN DIET", "target": "FADS1/2"}, {"weight": 9.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "PHYSICAL ACTIVITY", "target": "CASES"}, {"weight": 10.0, "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "PHYSICAL ACTIVITY", "target": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"weight": 2.0, "description": "Genetic variants in the TCF7L2 gene are associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "T2D", "target": "TCF7L2 VARIANTS"}, {"weight": 3.0, "description": "Individuals carrying the diabetogenic variant of the ENPP1 gene may benefit from weight loss interventions in reducing their risk of developing type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "ENPP1"}, {"weight": 5.0, "description": "The PPAR\u03b3 gene plays a role in glucose metabolism and insulin sensitivity, potentially influencing the effectiveness of weight loss interventions for individuals at risk of type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "PPAR\u0393"}, {"weight": 6.0, "description": "Increased TNF\u03b1 activity may contribute to inflammation and insulin resistance, factors associated with type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "TNF\u0391"}, {"weight": 7.0, "description": "The ADRA2B gene may influence blood pressure regulation and glucose metabolism, potentially impacting the risk of developing type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "ADRA2B"}, {"weight": 8.0, "description": "The LIPC gene plays a role in lipid metabolism, which is interconnected with glucose homeostasis and the development of type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "LIPC"}, {"weight": 10.0, "description": "The rs7903146 variant may influence susceptibility to type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "RS7903146"}, {"weight": 11.0, "description": "Individuals carrying the diabetogenic variant of the ENPP1 gene (rs1044498) may benefit from weight loss interventions in reducing their risk of developing type 2 diabetes.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "RS1044498"}, {"weight": 12.0, "description": "The MC4R gene variant rs17066829 may influence susceptibility to type 2 diabetes, and its interaction with weight loss interventions warrants further investigation.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "T2D", "target": "RS17066829"}, {"weight": 1.0, "description": "The rs4420638 SNP near the APOC1 gene is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "T2D", "target": "RS4420638"}, {"weight": 0.25, "description": "The rs10399931 variant was not associated with T2D after adjusting for age, sex, BMI and glucose tolerance.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "T2D", "target": "RS10399931"}, {"weight": 0.25, "description": "The rs4950928 variant was not associated with T2D after adjusting for age, sex, BMI and glucose tolerance.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "T2D", "target": "RS4950928"}, {"weight": 2.0, "description": "The study investigated the association between variations within the CHI3LI gene and T2D.)<SEP>The study investigated the association of CHI3LI gene variants with T2D.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "T2D", "target": "CHI3LI"}, {"weight": 7.0, "description": "Interaction of carbohydrates and total fat with IRS1 rs2943641 was reported by MDCS.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "IRS1", "target": "CARBOHYDRATES & FAT"}, {"weight": 9.0, "description": "A trend for interaction (P = .05) was observed between fat intake and the PPAR\u03b3 variants rs1801282 and rs3856806 in DESIR.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "PPAR\u0393", "target": "FAT"}, {"weight": 10.0, "description": "H-allele carriers of the FFAR4 variant rs116454156 had a fourfold higher T2D incidence in DESIR than RR-allele carriers but only with low fat intake.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "FFAR4", "target": "FAT"}, {"weight": 11.0, "description": "An interaction between the CAV2 variant rs2270188 and total fat and saturated fatty acids was reported in EPIC-Potsdam, but not replicated in EPIC-InterAct.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "CAV2", "target": "FAT"}, {"weight": 12.0, "description": "An interaction of alcohol with the ADH1C *1/*2 variant was reported by NHS. The ADH1C*2 allele attenuated the lower diabetes risk among alcohol drinking US women.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "ADH1C", "target": "ALCOHOL"}, {"weight": 13.0, "description": "Higher heme iron intake was associated with increased T2D risk among women with the haemochromatosis-associated HFE variants rs1799945 (H63D) or rs1800562 (C282Y).)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "HFE", "target": "HEME IRON"}, {"weight": 1.0, "description": "HFE variants, such as rs1799945 (H63D) and rs1800562 (C282Y), are linked to an increased risk of type 2 diabetes (T2D).)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "HFE", "target": "T2D RISK"}, {"weight": 14.0, "description": "Interaction of heme iron with T2D incidence is modified by a GRS of nine T2D associated loci and genetic variants of HFE, SLC40A1, and TMPRSS6.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "SLC40A1", "target": "HEME IRON"}, {"weight": 2.0, "description": "The SLC40A1 rs744653 variant interacts with heme iron intake, potentially influencing T2D risk in men.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "SLC40A1", "target": "IRON INTAKE"}, {"weight": 15.0, "description": "Interaction of heme iron with T2D incidence is modified by a GRS of nine T2D associated loci and genetic variants of HFE, SLC40A1, and TMPRSS6.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "TMPRSS6", "target": "HEME IRON"}, {"weight": 3.0, "description": "The TMPRSS6 rs855791 variant showed a borderline significant interaction with heme iron intake in the total sample.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "TMPRSS6", "target": "IRON INTAKE"}, {"weight": 4.0, "description": "rs1011527 is a SNP located in the LEPR gene and interacts with fasting plasma glucose (FPG) to influence BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "LEPR", "target": "RS1011527"}, {"weight": 20.0, "description": "The APOE \u03b54 allele is a significant genetic risk factor for Alzheimer\'s disease.)", "source_id": "chunk-ab449d4ec9f3baa290d63f09fdbd3fbc", "order": 1, "source": "APOE", "target": "ALZHEIMER\'S DISEASE"}, {"weight": 4.0, "description": "The SLC30A8 variants rs16889462, 8_118252314, and 8_118252435 interacted with zinc intake in DPP.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "SLC30A8", "target": "ZINC INTAKE"}, {"weight": 4.0, "description": "SLC30A8 genotype was studied in the DPP cohort.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "SLC30A8", "target": "DPP COHORT"}, {"weight": 5.0, "description": "The DPP study investigated the interaction of SLC30A8 variants with zinc intake, but no clear trend for association with T2D incidence was observed.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "DPP", "target": "SLC30A8 VARIANTS"}, {"weight": 6.0, "description": "High intake of red meat increased the risk of developing T2D in men with a high T2D-genetic risk score (GRS) but not in those with a low GRS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "RED MEAT", "target": "T2D\u2010GRS"}, {"weight": 7.0, "description": "Similar to red meat, high intake of processed meat increased the risk of developing T2D in men with a high T2D-GRS but not in those with a low GRS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PROCESSED MEAT", "target": "T2D\u2010GRS"}, {"weight": 9.0, "description": "The association of dairy products with T2D incidence may be modified by the LCT gene variant rs4988235, with higher risk among non-consumers carrying the lactase persistence allele.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "DAIRY", "target": "LCT GENE RS4988235"}, {"weight": 10.0, "description": "In EPIC-InterAct, coffee intake showed a stronger T2D risk-lowering effect for individuals with the risk allele of the TCF7L2 variant rs12255372.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "COFFEE", "target": "TCF7L2 VARIANT RS12255372"}, {"weight": 11.0, "description": "In KARE, coffee consumers with specific genetic variants (IGF2BP2 rs4402960, CDKAL1 rs7754840, and KCNJ11 rs5215) had a reduced risk of prediabetes and T2D compared to non-consumers.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "COFFEE", "target": "IGF2BP2 RS4402960, CDKAL1 RS7754840, AND KCNJ11 RS5215 VARIANTS"}, {"weight": 12.0, "description": "A Western dietary pattern was associated with higher T2D risk only among individuals with a high T2D-GRS in HPFS.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "WESTERN DIET", "target": "T2D\u2010GRS"}, {"weight": 17.0, "description": "Reduced leisure-time physical activity (LTPA) was associated with higher T2D incidence among individuals with the PPAR\u03b3 rs1801282 Ala-allele.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "PPAR\u0393 RS1801282", "target": "LTPA"}, {"weight": 18.0, "description": "Increased LTPA resulted in lower T2D incidence among individuals with the ADRA2B Glu12 allele.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "ADRA2B GLU12", "target": "LTPA"}, {"weight": 20.0, "description": "Variants in the KCNJ11 gene have been associated with an increased risk of T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "KCNJ11", "target": "T2D RISK"}, {"weight": 22.0, "description": "Variants in the IGF2BP2 gene have been linked to an increased risk of T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "IGF2BP2", "target": "T2D RISK"}, {"weight": 23.0, "description": "Variations in the CAPN10 gene are associated with an increased risk of T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "CAPN10", "target": "T2D RISK"}, {"weight": 24.0, "description": "Mutations in the WFS1 gene are linked to an increased risk of T2D.)", "source_id": "chunk-f7bf38c7a21b86ad85fa360a21bfb447", "order": 1, "source": "WFS1", "target": "T2D RISK"}, {"weight": 2.0, "description": "The rs10010131 variant is located in the WFS1 gene and is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "WFS1", "target": "RS10010131"}, {"weight": 1.0, "description": "Polymorphisms in the SLC2A2 gene may influence an individual\'s response to lifestyle interventions like LTPA.)", "source_id": "chunk-180ca3d6d27d84b30ebf5d20f135de18", "order": 1, "source": "SLC2A2", "target": "LTPA"}, {"weight": 0.0, "description": "Variants in SLC2A2 are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the SLC2A2 gene are nominally associated with AcAc and/or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "SLC2A2", "target": "ACAC/BHB"}, {"weight": 1.0, "description": "A genomic variant is an alteration within the DNA sequence of the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "GCK"}, {"weight": 19.0, "description": "Variants in the GCK gene can lead to MODY, affecting glucose regulation and leading to hyperglycemia.)<SEP>Variants in the GCK gene can lead to Maturity Onset Diabetes of the Young (MODY), a form of diabetes.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "MODY"}, {"weight": 18.0, "description": "Variants in the GCK gene can lead to a specific diabetes phenotype characterized by mild, stable fasting hyperglycemia.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "DIABETES PHENOTYPE"}, {"weight": 22.0, "description": "In some cases, the presence of a genomic variant and a disease phenotype co-segregate within families, suggesting a causal relationship.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "CO-SEGREGATION"}, {"weight": 23.0, "description": "The p.Leu307Phe sequence change was likely de novo, meaning it occurred spontaneously in the proband.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "DE NOVO"}, {"weight": 24.0, "description": "Various in silico tools were used to assess the predicted effects of different genomic variants.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "IN-SILICO TOOLS"}, {"weight": 26.0, "description": "A specific genomic variant was identified in the proband.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "PROBAND"}, {"weight": 28.0, "description": "The mother inherited a specific genomic variant from her parents.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "MOTHER"}, {"weight": 30.0, "description": "A genomic variant can be caused by a mutation.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "MUTATION"}, {"weight": 32.0, "description": "The parents may have contributed to the genomic variant found in their offspring.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "PARENTS"}, {"weight": 34.0, "description": "Specific genomic variants can be associated with particular clinical features.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "CLINICAL FEATURES"}, {"weight": 36.0, "description": "Genetic analysis techniques can be used to detect genomic variants.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "GENETIC ANALYSIS"}, {"weight": 38.0, "description": "Family history can be helpful in identifying potential genetic predispositions.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "FAMILY HISTORY"}, {"weight": 40.0, "description": "In silico tools and other methods are used in variant analysis to assess the potential impact of genomic variants.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GENOMIC VARIANT", "target": "VARIANT ANALYSIS"}, {"weight": 4.0, "description": "The SULT1A1 gene contains several detected variants, including rs142786317.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "GENOMIC VARIANT", "target": "SULT1A1"}, {"weight": 6.0, "description": "The SULT1A2 gene contains several SNPs, including rs4149403 and rs10797300.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "GENOMIC VARIANT", "target": "SULT1A2"}, {"weight": 14.0, "description": "The TUFM gene contains a previously unknown variant, c.3536C>G.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "GENOMIC VARIANT", "target": "TUFM"}, {"weight": 2.0, "description": "Certain genomic variants, such as TaqI and Cdx-2, have been studied for their potential role in influencing ovarian cancer risk.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "GENOMIC VARIANT", "target": "OVARIAN CANCER"}, {"weight": 9.0, "description": "Different melting temperatures indicate different genomic variants.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "GENOMIC VARIANT", "target": "MELTING TEMPERATURE (TM)"}, {"weight": 2.0, "description": "Mutations in the LPL gene can lead to hypertriglyceridemia.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "GENOMIC VARIANT", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 4.0, "description": "Genomic variants, such as missense mutations (p.Arg62Trp and p.Arg101His), frameshift mutation (c.58delG), and splice site mutation (c.1-1G>A) are present in the RPS19 gene.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "GENOMIC VARIANT", "target": "RPS19"}, {"weight": 2.0, "description": "Heavy alcohol consumption during pregnancy can increase the risk of FASD.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "ALCOHOL", "target": "FETAL ALCOHOL SPECTRUM DISORDER (FASD)"}, {"weight": 2.0, "description": "Genotype variation at rs2023239 affects individuals\' responses to alcohol consumption, including reward and craving.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "ALCOHOL", "target": "RS2023239"}, {"weight": 4.0, "description": "Individuals with the CT genotype reported greater drinks per drinking day compared to those with the TT genotype when treated with placebo.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "ALCOHOL", "target": "CT"}, {"weight": 4.0, "description": "The rs864745 variant is located in the JAZF1 gene and is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "JAZF1", "target": "RS864745"}, {"weight": 5.0, "description": "The rs4607103 variant is located in the ADAMTS9 gene and is associated with a decreased risk of type 2 diabetes, opposite to what was reported in European samples.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "ADAMTS9", "target": "RS4607103"}, {"weight": 1.0, "description": "Participants in Set 1 had a higher mean age at enrollment for the T2D-ESRD group compared to the control group.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "SET 1", "target": "T2D-ESRD GROUP"}, {"weight": 2.0, "description": "The participants in Set 2 with T2D had a higher mean age at enrollment than the control group.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "SET 2", "target": "T2D GROUP"}, {"weight": 6.0, "description": "Nominal analysis was used to assess the association between risk alleles and disease.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "RISK ALLELE", "target": "NOMINAL ANALYSIS"}, {"weight": 7.0, "description": "Ordinal analysis was used to assess the association between risk alleles and disease.)", "source_id": "chunk-6a7c69534e11aa2fc4bd948484aa81c4", "order": 1, "source": "RISK ALLELE", "target": "ORDINAL ANALYSIS"}, {"weight": 6.0, "description": "Individuals with higher cumulative risk scores based on their genetic variants are more likely to have T2D.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "CUMULATIVE RISK SCORE", "target": "T2D CASE"}, {"weight": 4.0, "description": "The mean African ancestry proportion in the study samples was estimated to be around 0.79, indicating a largely African American population.)", "source_id": "chunk-f9a60d3cf951d77afa115859755dac43", "order": 1, "source": "AFRICAN ANCESTRY PROPORTION", "target": "STUDY SAMPLES"}, {"weight": 3.0, "description": "One cohort included samples of East Asian ancestry.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "EAST ASIAN", "target": "COHORTS"}, {"weight": 2.0, "description": "rs2984618 is a SNP located in the TAL1 gene, and it is associated with an increased BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "TAL1", "target": "RS2984618"}, {"weight": 4.0, "description": "The rs1011527 SNP interacts with fasting plasma glucose (FPG) to influence BMI at baseline.)", "source_id": "chunk-1fde08e52a188ac6a549e7c11d59a092", "order": 1, "source": "RS1011527", "target": "FPG"}, {"weight": 12.0, "description": "Change in FPG levels was significantly associated with a positive increase in BMI change.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI CHANGE", "target": "FASTING PLASMA GLUCOSE CHANGE"}, {"weight": 14.0, "description": "Change in 2hPG levels was associated with an increase in BMI change.)", "source_id": "chunk-bb507a90a1f5d5ddd01a93200ff2d45e", "order": 1, "source": "BMI CHANGE", "target": "TWO-HOUR PLASMA GLUCOSE CHANGE"}, {"weight": 1.0, "description": "AcAc levels correlated significantly with FPG, indicating that higher AcAc levels may be associated with lower fasting blood sugar.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "FPG", "target": "ACAC"}, {"weight": 3.0, "description": "Survivors with MTHFR 1298AC/CC genotypes had a 3.0-fold increased risk of impairment (95% CI 1.1-8.1).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298AC/CC", "target": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"weight": 5.0, "description": "Survivors with MTHFR 1298AC/CC genotypes performed on average 7 points lower on TMTA (p=0.11).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298AC/CC", "target": "TMTA"}, {"weight": 7.0, "description": "Survivors with MTHFR 1298AC/CC genotypes performed on average 13 points lower on TMTB (p=0.001).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MTHFR 1298AC/CC", "target": "TMTB"}, {"weight": 4.0, "description": "Survivors with MS 2756 AA genotype were 3.8 times as likely to meet criteria for impairment on the battery.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "IMPAIRMENT ON THE DIVERGT BATTERY"}, {"weight": 6.0, "description": "Survivors with the MS 2756AA genotype scored on average 12.2 points lower on TMTA.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "TMTA"}, {"weight": 8.0, "description": "Survivors with the MS 2756AA genotype scored on average 5.3 points lower on TMTB.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "MS 2756AA", "target": "TMTB"}, {"weight": 2.0, "description": "Heterozygous mothers carrying the MTHFR SNP rs1476413 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "RS1476413"}, {"weight": 2.0, "description": "Heterozygous mothers carrying the MTHFR SNP rs1801131 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "RS1801131"}, {"weight": 2.0, "description": "Heterozygous mothers carrying the MTHFR SNP rs1801133 had a decreased risk of an NTD-affected pregnancy compared to those with the common homozygous genotype in the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFR", "target": "RS1801133"}, {"weight": 11.0, "description": "Survivors with the MTRR 66AA genotype scored on average 10.7 points lower on PEGNDH.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "PEGNDH", "target": "MTRR 66AA"}, {"weight": 12.0, "description": "Survivors with the MTRR 66AA genotype also scored 10.5 points lower on average on CFL, compared with survivors with the MTRR 66AG/GG genotypes.)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "CFL", "target": "MTRR 66AA"}, {"weight": 9.0, "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 10 points lower on TMTA (p=0.07).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TMTA", "target": "TSER 2R/3R AND 3R/3R"}, {"weight": 2.0, "description": "A higher GRS (genetic risk score) was associated with lower scores on the TMTA test.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "TMTA", "target": "GRS"}, {"weight": 10.0, "description": "Survivors with TSER 2R/3R and 3R/3R genotypes scored on average 11.4 points lower on TMTB (p=0.03).)", "source_id": "chunk-4b6e8f78911cafc70959cfdfed786c29", "order": 1, "source": "TMTB", "target": "TSER 2R/3R AND 3R/3R"}, {"weight": 4.0, "description": "A higher GRS (genetic risk score) was associated with lower scores on the TMTB test.)", "source_id": "chunk-ea6355aaf22d7cdd3331602638122ed7", "order": 1, "source": "TMTB", "target": "GRS"}, {"weight": 2.0, "description": "The C risk allele at rs13266634 is associated with higher fasting proinsulin levels.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "RS13266634", "target": "PROINSULIN"}, {"weight": 10.0, "description": "Troglitazone treatment led to a decrease in proinsulin levels.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "TROGLITAZONE"}, {"weight": 6.0, "description": "Proinsulin levels increased in the placebo group over the course of the study.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "PLACEBO"}, {"weight": 7.0, "description": "There was no significant genotype \u00d7 treatment interaction, suggesting that the dosage of SLC30A8 risk alleles did not modify the effectiveness of any treatment.)", "source_id": "chunk-8f23bd741f82dc8ca1e2600d790b690f", "order": 1, "source": "PROINSULIN", "target": "GENOTYPE \u00d7 TREATMENT INTERACTION"}, {"weight": 8.0, "description": "The presence of the minor allele (C) of rs2010963 was associated with a decrease in fasting insulin levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "FASTING INSULIN", "target": "RS2010963"}, {"weight": 5.0, "description": "An intronic variant in MTNR1B is strongly associated with fasting glucose.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "FASTING GLUCOSE", "target": "MTNR1B"}, {"weight": 25.0, "description": "A variant in SLC2A9 is associated with fasting glucose.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "FASTING GLUCOSE", "target": "SLC2A9"}, {"weight": 6.0, "description": "Olanzapine and placebo are compared in the study to assess their effects on craving, reward, and alcohol consumption.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "PLACEBO", "target": "OLANZAPINE"}, {"weight": 2.0, "description": "Topiramate was compared to placebo in a clinical trial.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "PLACEBO", "target": "TOPIRAMATE"}, {"weight": 1.0, "description": "A high carbohydrate diet increases the expression of PNPLA3 mRNA and protein in the liver of mice.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "HC DIET"}, {"weight": 2.0, "description": "Lipid emulsion attenuates the expression of PNPLA3 mRNA and protein in the liver of mice.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3", "target": "LIPID EMULSION"}, {"weight": 1.0, "description": "High glucose levels induce PNPLA3 expression, while low glucose levels suppress it.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "GLUCOSE METABOLISM"}, {"weight": 2.0, "description": "Citrate upregulates PNPLA3 expression.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "CITRATE"}, {"weight": 6.0, "description": "Unsaturated fatty acids like OA, LA, EPA, and DHA suppress PNPLA3 gene expression.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "OA, LA, EPA, DHA"}, {"weight": 7.0, "description": "Intralipid\u00ae, a mixture of unsaturated fatty acids, reverses the induction of PNPLA3 by a high-cholesterol diet in mouse liver.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "PNPLA3", "target": "INTRALIPID\u00ae"}, {"weight": 3.0, "description": "SREBP1c and ACC-1 show similar expression patterns to PNPLA3, indicating a potential relationship within the lipogenic pathway.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "SREBP1C", "target": "ACC-1"}, {"weight": 4.0, "description": "Unsaturated fatty acids suppress the expression of SREBP1c.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "SREBP1C", "target": "OA, LA, EPA, DHA"}, {"weight": 6.0, "description": "A high-fat diet increases hepatic triglyceride content in mice.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "HIGH-FAT DIET", "target": "HEPATIC TG CONTENT"}, {"weight": 10.0, "description": "Exercise attenuates the increase in hepatic triglyceride content induced by a high-fat diet in mice.)<SEP>Exercise reduces hepatic triglyceride content in mice fed a high-fat diet.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "EXERCISE", "target": "HEPATIC TG CONTENT"}, {"weight": 10.0, "description": "Exercise significantly suppresses SREBP1c gene expression in mice.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "EXERCISE", "target": "SREBP1C MRNA"}, {"weight": 12.0, "description": "Exercise significantly suppresses ACC-1 gene expression in mice.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "EXERCISE", "target": "ACC-1 MRNA"}, {"weight": 4.0, "description": "Higher TG levels are associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "TG", "target": "SUA"}, {"weight": 2.0, "description": "Citrate is an intermediate in the Krebs cycle.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "CITRATE", "target": "KREBS CYCLE"}, {"weight": 17.0, "description": "2-deoxy-D-glucose, a non-metabolizable glucose analog, suppresses SREBP1c mRNA expression in HepG2 cells.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "2-DEOXY-D-GLUCOSE", "target": "SREBP1C MRNA"}, {"weight": 3.0, "description": "2-deoxy-D-glucose reduces lipid accumulation.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "2-DEOXY-D-GLUCOSE", "target": "LIPID ACCUMULATION"}, {"weight": 4.0, "description": "Insulin stimulates the expression of FAS, a gene involved in fatty acid synthesis.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "INSULIN", "target": "FAS"}, {"weight": 5.0, "description": "Glucagon stimulates the expression of pyruvate carboxylase (PC), a key enzyme in gluconeogenesis.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "GLUCAGON", "target": "PYRUVATE CARBOXYLASE (PC)"}, {"weight": 1.0, "description": "Patients with CHI have persistent hypoglycemia due to excessive insulin production, leading to low blood glucose levels.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUCOSE", "target": "CHI"}, {"weight": 3.0, "description": "Elevated glucose metabolism can lead to increased lipid accumulation.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "LIPID ACCUMULATION", "target": "GLUCOSE METABOLISM"}, {"weight": 8.0, "description": "Knockdown of PNPLA3 increases FAS expression in HepG2 cells.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "FAS", "target": "PNPLA3 KNOCKDOWN"}, {"weight": 1.0, "description": "High glucose levels stimulate glycolysis.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "GLYCOLYSIS", "target": "HIGH GLUCOSE"}, {"weight": 5.0, "description": "Knockdown of PNPLA3 does not affect lipid droplet formation or content.)", "source_id": "chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f", "order": 1, "source": "LIPID DROPLETS", "target": "PNPLA3 KNOCKDOWN"}, {"weight": 4.0, "description": "There is a strong positive correlation between PNPLA3 mRNA levels and SREBP1c mRNA levels in mice fed HC diets with or without LE.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3 MRNA", "target": "SREBP1C MRNA"}, {"weight": 5.0, "description": "There is a very strong positive correlation between PNPLA3 mRNA levels and ACC-1 mRNA levels in mice fed HC diets with or without LE.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3 MRNA", "target": "ACC-1 MRNA"}, {"weight": 14.0, "description": "High glucose increases PNPLA3 mRNA levels in HepG2 cells.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "PNPLA3 MRNA", "target": "HIGH GLUCOSE"}, {"weight": 15.0, "description": "High glucose induces SREBP1c mRNA expression in HepG2 cells.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "SREBP1C MRNA", "target": "HIGH GLUCOSE"}, {"weight": 9.0, "description": "High-fat diet feeding reduces ACC-1 mRNA levels compared to LF diets.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "ACC-1 MRNA", "target": "HF DIET"}, {"weight": 8.0, "description": "High-fat diet feeding does not significantly alter FAS mRNA levels compared to LF diets.)", "source_id": "chunk-c27a7b63e450810a5d9f9e0f70b73a7a", "order": 1, "source": "FAS MRNA", "target": "HF DIET"}, {"weight": 3.0, "description": "The GCK protein is involved in regulating glucose metabolism, influencing blood sugar levels.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GLUCOSE METABOLISM", "target": "GCK PROTEIN"}, {"weight": 1.0, "description": "Prenatal stress exposure altered Axonal Guidance Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "AXONAL GUIDANCE SIGNALING"}, {"weight": 2.0, "description": "Prenatal stress exposure altered Protein Kinase A Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "PROTEIN KINASE A SIGNALING"}, {"weight": 3.0, "description": "Prenatal stress exposure altered Glutamate Receptor Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "GLUTAMATE RECEPTOR SIGNALING"}, {"weight": 4.0, "description": "Prenatal stress exposure altered Wnt/\u03b2-catenin Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "WNT/\u0392-CATENIN SIGNALING"}, {"weight": 5.0, "description": "Prenatal stress exposure altered CREB Signaling in Neurons pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "CREB SIGNALING IN NEURONS"}, {"weight": 6.0, "description": "Prenatal stress exposure altered Synaptic Long Term Depression pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "SYNAPTIC LONG TERM DEPRESSION"}, {"weight": 7.0, "description": "Prenatal stress exposure altered Synaptic Long Term Potentiation pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "SYNAPTIC LONG TERM POTENTIATION"}, {"weight": 8.0, "description": "Prenatal stress exposure altered Glucocorticoid Receptor Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "GLUCOCORTICOID RECEPTOR SIGNALING"}, {"weight": 9.0, "description": "Prenatal stress exposure altered IL-8 Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "IL-8 SIGNALING"}, {"weight": 10.0, "description": "Prenatal stress exposure altered STAT3 Pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "STAT3 PATHWAY"}, {"weight": 11.0, "description": "Prenatal stress exposure altered CDK5 Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "CDK5 SIGNALING"}, {"weight": 12.0, "description": "Prenatal stress exposure altered IL-1 Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "IL-1 SIGNALING"}, {"weight": 13.0, "description": "Prenatal stress exposure altered IL-6 Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "IL-6 SIGNALING"}, {"weight": 14.0, "description": "Prenatal stress exposure altered BMP signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "BMP SIGNALING PATHWAY"}, {"weight": 15.0, "description": "Prenatal stress exposure altered TGF-\u03b2 Signaling pathway.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "TGF-\u0392 SIGNALING"}, {"weight": 1.0, "description": "Prenatal stress exposure affects gene expression in the hippocampus.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "HIPPOCAMPUS"}, {"weight": 3.0, "description": "Prenatal stress exposure alters the expression of miRNAs in the rat hippocampus.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "MIRNOME"}, {"weight": 4.0, "description": "Prenatal stress exposure affects mRNA expression in the hippocampus.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PNS", "target": "MRNA"}, {"weight": 2.0, "description": "miRNAs levels are investigated in the hippocampus of PNS rats.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "HIPPOCAMPUS", "target": "MIRNAS"}, {"weight": 13.0, "description": "Individuals exposed to early life trauma show altered expression of Isochorismatase Domain Containing 1 (ISOC1).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "ISOCHORISMATASE DOMAIN CONTAINING 1 (ISOC1)", "target": "EARLY LIFE TRAUMA"}, {"weight": 14.0, "description": "Individuals exposed to early life trauma show altered expression of Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "LOW DENSITY LIPOPROTEIN RECEPTOR ADAPTER PROTEIN 1 (LDLRAP1)", "target": "EARLY LIFE TRAUMA"}, {"weight": 15.0, "description": "Individuals exposed to early life trauma show altered expression of Leucine-rich repeat neuronal protein 3 (LRRN3).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "LEUCINE-RICH REPEAT NEURONAL PROTEIN 3 (LRRN3)", "target": "EARLY LIFE TRAUMA"}, {"weight": 16.0, "description": "Individuals exposed to early life trauma show altered expression of Myosin ID (MYO1D).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "MYOSIN ID (MYO1D)", "target": "EARLY LIFE TRAUMA"}, {"weight": 17.0, "description": "Individuals exposed to early life trauma show altered expression of Phosphatidylinositol-4-Phosphate 3-Kinase, Catalytic Subunit Type 2 Beta (PIK3C2B).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "PHOSPHATIDYLINOSITOL-4-PHOSPHATE 3-KINASE, CATALYTIC SUBUNIT TYPE 2 BETA (PIK3C2B)", "target": "EARLY LIFE TRAUMA"}, {"weight": 1.0, "description": "A2M, FoxO1, and TGF-\u03b21 form a cluster of interacting genes involved in cytokine signaling, TGF-\u03b21 signaling, and glucocorticoid receptor signaling.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "A2M"}, {"weight": 2.0, "description": "A2M, FoxO1, and TGF-\u03b21 form a cluster of interacting genes involved in cytokine signaling, TGF-\u03b21 signaling, and glucocorticoid receptor signaling.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "TGF-\u03921"}, {"weight": 2.0, "description": "Both ISOC1 and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "ISOC1"}, {"weight": 2.0, "description": "Both LDLRAP1 and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "LDLRAP1"}, {"weight": 2.0, "description": "Both LRRN3 and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "LRRN3"}, {"weight": 2.0, "description": "Both MYO1D and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "MYO1D"}, {"weight": 2.0, "description": "Both PIK3C2B and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "PIK3C2B"}, {"weight": 2.0, "description": "Both PPAP2A and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "PPAP2A"}, {"weight": 2.0, "description": "Both SAMD12 and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "SAMD12"}, {"weight": 2.0, "description": "Both SERINC5 and FoxO1 are part of a gene network potentially related to depression.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "SERINC5"}, {"weight": 3.0, "description": "BCL2 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "BCL2"}, {"weight": 3.0, "description": "BCL9 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "BCL9"}, {"weight": 3.0, "description": "LEF1 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "LEF1"}, {"weight": 3.0, "description": "LIN54 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "LIN54"}, {"weight": 3.0, "description": "PGAP1 is differentially expressed between rats and humans, while FoxO1 was modulated both in animals and humans, suggesting potential interactions.)", "source_id": "chunk-01cd90d27130aab1a096ad616e05f182", "order": 1, "source": "FOXO1", "target": "PGAP1"}, {"weight": 2.0, "description": "Cortisol exposure activates FoxO1 in hippocampal progenitor stem cells.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "CORTISOL"}, {"weight": 4.0, "description": "FoxO1 mediates the negative effect of stress on neurogenesis.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "NEUROGENESIS"}, {"weight": 6.0, "description": "The cell-permeable inhibitor AS1842856 can completely inhibit the cortisol-induced upregulation of FoxO1.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "FOXO1", "target": "AS1842856"}, {"weight": 10.0, "description": "Cortisol treatment upregulates SGK-1 mRNA levels.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "SGK-1"}, {"weight": 6.0, "description": "The HPC0A07/03C cell line was treated with cortisol to investigate its effects on neuronal proliferation.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "CORTISOL", "target": "HPC0A07/03C"}, {"weight": 7.0, "description": "Daily alcohol consumption was positively associated with blood cortisol levels in both sexes.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "CORTISOL", "target": "ALCOHOL CONSUMPTION"}, {"weight": 8.0, "description": "AS1842856 inhibits the cortisol-induced reduction in neuronal proliferation, suggesting that FoxO1 mediates this effect.)", "source_id": "chunk-704d1bc6fcda99ac888bd36c954fdb98", "order": 1, "source": "AS1842856", "target": "CORTISOL-INDUCED REDUCTION IN NEURONAL PROLIFERATION"}, {"weight": 5.0, "description": "Analysis of blood transcriptomics reveals altered gene expression in individuals exposed to early life trauma.)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "BLOOD TRANSCRIPTOMICS", "target": "EARLY LIFE TRAUMA"}, {"weight": 6.0, "description": "Individuals exposed to early life trauma show altered expression of Alpha-2-Macroglobulin (A2M).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "ALPHA-2-MACROGLOBULIN (A2M)"}, {"weight": 7.0, "description": "Individuals exposed to early life trauma show altered expression of AT-Rich Interaction Domain 5B (ARID5B).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "AT-RICH INTERACTION DOMAIN 5B (ARID5B)"}, {"weight": 8.0, "description": "Individuals exposed to early life trauma show altered expression of Arrestin Domain Containing 4 (ARRDC4).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "ARRESTIN DOMAIN CONTAINING 4 (ARRDC4)"}, {"weight": 9.0, "description": "Individuals exposed to early life trauma show altered expression of EPH Receptor A4 (EPHA4).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "EPH RECEPTOR A4 (EPHA4)"}, {"weight": 10.0, "description": "Individuals exposed to early life trauma show altered expression of F-Box Protein 32 (FBXO32).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "F-BOX PROTEIN 32 (FBXO32)"}, {"weight": 11.0, "description": "Individuals exposed to early life trauma show altered expression of Forkhead box protein O1 (FoxO1).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "FORKHEAD BOX PROTEIN O1 (FOXO1)"}, {"weight": 12.0, "description": "Individuals exposed to early life trauma show altered expression of Heat Shock Transcription Factor 2 (HSF2).)", "source_id": "chunk-37088dc7c337929125b7fb31c9bf64cf", "order": 1, "source": "EARLY LIFE TRAUMA", "target": "HEAT SHOCK TRANSCRIPTION FACTOR 2 (HSF2)"}, {"weight": 0.9, "description": "The SNP rs4771122 was associated with long-term weight loss, with each additional copy of the minor (G) allele linked to a larger percentage weight lost.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "LONG TERM WEIGHT LOSS"}, {"weight": 0.8, "description": "The association between rs4771122 and long-term weight loss was adjusted for pre-surgical BMI.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL BMI"}, {"weight": 0.7, "description": "Additional copies of the minor (G) allele were associated with increased pre-surgical weight.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "PRE-SURGICAL WEIGHT"}, {"weight": 0.6, "description": "rs4771122 was nominally significantly associated with trajectory group membership.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "TRAJECTORY GROUP MEMBERSHIP"}, {"weight": 0.5, "description": "rs4771122 was nominally significantly associated with nadir percent weight loss.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "NADIR PERCENT WEIGHT LOSS"}, {"weight": 0.4, "description": "rs4771122 was nominally significantly associated with 2 year percent weight loss.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "RS4771122", "target": "2 YEAR PERCENT WEIGHT LOSS"}, {"weight": 0.8, "description": "This study examined the association of genetic variants with long-term weight loss after bariatric surgery.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "BARIATRIC SURGERY", "target": "LONG TERM WEIGHT LOSS"}, {"weight": 0.7, "description": "Longer follow-up periods allow for a more accurate assessment of long-term weight loss.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "FOLLOW-UP", "target": "LONG TERM WEIGHT LOSS"}, {"weight": 0.5, "description": "The study population included a high proportion of females, typical for bariatric surgery patients.)", "source_id": "chunk-b3d775642c43fa3524a531a3f6ec1e41", "order": 1, "source": "GENDER", "target": "BARIATRIC SURGERY PATIENTS"}, {"weight": 12.0, "description": "Males had a significantly higher mean social disinhibition score than females.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "GENDER", "target": "SOCIAL DISINHIBITION"}, {"weight": 4.0, "description": "Met210dup is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "MET210DUP"}, {"weight": 5.0, "description": "p.Lys13X is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.LYS13X"}, {"weight": 6.0, "description": "p.Leu185Pro is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.LEU185PRO"}, {"weight": 7.0, "description": "p.Val207Leu is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.VAL207LEU"}, {"weight": 8.0, "description": "p.Glu227Hisfs*47 is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.GLU227HISFS*47"}, {"weight": 9.0, "description": "p.Cys252Trp is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.CYS252TRP"}, {"weight": 10.0, "description": "p.Arg275Leu is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.ARG275LEU"}, {"weight": 11.0, "description": "p.Ser281Pro is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.SER281PRO"}, {"weight": 12.0, "description": "p.Ser127Pro is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.SER127PRO"}, {"weight": 13.0, "description": "p.His141Pro is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.HIS141PRO"}, {"weight": 14.0, "description": "c.579+4delA is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "C.579+4DELA"}, {"weight": 15.0, "description": "p.Leu307Phe is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.LEU307PHE"}, {"weight": 16.0, "description": "p.His317Gln is a type of genomic variant that occurs within the GCK gene.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "GCK", "target": "P.HIS317GLN"}, {"weight": 19.0, "description": "Diabetes phenotype often includes symptoms such as fasting hyperglycemia.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "DIABETES PHENOTYPE", "target": "FASTING HYPERGLYCEMIA"}, {"weight": 20.0, "description": "HbA1c levels are often used to monitor and manage diabetes phenotype.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "DIABETES PHENOTYPE", "target": "HBA1C"}, {"weight": 21.0, "description": "The proband and her mother exhibited stable, mild fasting hyperglycemia.)", "source_id": "chunk-658df2fc2f9361a65ff1d22464744763", "order": 1, "source": "DIABETES PHENOTYPE", "target": "STABLE, MILD FASTING HYPERGLYCEMIA"}, {"weight": 6.0, "description": "Higher adherence to the Mediterranean diet was associated with lower HbA1c concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "HBA1C", "target": "MEDITERRANEAN DIET ADHERENCE"}, {"weight": 0.6, "description": "The APOC1 gene showed a decreased association with HbA1C after adjusting for CRP, suggesting possible pleiotropic effects.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "HBA1C", "target": "APOC1"}, {"weight": 2.0, "description": "Higher adherence to the Mediterranean diet was associated with lower TAG concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "TAG"}, {"weight": 4.0, "description": "Higher adherence to the Mediterranean diet was associated with higher HDL-C concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "HDL-C"}, {"weight": 14.0, "description": "Higher adherence to the Mediterranean diet was associated with a lower risk of hypertriacylglycerolaemia.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "MEDITERRANEAN DIET ADHERENCE", "target": "HYPERTRIACYLGLYCEROLAEMIA"}, {"weight": 8.0, "description": "Individuals with the AA genotype of rs780094 had higher TAG concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TAG", "target": "RS780094 (AA GENOTYPE)"}, {"weight": 12.0, "description": "Individuals with the AA genotype of rs780094 had higher ApoB concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "APOB", "target": "RS780094 (AA GENOTYPE)"}, {"weight": 3.7, "description": "The C allele of rs780094 SNP in the GCKR gene is associated with elevated levels of BHB. ", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "RS780094", "target": "BHB"}, {"weight": 10.0, "description": "Individuals with the AA genotype of rs780094 had higher TC concentrations.)", "source_id": "chunk-c6fdc5ed25c4e17b8c421a952bb05450", "order": 1, "source": "TC", "target": "RS780094 (AA GENOTYPE)"}, {"weight": 2.0, "description": "The smoking status (smoker vs. non-smoker) was examined to determine if there was a significant interaction between genes and diet in the outcomes analyzed.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "SMOKING STATUS", "target": "GENE\u2013DIET INTERACTION"}, {"weight": 11.0, "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "SMOKING STATUS", "target": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"weight": 2.0, "description": "There were differences by genotype in TAG levels observed in both smoker and non-smoker strata.)", "source_id": "chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6", "order": 1, "source": "TAG LEVELS", "target": "GENOTYPE"}, {"weight": 1.0, "description": "The miR-34b/c rs4938723 SNP has different genotype variations (e.g., CC, CT, TT).)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "GENOTYPE", "target": "MIR-34B/C RS4938723"}, {"weight": 1.0, "description": "The TP53 Arg72Pro SNP has different genotype variations (e.g., CG, CC, GG).)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "GENOTYPE", "target": "TP53 ARG72PRO"}, {"weight": 2.0, "description": "The FADS1/2 haplotype was defined by 4 SNPs and the genotype distribution followed Hardy-Weinberg equilibrium.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "GENOTYPE", "target": "FADS1/2"}, {"weight": 4.0, "description": "The genotype distribution for each SNP did not deviate from Hardy-Weinberg equilibrium.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "GENOTYPE", "target": "HARDY-WEINBERG EQUILIBRIUM"}, {"weight": 18.0, "description": "The presence of any minor alleles was highly significantly associated with baseline serum 20:4, n-6 concentrations and 18:3, n-3 concentration.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "GENOTYPE", "target": "SERUM FATTY ACIDS"}, {"weight": 2.0, "description": "Mutations in the ABCC8 gene are a common cause of CHI.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "ABCC8 GENE MUTATIONS"}, {"weight": 1.0, "description": "CHI is characterized by persistent hypoglycemia due to excessive insulin production.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "CHI", "target": "HYPOGLYCEMIA"}, {"weight": 3.0, "description": "Diazoxide inhibits insulin production, helping to manage blood glucose levels in CHI patients.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "DIAZOXIDE", "target": "INSULIN PRODUCTION"}, {"weight": 4.0, "description": "Diazoxide inhibits insulin secretion by blocking calcium channels in pancreatic beta cells.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "DIAZOXIDE", "target": "INSULIN SECRETION"}, {"weight": 12.0, "description": "Diazoxide is used to treat hypoglycaemia in patients with HI/HA.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIAZOXIDE", "target": "HYPOGLYCEMIA"}, {"weight": 2.0, "description": "Mutations in the ABCC8 gene can lead to dysfunctional ATP-sensitive potassium channels in beta cells, causing overproduction of insulin.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "ABCC8 GENE MUTATIONS", "target": "INSULIN OVERPRODUCTION"}, {"weight": 4.0, "description": "Mutations in the GLUD1 gene can lead to persistent hypoglycemia.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUD1 GENE MUTATIONS", "target": "HYPOGLYCEMIA"}, {"weight": 3.0, "description": "Mutations in the GLUD1 gene disrupt glutamate metabolism, contributing to CHI development.)", "source_id": "chunk-f921f48a406901d82ec2e32af99485bf", "order": 1, "source": "GLUD1 GENE MUTATIONS", "target": "GLUTAMATE METABOLISM"}, {"weight": 2.0, "description": "Mutations in the GLUD1 gene have been linked to hypoglycaemia in patients.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCEMIA", "target": "GLUD1"}, {"weight": 14.0, "description": "Octreotide is used as an alternative treatment for hypoglycaemia in patients unresponsive to diazoxide.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCEMIA", "target": "OCTREOTIDE"}, {"weight": 16.0, "description": "Pancreatectomy is a surgical treatment for severe and persistent hypoglycaemia.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "HYPOGLYCEMIA", "target": "PANCREATECTOMY"}, {"weight": 4.0, "description": "The p.Arg322 His mutation is a genetic variant associated with HI/HA syndrome.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.ARG322 HIS", "target": "HI/HA"}, {"weight": 6.0, "description": "The p.Ser498Leu mutation is a genetic variant associated with HI/HA syndrome.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.SER498LEU", "target": "HI/HA"}, {"weight": 8.0, "description": "The p.Asn463Asp mutation is a genetic variant associated with HI/HA syndrome.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "P.ASN463ASP", "target": "HI/HA"}, {"weight": 18.0, "description": "Patients with pancreatic disease are susceptible to developing diabetes mellitus.)", "source_id": "chunk-2b81371954b99facae9a0056e70aa7bd", "order": 1, "source": "DIABETES MELLITUS", "target": "PANCREATIC DISEASE"}, {"weight": 0.44, "description": "Expression of ACAT1 is negatively correlated with insulin secretion.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "INSULIN SECRETION", "target": "ACAT1"}, {"weight": 5.0, "description": "Higher insulin sensitivity was inversely associated with AcAc levels, indicating that individuals with better insulin sensitivity may have lower AcAc levels.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "INSULIN SENSITIVITY"}, {"weight": 1.0, "description": "AcAc levels were assessed across different glucose tolerance categories, including IFG, IGT, and newly diagnosed diabetes.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "ACAC", "target": "GLUCOSE TOLERANCE CATEGORIES"}, {"weight": 2.0, "description": "BHB levels correlated significantly with 2hPG, suggesting a potential link between BHB and postprandial glucose levels.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "2HPG"}, {"weight": 4.0, "description": "Elevated BHB levels were associated with higher glucose AUC, suggesting a role in hyperglycemia development.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "HYPERGLYCEMIA"}, {"weight": 2.0, "description": "Higher BHB levels were associated with lower insulin sensitivity, suggesting a potential negative impact on glucose regulation.)", "source_id": "chunk-f2e122f964bade37f487049bd69a3f9f", "order": 1, "source": "BHB", "target": "INSULIN SENSITIVITY"}, {"weight": 3.7, "description": "The glucose-increasing C allele of rs780094 in GCKR is associated with elevated BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "BHB", "target": "GCKR"}, {"weight": 6.0, "description": "Impaired Fasting Glucose (IFG) is a condition of prediabetes.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "IFG", "target": "PREDIABETES"}, {"weight": 0.7, "description": "Multiple alleles, excluding (CA)16, were negatively correlated with IFG, suggesting a protective effect of these alleles against IFG.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IFG", "target": "(CA)16 ALLELE"}, {"weight": 0.8, "description": "IFG and IGT are both markers for impaired glucose regulation, often preceding the development of T2DM.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IFG", "target": "IGT"}, {"weight": 0.6, "description": "Multiple alleles including (CA)15, (CA)17, (CA)18, and (CA)19 were negatively correlated with IFG.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IFG", "target": "MULTIPLE ALLELES"}, {"weight": 8.0, "description": "Impaired Glucose Tolerance (IGT) is a condition of prediabetes.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "IGT", "target": "PREDIABETES"}, {"weight": 0.7, "description": "Multiple alleles, excluding (CA)16, were negatively correlated with IGT, suggesting a protective effect of these alleles against IGT.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IGT", "target": "(CA)16 ALLELE"}, {"weight": 0.6, "description": "Multiple alleles including (CA)15, (CA)17, (CA)18, and (CA)19 were negatively correlated with IGT.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "IGT", "target": "MULTIPLE ALLELES"}, {"weight": 0.4, "description": "Expression of CPT1A is positively correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "CPT1A"}, {"weight": 0.31, "description": "Expression of ACAT1 is negatively correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "ACAT1"}, {"weight": 0.2, "description": "Expression of BDH1 is inversely correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "BDH1"}, {"weight": 0.3, "description": "Expression of OXCT1 is inversely correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "OXCT1"}, {"weight": 0.2, "description": "Expression of ACSS2 is inversely correlated with glucose AUC.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "GLUCOSE AUC", "target": "ACSS2"}, {"weight": 6.0, "description": "The GCKR gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "GCKR", "target": "CRP"}, {"weight": 10.0, "description": "The GCKR gene is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "GCKR", "target": "EGFR"}, {"weight": 4.0, "description": "rs1260326 is a variant in the GCKR gene.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "GCKR", "target": "RS1260326"}, {"weight": 0.0, "description": "Variants in FADS1 are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the FADS1 gene are nominally associated with AcAc and/or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "FADS1", "target": "ACAC/BHB"}, {"weight": 0.0, "description": "Variants in ANK1 are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the ANK1 gene are nominally associated with AcAc and/or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ANK1", "target": "ACAC/BHB"}, {"weight": 0.0, "description": "Variants in HMGA2 are nominally associated with AcAc and/or BHB levels.)<SEP>Variants in the HMGA2 gene are nominally associated with AcAc and/or BHB levels.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "HMGA2", "target": "ACAC/BHB"}, {"weight": 14.0, "description": "SNP rs17101923 is located within the HMGA2 gene.)<SEP>rs17101923 is a genomic variant in the HMGA2 gene and is associated with face width.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "HMGA2", "target": "RS17101923"}, {"weight": 1.0, "description": "rs1351394 is a SNP in HMGA2 associated with both age at first tooth and number of teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "HMGA2", "target": "RS1351394"}, {"weight": 0.4, "description": "Expression of CPT1A is inversely correlated with Matsuda ISI.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "CPT1A", "target": "MATSUDA ISI"}, {"weight": 0.48, "description": "Expression of ACAT1 is positively correlated with Matsuda ISI.)", "source_id": "chunk-bc2193bd869a06007022e1aa75877336", "order": 1, "source": "ACAT1", "target": "MATSUDA ISI"}, {"weight": 3.0, "description": "SENP1-aP2KO mice developed hyperglycemia earlier under HFD conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HYPERGLYCEMIA", "target": "SENP1-AP2KO"}, {"weight": 2.0, "description": "The APOC1 gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "APOC1", "target": "CRP"}, {"weight": 4.0, "description": "The HNF1A gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF1A", "target": "CRP"}, {"weight": 8.0, "description": "The IL6R gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "IL6R", "target": "CRP"}, {"weight": 10.0, "description": "The PPP1R3B gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PPP1R3B", "target": "CRP"}, {"weight": 12.0, "description": "The HNF4A gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "HNF4A", "target": "CRP"}, {"weight": 14.0, "description": "The PABPC4 gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PABPC4", "target": "CRP"}, {"weight": 16.0, "description": "The BCL7B gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "BCL7B", "target": "CRP"}, {"weight": 20.0, "description": "The TMEM18 gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "TMEM18", "target": "CRP"}, {"weight": 22.0, "description": "The PLTP gene is associated with elevated serum CRP levels.)", "source_id": "chunk-ad609cb10e900d42a6901eea1591d8ba", "order": 1, "source": "PLTP", "target": "CRP"}, {"weight": 1.5, "description": "The rs1183910 SNP in the HNF1A gene is associated with a lower risk of coronary artery disease.)", "source_id": "chunk-372184452f1f9156514992455057f843", "order": 1, "source": "RS1183910", "target": "CAD"}, {"weight": 2.0, "description": "Genomic variant rs20417 explains a large part of the heterogeneity in CAD percentage between patients and controls.)", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "CAD", "target": "RS20417"}, {"weight": 1.0, "description": "The CC genotype of miR-34b/c rs4938723 is associated with a decreased risk of IA, compared to the TT genotype.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "IA"}, {"weight": 1.0, "description": "The combined genotypes of miR-34b/c rs4938723CC and TP53 Arg72Pro CG/CC/GG have a decreased risk of IA compared to other combinations.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "TP53 ARG72PRO"}, {"weight": 1.0, "description": "This SNP represents specific alleles (e.g., C and T). )", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "MIR-34B/C RS4938723", "target": "ALLELE"}, {"weight": 0.0, "description": "No association was observed between TP53 Arg72Pro and the risk of IA.)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "IA"}, {"weight": 1.0, "description": "This SNP represents specific alleles (e.g., R and P).)", "source_id": "chunk-055177812e320344d131432b292111b0", "order": 1, "source": "TP53 ARG72PRO", "target": "ALLELE"}, {"weight": 0.7, "description": "The control group was used to compare the frequency of the T allele in individuals with CRC.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CONTROL GROUP", "target": "CRC PATIENTS"}, {"weight": 6.0, "description": "Mice that received no treatment served as controls for comparison to TAG72-BB\u03b6 CAR T cell treated groups.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "CONTROL GROUP", "target": "MOCK-TREATED MICE"}, {"weight": 2.0, "description": "The rs1056513 SNP in the INADL gene is associated with weight, BMI, FFM, FM, trunk FM, and hip circumference.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "INADL", "target": "RS1056513"}, {"weight": 3.0, "description": "An intronic variant in COL4A1 is associated with weight z-score change.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "COL4A1", "target": "WEIGHT Z-SCORE CHANGE"}, {"weight": 4.0, "description": "A variant in the 5\u2032UTR region of TSEN34 is associated with linear growth (height change).)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "TSEN34", "target": "LINEAR GROWTH (HEIGHT CHANGE)"}, {"weight": 7.0, "description": "An intronic variant in PCSK2 is associated with total antioxidants.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "PCSK2", "target": "TOTAL ANTIOXIDANTS"}, {"weight": 8.0, "description": "A variant in the flanking 3\u2032UTR region of RNASE1 is associated with 24-h urinary nitrogen excretion.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "RNASE1", "target": "24-H URINARY NITROGEN EXCRETION"}, {"weight": 9.0, "description": "A variant in the flanking 3\u2032UTR region of ASS1P11 is associated with creatinine excretion.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "ASS1P11", "target": "CREATININE EXCRETION"}, {"weight": 10.0, "description": "An intronic SNP in GCH1 is associated with 24-h urinary dopamine: creatinine ratio.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "GCH1", "target": "24-H URINARY DOPAMINE: CREATININE RATIO"}, {"weight": 11.0, "description": "A nonsynonymous SNP (rs3733402; S143T) in KLKB1 is identified for serum free IGF-1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "KLKB1", "target": "SERUM FREE IGF-1"}, {"weight": 12.0, "description": "An intronic SNP in MPRIP is associated with serum IGFBP-3.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "MPRIP", "target": "SERUM IGFBP-3"}, {"weight": 13.0, "description": "A block of twenty-three SNPs in the flanking 5\u2032UTR region of XPA/FOXE1 (TTF-2) are highly associated with serum TSH.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "XPA/FOXE1 (TTF-2)", "target": "SERUM TSH"}, {"weight": 14.0, "description": "Highly significant associations for a nonsynonymous SNP (rs12075; G42D) and an intronic SNP in DARC are identified for MCP-1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "DARC", "target": "MCP-1"}, {"weight": 15.0, "description": "Coding variants in GREB1 on chromosome 2 are associated with MCP-1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "GREB1", "target": "MCP-1"}, {"weight": 16.0, "description": "Coding variants in DFNB31 on chromosome 9 are associated with MCP-1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "DFNB31", "target": "MCP-1"}, {"weight": 17.0, "description": "A variant in the 3\u2032UTR for CCR3 is highly associated with MCP1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "CCR3", "target": "MCP-1"}, {"weight": 18.0, "description": "A variant in the intronic region of RASGEF1A is associated with MCP-1.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "RASGEF1A", "target": "MCP-1"}, {"weight": 19.0, "description": "A variant in the intronic region of ABO is strongly associated with IL-6.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "ABO", "target": "IL-6"}, {"weight": 20.0, "description": "An intronic variant in TMEM229B on chromosome 14 is associated with ad libitum energy intake at dinner.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "TMEM229B", "target": "AD LIBITUM ENERGY INTAKE AT DINNER"}, {"weight": 22.0, "description": "An intronic variant in ARHGAP11A on chromosome 15 is associated with sleep duration.)<SEP>An intronic variant in ARHGAP11A was associated with sleep duration.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2<SEP>chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "ARHGAP11A", "target": "SLEEP DURATION"}, {"weight": 1.0, "description": "An intronic variant in ARHGAP11A was associated with sleep duration.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "ARHGAP11A", "target": "INTRONIC VARIANT"}, {"weight": 22.0, "description": "A SNP in the intronic region of C21orf34 is detected for respiratory quotient (RQ) during sleep.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "C21ORF34", "target": "RESPIRATORY QUOTIENT (RQ) DURING SLEEP"}, {"weight": 2.0, "description": "A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "C21ORF34", "target": "RESPIRATORY QUOTIENT (RQ)"}, {"weight": 23.0, "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "RPL", "target": "ACCELEROMETER-MEASURED LIGHT ACTIVITY"}, {"weight": 31.0, "description": "Variants in PPARG are associated with BMI and body fat percentage.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "PPARG", "target": "BMI AND BODY FAT PERCENTAGE"}, {"weight": 33.0, "description": "Variants in ADRB2 are associated with weight loss response to exercise.)", "source_id": "chunk-6794be47bcde46ad4a07e0cc372ea3d2", "order": 1, "source": "ADRB2", "target": "WEIGHT LOSS RESPONSE TO EXERCISE"}, {"weight": 3.0, "description": "A variant was identified for accelerometer-measured light activity in the 5\u2032UTR region of RPL7P3.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RPL7P3", "target": "LIGHT ACTIVITY"}, {"weight": 3.0, "description": "A variant was identified in the 5\u2032UTR region of RPL7P3 on chromosome 9.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "RPL7P3", "target": "5\' UTR REGION"}, {"weight": 4.0, "description": "A variant was identified for sedentary-light activity in the 3\u2032UTR of CTCFL.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CTCFL", "target": "SEDENTARY-LIGHT ACTIVITY"}, {"weight": 4.0, "description": "A variant was identified in the 3\u2032UTR of CTCFL on chromosome 20.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CTCFL", "target": "3\' UTR REGION"}, {"weight": 5.0, "description": "Highly significant variants were identified for total energy expenditure for MATK.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK", "target": "TOTAL ENERGY EXPENDITURE"}, {"weight": 5.0, "description": "Highly significant variants were identified for total energy expenditure for MATK.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "MATK", "target": "VARIANT"}, {"weight": 6.0, "description": "Highly significant variants were identified for sleeping energy expenditure for CHRNA3.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3", "target": "SLEEPING ENERGY EXPENDITURE"}, {"weight": 6.0, "description": "Highly significant variants were identified for sleeping energy expenditure for CHRNA3.)", "source_id": "chunk-46227b557f62c59155b1b9cef71d0d17", "order": 1, "source": "CHRNA3", "target": "VARIANT"}, {"weight": 15.0, "description": "Elevated levels of IL-6 are associated with Th17 cell differentiation and proliferation.)<SEP>IL-6 is a key inducer of Th17 cells.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-6", "target": "TH17 RESPONSE"}, {"weight": 16.0, "description": "IL-6 is broadly necessary for T cell expansion and colitis in Rag1\u2212/\u2212 mice.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-6", "target": "T CELL EXPANSION"}, {"weight": 9.0, "description": "Increased IL-6 levels are associated with inflammatory diseases.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-6", "target": "DISEASE"}, {"weight": 2.0, "description": "IL-6, TNF and IL-1\u03b2 are proinflammatory cytokines that contribute to inflammation.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "IL-6", "target": "TNF"}, {"weight": 5.0, "description": "SENP1 deletion increases the production of IL-6 and other proinflammatory cytokines.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "IL-6", "target": "SENP1"}, {"weight": 16.0, "description": "Sleep duration is correlated with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SLEEP DURATION", "target": "SNORING"}, {"weight": 4.0, "description": "The SLC2A9 rs3733591 polymorphism is associated with serum uric acid (sUA) levels.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC2A9", "target": "SUA LEVEL"}, {"weight": 2.0, "description": "The genomic variant rs142786317 affects the transcript of the SULT1A1 gene.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "RS142786317", "target": "SULT1A1 TRANSCRIPT"}, {"weight": 8.0, "description": "SNP rs145008170 is located near Lys48, which is crucial for p-nitrophenol binding in SULT1A2.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS145008170"}, {"weight": 10.0, "description": "SNP rs4987024 causes a Tyr62Phe amino acid change in the SULT1A2 protein.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS4987024"}, {"weight": 12.0, "description": "SNP rs142241142 results in an Ala164Val amino acid change in the SULT1A2 protein.)", "source_id": "chunk-607feda7df4db8151b99560074c91eea", "order": 1, "source": "SULT1A2", "target": "RS142241142"}, {"weight": 2.0, "description": "The genomic variant rs61737565 is located within the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "RS61737565"}, {"weight": 4.0, "description": "The genomic variant rs8061877 is located within the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "RS8061877"}, {"weight": 6.0, "description": "The genomic variant g.28854194C/G is located within the TUFM gene.)", "source_id": "chunk-fde6653b9d9013ed054505cfe4cd1455", "order": 1, "source": "TUFM", "target": "G.28854194C/G"}, {"weight": 1.0, "description": "ALOX5 (arachidonate 5-lipoxygenase) rs1864414 has been linked to decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "ALOX5", "target": "OVARIAN CANCER"}, {"weight": 10.0, "description": "IL1B rs7596684 is suggested to be associated with increased risk of ovarian cancer.)<SEP>The rs7596684 variant in the IL1B gene is associated with an increased risk of ovarian cancer.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403<SEP>chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "IL1B", "target": "OVARIAN CANCER"}, {"weight": 2.0, "description": "NOS3 (nitric oxide synthase 3) rs743507 is associated with decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "NOS3", "target": "OVARIAN CANCER"}, {"weight": 1.8, "description": "The rs3918186 SNP in the NOS3 gene is associated with a 2.16 times increased risk of developing childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3", "target": "CHILDHOOD ALL"}, {"weight": 2.0, "description": "rs3918186 is a SNP located in the NOS3 gene.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "NOS3", "target": "RS3918186"}, {"weight": 5.0, "description": "PTGS1 rs2282169 is suggested to be associated with increased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "PTGS1", "target": "OVARIAN CANCER"}, {"weight": 3.0, "description": "IL1A rs17561 is associated with decreased risk of ovarian cancer.)", "source_id": "chunk-089bcdf055eb2f007db49dbe2409429b", "order": 1, "source": "IL1A RS17561", "target": "OVARIAN CANCER"}, {"weight": 4.0, "description": "rs2282169 is a genomic variant within the PTGS1 gene.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "RS2282169"}, {"weight": 8.0, "description": "The rs2282169 variant in the PTGS1 gene is associated with an increased risk of ovarian cancer.)", "source_id": "chunk-b6ea16f7f7eb8bc6f36f2be03fe62403", "order": 1, "source": "PTGS1 (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)", "target": "OVARIAN CANCER"}, {"weight": 2.0, "description": "The FokI variant is significantly associated with an increased risk of ovarian cancer as determined by meta-analysis.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER", "target": "FOKI"}, {"weight": 0.0, "description": "There was no significant association found between the ApaI variant and ovarian cancer risk in meta-analysis.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER", "target": "APAI"}, {"weight": 0.0, "description": "The meta-analysis suggested no significant association between the BsmI variant and ovarian cancer risk.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "OVARIAN CANCER", "target": "BSMI"}, {"weight": 2.0, "description": "Studies have investigated the association of Cdx-2 with ovarian cancer risk.)", "source_id": "chunk-dc5e8cc04a1b16b1e00f3a4120e004c4", "order": 1, "source": "OVARIAN CANCER", "target": "CDX-2"}, {"weight": 6.0, "description": "OVCAR3 is a human ovarian cancer cell line used in the study.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "OVARIAN CANCER", "target": "OVCAR3"}, {"weight": 1.0, "description": "MTHFD2 gene is involved in folate metabolism and may contribute to childhood ALL risk.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "MTHFD2", "target": "CHILDHOOD ALL"}, {"weight": 1.0, "description": "BHMT2 gene is involved in folate metabolism and may contribute to childhood ALL risk.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "BHMT2", "target": "CHILDHOOD ALL"}, {"weight": 1.6, "description": "The rs1051266 SNP in the SLC19A1 gene is associated with a 2.07 times increased risk of developing childhood ALL.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1", "target": "CHILDHOOD ALL"}, {"weight": 2.0, "description": "rs1051266 is a SNP located in the SLC19A1 gene.)", "source_id": "chunk-0ce38a2d49e01ec790464306e01de9b4", "order": 1, "source": "SLC19A1", "target": "RS1051266"}, {"weight": 6.0, "description": "The Healthy Eating group showed a significant increase in long chain n-3 PUFA intake after 6 months.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "LONG CHAIN N-3 PUFA"}, {"weight": 10.0, "description": "The Healthy Eating group showed a significant reduction in SFA intake after 6 months.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "SFA"}, {"weight": 11.0, "description": "The Healthy Eating group showed a significant increase in MUFA intake after 6 months.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "MUFA"}, {"weight": 12.0, "description": "The decrease in mean SFA resulted in an increased polyunsaturated fat: saturated fat ratio from 0.60 to 0.92 in the Healthy Eating group (p=0.008).)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "HEALTHY EATING", "target": "POLYUNSATURATED FAT: SATURATED FAT RATIO"}, {"weight": 6.0, "description": "Individuals with the AA genotype of the ALDH2 rs671 variant tend to have the lowest levels of daily alcohol consumption.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "AA", "target": "ALCOHOL CONSUMPTION"}, {"weight": 1.0, "description": "The CDC MBA method measures folate concentrations in serum samples.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "SERUM", "target": "CDC MBA"}, {"weight": 1.0, "description": "The CDC HPLC-MS/MS method measures folate concentrations in serum samples.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "SERUM", "target": "CDC HPLC-MS/MS"}, {"weight": 0.7, "description": "The distribution of rs1138272 polymorphism in both case and control groups showed no deviation from Hardy-Weinberg equilibrium.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "RS1138272 POLYMORPHISM"}, {"weight": 1.0, "description": "Observed genotype frequencies deviated from Hardy-Weinberg equilibrium in Romania (p=0.02), suggesting genetic influences on allele distribution.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "GENOTYPE FREQUENCIES"}, {"weight": 3.0, "description": "The five candidate SNPs used in the study were all found to be in agreement with Hardy-Weinberg Equilibrium.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HARDY-WEINBERG EQUILIBRIUM", "target": "FIVE CANDIDATE SNPS"}, {"weight": 10.0, "description": "A greater number of minor alleles was significantly associated with lower AA concentration in serum.)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "AA CONCENTRATION", "target": "NUMBER OF MINOR ALLELES"}, {"weight": 12.0, "description": "There was no significant association of genotype with EPA nor with long chain n-3 fatty acids (the sum of EPA and DHA).)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "NUMBER OF MINOR ALLELES", "target": "EPA CONCENTRATION"}, {"weight": 14.0, "description": "There was no significant association of genotype with EPA nor with long chain n-3 fatty acids (the sum of EPA and DHA).)", "source_id": "chunk-8b9890cf10c4a751a1d0ec7e9843002d", "order": 1, "source": "NUMBER OF MINOR ALLELES", "target": "DHA CONCENTRATION"}, {"weight": 4.0, "description": "Males are at a higher risk of snoring than females.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SEX"}, {"weight": 18.0, "description": "The prevalence of sleep apnoea is higher in individuals who snore.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SLEEP APNOEA"}, {"weight": 10.0, "description": "Smoking frequency is positively correlated with snoring prevalence in females and to a lesser extent in males.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "SMOKING FREQUENCY"}, {"weight": 12.0, "description": "Alcohol consumption frequency is associated with snoring in males and to a lesser extent in females.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "ALCOHOL CONSUMPTION FREQUENCY"}, {"weight": 14.0, "description": "Higher whole-body fat mass is correlated with snoring.)", "source_id": "chunk-9977706363cc368b3be503d07ed3ef62", "order": 1, "source": "SNORING", "target": "WHOLE-BODY FAT MASS"}, {"weight": 1.0, "description": "SNP rs199797821 was associated with snoring in a sex-stratified GWAS.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "RS199797821"}, {"weight": 2.0, "description": "SNP rs200391180 was associated with snoring in a sex-stratified GWAS.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "RS200391180"}, {"weight": 2.0, "description": "Males exhibited a higher prevalence of snoring compared to females.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "MALE SEX"}, {"weight": 3.0, "description": "Females exhibited a lower prevalence of snoring compared to males.)", "source_id": "chunk-a34b927ed42ff0917960122b4d203f83", "order": 1, "source": "SNORING", "target": "FEMALE SEX"}, {"weight": 8.0, "description": "SNP rs9316505 is located within the DLEU7 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "DLEU7", "target": "RS9316505"}, {"weight": 10.0, "description": "SNP rs2520397 is located within the MSRB3 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "MSRB3", "target": "RS2520397"}, {"weight": 9.0, "description": "The distribution of sexes among HIV-infected individuals...)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "SEX", "target": "HIV-INFECTED INDIVIDUALS"}, {"weight": 2.0, "description": "The minor allele (C) of rs3025020 was associated with an increased risk of PCOS.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "PCOS"}, {"weight": 6.0, "description": "Carriage of the minor (C) allele of rs3025020 was associated with increased VEGF serum levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "VEGF SERUM LEVELS"}, {"weight": 10.0, "description": "Carriage of the minor (C) allele of rs3025020 was positively associated with hs-CRP levels.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS3025020", "target": "HS-CRP"}, {"weight": 4.0, "description": "The heterozygous -634C/G genotype of rs2010963 was associated with a reduced risk of PCOS.)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "PCOS"}, {"weight": 12.0, "description": "The presence of the minor allele (C) of rs2010963 was negatively associated with erythrocyte sedimentation rate (ESR).)", "source_id": "chunk-2c178ae99eeffdddbea511cafbe4a7d5", "order": 1, "source": "RS2010963", "target": "ESR"}, {"weight": 2.0, "description": "Val carriers exhibited higher response bias compared to iso homozygotes.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "VAL CARRIER", "target": "RESPONSE BIAS"}, {"weight": 4.0, "description": "Val carriers selected a lower level of shock intensity compared to iso homozygotes.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "VAL CARRIER", "target": "SHOCK INTENSITY"}, {"weight": 2.0, "description": "The val allele was associated with lower response bias in the stress condition compared to the no-stress condition.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "VAL ALLELE", "target": "STRESS CONDITION"}, {"weight": 4.0, "description": "Val carriers had lower response bias in the stress condition compared to iso homozygotes.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "VAL ALLELE", "target": "ISO HOMOZYGOTES"}, {"weight": 11.0, "description": "Participants showed a reduced response bias towards rewarded stimuli in the stress condition compared to the no-stress condition.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "STRESS CONDITION"}, {"weight": 4.0, "description": "The probabilistic reward task measured response bias in both stress and no-stress conditions.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "RESPONSE BIAS", "target": "PROBABILISTIC REWARD TASK"}, {"weight": 6.0, "description": "Participants reported significantly higher STAI scores during the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "STRESS CONDITION"}, {"weight": 10.0, "description": "STAI scores significantly increased over time in both the stress and no-stress conditions.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "STAI SCORES", "target": "TIME"}, {"weight": 8.0, "description": "Participants reported elevated NA scores during the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "PANAS NA", "target": "STRESS CONDITION"}, {"weight": 12.0, "description": "NA scores significantly increased over time in both the stress and no-stress conditions.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "PANAS NA", "target": "TIME"}, {"weight": 14.0, "description": "There were significantly more SC responses in the stress condition compared to the no-stress condition.)", "source_id": "chunk-4b4f7d54511e2d8bbf5af6073d25b647", "order": 1, "source": "SC RESPONSES", "target": "STRESS CONDITION"}, {"weight": 6.0, "description": "The probabilistic reward task measured response bias in both stress and no-stress conditions.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "STRESS CONDITION", "target": "NO-STRESS CONDITION"}, {"weight": 7.0, "description": "Val carriers had higher skin conductance responses in the stress condition compared to iso homozygotes.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "STRESS CONDITION", "target": "SKIN CONDUCTANCE RESPONSES"}, {"weight": 8.0, "description": "Discrimination was measured to control for potential confounding factors in the analysis.)", "source_id": "chunk-5e709975097a773fb3d31e265d76a71b", "order": 1, "source": "DISCRIMINABILITY", "target": "CONTROL ANALYSES"}, {"weight": 1.0, "description": "SNP rs17563 is located within the BMP4 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "BMP4", "target": "RS17563"}, {"weight": 2.0, "description": "Variants in BMP4 are associated with the number of teeth.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "BMP4", "target": "NUMBER OF TEETH"}, {"weight": 2.0, "description": "SNP rs10740993 is located within the CACNB2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CACNB2", "target": "RS10740993"}, {"weight": 3.0, "description": "SNP rs4937076 is located within the CDON gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CDON", "target": "RS4937076"}, {"weight": 4.0, "description": "SNP rs1799922 is located within the CALU/OPN1SW gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "CALU/OPN1SW", "target": "RS1799922"}, {"weight": 5.0, "description": "SNP rs997154 is located within the AJUBA/C14orf93 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "AJUBA/C14ORF93", "target": "RS997154"}, {"weight": 8.0, "description": "SNP rs7924176 is located within the ADK gene.)<SEP>rs7924176 is a genomic variant in the ADK gene and is associated with nose width.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4<SEP>chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "ADK", "target": "RS7924176"}, {"weight": 7.0, "description": "SNP rs412000 is located within the TEX14/RAD51C gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "TEX14/RAD51C", "target": "RS412000"}, {"weight": 9.0, "description": "SNP rs11077486 is located within the KCNJ2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "KCNJ2", "target": "RS11077486"}, {"weight": 11.0, "description": "SNP rs1472259 is located within the IGF2BP1 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "IGF2BP1", "target": "RS1472259"}, {"weight": 12.0, "description": "SNP rs2804391 is located within the EDA gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "EDA", "target": "RS2804391"}, {"weight": 14.0, "description": "SNP rs17105278 is located within the RAD51L1 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RAD51L1", "target": "RS17105278"}, {"weight": 4.0, "description": "rs1570106 in RAD51L1 is associated with age at first tooth and number of teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "RAD51L1", "target": "RS1570106"}, {"weight": 1.0, "description": "SNP rs145738267 is located within the PAX9 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "PAX9", "target": "RS145738267"}, {"weight": 2.0, "description": "SNP rs10493984 is located within the MSX1 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "MSX1", "target": "RS10493984"}, {"weight": 3.0, "description": "SNP rs11706489 is located within the RUNX2 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "RUNX2", "target": "RS11706489"}, {"weight": 4.0, "description": "SNP rs54810367 is located within the SHH gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "SHH", "target": "RS54810367"}, {"weight": 5.0, "description": "SNP rs10835967 is located within the WNT2B gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "WNT2B", "target": "RS10835967"}, {"weight": 6.0, "description": "SNP rs11370467 is located within the FGF8 gene.)", "source_id": "chunk-50e07db177a6a08799261934e8e71ac4", "order": 1, "source": "FGF8", "target": "RS11370467"}, {"weight": 3.0, "description": "rs997154 is a genomic variant in the AJUBA gene and is associated with mid-brow prominence.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "AJUBA", "target": "RS997154"}, {"weight": 3.0, "description": "Genome-wide significant SNPs for \'Age at first tooth\' showed moderate evidence of association with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "AGE AT FIRST TOOTH", "target": "SNPS"}, {"weight": 4.0, "description": "Genome-wide significant SNPs for \'Number of teeth\' showed moderate evidence of association with height.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "NUMBER OF TEETH", "target": "SNPS"}, {"weight": 1.0, "description": "ALLIGATOR software was used to conduct pathway analysis on GWAS data.)", "source_id": "chunk-c63d60b991cd7442f690dcc364af47dd", "order": 1, "source": "ALLIGATOR", "target": "GWAS"}, {"weight": 1.0, "description": "MR Egger analysis utilizes SNPs as instrumental variables to assess causal relationships.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "SNPS", "target": "MR EGGER"}, {"weight": 1.0, "description": "IVW analysis combines estimates from multiple SNPs to estimate causal effects.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "SNPS", "target": "IVW ANALYSIS"}, {"weight": 0.7, "description": "This study investigated potential associations between SNPs and treatment response.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "SNPS", "target": "TREATMENT RESPONSE"}, {"weight": 2.0, "description": "rs12534093 is a SNP in IGF2BP3 associated with age at first tooth and number of teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "IGF2BP3", "target": "RS12534093"}, {"weight": 3.0, "description": "rs1490384 near C6orf173 is associated with age at first tooth and number of teeth.)", "source_id": "chunk-29b3ac5f9dbe166f36559a272d7bcba1", "order": 1, "source": "C6ORF173", "target": "RS1490384"}, {"weight": 1.0, "description": "Interleukin-10 plays a protective role in T cell transfer colitis by modulating immune responses.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "IL-10", "target": "T CELL TRANSFER COLITIS"}, {"weight": 3.0, "description": "IL-10 is produced by macrophages and acts as an immunosuppressive cytokine.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10", "target": "MACROPHAGE"}, {"weight": 11.0, "description": "IL-10 plays a protective role in suppressing inflammation and resolving inflammatory responses.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10", "target": "DISEASE"}, {"weight": 1.0, "description": "IL-10 treatment diminished pro-IL-\u03b2 levels in Rag1\u2212/\u2212 cultures.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10", "target": "PRO-IL-\u0392"}, {"weight": 3.0, "description": "IL-10 treatment suppressed caspase-1 activation, while anti-IL-10R\u03b1 Ab increased it.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-10", "target": "CASPASE-1 ACTIVATION"}, {"weight": 1.0, "description": "rs1800896 A/G is a variation located within the IL-10 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-10", "target": "RS1800896 A/G"}, {"weight": 5.0, "description": "T cells interact with macrophages and influence their cytokine production.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "T CELL", "target": "MACROPHAGE"}, {"weight": 1.0, "description": "LYP-620R expression affects TCR signaling in various T cell subsets, including na\u00efve, memory, and regulatory T cells.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "T CELL", "target": "LYP-620R"}, {"weight": 4.0, "description": "TCRs are expressed on T cells and recognize peptide-HLA complexes.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "T CELL", "target": "TCR"}, {"weight": 3.0, "description": "Rag1\u2212/\u2212 mice are used as recipients in T cell transfer colitis models due to their immunodeficiency.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "RAG1\u2212/\u2212", "target": "T CELL TRANSFER COLITIS"}, {"weight": 2.0, "description": "Anti-IL-10R antibody elevated mature IL-1\u03b2 levels in Rag1\u2212/\u2212 cultures.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "RAG1\u2212/\u2212", "target": "MATURE IL-1\u0392"}, {"weight": 14.0, "description": "The IL-10 receptor alpha Mdel variant leads to increased pro-IL-1\u03b2 production in LPM\u03d5s, exacerbating colitis.)<SEP>The IL-10R\u03b1Mdel genetic modification leads to increased disease severity in colitis, indicating its role in disease development.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6<SEP>chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-10R\u0391MDEL", "target": "DISEASE"}, {"weight": 2.0, "description": "Mice lacking IL-10 receptor alpha specifically in macrophages develop more severe colitis compared to control mice.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "COLITIS", "target": "IL-10R\u0391 DELETION (M\u03a6 SPECIFIC)"}, {"weight": 6.0, "description": "IL-10R\u03b1MdelRag1\u2212/\u2212 mice are more susceptible to colitis.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"weight": 10.0, "description": "Transfer of IL-6R\u03b1\u2212/\u2212 T cells into Rag1\u2212/\u2212 mice did not induce colitis.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-6R\u0391\u2212/\u2212 T CELLS"}, {"weight": 18.0, "description": "IL-1\u03b2 plays a role in the development of intestinal Th17 cells and promotes the Th17 response during colitis.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1\u0392"}, {"weight": 20.0, "description": "Transfer of IL-1R\u2212/\u2212 T cells into Rag1\u2212/\u2212 mice resulted in diminished clinical and histologic measures of colitis compared to WT T cell transfers.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "COLITIS", "target": "IL-1R\u2212/\u2212 T CELLS"}, {"weight": 4.0, "description": "The Card9 gene plays a role in shaping the bacterial and fungal gut microbiota, influencing colitis susceptibility.)<SEP>The gut microbiota of Card9\u2212/\u2212 mice contributes to colitis susceptibility.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd<SEP>chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "CARD9"}, {"weight": 18.0, "description": "Mice colonized with WT microbiota displayed a milder colitis phenotype compared to those colonized with Card9\u2212/\u2212 microbiota.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "WT\u2192GF"}, {"weight": 20.0, "description": "Mice colonized with Card9\u2212/\u2212 microbiota exhibited increased susceptibility to colitis and impaired recovery.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "COLITIS", "target": "CARD9\u2212/\u2212\u2192GF"}, {"weight": 1.0, "description": "The gut microbiota contributes to colitis susceptibility.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "COLITIS", "target": "MICROBIOTA"}, {"weight": 8.0, "description": "Increased Th17 cells are observed in the colon of mice receiving IL-1R\u2212/\u2212 T cells, suggesting their role in driving inflammation and disease progression.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "TH17", "target": "DISEASE"}, {"weight": 5.0, "description": "The Lys-M-Cre transgene used to ablate IL-10R\u03b1 in the IL-10R\u03b1MdelRag1\u2212/\u2212 mice is driven by the CX3CR1 promoter.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "CX3CR1", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212"}, {"weight": 17.0, "description": "A significant increase of neutrophils was observed in the dermis of paradoxical skin reactions.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "NEUTROPHILS", "target": "PARADOXICAL PSORIASIS"}, {"weight": 3.0, "description": "Elevated levels of IL-1\u03b2 are produced by LPM\u03d5s in IL-10R\u03b1MdelRag1\u2212/\u2212 mice compared to Rag1\u2212/\u2212 controls.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "LPM\u03a6S", "target": "IL-1\u0392"}, {"weight": 10.0, "description": "EBNA2 binds preferentially to the protective allele of CD40, leading to relatively lower expression.)<SEP>EBNA2 preferentially binds to the risk allele of the CD40 locus.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "CD40", "target": "EBNA2"}, {"weight": 12.0, "description": "Inhibition of EBNA2 with TAT treatment decreases CD40 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "CD40", "target": "EBNA2-TAT"}, {"weight": 2.0, "description": "Mice with the IL-10R\u03b1MdelRag1\u2212/\u2212 genetic modification exhibit increased disease severity in colitis.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "DISEASE"}, {"weight": 14.0, "description": "IL-10R\u03b1MdelRag1\u2212/\u2212 mice show a relative expansion of Th17 cells at the site of inflammation.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "TH17 CELL EXPANSION"}, {"weight": 4.0, "description": "Th17 cells are essential for the development of colitis in Rag1\u2212/\u2212 mice.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "TH17 CELL", "target": "DISEASE"}, {"weight": 2.0, "description": "ROR\u03b3T protein is required for Th17 cell development.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "ROR\u0393T", "target": "TH17 CELLS"}, {"weight": 6.0, "description": "Elevated levels of IL-1\u03b2 are associated with an intensified Th17 response.)", "source_id": "chunk-8fb20f873daf79a9b7d6e8d25c8889d6", "order": 1, "source": "IL-1\u0392", "target": "TH17 RESPONSE"}, {"weight": 10.0, "description": "Elevated IL-1\u03b2 is a hallmark of inflammatory conditions.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "IL-1\u0392", "target": "DISEASE"}, {"weight": 7.0, "description": "SENP1 deletion increases the production of IL-1\u03b2 and other proinflammatory cytokines.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "IL-1\u0392", "target": "SENP1"}, {"weight": 1.0, "description": "rs16944 is a variation located within the IL-1\u03b2 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-1\u0392", "target": "RS16944"}, {"weight": 6.0, "description": "SENP1 deletion increases the production of TNF-\u03b1 and other proinflammatory cytokines.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "TNF-\u0391", "target": "SENP1"}, {"weight": 23.0, "description": "Decreased TNF-\u03b1 positivity was observed in skin T lymphocytes of patients with paradoxical psoriasis compared to classical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "TNF-\u0391", "target": "PARADOXICAL PSORIASIS"}, {"weight": 1.0, "description": "rs1800629 C/G is a variation located within the TNF-\u03b1 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TNF-\u0391", "target": "RS1800629 C/G"}, {"weight": 5.0, "description": "The expression of proinflammatory cytokines IL-6, TNF-\u03b1, and IL-1\u03b2 are increased in SENP1 knockdown cells, while IFN-\u03b3 expression remains unchanged.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "IFN-\u0393", "target": "IL-6, TNF-\u0391, AND IL-1\u0392"}, {"weight": 21.0, "description": "Decreased IFN-\u03b3 immunoreactivity was observed in paradoxical psoriasiform reactions compared to classical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "IFN-\u0393", "target": "PARADOXICAL PSORIASIS"}, {"weight": 1.0, "description": "The presence of the PTPN2:rs478582 variant was associated with higher expression of IFN-\u03b3 in CD subjects compared to those without it.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "PTPN2:RS478582"}, {"weight": 2.0, "description": "Heterozygous or minor alleles in PTPN22:rs2476601 were associated with higher IFN-\u03b3 expression in CD subjects with MAPbacteremia compared to those without it.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "PTPN22:RS2476601"}, {"weight": 3.0, "description": "CD subjects with MAPbacteremia had higher IFN-\u03b3 expression compared to those without it.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "IFN-\u0393", "target": "MAPBACTEREMIA"}, {"weight": 4.0, "description": "T cell IL-6 responsiveness is clinically important in Rag1\u2212/\u2212 colitis, suggesting a role of IL-6 signaling in disease development.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "IL-6R\u0391"}, {"weight": 6.0, "description": "T cell IL-1 response modulates both Rag1\u2212/\u2212 and IL-10R\u03b1MdelRag1\u2212/\u2212 disease severity, indicating its involvement in colitis.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "IL-1R\u0391"}, {"weight": 10.0, "description": "Mice with Rag1 deficiency (Rag1\u2212/\u2212) develop colitis, highlighting its importance in immune system development and regulation.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "RAG1"}, {"weight": 14.0, "description": "Increased pro-IL-1\u03b2 levels in LPM\u03d5s from diseased mice contribute to the development and progression of colitis.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "LPM\u03a6"}, {"weight": 16.0, "description": "IL-1\u03b2 is primarily produced by CD11b+ cells, suggesting their role as key contributors to inflammation.)", "source_id": "chunk-f2c864ef2d87119a8129e011b1c42e3c", "order": 1, "source": "DISEASE", "target": "CD11B"}, {"weight": 6.0, "description": "Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "DISEASE", "target": "T2DM"}, {"weight": 8.0, "description": "Blocking IL-6 signaling partially inhibited Th17 cell formation with Rag1\u2212/\u2212 LPM\u03d5s.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "\u0391IL-6R\u0391 BLOCKING ANTIBODY", "target": "TH17 CELL MATURATION IN RAG1\u2212/\u2212 MICE"}, {"weight": 6.0, "description": "The Lys-M-Cre transgene is expressed in granulocytes, including neutrophils.)", "source_id": "chunk-bcd248f7a9b2453bfc563b9439fbdd51", "order": 1, "source": "GRANULOCYTES", "target": "LYS-M-CRE"}, {"weight": 4.0, "description": "Del Rag1\u2212/\u2212 mice have an increased Th17 response.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "TH17 RESPONSE", "target": "RAG1\u2212/\u2212 MICE"}, {"weight": 12.0, "description": "IL-6R\u03b1 signaling supports but is not essential for Th17 cell formation.)", "source_id": "chunk-35d8a4ea86cb92d18ee1c857a318d2d8", "order": 1, "source": "IL-6R\u0391\u2212/\u2212 T CELLS", "target": "TH17 CELL FORMATION"}, {"weight": 4.0, "description": "LPS and ATP stimulation induced modest activated caspase-1 levels in Rag1\u2212/\u2212 M\u03d5s.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "ACTIVATED CASPASE-1", "target": "LPS & ATP"}, {"weight": 5.0, "description": "Caspase-1 activation was increased regardless of IL-10 or anti-IL-10R\u03b1 Ab treatment in IL-10R\u03b1MdelRag1\u2212/\u2212 M\u03d5s.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "ACTIVATED CASPASE-1", "target": "IL-10R\u0391MDELRAG1\u2212/\u2212 M\u03a6S"}, {"weight": 6.0, "description": "LPM\u03d5s from diseased IL-10R\u03b1MdelRag1\u2212/\u2212 mice promoted higher Th17 cell maturation compared to control Rag1\u2212/\u2212 LPM\u03d5s.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "LPM\u03a6S FROM IL-10R\u0391MDELRAG1\u2212/\u2212 MICE", "target": "TH17 CELL MATURATION"}, {"weight": 7.0, "description": "Increased IL-1 and IL-6 from LPM\u03d5s promoted Th17 cell maturation.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "TH17 CELL MATURATION", "target": "IL-1 & IL-6 FROM LPM\u03a6S"}, {"weight": 9.0, "description": "Blocking IL-1 signaling substantially inhibited Th17 development in IL-10R\u03b1Mdel Rag1\u2212/\u2212-derived LPM\u03d5s.)", "source_id": "chunk-b971aa450a9b220806bdc000eb5efaad", "order": 1, "source": "IL-1 SIGNALING BLOCKAGE", "target": "TH17 CELL MATURATION IN IL-10R\u0391MDELRAG1\u2212/\u2212 MICE"}, {"weight": 2.0, "description": "Faecalibacterium was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "FAECALIBACTERIUM", "target": "CORE MICROBIOTA"}, {"weight": 3.0, "description": "Blautia was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "BLAUTIA", "target": "CORE MICROBIOTA"}, {"weight": 4.0, "description": "Alistipes was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ALISTIPES", "target": "CORE MICROBIOTA"}, {"weight": 5.0, "description": "Ruminococcus was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "RUMINOCOCCUS", "target": "CORE MICROBIOTA"}, {"weight": 6.0, "description": "Lachnoclostridium was identified as one of the nine genera that comprise the core microbiota, being present in over 95% of individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "LACHNOCLOSTRIDIUM", "target": "CORE MICROBIOTA"}, {"weight": 1.0, "description": "Both Ruminiclostridium 9 and Peptostreptococcaeae passed the significance threshold in LD score regression for association with gut microbiome.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "RUMINICLOSTRIDIUM 9", "target": "PEPTOSTREPTOCOCCAEAE"}, {"weight": 2.0, "description": "One cohort included samples of Middle Eastern ancestry.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "MIDDLE-EASTERN", "target": "COHORTS"}, {"weight": 4.0, "description": "One cohort included samples of American Hispanic/Latin ancestry.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "AMERICAN HISPANIC/LATIN", "target": "COHORTS"}, {"weight": 5.0, "description": "One cohort included samples of African American ancestry.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "AFRICAN AMERICAN", "target": "COHORTS"}, {"weight": 6.0, "description": "Twenty-two cohorts comprised adult or adolescent individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ADULT", "target": "COHORTS"}, {"weight": 7.0, "description": "Twenty-two cohorts comprised adult or adolescent individuals.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "ADOLESCENT", "target": "COHORTS"}, {"weight": 8.0, "description": "Two cohorts consisted of children.)", "source_id": "chunk-2c395e2fed68f9267c06e9fcee853aae", "order": 1, "source": "CHILD", "target": "COHORTS"}, {"weight": 2.0, "description": "The LCT locus is associated with the abundance of Bifidobacterium, as shown by GWAS meta-analysis.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT LOCUS", "target": "BIFIDOBACTERIUM"}, {"weight": 1.0, "description": "The rs182549 SNP is located within the LCT locus.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT LOCUS", "target": "RS182549"}, {"weight": 3.0, "description": "Both the LCT locus and the FUT2 gene are implicated in gut microbiome composition.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT LOCUS", "target": "FUT2 GENE"}, {"weight": 10.0, "description": "The rs182549 variant is associated with Bifidobacterium abundance.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "BIFIDOBACTERIUM", "target": "RS182549"}, {"weight": 1.6, "description": "Higher abundance of Bifidobacterium may have a protective effect on ulcerative colitis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "BIFIDOBACTERIUM", "target": "ULCERATIVE COLITIS"}, {"weight": 3.0, "description": "Prior studies suggest that the FUT2 gene plays a role in shaping the gut microbiota.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "GUT MICROBIOTA", "target": "FUT2 GENE"}, {"weight": 5.0, "description": "The gut microbiota produces AHR ligands.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "GUT MICROBIOTA", "target": "AHR LIGANDS"}, {"weight": 8.0, "description": "The rs182549 SNP is strongly associated with Bifidobacterium abundance, particularly in adults.)<SEP>The rs182549 SNP is strongly associated with Bifidobacterium abundance.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "RS182549", "target": "BIFIDOBACTERIUM ABUNDANCE"}, {"weight": 5.0, "description": "The rs182549 variant is located in the LCT gene.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "LCT"}, {"weight": 11.0, "description": "The rs182549 variant predisposes individuals to lactose intolerance.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "LACTOSE INTOLERANCE"}, {"weight": 12.0, "description": "The rs182549 variant is associated with an increased risk of type 2 diabetes.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "TYPE 2 DIABETES MELLITUS"}, {"weight": 22.0, "description": "The rs182549 variant is associated with Bifidobacterium adolescentis abundance.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "BIFIDOBACTERIUM ADOLESCENTIS"}, {"weight": 26.0, "description": "The rs182549 variant is associated with increased antibiotic resistance.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS182549", "target": "ANTIBIOTIC RESISTANCE"}, {"weight": 1.0, "description": "Silencing LOC100507600 lncRNA reduces LCT mRNA levels, suggesting regulation of LCT expression by LOC100507600.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT", "target": "LOC100507600"}, {"weight": 6.0, "description": "The rs35866622 variant is located in the FUT1/FUT2 gene locus.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "FUT1/FUT2"}, {"weight": 14.0, "description": "The rs35866622 variant is positively associated with fish intake.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "FISH INTAKE"}, {"weight": 16.0, "description": "The rs35866622 variant is negatively associated with the risk of cholelithiasis.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "CHOLELITHIASIS"}, {"weight": 17.0, "description": "The rs35866622 variant is negatively associated with the risk of Crohn\u2019s disease.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "CROHN\'S DISEASE"}, {"weight": 18.0, "description": "The rs35866622 variant is negatively associated with high cholesterol.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "HIGH CHOLESTEROL"}, {"weight": 19.0, "description": "The rs35866622 variant is negatively associated with waist-to-hip ratio.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS35866622", "target": "WAIST-TO-HIP RATIO"}, {"weight": 1.0, "description": "The rs7574352 SNP is associated with the abundance of the Peptococcaceae family.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "PEPTOCOCCACEAE"}, {"weight": 4.0, "description": "The genomic variant rs7574352 is located near the IRF1 gene.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "IRF1"}, {"weight": 20.0, "description": "The rs7574352 SNP is associated with altered abundance of Escherichia coli.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "ESCHERICHIA COLI"}, {"weight": 21.0, "description": "The rs7574352 SNP is associated with altered abundance of Bacteroides fragilis.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "BACTEROIDES FRAGILIS"}, {"weight": 23.0, "description": "The rs7574352 SNP is associated with altered abundance of Faecalibacterium prausnitzii.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "FAECALIBACTERIUM PRAUSNITZII"}, {"weight": 24.0, "description": "The rs7574352 SNP is associated with levels of short-chain fatty acids.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "SHORT-CHAIN FATTY ACIDS"}, {"weight": 25.0, "description": "The rs7574352 SNP is associated with methane production in the gut.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "RS7574352", "target": "METHANE"}, {"weight": 2.0, "description": "The Peptococcaceae family is negatively associated with stool levels of chromogranin A.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "CHROMOGRANIN A", "target": "PEPTOCOCCACEAE"}, {"weight": 3.0, "description": "The Peptococcaceae family is negatively associated with stool levels of calprotectin.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "CALPROTECTIN", "target": "PEPTOCOCCACEAE"}, {"weight": 5.0, "description": "The rs181206 variant causes decreased expression of IRF1.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "IRF1", "target": "RS181206"}, {"weight": 1.0, "description": "The rs181206[G] SNP is associated with decreased expression of IRF1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "RS181206[G]"}, {"weight": 2.0, "description": "There is a positive correlation between the expression levels of IRF1 and STAT1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "STAT1"}, {"weight": 3.0, "description": "IL-27, through its receptor IL27RA and gp130, induces transcription of IRF1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IRF1", "target": "IL27"}, {"weight": 7.0, "description": "The rs4428215 variant is associated with the FNDC3B gene.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "FNDC3B", "target": "RS4428215"}, {"weight": 8.0, "description": "The rs11647069 variant is associated with the PM FBP1 gene.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "PM FBP1", "target": "RS11647069"}, {"weight": 9.0, "description": "The rs9474033 variant is associated with the PKHD1 gene.)", "source_id": "chunk-938d8bf2e56584de9dd556be5eb70964", "order": 1, "source": "PKHD1", "target": "RS9474033"}, {"weight": 0.9, "description": "Higher abundance of Actinobacteria may have a protective effect on ulcerative colitis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "ACTINOBACTERIA", "target": "ULCERATIVE COLITIS"}, {"weight": 8.0, "description": "Lower abundance of Actinobacteria was found in the gut microbiome of Card9\u2212/\u2212 mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "ACTINOBACTERIA", "target": "CARD9\u2212/\u2212"}, {"weight": 1.4, "description": "Higher abundance of Oxalobacteraceae has a protective effect on rheumatoid arthritis.", "source_id": "chunk-159d4c797dae6eb825c74067af703228", "order": 1, "source": "OXALOBACTERACEAE", "target": "RHEUMATOID ARTHRITIS"}, {"weight": 4.0, "description": "The number of mbQTLs associated with a relaxed threshold is correlated with heritability significance.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "HERITABILITY OF MICROBIAL TAXA", "target": "MBQTLS"}, {"weight": 5.0, "description": "Individuals homozygous for the low-function LCT haplotype show a positive correlation between Bifidobacterium abundance and milk product intake.)", "source_id": "chunk-af413a33fae8d27bdb15cd18447dfad4", "order": 1, "source": "LCT GENE", "target": "MILK PRODUCTS"}, {"weight": 6.0, "description": "E. coli was used to produce recombinant HLA-B*15:01 molecules for binding studies.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ESCHERICHIA COLI", "target": "PROTEIN PRODUCTION"}, {"weight": 2.0, "description": "One additional LP allele (rs4988235) was associated with a higher intake of milk (\u03b2 17.1 g/day).)<SEP>One additional LP allele (rs4988235) was associated with a higher intake of milk.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "MILK"}, {"weight": 4.0, "description": "One additional LP allele (rs4988235) was associated with a higher intake of milk beverages (\u03b2 2.8 g/day).)<SEP>One additional LP allele (rs4988235) was associated with a higher intake of milk beverages.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "MILK BEVERAGES"}, {"weight": 6.0, "description": "One additional LP allele (rs4988235) was not associated with the intake of other dairy products.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "DAIRY PRODUCTS (GENERAL)"}, {"weight": 8.0, "description": "rs4988235 was associated with a higher plasma C15:0 level (\u03b2 0.003 % of total fats). )<SEP>rs4988235 was associated with a higher plasma C15:0 level.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "C15:0"}, {"weight": 10.0, "description": "A similar association was suggested for C17:0 levels, but this was not statistically significant.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "C17:0"}, {"weight": 12.0, "description": "rs4988235 was associated with a modestly lower HDL cholesterol (\u03b2 -0.017). )<SEP>rs4988235 was associated with a modestly lower HDL cholesterol level.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "HDL CHOLESTEROL"}, {"weight": 14.0, "description": "After multivariable adjustment, rs4988235 was associated with higher potato intake (\u03b2 3.0). )<SEP>After multivariable adjustment, rs4988235 was associated with higher potato intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "POTATOES"}, {"weight": 16.0, "description": "After multivariable adjustment, rs4988235 was associated with lower cereal product intake (\u03b2 -3.5). )<SEP>After multivariable adjustment, rs4988235 was associated with lower cereal product intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "CEREAL PRODUCTS"}, {"weight": 18.0, "description": "After multivariable adjustment, rs4988235 was associated with lower fruit intake (\u03b2 -7.0). )<SEP>After multivariable adjustment, rs4988235 was associated with lower fruit intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "FRUITS"}, {"weight": 20.0, "description": "After multivariable adjustment, rs4988235 was associated with lower poultry intake (\u03b2 -0.8). )<SEP>After multivariable adjustment, rs4988235 was associated with lower poultry intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "POULTRY"}, {"weight": 22.0, "description": "After multivariable adjustment, rs4988235 was associated with lower non-alcoholic beverage intake (\u03b2 -18.0). )<SEP>After multivariable adjustment, rs4988235 was associated with lower non-alcoholic beverage intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "NON-ALCOHOLIC BEVERAGES"}, {"weight": 24.0, "description": "After multivariable adjustment, rs4988235 was associated with lower wine intake (\u03b2 -4.8). )<SEP>After multivariable adjustment, rs4988235 was associated with lower wine intake.)", "source_id": "chunk-770a24a1a31cf671a7681e7c98a7ee91", "order": 1, "source": "RS4988235", "target": "WINE"}, {"weight": 1.0, "description": "The rs4988235 variant determines lactase persistence or non-persistence.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "LACTASE PERSISTENCE"}, {"weight": 1.0, "description": "The T allele at rs4988235 indicates lactase persistence.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "T ALLELE"}, {"weight": 1.0, "description": "The C allele at rs4988235 indicates lactase non-persistence.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RS4988235", "target": "C ALLELE"}, {"weight": 1.0, "description": "Choline supplementation may promote catch-up growth in infants, particularly in weight and head circumference.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "CHOLINE", "target": "INFANT GROWTH"}, {"weight": 3.0, "description": "Methamphetamine use during pregnancy can lead to various complications for both mother and fetus.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "METHAMPHETAMINE", "target": "PREGNANCY COMPLICATIONS"}, {"weight": 4.0, "description": "Cocaine use during pregnancy is associated with numerous adverse outcomes for the baby.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "COCAINE", "target": "PREGNANCY COMPLICATIONS"}, {"weight": 5.0, "description": "Heroin exposure in utero can result in NAS, a withdrawal syndrome in newborns.)", "source_id": "chunk-a9cd8765fac3ebb933c3fade561bc42e", "order": 1, "source": "HEROIN", "target": "NEONATAL ABSTINENCE SYNDROME (NAS)"}, {"weight": 3.0, "description": "The ALDH2 rs671 variant is linked to differences in daily alcohol consumption, with GG genotype individuals typically consuming more alcohol than those with GA or AA genotypes.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "ALDH2 RS671"}, {"weight": 4.0, "description": "Individuals with the GG genotype of the ALDH2 rs671 variant tend to have the highest levels of daily alcohol consumption.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "GG"}, {"weight": 5.0, "description": "Individuals with the GA genotype of the ALDH2 rs671 variant tend to have intermediate levels of daily alcohol consumption.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "GA"}, {"weight": 14.0, "description": "There were no significant differences in the distribution of TLR7 rs179008 and rs179009 genotypes between HIV-infected individuals who consumed alcohol and those who did not.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "ALCOHOL CONSUMPTION", "target": "TLR7 RS179008/RS179009 GENOTYPES"}, {"weight": 0.8, "description": "Maternal and fetal B12 levels did not significantly influence offspring birthweight according to MR analysis.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "B12 LEVELS"}, {"weight": 1.2, "description": "Maternal folate levels positively influenced offspring birthweight, while fetal folate levels negatively impacted their own birthweight.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "BIRTHWEIGHT", "target": "FOLATE LEVELS"}, {"weight": 4.0, "description": "Infants in the choline arm had a higher rate of PFAS diagnosis compared to the placebo arm.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PFAS", "target": "CHOLINE ARM"}, {"weight": 6.0, "description": "The rs12325817 variant is located within the PEMT gene and reduces its activity, leading to decreased choline synthesis.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PEMT", "target": "RS12325817"}, {"weight": 5.0, "description": "The PEMT gene encodes the enzyme responsible for endogenous choline synthesis.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "PEMT", "target": "ENDOGENOUS CHOLINE SYNTHESIS"}, {"weight": 4.0, "description": "A mother\'s dietary choline intake directly influences her child\'s dietary choline status.)", "source_id": "chunk-d594d57f0043cce2b3d29c80323b1a11", "order": 1, "source": "DIETARY CHOLINE STATUS", "target": "MATERNAL DIETARY CHOLINE INTAKE"}, {"weight": 2.0, "description": "The rs10886471 SNP is located within the GRK5 gene.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "RS10886471", "target": "GRK5"}, {"weight": 0.5, "description": "The (CA)16 allele was used as a reference for comparing alleles associated with T2DM.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "T2DM", "target": "(CA)16 ALLELE"}, {"weight": 0.6, "description": "Multiple alleles including (CA)15, (CA)17, (CA)18, and (CA)19 were negatively correlated with T2DM.)", "source_id": "chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9", "order": 1, "source": "T2DM", "target": "MULTIPLE ALLELES"}, {"weight": 8.0, "description": "HFD augmented both T1DM and T2DM phenotypes in SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "T2DM", "target": "HFD"}, {"weight": 4.0, "description": "CA repeat sequences in introns can influence enhancer or repressor splicing during gene expression.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "CA REPEAT SEQUENCES", "target": "GENE EXPRESSION"}, {"weight": 3.0, "description": "CTCF binding can activate tissue-specific gene expression and facilitate interactions between enhancers and promoters.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "GENE EXPRESSION", "target": "CTCF"}, {"weight": 4.0, "description": "Expression quantitative trait loci (eQTLs) are genetic variants associated with changes in gene expression.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "GENE EXPRESSION", "target": "EQTLS"}, {"weight": 14.0, "description": "EBNA2 alters the expression of MS risk genes, such as TRAF3, CD40, CLECL1, TNFAIP8, and TNFRSF1A.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "GENE EXPRESSION", "target": "EBNA2"}, {"weight": 6.0, "description": "Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) both indicate elevated blood glucose levels.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "BLOOD GLUCOSE ELEVATION", "target": "IFG, IGT"}, {"weight": 7.0, "description": "These clinical parameters are associated with increased blood glucose levels in individuals with prediabetes and T2DM.)", "source_id": "chunk-66f614368ca7f1bd578d9eb259083dd9", "order": 1, "source": "INCREASED BLOOD GLUCOSE", "target": "WAIST CIRCUMFERENCE, BMI, SBP, DBP, FPG, 2 H PG"}, {"weight": 2.0, "description": "The WHI Observational Study investigated the relationship between serum selenium concentration and colorectal cancer risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "WHI OBSERVATIONAL STUDY", "target": "COLORECTAL CANCER"}, {"weight": 4.0, "description": "Cases were individuals diagnosed with colorectal cancer, while controls were healthy individuals without the disease.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "CONTROLS"}, {"weight": 7.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "RACE/ETHNICITY"}, {"weight": 11.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "POSTMENOPAUSAL HORMONE USE"}, {"weight": 12.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "NSAIDS"}, {"weight": 13.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "SELENIUM SUPPLEMENTS"}, {"weight": 14.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "CALCIUM"}, {"weight": 15.0, "description": "Controls", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "CASES", "target": "DIETARY FIBER"}, {"weight": 1.0, "description": "Minor allele frequencies for rs4988235 were observed in controls across different populations.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "CONTROLS", "target": "GENOTYPE FREQUENCIES"}, {"weight": 6.0, "description": "The study aimed to determine if serum selenium concentration was associated with the risk of developing colorectal cancer.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "SERUM SELENIUM CONCENTRATION"}, {"weight": 8.0, "description": "Genetic variants in the GPX4 gene were analyzed for their potential influence on colorectal cancer risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "GPX4 GENE"}, {"weight": 10.0, "description": "The SNP rs8178974 within the GPX4 gene was significantly associated with colorectal cancer risk.)", "source_id": "chunk-d311ac0182b37003c75c0005b4337fa6", "order": 1, "source": "COLORECTAL CANCER", "target": "RS8178974"}, {"weight": 6.0, "description": "An IBD-associated single-nucleotide polymorphism (SNP) within CARD9 is associated with reduced AHR activation by microbiota-derived metabolites in patients with IBD.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "CARD9", "target": "IBD"}, {"weight": 12.0, "description": "Wild-type mice displayed a higher biodiversity in their gut microbiome compared to Card9 knockout mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "WT", "target": "BIODIVERSITY"}, {"weight": 20.0, "description": "Card9 knockout mice exhibited an unusual positive correlation between bacterial and fungal biodiversity.)<SEP>Card9 knockout mice show decreased biodiversity in their gut microbiome compared to wild-type mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "BIODIVERSITY"}, {"weight": 6.0, "description": "Decreased levels of Adlercreutzia were observed in the Card9\u2212/\u2212 mouse microbiota.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "ADLERCREUTZIA"}, {"weight": 10.0, "description": "Reduced levels of Lactobacillus reuteri were detected in the microbiota of Card9\u2212/\u2212 mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "CARD9\u2212/\u2212", "target": "LACTOBACILLUS REUTERI"}, {"weight": 24.0, "description": "Reduced Reg3g and Reg3b expression levels were found in Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "REG3G", "target": "CARD9\u2212/\u2212\u2192GF"}, {"weight": 1.0, "description": "IL-22 is required for the production of AHR ligands by the microbiota.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IL-22", "target": "AHR"}, {"weight": 22.0, "description": "Increased IL-22 positivity was observed in paradoxical psoriasiform reactions, particularly in cells with a macrophage-like morphology.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "IL-22", "target": "PARADOXICAL PSORIASIS"}, {"weight": 1.0, "description": "rs1179251 C/G is a variation located within the IL-22 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22", "target": "RS1179251 C/G"}, {"weight": 1.0, "description": "rs2227485 C/T is a variation located within the IL-22 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-22", "target": "RS2227485 C/T"}, {"weight": 24.0, "description": "IL-17A positivity was comparable in patient 1 and psoriatic patients, whereas it was very high in T cells isolated from the skin of patient 2.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "IL-17A", "target": "PARADOXICAL PSORIASIS"}, {"weight": 4.0, "description": "\u03b2 cells in SENP1-deficient mice undergo apoptosis (programmed cell death), leading to pancreatic islet dysfunction.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "APOPTOSIS", "target": "PANCREATIC ISLET \u0392 CELLS"}, {"weight": 22.0, "description": "Decreased IL-22 expression was observed in Card9\u2212/\u2212\u2192GF mice, contributing to their impaired recovery from DSS-induced epithelial injury.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL22", "target": "DSS-INDUCED INJURY"}, {"weight": 26.0, "description": "No significant differences in Il17a expression were observed between Card9\u2212/\u2212\u2192GF and WT\u2192GF mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL17A", "target": "CARD9\u2212/\u2212\u2192GF"}, {"weight": 1.0, "description": "The Card9 gene is involved in the production of IL-22 by T cells and ILCs in the colon.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9</ENTITY>", "target": "IL-22 PRODUCTION</ENTITY>"}, {"weight": 2.0, "description": "Defects in the Card9 gene lead to increased susceptibility to DSS-induced colitis.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9</ENTITY>", "target": "COLITIS SUSCEPTIBILITY</ENTITY>"}, {"weight": 9.0, "description": "Administration of DSS causes inflammation and damage to the colon, mimicking inflammatory bowel disease.)<SEP>Administration of DSS induces colitis in mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "DSS</ENTITY>", "target": "COLITIS INDUCTION</ENTITY>"}, {"weight": 5.0, "description": "Tryptophan metabolites, such as IAA, can activate the AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "TRYPTOPHAN METABOLISM</ENTITY>", "target": "AHR ACTIVATION</ENTITY>"}, {"weight": 7.0, "description": "IAA activates the AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IAA</ENTITY>", "target": "AHR ACTIVATION</ENTITY>"}, {"weight": 9.0, "description": "IDO1 catalyzes the production of Kyn from tryptophan.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IDO1</ENTITY>", "target": "KYN PRODUCTION</ENTITY>"}, {"weight": 1.0, "description": "The absence of Card9 leads to reduced IL-22 production by T cells and ILCs in the colon.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9\u2212/\u2212</ENTITY>", "target": "IL-22 PRODUCTION</ENTITY>"}, {"weight": 1.0, "description": "Card9\u2212/\u2212 mice exhibit increased susceptibility to DSS-induced colitis.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "CARD9\u2212/\u2212</ENTITY>", "target": "COLITIS SUSCEPTIBILITY</ENTITY>"}, {"weight": 6.0, "description": "IL-23 stimulates the production of IL-22 by T cells and ILCs.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-23</ENTITY>", "target": "IMMUNE CELL STIMULATION</ENTITY>"}, {"weight": 7.0, "description": "\u03b3\u03b4 T cells can produce IL-22 upon activation.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "\u0393\u0394 T CELLS</ENTITY>", "target": "IL-22 PRODUCTION</ENTITY>"}, {"weight": 9.0, "description": "Expression of Reg3g and Reg3b is protective against colitis by inhibiting bacterial growth.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "REG3G & REG3B</ENTITY>", "target": "COLITIS PROTECTION</ENTITY>"}, {"weight": 13.0, "description": "Ficz is an agonist that activates the AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "FICZ (6-FORMYLINDOLO(3,2-B)CARBAZOLE)</ENTITY>", "target": "AHR AGONIST</ENTITY>"}, {"weight": 4.0, "description": "Patients with IBD have decreased levels of tryptophan and IAA, and increased levels of Kyn in fecal samples.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IBD", "target": "TRYPTOPHAN METABOLITES"}, {"weight": 3.0, "description": "The microbiota produces AHR ligands.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "MICROBIOTA", "target": "AHR LIGANDS"}, {"weight": 2.0, "description": "IDO1 catalyzes the conversion of tryptophan to Kynurenine.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "IDO1", "target": "TRYPTOPHAN METABOLISM"}, {"weight": 4.0, "description": "An IBD-associated CARD9 SNP is associated with reduced AHR activation by microbiota-derived metabolites.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "CARD9 GENOTYPE", "target": "AHR ACTIVATION"}, {"weight": 14.0, "description": "In WT mice, there was a negative correlation between bacterial and fungal biodiversity, suggesting competition.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "BACTERIAL BIODIVERSITY", "target": "FUNGAL BIODIVERSITY"}, {"weight": 28.0, "description": "TH22 cells were found to produce less IL-22 in the colon lamina propria of Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 PRODUCTION", "target": "TH22 CELLS"}, {"weight": 30.0, "description": "NKp46+ ILCs produced less IL-22 in the colon lamina propria of Card9\u2212/\u2212\u2192GF mice compared to WT\u2192GF mice.)", "source_id": "chunk-e025ebd5580ff5f1a76bedbcaed2a0b6", "order": 1, "source": "IL-22 PRODUCTION", "target": "NKP46+ ILCS"}, {"weight": 3.0, "description": "Production of IL-22 is crucial for recovery from DSS-induced colitis.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-22 PRODUCTION</ENTITY>", "target": "COLITIS RECOVERY</ENTITY>"}, {"weight": 6.0, "description": "Activation of AHR leads to increased IL-22 production.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-22 PRODUCTION</ENTITY>", "target": "AHR ACTIVATION</ENTITY>"}, {"weight": 8.0, "description": "ILCs are important producers of IL-22 in the gut.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "IL-22 PRODUCTION</ENTITY>", "target": "ILC</ENTITY>"}, {"weight": 1.0, "description": "Mice lacking Card9 are more susceptible to colitis compared to wild-type mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS SUSCEPTIBILITY</ENTITY>", "target": "CARD9\u2212/\u2212 MICE</ENTITY>"}, {"weight": 1.0, "description": "Wild-type mice are less susceptible to colitis compared to Card9\u2212/\u2212 mice.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS SUSCEPTIBILITY</ENTITY>", "target": "WT</ENTITY>"}, {"weight": 4.0, "description": "Germ-free mice are less susceptible to colitis compared to conventional mice with microbiota.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS SUSCEPTIBILITY</ENTITY>", "target": "GF</ENTITY>"}, {"weight": 8.0, "description": "Kyn can also modulate AHR activity.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION</ENTITY>", "target": "KYNURENINE</ENTITY>"}, {"weight": 11.0, "description": "L. reuteri can activate AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION</ENTITY>", "target": "L. REUTERI</ENTITY>"}, {"weight": 12.0, "description": "Allobaculum sp. can activate AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION</ENTITY>", "target": "ALLOBACULUM</ENTITY>"}, {"weight": 10.0, "description": "Activation of AHR promotes the production of IL-22 and protects against colitis.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "AHR ACTIVATION</ENTITY>", "target": "COLITIS PROTECTION</ENTITY>"}, {"weight": 11.0, "description": "Administration of Ficz reduces colitis severity by activating AHR.)", "source_id": "chunk-29025895ac187b8e88dec5cea9478842", "order": 1, "source": "COLITIS TREATMENT</ENTITY>", "target": "FICZ</ENTITY>"}, {"weight": 3.0, "description": "Impaired tryptophan metabolism leads to defective AHR activation.)", "source_id": "chunk-c791a4e35844d642ba0c69774072f7cd", "order": 1, "source": "AHR ACTIVATION", "target": "TRYPTOPHAN METABOLISM"}, {"weight": 2.0, "description": "Baseline \u03b22M concentration was positively associated with prevalent hypertension after adjusting for clinical covariates.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "HYPERTENSION"}, {"weight": 4.0, "description": "The rs3184504 polymorphism, associated with both \u03b22M levels and SH2B3 expression, suggests a link between these genes.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "SH2B3"}, {"weight": 6.0, "description": "Decreased SH2B3 expression was found to be causally related to higher \u03b22M levels.)", "source_id": "chunk-c29d575e156569afaa1ca3d6418a71b9", "order": 1, "source": "\u03922M", "target": "SH2B3 EXPRESSION"}, {"weight": 3.0, "description": "\u03b22 microglobulin forms part of the HLA-A*01:01 MHC complex.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "\u03922M", "target": "HLA-A*01:01"}, {"weight": 12.0, "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "HYPERTENSION", "target": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"weight": 9.0, "description": "Hypertension is associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HYPERTENSION", "target": "SUA"}, {"weight": 1.0, "description": "Carriers of the rs2231142 T allele have a significantly increased risk of developing hypertension associated with high uric acid levels.)", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "HYPERTENSION", "target": "RS2231142"}, {"weight": 2.0, "description": "SNP rs2236224 in the MTHFD1 gene was associated with an increased risk of NTDs in infants with low folate intake compared to those with high folate intake.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1", "target": "RS2236224"}, {"weight": 2.0, "description": "SNP rs2236225 in the MTHFD1 gene was associated with an increased risk of NTDs in infants with low folate intake compared to those with high folate intake.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1", "target": "RS2236225"}, {"weight": 2.0, "description": "SNP rs11627387 in the MTHFD1 gene was associated with a four-fold increase in NTD risk when there was low maternal folate intake compared to infants with the GG genotype and high maternal folate intake.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "MTHFD1", "target": "RS11627387"}, {"weight": 3.0, "description": "The MTHFD1 protein has three enzyme activities involved in the interconversion reactions of one-carbon derivatives of THF.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "ONE-CARBON METABOLISM"}, {"weight": 4.0, "description": "Mutations in MTHFD1 are clinically associated with susceptibility to neural tube defects sensitive to folates.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "NTDS"}, {"weight": 5.0, "description": "The rs2236225 polymorphism in MTHFD1 is more frequent in TMD patients compared to controls.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTHFD1", "target": "TMD"}, {"weight": 2.0, "description": "The maternal SHMT1 SNP rs669340 CG genotype was associated with a reduced risk of an NTD-affected pregnancy compared to mothers with the CC genotype.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "SHMT1", "target": "RS669340"}, {"weight": 2.0, "description": "An interaction effect was observed for risk of NTDs in infants with the SHMT1 SNP rs12939757 AG genotype that were in the low folate intake group compared to infants with the AA genotype that were in the high folate intake group.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "SHMT1", "target": "RS12939757"}, {"weight": 1.0, "description": "The SHMT1 enzyme catalyzes reactions essential for pyrimidine synthesis.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "PYRIMIDINE SYNTHESIS"}, {"weight": 2.0, "description": "Polymorphisms in the SHMT1 gene, rs1979277 and rs638416, are significantly associated with TMD.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "SHMT1", "target": "TMD"}, {"weight": 2.0, "description": "The TYMS SNP rs502396 heterozygous genotype was associated with a reduced risk of NTDs for mothers in the low folate intake group compared to the high folate intake group with the common homozygous genotype.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "RS502396"}, {"weight": 2.0, "description": "The TYMS SNP rs699517 heterozygous genotype was associated with a reduced risk of NTDs for mothers in the low folate intake group compared to the high folate intake group with the common homozygous genotype.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "RS699517"}, {"weight": 2.0, "description": "The TYMS SNP rs2847153 AG genotype was associated with a reduced risk of NTDs in infants.)", "source_id": "chunk-9a35876dc1aaf7342f023cab4f5b9914", "order": 1, "source": "TYMS", "target": "RS2847153"}, {"weight": 0.98, "description": "There is a causal effect of folate levels on B12 levels, as indicated by the IVW analysis.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "FOLATE", "target": "B12"}, {"weight": 1.0, "description": "No evidence was found for a causal effect of maternal or fetal folate levels on gestational duration.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "FOLATE", "target": "GESTATIONAL DURATION"}, {"weight": 1.0, "description": "5-methylTHF and Folic Acid are both forms of the essential nutrient folate.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "FOLATE", "target": "NUTRIENT"}, {"weight": 0.03, "description": "The rs10399931 variant showed a significant association with serum C-peptide concentration after 2 hours (p\u200a=\u200a0.03).)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "RS10399931", "target": "SERUM C-PEPTIDE CONCENTRATION"}, {"weight": 1.0, "description": "The rs4950928 variant did not show a significant association with serum C-peptide concentration.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "RS4950928", "target": "SERUM C-PEPTIDE CONCENTRATION"}, {"weight": 1.0, "description": "Individuals with normal glucose tolerance were recruited from Steno Diabetes Center.)", "source_id": "chunk-44a871da300abc9be525b468f502f5cb", "order": 1, "source": "STENO DIABETES CENTER", "target": "INDIVIDUALS WITH NORMAL GLUCOSE TOLERANCE"}, {"weight": 1.0, "description": "Women with two copies of the Y402H CFH risk allele had 2.4 times greater odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "CFH Y402H RISK ALLELE"}, {"weight": 2.0, "description": "Women with two copies of the A69S CFH risk allele had 2.2 times greater odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "A69S RISK ALLELE"}, {"weight": 3.0, "description": "Homozygosity for the G allele of rs641153 was associated with increased odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "RS641153 (CFB/C2)"}, {"weight": 4.0, "description": "Women with low HLS scores had higher odds of AMD compared to women with high HLS scores.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "HLS"}, {"weight": 5.0, "description": "Each additional risk CFH allele increased odds for AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "CFH GENOTYPE"}, {"weight": 6.0, "description": "Low HLS was associated with increased odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "HEALTHY LIFESTYLE SCORE (HLS)"}, {"weight": 7.0, "description": "The joint effect of low HLS and high-risk CFH genotype on AMD risk was greater than the sum of their individual effects, suggesting synergy.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "CFH GENOTYPE & HLS"}, {"weight": 8.0, "description": "At least one ARMS2 risk allele was associated with increased odds of AMD.)", "source_id": "chunk-23a090455f50ab98c53e8b90941c6da5", "order": 1, "source": "AMD", "target": "ARMS2 RISK ALLELE"}, {"weight": 2.0, "description": "The ARMS2 gene has been linked to an increased risk of developing AMD.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "AMD", "target": "ARMS2"}, {"weight": 0.8, "description": "There\'s an interaction between the ARMS2 genotype and healthy lifestyle score in influencing AMD risk. )", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "ARMS2", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 10.0, "description": "Omega-3 fatty acids may help reduce triglyceride levels.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "OMEGA-3 FATTY ACIDS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 0.8, "description": "The interaction between CFB/C2 genotype and healthy lifestyle score on AMD risk is unclear due to inconsistent data.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "CFB/C2", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 0.8, "description": "The interaction between the C3 rs2230199 variant and healthy lifestyle score on AMD risk is unclear due to inconsistent data.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "C3 RS2230199", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 0.8, "description": "The interaction between the CFI rs10033900 variant and healthy lifestyle score on AMD risk is unclear due to inconsistent data.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "CFI RS10033900", "target": "HEALTHY LIFESTYLE SCORE"}, {"weight": 0.7, "description": "The synergy index (SI) was used to assess potential interactions between ARMS2 genotype and healthy lifestyle score.)", "source_id": "chunk-a7d0bfa8b16262a1f313b7e3060969c6", "order": 1, "source": "HEALTHY LIFESTYLE SCORE", "target": "SYNERGY INDEX (SI)"}, {"weight": 1.0, "description": "Habitual coffee consumption, especially black coffee, was associated with a reduced risk of developing prediabetes and type 2 diabetes combined.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "COFFEE CONSUMPTION", "target": "PREDIABETES AND TYPE 2 DIABETES COMBINED"}, {"weight": 1.0, "description": "Participants who consumed \u22652 cups/day of black coffee had a lower risk of developing prediabetes and type 2 diabetes combined.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION", "target": "PREDIABETES AND TYPE 2 DIABETES COMBINED"}, {"weight": 2.0, "description": "Participants who consumed \u22652 cups/day of black coffee had a lower risk of prediabetes and type 2 diabetes compared to non-black-coffee consumers.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION", "target": "PREDIABETES AND TYPE 2 DIABETES RISK"}, {"weight": 2.0, "description": "Participants who consumed sugary coffee had a lower risk of developing prediabetes and type 2 diabetes combined.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "PREDIABETES AND TYPE 2 DIABETES COMBINED", "target": "SUGARY COFFEE CONSUMPTION"}, {"weight": 3.0, "description": "The inverse association between black coffee consumption and the risk of prediabetes and type 2 diabetes was more pronounced among individuals with high genetic risk scores, although not statistically significant.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION EFFECT ON PREDIABETES AND TYPE 2 DIABETES", "target": "HIGH GENETIC RISK SCORE"}, {"weight": 8.0, "description": "For each coffee-related SNP, the association between black coffee consumption and the risk of prediabetes and type 2 diabetes was inverse for the minor allele.)<SEP>Specific genetic variations (SNPs) in genes like HECTD4, ACAD10, MYL2, and CUX2 were associated with coffee consumption and potentially influence the relationship between coffee and diabetes risk.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "BLACK COFFEE CONSUMPTION EFFECT ON PREDIABETES AND TYPE 2 DIABETES", "target": "COFFEE-RELATED SNPS"}, {"weight": 3.0, "description": "Similar to black coffee, sugared coffee consumption was associated with a reduced risk of prediabetes and type 2 diabetes.)", "source_id": "chunk-1f20dbdcc9de443dada1a2045dc7832b", "order": 1, "source": "PREDIABETES AND TYPE 2 DIABETES RISK", "target": "SUGARED COFFEE CONSUMPTION"}, {"weight": 1.0, "description": "Deletion of SENP1 leads to increased CCL5 expression in pancreatic islets.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1", "target": "CCL5"}, {"weight": 3.0, "description": "SENP1 deficiency leads to increased production of proinflammatory cytokines by adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1", "target": "CYTOKINE PRODUCTION"}, {"weight": 4.0, "description": "SENP1 deletion increases NF-\u03baB activation in adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1", "target": "NF-\u039aB ACTIVATION"}, {"weight": 4.0, "description": "SENP1 regulates the activation of NF-\u03baB signaling pathway.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "NF-\u039aB"}, {"weight": 6.0, "description": "SENP1 deletion augments phosphorylation of IKK.)<SEP>SENP1 deletion leads to increased phosphorylation of IKK.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "IKK"}, {"weight": 3.0, "description": "SENP1 regulates phosphorylation of NF-\u03baB p65/RelA.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "NF-\u039aB P65/RELA"}, {"weight": 8.0, "description": "SENP1 deletion leads to increased SUMOylation of NEMO.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "NEMO"}, {"weight": 10.0, "description": "SENP1 deletion enhances both basal and stress-induced IKK and p65/RelA activation by etoposide VP16.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "ETOPOSIDE VP16"}, {"weight": 2.0, "description": "SENP1 siRNA reduces the expression of SENP1.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "SENP1 SIRNA"}, {"weight": 6.0, "description": "SENP1-aP2KO mice lack functional SENP1 protein in their adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "SENP1-AP2KO MICE"}, {"weight": 8.0, "description": "While SENP1 has a similar function to SENP2, it plays a more crucial role in adipocytes.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "SENP2"}, {"weight": 9.0, "description": "Overexpression of Flag-NEMO allows researchers to study its role in NF-\u03baB signaling.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1", "target": "FLAG-NEMO"}, {"weight": 2.0, "description": "SENP1 expression is correlated with the progression of T1DM.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1", "target": "T1DM"}, {"weight": 2.0, "description": "Deletion of SENP1 leads to increased infiltration of immune cells into the pancreas.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1-AP2KO", "target": "IMMUNE CELL INFILTRATION"}, {"weight": 4.0, "description": "SENP1-aP2KO mice exhibit more severe hyperglycaemia compared to NOD mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO", "target": "HYPERGLYCAEMIA"}, {"weight": 6.0, "description": "SENP1-aP2KO mice display greater islet disruption compared to NOD mice.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "SENP1-AP2KO", "target": "ISLET DISRUPTION"}, {"weight": 2.0, "description": "SENP1-aP2KO mice exhibited altered adipocyte size and number in PATs compared to Ctrl mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "PATS"}, {"weight": 6.0, "description": "SENP1 knockout (KO) mice exhibited increased liver insulin resistance under HFD conditions.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-AP2KO", "target": "LIVER INSULIN RESISTANCE"}, {"weight": 10.0, "description": "A common autoimmune manifestation seen in CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "TYPE 1 DIABETES MELLITUS", "target": "CD"}, {"weight": 8.0, "description": "Cytotoxic CD8+ T cells attack and kill pancreatic islet \u03b2 cells, contributing to the development of type 1 diabetes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "PANCREATIC ISLET \u0392 CELLS", "target": "CD8+ T CELLS"}, {"weight": 2.0, "description": "SENP1-deficient mice develop autoimmune mediated damages resembling type 1 diabetes, including \u03b2 cell destruction and autoantibody production.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "SENP1-DEFICIENT MICE", "target": "TYPE 1 DIABETES"}, {"weight": 6.0, "description": "Similar insulin responses were observed between SENP1-deficient mice and Ctrl under standard chow in the ITT assay.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "SENP1-DEFICIENT MICE", "target": "ITT ASSAY"}, {"weight": 6.0, "description": "Immune cell invasion, particularly by T cells, plays a crucial role in the T-cell mediated destruction of \u03b2 cells in diabetes.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "IMMUNE CELL INVASION", "target": "T-CELL MEDIATED DESTRUCTION"}, {"weight": 10.0, "description": "Elevated levels of insulin autoantibodies (IAA) are a diagnostic marker for type 1 diabetes, indicating an autoimmune attack on \u03b2 cells.)", "source_id": "chunk-fc33d6399ec56e65d007269407f1953d", "order": 1, "source": "TYPE 1 DIABETES", "target": "INSULIN AUTOANTIBODY (IAA)"}, {"weight": 6.0, "description": "CD8+ T cells recognize neoepitopes presented by MHC molecules.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "NEOEPITOPE"}, {"weight": 8.0, "description": "PBMCs contain CD8+ T cells.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "CD8+ T CELLS", "target": "PBMCS"}, {"weight": 8.0, "description": "The NOD mouse is a model commonly used for studying T1DM.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "T1DM", "target": "NOD MOUSE"}, {"weight": 7.0, "description": "HFD augmented both T1DM and T2DM phenotypes in SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "T1DM", "target": "HFD"}, {"weight": 7.0, "description": "Expression of various SENPs, including SENP1 and SENP2, is examined in PATs.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "PATS", "target": "SENPS"}, {"weight": 1.0, "description": "HFD increased fat weight in all adipose depots, including PATs.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "PATS", "target": "HFD"}, {"weight": 16.0, "description": "A significant increase of macrophages was observed in the dermis of paradoxical skin reactions.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "MACROPHAGES", "target": "PARADOXICAL PSORIASIS"}, {"weight": 1.0, "description": "IL\u201022 was similar in T cells of psoriasiform lesions and classical psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "T CELLS", "target": "IL\u201022"}, {"weight": 1.0, "description": "Ctrl serves as a baseline compared to SENP1 knockdown cells.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "CTRL", "target": "SENP1 SIRNA"}, {"weight": 6.0, "description": "SENP1-deficient adipocytes have smaller cell sizes compared to control adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1-AP2KO ADIPOCYTES", "target": "SMALLER CELL SIZE"}, {"weight": 1.0, "description": "SENP1-deficient adipocytes produce higher levels of proinflammatory cytokines compared to control adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "SENP1-AP2KO ADIPOCYTES", "target": "PROINFLAMMATORY CYTOKINE PRODUCTION"}, {"weight": 9.0, "description": "NEMO can be SUMOylated by SUMO1.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NEMO", "target": "SUMO1"}, {"weight": 3.0, "description": "siRNA is introduced into adipocytes to manipulate SENP1 expression.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "SENP1 SIRNA", "target": "ADIPOCYTES"}, {"weight": 15.0, "description": "The LPL gene is expressed in adipocytes, which produce lipoprotein lipase.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "ADIPOCYTES", "target": "LPL"}, {"weight": 10.0, "description": "The expression of SENP1 in adipocytes of NOD mice is investigated to determine its relevance to T1DM.)", "source_id": "chunk-f290cff8dac7b522b4f56d03e8df48ce", "order": 1, "source": "NOD MICE", "target": "SENP1 EXPRESSION"}, {"weight": 3.0, "description": "HFD significantly augmented the production of IL-6, TNF-\u03b1, and IL-1\u03b2 in PATs.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "CYTOKINE PRODUCTION"}, {"weight": 10.0, "description": "HFD caused insulin resistance in both Ctrl and SENP1-aP2KO mice, but the phenotype was more severe in SENP1-aP2KO mice.)<SEP>HFD induced insulin resistance in both Ctrl and SENP1-aP2KO mice, but the phenotype was more severe in SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "INSULIN RESISTANCE"}, {"weight": 1.0, "description": "HFD increased fat weight in epididymal fat depots.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "EPIDIDYMAL FAT"}, {"weight": 2.0, "description": "HFD increased body weight in SENP1-aP2KO mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "BODY WEIGHT"}, {"weight": 4.0, "description": "HFD further reduced insulin levels in SENP1-aP2KO mice, but not in Ctrl mice.)", "source_id": "chunk-174831b97ed170039b374ba254d4f506", "order": 1, "source": "HFD", "target": "INSULIN LEVELS"}, {"weight": 4.0, "description": "Deletion of SENP1 leads to increased NF-\u03baB activation in adipocytes.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "NF-\u039aB ACTIVATION", "target": "SENP1 DELETION"}, {"weight": 5.0, "description": "Cytokines secreted from SENP1-deficient adipocytes induce \u03b2 cell death in pancreatic islets.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "ADIPOCYTE-DERIVED CYTOKINES", "target": "\u0392 CELL DEATH"}, {"weight": 3.0, "description": "Adipocytes from SENP1-deficient mice exhibit reduced adipogenic differentiation markers.)", "source_id": "chunk-eaf655c4dd9244523b048a122e232be4", "order": 1, "source": "REDUCED ADIPOGENESIS", "target": "SENP1-DEFICIENT ADIPOCYTES"}, {"weight": 10.0, "description": "Proinflammatory cytokine levels are significantly higher in human T1DM patients compared to healthy individuals.)", "source_id": "chunk-8382a49b61215482f9fc75e3a86cb987", "order": 1, "source": "HUMAN T1DM PATIENTS", "target": "PROINFLAMMATORY CYTOKINES"}, {"weight": 1.0, "description": "FokI is also known as the genomic variant with identifier rs2228570.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "FOKI", "target": "RS2228570"}, {"weight": 1.0, "description": "FokI is also known as the genomic variant with identifier rs10735810.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "FOKI", "target": "RS10735810"}, {"weight": 1.0, "description": "ApaI is also known as the genomic variant with identifier rs7975232.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "APAI", "target": "RS7975232"}, {"weight": 1.0, "description": "BsmI is also known as the genomic variant with identifier rs1544410.)", "source_id": "chunk-1c470c93632f3704d6f3566de7a1dd0c", "order": 1, "source": "BSMI", "target": "RS1544410"}, {"weight": 4.0, "description": "rs2228570 is a variant within the VDR gene.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "VDR"}, {"weight": 8.0, "description": "rs2228570 shows low linkage disequilibrium (LD) with the other SNPs.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "RS731236"}, {"weight": 20.0, "description": "The rs2228570 variant is associated with susceptibility to T. cruzi infection.)<SEP>The rs2228570 variant may protect against _T. cruzi_ infection, as individuals with the minor allele have lower risk.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "T. CRUZI INFECTION"}, {"weight": 22.0, "description": "The rs2228570 variant is associated with susceptibility to Chagas cardiomyopathy (CCC).)<SEP>The rs2228570 variant may be protective against Chagas cardiomyopathy (CCC), as its minor allele is less common in patients with CCC.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS2228570", "target": "CCC"}, {"weight": 2.0, "description": "rs7975232 is a variant within the VDR gene.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS7975232", "target": "VDR"}, {"weight": 5.0, "description": "rs731236 and rs7975232 show high linkage disequilibrium (LD) in this population.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS7975232", "target": "RS731236"}, {"weight": 7.0, "description": "rs7975232 and rs1544410 show high LD in this population.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS7975232", "target": "RS1544410"}, {"weight": 3.0, "description": "rs1544410 is a variant within the VDR gene.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS1544410", "target": "VDR"}, {"weight": 6.0, "description": "rs731236 and rs1544410 show high LD in this population.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "RS1544410", "target": "RS731236"}, {"weight": 1.0, "description": "rs731236 is a variant within the VDR gene.)", "source_id": "chunk-6600322cc75094b1c57707e4b9c85954", "order": 1, "source": "VDR", "target": "RS731236"}, {"weight": 1.0, "description": "The IL-1A -889C>T genotype was more frequent in HNP patients compared to controls.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "HNP", "target": "IL-1A -889C>T"}, {"weight": 2.0, "description": "The CT genotype and T allele of TNF-A 238G>A were more frequent in healthy controls than in HNP cases.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "HNP", "target": "TNF-A 238G>A"}, {"weight": 3.0, "description": "No association was observed between VDR TaqI genotypes and HNP susceptibility.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "HNP", "target": "VDR TAQI"}, {"weight": 4.0, "description": "Patients with the CT genotype of IL-1A -889C>T were more frequent in HNP cases compared to healthy controls.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "CT GENOTYPE"}, {"weight": 5.0, "description": "Patients with the TT genotype of IL-1A -889C>T were more frequent in HNP cases compared to healthy controls.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "IL-1A -889C>T", "target": "TT GENOTYPE"}, {"weight": 6.0, "description": "The CT genotype of TNF-A 238G>A was more frequent in healthy controls compared to HNP cases.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "CT GENOTYPE"}, {"weight": 7.0, "description": "The T allele of TNF-A 238G>A was more frequent in healthy controls compared to HNP cases.)", "source_id": "chunk-ba82b7eb40cf9eea561d839b20584f91", "order": 1, "source": "TNF-A 238G>A", "target": "T ALLELE"}, {"weight": 3.0, "description": "Individuals with the CC genotype at the C-13910 locus exhibit lactase non-persistence.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "CC GENOTYPE", "target": "LACTASE NON-PERSISTENCE"}, {"weight": 1.6, "description": "There was a statistically significant association between the CC genotype and the occurrence of colorectal cancer (CRC).)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "CC GENOTYPE", "target": "CRC"}, {"weight": 4.0, "description": "Individuals with the TT genotype at the C-13910 locus exhibit lactase persistence.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "TT GENOTYPE", "target": "LACTASE PERSISTENCE"}, {"weight": 5.0, "description": "Presence of the TT genotype at the rs4073 locus is associated with a higher risk of asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "TT GENOTYPE", "target": "ASTHMA RISK"}, {"weight": 0.6, "description": "The presence of the T allele was slightly less common in individuals with CRC, but this association did not reach statistical significance.)", "source_id": "chunk-5b0cc96debf110f3544685d3b227ff27", "order": 1, "source": "T ALLELE", "target": "CRC"}, {"weight": 1.0, "description": "No evidence was found for a causal effect of maternal or fetal B12 levels on gestational duration.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "B12", "target": "GESTATIONAL DURATION"}, {"weight": 2.0, "description": "Low serum folate concentration can lead to elevated homocysteine levels.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SERUM FOLATE CONCENTRATION", "target": "HOMOCYSTEINE CONCENTRATION (THCY)"}, {"weight": 1.0, "description": "The Danish cohort studies measured maternal B12 levels in pregnant women.)", "source_id": "chunk-22216738ccbae0a6276bb4499018c434", "order": 1, "source": "DANISH COHORT", "target": "MATERNAL B12 LEVELS"}, {"weight": 0.6, "description": "The MMACHC variant (rs12272669) appeared to have little effect on B12 levels in pregnant women at 28 weeks of gestation.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "B12 LEVELS", "target": "MMACHC VARIANT"}, {"weight": 1.0, "description": "The FUT2 variant contributed to the variance in serum B12 and folate concentrations in the original GWAS.)", "source_id": "chunk-1d2a8d3ce4f9baae7e1c9c14410045d0", "order": 1, "source": "B12 AND FOLATE CONCENTRATIONS", "target": "FUT2 VARIANT"}, {"weight": 2.8, "description": "A higher prevalence of MTHFR C677T variant carriers was observed in LV patients compared to the general population.)<SEP>MTHFR C677T variant carrier rates were evaluated in LV patients across different regions.)<SEP>The MTHFR C677T variant was found in a proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR C677T", "target": "LV PATIENTS"}, {"weight": 1.7, "description": "MTHFR A1298C variant carrier rates were evaluated in LV patients across different regions.)<SEP>The MTHFR A1298C variant was found in a proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "MTHFR A1298C", "target": "LV PATIENTS"}, {"weight": 1.9, "description": "PAI\u20101 \u2010675 4G/5G polymorphism carrier rates were evaluated in LV patients across different regions.)<SEP>The PAI\u20101 \u2010675 4G/5G variant was found in a high proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 \u2010675 4G/5G", "target": "LV PATIENTS"}, {"weight": 2.6, "description": "PAI\u20101 A844G polymorphism has not been tested in Asian LV patients.)<SEP>The PAI\u20101 A844G variant was found in a moderate proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PAI\u20101 A844G", "target": "LV PATIENTS"}, {"weight": 1.3, "description": "Prothrombin G20210A variant carrier rates were evaluated in LV patients across different regions.)<SEP>The Prothrombin G20210A variant was found in a low proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "PROTHROMBIN G20210A", "target": "LV PATIENTS"}, {"weight": 1.4, "description": "Factor V G1691A variant carrier rates were evaluated in LV patients across different regions.)<SEP>The Factor V G1691A variant was found in a relatively low proportion of LV patients across various studies.)", "source_id": "chunk-d0476488384aadcae4630e94d982d2e0<SEP>chunk-b025a32e74a29cbbd5a0ce3d051f3fdb", "order": 1, "source": "FACTOR V G1691A", "target": "LV PATIENTS"}, {"weight": 1.0, "description": "Infertile men generally have poorer semen quality compared to fertile men.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "SEMEN QUALITY"}, {"weight": 3.0, "description": "Homozygosity for the PEMT M175V minor V allele is associated with male infertility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "PEMT M175V MINOR V ALLELE"}, {"weight": 4.0, "description": "Heterozygosity for the TCblR rs173665 variant is associated with reduced risk of male infertility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "TCBLR RS173665"}, {"weight": 4.0, "description": "Higher levels of DNA fragmentation in sperm are associated with male infertility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "DNA FRAGMENTATION"}, {"weight": 5.0, "description": "Infertile men often have lower semen concentration than fertile men.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "SEMEN CONCENTRATION"}, {"weight": 6.0, "description": "Infertile men often have a lower sperm number compared to fertile men.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "SPERM NUMBER"}, {"weight": 7.0, "description": "Infertile men may have a higher percentage of non-motile sperm.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "NON-MOTILE SPERM"}, {"weight": 8.0, "description": "Infertile men may have a higher semen volume compared to fertile men.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "SEMEN VOLUME"}, {"weight": 10.0, "description": "Studies suggest a correlation between education level and infertility, though the exact relationship is complex.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "INFERTILITY", "target": "EDUCATION LEVEL"}, {"weight": 2.0, "description": "A measure of sperm motility.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SEMEN QUALITY", "target": "TOTAL PROGRESSIVE SPERM"}, {"weight": 3.0, "description": "A measure of sperm shape.)", "source_id": "chunk-c9badb9a0fb813f42383cc8afc57ad45", "order": 1, "source": "SEMEN QUALITY", "target": "NORMAL SPERM MORPHOLOGY"}, {"weight": 6.0, "description": "The GSTM1 enzyme is involved in detoxifying electrophilic compounds, including carcinogens and toxins.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "GSTM1", "target": "DETOXIFICATION"}, {"weight": 7.0, "description": "The deletion of the GSTM1 gene is associated with an increased risk of cancer.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "GSTM1-NULL POLYMORPHISM", "target": "INCREASED CANCER RISK"}, {"weight": 8.0, "description": "The MTRR protein regenerates Methionine Synthase (MTR) by reductive methylation.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTRR", "target": "METHIONINE SYNTHASE REGENERATION"}, {"weight": 9.0, "description": "Increased frequency of the A allele in rs1801394 polymorphism within MTRR gene is found in TMD patients.)", "source_id": "chunk-382f24e5db6941e2e3db379fe499b223", "order": 1, "source": "MTRR", "target": "TMD"}, {"weight": 1.998, "description": "The CDC MBA and CDC HPLC-MS/MS methods are two different approaches for measuring serum folate concentrations.)", "source_id": "chunk-dd3c1834035af8b4436c8058609b6fd8", "order": 1, "source": "CDC MBA", "target": "CDC HPLC-MS/MS"}, {"weight": 6.0, "description": "Serum samples of S-FOL were compared with IH-CAL as a calibrator.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "IH-CAL", "target": "S-FOL"}, {"weight": 8.0, "description": "Whole blood samples of WB-FOL were compared with IH-CAL as a calibrator.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "IH-CAL", "target": "WB-FOL"}, {"weight": 2.0, "description": "Serum and whole blood samples of S-FOL were compared with CDC-CAL as a calibrator.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "S-FOL", "target": "CDC-CAL"}, {"weight": 1.0, "description": "S-FOL measurements are compared to the CDC MBA target value for accuracy assessment.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "S-FOL", "target": "CDC MBA TARGET VALUE"}, {"weight": 3.0, "description": "The use of IH reagents influences the accuracy of S-FOL measurement.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "S-FOL", "target": "IH REAGENTS"}, {"weight": 5.0, "description": "The use of CDC reagents improves the accuracy of S-FOL measurement compared to IH reagents.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "S-FOL", "target": "CDC REAGENTS"}, {"weight": 4.0, "description": "Serum and whole blood samples of WB-FOL were compared with CDC-CAL as a calibrator.)", "source_id": "chunk-257a38a8ce6582c434f31b023b4a9704", "order": 1, "source": "WB-FOL", "target": "CDC-CAL"}, {"weight": 2.0, "description": "WB-FOL measurements are compared to the CDC MBA target value for accuracy assessment.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "WB-FOL", "target": "CDC MBA TARGET VALUE"}, {"weight": 4.0, "description": "The use of IH reagents influences the accuracy of WB-FOL measurement.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "WB-FOL", "target": "IH REAGENTS"}, {"weight": 6.0, "description": "The use of CDC reagents improves the accuracy of WB-FOL measurement compared to IH reagents.)", "source_id": "chunk-7c25217961fba65d15f20beda8a58f1c", "order": 1, "source": "WB-FOL", "target": "CDC REAGENTS"}, {"weight": 1.0, "description": "The GG genotype of rs1695 polymorphism is associated with an increased risk of breast cancer (OR= 3.1532).)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "RS1695", "target": "BREAST CANCER"}, {"weight": 8.0, "description": "The rs1695 variant in the GSTP1 gene was associated with a reduced risk of using colony-stimulating factors (CSFs).)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1695", "target": "CSF USE"}, {"weight": 0.0, "description": "Neither the TT nor CT genotype of rs1138272 polymorphism is significantly associated with breast cancer.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "RS1138272", "target": "BREAST CANCER"}, {"weight": 3.0, "description": "Individuals with the CT genotype reported greater craving when treated with placebo compared to olanzapine.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "CT", "target": "OLANZAPINE"}, {"weight": 1.0, "description": "The GG genotype of rs1695 is associated with an increased risk of breast cancer (OR= 3.1532).)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "BREAST CANCER", "target": "RS1695 POLYMORPHISM"}, {"weight": 1.0, "description": "A substantial number of patients had breast malignancies.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "BREAST CANCER", "target": "PATIENT CHARACTERISTIC"}, {"weight": 0.3, "description": "The Ile105Val SNP does not influence the aggregation tendency or chaperone binding tendency of GSTP1 protein.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL", "target": "GSTP1 FUNCTION"}, {"weight": 0.7, "description": "The Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL", "target": "AMYLOID PROPENSITY"}, {"weight": 0.3, "description": "The Ile105Val SNP does not influence the aggregation tendency or chaperone binding tendency of GSTP1 protein.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL SNP", "target": "GSTP1 FUNCTION"}, {"weight": 0.7, "description": "The Ile105Val polymorphism decreases the amyloid propensity of the GSTP1 enzyme.)", "source_id": "chunk-ab5011584b0230efbf80a98b2a693a0e", "order": 1, "source": "ILE105VAL SNP", "target": "AMYLOID PROPENSITY"}, {"weight": 2.0, "description": "The p.R778L variant is strongly associated with haplogroup A, which is overwhelmingly common on WD chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP A"}, {"weight": 6.0, "description": "The p.R778L variant is strongly associated with Haplogroup A1, a subvariant of Haplogroup A.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP A1"}, {"weight": 7.0, "description": "The p.R778L variant is less commonly associated with Haplogroup B.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP B"}, {"weight": 8.0, "description": "The p.R778L variant is rarely associated with Haplogroup C.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.R778L", "target": "HAPLOGROUP C"}, {"weight": 2.0, "description": "The pathogenic variant p.P9992L is associated with WD (Wilson\'s Disease).)", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.P992L", "target": "WD"}, {"weight": 6.0, "description": "The p.P992L variant is associated with haplogroup E, which is more common on WD chromosomes than control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E"}, {"weight": 9.0, "description": "The p.P992L variant is more strongly associated with Haplogroup E1, a subvariant of Haplogroup E.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E1"}, {"weight": 10.0, "description": "The p.P992L variant is weakly associated with Haplogroup E2.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP E2"}, {"weight": 11.0, "description": "The p.P992L variant shows sporadic association with Haplogroups D, F, G, H, and I.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.P992L", "target": "HAPLOGROUP D, F, G, H, I"}, {"weight": 3.0, "description": "The pathogenic variant p.T935M is associated with WD (Wilson\'s Disease).)", "source_id": "chunk-047f259db19cbb4de945706a1bd1b450", "order": 1, "source": "P.T935M", "target": "WD"}, {"weight": 10.0, "description": "The p.T935M variant is associated with a uniform haplogroup J, which is significantly more common on WD chromosomes compared to control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J"}, {"weight": 12.0, "description": "The p.T935M variant is strongly associated with Haplogroup J1, a subvariant of Haplogroup J.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J1"}, {"weight": 13.0, "description": "The p.T935M variant shows weaker association with Haplogroup J2.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "P.T935M", "target": "HAPLOGROUP J2"}, {"weight": 4.0, "description": "Haplogroup A is prevalent on WD chromosomes compared to control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP A", "target": "WD CHROMOSOMES"}, {"weight": 8.0, "description": "Haplogroup E is more prevalent on WD chromosomes compared to control chromosomes.)", "source_id": "chunk-fa2d834930246b534181c3d6d2c049e1", "order": 1, "source": "HAPLOGROUP E", "target": "WD CHROMOSOMES"}, {"weight": 2.0, "description": "The SNPs rs1799853, rs1057910, and rs9923231 are combined into a CYP2C9 star variant group due to low frequency.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9*2", "target": "CYP2C9*3"}, {"weight": 4.0, "description": "The SNPs rs1799853, rs1057910, and rs9923231 are combined into a CYP2C9 star variant group due to low frequency.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9*5", "target": "CYP2C9*8"}, {"weight": 6.0, "description": "The SNPs rs1799853, rs1057910, and rs9923231 are combined into a CYP2C9 star variant group due to low frequency.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9*11", "target": "CYP2C9 STAR VARIANT GROUP"}, {"weight": 1.0, "description": "The AA algorithm significantly outperformed IWPC algorithms in correctly identifying high-dose patients.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "AA ALGORITHM", "target": "HIGH DOSE GROUP"}, {"weight": 6.0, "description": "The AA algorithm outperformed the IWPC clinical algorithm in predicting accurate drug doses.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "AA ALGORITHM", "target": "IWPC CLINICAL ALGORITHM"}, {"weight": 4.0, "description": "The IWPC pharmacogenomics algorithm predicts drug doses based on genetic information.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "PREDICTED DOSE", "target": "IWPC PHARMACOGENOMICS ALGORITHM"}, {"weight": 4.0, "description": "A NNG of approximately three patients genotyped was estimated to prevent one predicted dose from being outside the 20% therapeutic dose range.)", "source_id": "chunk-b2730f3087aee6d9cff6e4939b229323", "order": 1, "source": "PREDICTED DOSE", "target": "NNG"}, {"weight": 4.0, "description": "The CYP2C9 star variant group is associated with an increased risk of DVT/PE.)", "source_id": "chunk-f433e179cd5e32035a0303b9a14da3f1", "order": 1, "source": "CYP2C9 STAR VARIANT GROUP", "target": "DVT/PE"}, {"weight": 1.0, "description": "The c.428_430delAAG variant is a mutation in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "C.428_430DELAAG"}, {"weight": 2.0, "description": "The c.1186C\u2009>\u2009T variant is another mutation in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "C.1186C\u2009>\u2009T"}, {"weight": 3.0, "description": "The compound heterozygous sample carries both the c.428_430delAAG and c.1186C\u2009>\u2009T variants in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "COMPOUND HETEROZYGOUS SAMPLE"}, {"weight": 12.0, "description": "HRMA is a method used to genotype variations in the CYP24A1 gene.)<SEP>HRMA was used to genotype variations in the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "HRMA"}, {"weight": 5.0, "description": "Sanger sequencing was used to confirm genotypes of the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "SANGER SEQUENCING"}, {"weight": 6.0, "description": "The rs777676129 variant is a SNP located within the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "RS777676129"}, {"weight": 7.0, "description": "The rs114368325 variant is a SNP located within the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "RS114368325"}, {"weight": 10.0, "description": "Two samples with no CYP24A1 variants were used as wild-type controls.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "WILD-TYPE (WT)"}, {"weight": 11.0, "description": "One sample was heterozygous for the c.1186C\u2009>\u2009T variant.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "HETEROZYGOUS"}, {"weight": 12.0, "description": "One sample was homozygous for the c.1186C\u2009>\u2009T variant.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "HOMOZYGOUS"}, {"weight": 13.0, "description": "One sample was compound heterozygous, carrying both the c.428_430delAAG and c.1186C\u2009>\u2009T variants.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "COMPOUND HETEROZYGOUS"}, {"weight": 15.0, "description": "Direct DNA sequencing was used to confirm genotypes of the CYP24A1 gene.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "CYP24A1", "target": "DIRECT DNA SEQUENCING"}, {"weight": 1.0, "description": "A suggestive relationship was observed between the CYP24A1 SNP rs927650 and concentrations of 25(OH)D.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS927650", "target": "25(OH)D"}, {"weight": 3.0, "description": "The minor allele (A) of rs35051736 was completely absent in individuals with advanced lesions.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS35051736", "target": "ADVANCED ADENOMA"}, {"weight": 4.0, "description": "Increasing number of copies of the G allele in CYP24A1 rs2296241 were associated with higher odds for any adenoma recurrence.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "RS2296241", "target": "ADENOMA RECURRENCE"}, {"weight": 5.0, "description": "There was a nominally statistically significant interaction between CYP24A1 SNP rs2296241 and 25(OH)D.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "25(OH)D", "target": "CYP24A1 SNP RS2296241"}, {"weight": 6.0, "description": "There was a nominally statistically significant interaction between CYP24A1 SNP rs2762939 and 1,25(OH)2D.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "1,25(OH)2D", "target": "CYP24A1 RS2762939"}, {"weight": 2.0, "description": "There was a nominally statistically significant association between the CYP24A1 SNP rs927650 and odds for any adenoma recurrence.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "ADENOMA RECURRENCE", "target": "CYP24A1 SNP RS927650"}, {"weight": 3.0, "description": "The minor allele (A) was completely absent in individuals with advanced lesions.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "ADVANCED ADENOMA", "target": "CYP24A1 RS35051736"}, {"weight": 4.0, "description": "There was a nominally statistically significant association between increasing number of copies of the G allele in CYP24A1 rs2296241 and higher odds for recurrent adenomas with villous histology.)", "source_id": "chunk-2fb95100a1290b27baae869c6560419a", "order": 1, "source": "CYP24A1 RS2296241", "target": "VILLOUS HISTOLOGY"}, {"weight": 14.0, "description": "The genotype assignments obtained by dHRMA were concordant with results of single plex HRMA and Sanger sequencing.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "HRMA", "target": "GENOTYPE ASSIGNMENT"}, {"weight": 16.0, "description": "The inter-assay precision was assessed running the same samples in triplicates on 3 different PCR/HRM experiments.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "HRMA", "target": "INTER-ASSAY PRECISION"}, {"weight": 17.0, "description": "The intra-assay precision was analyzed by running 5 replicates of one single wild-type and homozygous/heterozygous samples, respectively.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "HRMA", "target": "INTRA-ASSAY PRECISION"}, {"weight": 18.0, "description": "Serial dilutions were used to evaluate the sensitivity of HRMA.)", "source_id": "chunk-1327975b50e4a0aac1792cb595041ee5", "order": 1, "source": "HRMA", "target": "SERIAL DILUTIONS"}, {"weight": 2.0, "description": "The P1001L mutation is associated with Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "P1001L", "target": "MENKES DISEASE"}, {"weight": 1.0, "description": "Mutations in the ATP7A gene cause Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "ATP7A", "target": "MENKES DISEASE"}, {"weight": 3.0, "description": "Elevated b2-microglobulin levels indicate potential copper overload, a feature of Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "COPPER OVERLOAD", "target": "B2-MICROGLOBULIN"}, {"weight": 4.0, "description": "Deficient dopamine-\u03b2-hydroxylase activity suggests copper deficiency, which is inconsistent with Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "COPPER OVERLOAD", "target": "DOPAMINE-\u0392-HYDROXYLASE"}, {"weight": 5.0, "description": "Elevated cerebrospinal fluid copper is a diagnostic indicator of Menkes disease.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "CEREBROSPINAL FLUID COPPER", "target": "MENKES DISEASE"}, {"weight": 6.0, "description": "Tissue-specific mosaicism was observed for the P1001L mutation, with different levels of mutant allele expression in fibroblasts compared to blood DNA.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "FIBROBLAST", "target": "ATP7A MOSAICISM"}, {"weight": 7.0, "description": "Mosaic P1001L mutation was detected in the patient\u2019s blood DNA, indicating a mixture of wild-type and mutant alleles.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "BLOOD DNA", "target": "ATP7A MOSAICISM"}, {"weight": 8.0, "description": "Mosaic P1001L mutation was analyzed in a primary fibroblast culture, revealing higher mutant allele proportion compared to blood DNA.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "PRIMARY FIBROBLAST CULTURE", "target": "ATP7A MOSAICISM"}, {"weight": 9.0, "description": "Q-RT-PCR analysis confirmed tissue-specific mosaicism for the P1001L mutation, with varying allele ratios in blood and fibroblasts.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "Q-RT-PCR", "target": "ATP7A MOSAICISM"}, {"weight": 10.0, "description": "The patient\'s performance on the Denver Developmental Screening Test II indicated delays in gross motor, fine motor, language, and personal-social development.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "DENVER DEVELOPMENTAL SCREENING TEST II", "target": "DEVELOPMENTAL DELAY"}, {"weight": 1.0, "description": "Abnormalities in median nerve compound motor action potentials can indicate neurological dysfunction.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIAL", "target": "NEUROLOGICAL FUNCTION"}, {"weight": 2.0, "description": "Slowed median nerve conduction velocity can be a sign of nerve damage.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "MEDIAN NERVE CONDUCTION VELOCITY", "target": "NEUROLOGICAL FUNCTION"}, {"weight": 3.0, "description": "Abnormal sensory action potentials can indicate problems with sensory perception.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "SENSORY ACTION POTENTIAL", "target": "NEUROLOGICAL FUNCTION"}, {"weight": 4.0, "description": "Brain MRI results can reveal structural abnormalities in the brain, such as atrophy and delayed myelination.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "BRAIN MRI", "target": "NEUROLOGICAL EXAMINATION"}, {"weight": 5.0, "description": "Brain atrophy can be a sign of neurological disorders.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "ATROPHY", "target": "NEUROLOGICAL DISORDER"}, {"weight": 6.0, "description": "Delayed myelination can affect neurological development.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "DELAYED MYELINATION", "target": "NEUROLOGICAL DEVELOPMENT"}, {"weight": 7.0, "description": "These tests can help diagnose nerve disorders.)", "source_id": "chunk-c5f88943265b25ad302b08fd04a602d7", "order": 1, "source": "CLINICAL NEUROPHYSIOLOGY STUDIES", "target": "NEUROLOGICAL FUNCTION"}, {"weight": 1.0, "description": "The expression of GPx4 was greater in IDI-C cells when sufficient Se was present.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX4", "target": "IDI-C"}, {"weight": 2.0, "description": "The expression of GPx4 was similar in both IDI-T and IDI-C cells when grown in either Se-depleted or supplemented medium.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX4", "target": "IDI-T"}, {"weight": 5.0, "description": "When grown in Se supplemented medium, IDI-T cells showed less sensitivity to oxidative stress than IDI-C cells after tert-butylhydroperoxide challenge.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-T", "target": "OXIDATIVE STRESS"}, {"weight": 2.0, "description": "IDI-T cells express the IDI transcript, leading to altered ROS response compared to IDI-C cells.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-T", "target": "IDI TRANSCRIPT"}, {"weight": 3.0, "description": "The levels of selenoprotein H mRNA were significantly lower in IDI-C cells compared with IDI-T whether the cells were grown in either Se-depleted or supplemented medium.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C", "target": "SELENOPROTEIN H MRNA"}, {"weight": 4.0, "description": "Under low Se supply, IDI-C cells experienced greater oxidative stress than IDI-T cells after a challenge with tert-butylhydroperoxide.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C", "target": "OXIDATIVE STRESS"}, {"weight": 1.0, "description": "IDI-C cells express the IDI transcript, leading to increased GPx4 activity and altered ROS response.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C", "target": "IDI TRANSCRIPT"}, {"weight": 4.0, "description": "IDI-C cells showed a greater increase in ROS levels after tert-butylhydroperoxide challenge compared to IDI-T cells.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "IDI-C", "target": "ROS"}, {"weight": 2.0, "description": "GSH levels reflect the balance between oxidized and reduced glutathione, a key indicator of oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "GSH"}, {"weight": 3.0, "description": "Elevated GSSG/GSH ratio indicates increased oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "GSSG"}, {"weight": 4.0, "description": "High homocysteine levels are associated with increased oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "HCY"}, {"weight": 5.0, "description": "Oxidation of LDL is a marker of lipid peroxidation and oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "OXLDL"}, {"weight": 6.0, "description": "CD is a marker of lipid peroxidation, an indicator of oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "CD"}, {"weight": 7.0, "description": "BCD-LDL measures products of lipid peroxidation and reflects oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "BCD-LDL"}, {"weight": 8.0, "description": "Total antioxidant capacity (TAOC) reflects the body\'s ability to neutralize free radicals and combat oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "OXIDATIVE STRESS", "target": "TAOC"}, {"weight": 0.7, "description": "Methylation of BCL2L11 is associated with oxidative stress markers like TGSH and GSH.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "OXIDATIVE STRESS", "target": "BCL2L11"}, {"weight": 5.0, "description": "Higher Se concentrations led to increased GPx activity in IDI-C cells.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GPX ACTIVITY", "target": "SE CONCENTRATION"}, {"weight": 3.0, "description": "Expression levels of the IDI transcript were normalized to GAPDH expression.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "GAPDH", "target": "IDI TRANSCRIPT"}, {"weight": 6.0, "description": "Higher concentrations of Se led to greater GPx4 activity in IDI-C cells.)", "source_id": "chunk-a908a3115a9120ca2623513fe4a5e13a", "order": 1, "source": "SE CONCENTRATION", "target": "GPX4 ACTIVITY"}, {"weight": 8.0, "description": "The p.Thr553Asn mutation affects the ChAT protein.)<SEP>p.Thr553Asn is a missense mutation in the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.THR553ASN"}, {"weight": 11.0, "description": "The p.Ser704Pro mutation affects the ChAT protein.)<SEP>p.Ser704Pro is a missense mutation in the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.SER704PRO"}, {"weight": 14.0, "description": "The p.Ala557Thr mutation affects the ChAT protein.)<SEP>p.Ala557Thr is a missense mutation in the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.ALA557THR"}, {"weight": 17.0, "description": "The p.Val136Met mutation affects the ChAT protein.)<SEP>p.Val136Met is a missense mutation in the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.VAL136MET"}, {"weight": 20.0, "description": "The p.Ile689Ser mutation affects the ChAT protein.)<SEP>p.Ile689Ser is a missense mutation in the CHAT gene.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "CHAT", "target": "P.ILE689SER"}, {"weight": 11.0, "description": "ChAT cDNAs were genetically engineered into Bosc 23 cells to study mutant and wild-type protein expression.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "BOSC 23 CELLS", "target": "CHAT CDNAS"}, {"weight": 12.0, "description": "His-tagged ChAT cDNAs were transformed into E. coli to purify the enzymes.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "E. COLI", "target": "CHAT CDNAS"}, {"weight": 13.0, "description": "His-tagged ChAT was purified from E. coli lysates using a Ni-NTA column.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "NI-NTA COLUMN", "target": "CHAT CDNAS"}, {"weight": 14.0, "description": "Purified ChAT was further purified using fast protein liquid chromatography.)", "source_id": "chunk-2266e03ff38ff200390d9e9e50efbd74", "order": 1, "source": "FAST PROTEIN LIQUID CHROMATOGRAPHY", "target": "CHAT CDNAS"}, {"weight": 2.0, "description": "Patients with CD experience chronic diarrhea, abdominal pain, anorexia and abdominal distension.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "CLINICAL SYMPTOMS"}, {"weight": 4.0, "description": "Autoimmune manifestations in CD patients include type 1 diabetes mellitus, autoimmune thyroiditis, and systemic lupus erythematosus.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "AUTOIMMUNE MANIFESTATIONS"}, {"weight": 6.0, "description": "Non-autoimmune disease manifestations in CD patients include osteomalacia, seizure disorders, and Down syndrome.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "NON-AUTOIMMUNE DISEASE MANIFESTATIONS"}, {"weight": 8.0, "description": "Minor \'G\' allele of rs2395182 is more prevalent in healthy controls compared to CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "RS2395182"}, {"weight": 10.0, "description": "Minor \'C\' allele of rs7775228 is more frequent in controls compared to CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "RS7775228"}, {"weight": 12.0, "description": "Minor \'T\' allele of rs2187668 is more prevalent in CD patients compared to healthy controls.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "RS2187668"}, {"weight": 14.0, "description": "Homozygous DQ2.5 haplotype is significantly higher in CD patients compared to healthy controls.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "HLA-DQ2.5"}, {"weight": 16.0, "description": "DQ8/DQX haplotype is more frequent among CD patients compared to controls.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "HLA-DQ8/DQX"}, {"weight": 12.0, "description": "A common autoimmune manifestation seen in CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "AUTOIMMUNE THYROIDITIS"}, {"weight": 14.0, "description": "A common autoimmune manifestation seen in CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "SYSTEMIC LUPUS ERYTHEMATOSUS"}, {"weight": 16.0, "description": "A non-autoimmune manifestation seen in some CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "OSTEOMALACIA"}, {"weight": 18.0, "description": "A non-autoimmune manifestation seen in some CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "SEIZURE DISORDERS"}, {"weight": 20.0, "description": "A non-autoimmune manifestation seen in some CD patients.)", "source_id": "chunk-1418daebca32811d9530c70d8e9bf4cc", "order": 1, "source": "CD", "target": "DOWN SYNDROME"}, {"weight": 2.0, "description": "The presence of specific alleles (TC or CC) in the PTPN2:rs478582 SNP was significantly associated with an increased risk of CD compared to healthy controls. The odds ratio for CD patients carrying these alleles was 3.03.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD", "target": "PTPN2:RS478582"}, {"weight": 8.0, "description": "The C-G haplotype, which combines a minor allele of PTPN2:rs478582 with a major allele of PTPN22:rs2476601, was more prevalent in CD patients compared to healthy controls.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD", "target": "C-G HAPLOTYPE"}, {"weight": 10.0, "description": "The C-A haplotype, which combines minor alleles of both SNPs, was significantly associated with CD.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "CD", "target": "C-A HAPLOTYPE"}, {"weight": 7.0, "description": "CD subjects had a higher T-cell proliferation response to PHA and MAP PPD-like compared to healthy controls.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "CD", "target": "T-CELLS"}, {"weight": 0.5, "description": "Methylation variations in BCL2L11 are associated with CHD risk.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "BCL2L11", "target": "CHD"}, {"weight": 2.0, "description": "The BCL2L11 gene has a CpG site annotated to cg07547695, which was associated with methylation.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "BCL2L11", "target": "CPG SITE CG07547695"}, {"weight": 9.0, "description": "SEMA6A is involved in inhibiting angiogenesis, a process often associated with tumor growth and oxidative stress.)", "source_id": "chunk-491fec1ffc43ca0e67c1080702f038a7", "order": 1, "source": "SEMA6A", "target": "ANTI-ANGIOGENIC FUNCTION"}, {"weight": 0.5, "description": "The RegulomeDB score helps determine the strength of evidence for CpG sites being located in functional regulatory regions.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CPGS", "target": "REGULOMEDB"}, {"weight": 0.8, "description": "E2F1 has been implicated in the development of atherosclerosis.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "E2F1", "target": "ATHEROSCLEROSIS"}, {"weight": 0.6, "description": "E2F1 plays a role in the development of CHD.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "E2F1", "target": "CHD"}, {"weight": 0.7, "description": "CpGs associated with oxidative stress markers show altered methylation patterns.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "CPG", "target": "OXIDATIVE STRESS MARKERS"}, {"weight": 0.6, "description": "A higher proportion of phenotype-associated CpGs were located in promoters compared to all CpGs.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PROMOTER", "target": "PHENOTYPE-ASSOCIATED CPGS"}, {"weight": 0.4, "description": "The analysis identified significant enrichment of E2F1 binding sites among phenotype-associated CpGs.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "TF BINDING SITE", "target": "E2F1 BINDING SITE"}, {"weight": 0.3, "description": "Gene set enrichment analysis revealed that genes associated with oxidative stress-linked CpGs were enriched for terms related to phosphorylation and phosphate metabolism.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PHOSPHORYLATION", "target": "GENES ANNOTATED TO CPGS"}, {"weight": 0.2, "description": "Gene set enrichment analysis showed an association between oxidative stress-linked genes and pleckstrin domains.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "PLECKSTRIN DOMAIN", "target": "GENES ANNOTATED TO CPGS"}, {"weight": 0.1, "description": "A significant proportion of CpGs associated with oxidative stress had corresponding meQTL SNPs.)", "source_id": "chunk-b05610f4a9a1033449b92655bfb67b28", "order": 1, "source": "MEQTL", "target": "CPG SITES"}, {"weight": 2.0, "description": "The CEP55 gene has a CpG site annotated to cg24371383, which was associated with methylation.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CEP55", "target": "CPG SITE CG24371383"}, {"weight": 2.0, "description": "The CPB1 gene has a CpG site annotated to cg04072156, which was associated with methylation.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "CPB1", "target": "CPG SITE CG04072156"}, {"weight": 2.0, "description": "The HIST1H4D gene had a CpG site in its 3\'-UTR annotated to cg08170869, which was associated with T2D.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "HIST1H4D", "target": "CPG SITE CG08170869"}, {"weight": 2.0, "description": "The DVL1 gene had a CpG site in its body annotated to cg03465880, which was associated with T2D.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "DVL1", "target": "CPG SITE CG03465880"}, {"weight": 2.0, "description": "The ZNF341 gene had a CpG site annotated to cg11842944, which was associated with heart failure.)", "source_id": "chunk-8276370dea9f12d2b305c355f74c7f6e", "order": 1, "source": "ZNF341", "target": "CPG SITE CG11842944"}, {"weight": 2.0, "description": "Mutations in the MT-ATP6 gene can lead to Leigh syndrome.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6", "target": "LEIGH SYNDROME"}, {"weight": 3.0, "description": "The MT-ATP6 gene encodes a subunit of ATP synthase complex V.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "MT-ATP6", "target": "ATP SYNTHASE COMPLEX V"}, {"weight": 1.0, "description": "The 8993T>G variant in MT-ATP6 is known to cause Leigh syndrome.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "LEIGH SYNDROME", "target": "8993T>G"}, {"weight": 2.0, "description": "Mutations in mtDNA, including MT-ATP6, can cause Leigh syndrome.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "LEIGH SYNDROME", "target": "MTDNA VARIANTS"}, {"weight": 2.0, "description": "Complex I is part of the electron transport chain, facilitating electron transfer.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "ELECTRON TRANSPORT CHAIN", "target": "COMPLEX I"}, {"weight": 1.0, "description": "Subunit 1 is a component of Complex I, contributing to its function.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COMPLEX I", "target": "NADH DEHYDROGENASE SUBUNIT 1"}, {"weight": 5.0, "description": "Complex I transfers electrons to ubiquinone in the electron transport chain.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COMPLEX I", "target": "UBIQUINONE"}, {"weight": 5.0, "description": "Subunit 1 is one of seven mtDNA encoded subunits included among the approximately 41 polypeptides of respiratory complex I.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "NADH DEHYDROGENASE SUBUNIT 1", "target": "RESPIRATORY COMPLEX I"}, {"weight": 3.0, "description": "The NADH dehydrogenase subunit 1 protein contains an FMN binding site.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "NADH DEHYDROGENASE SUBUNIT 1", "target": "FMN BINDING SITE"}, {"weight": 4.0, "description": "The NADH dehydrogenase subunit 1 protein is predicted to contain iron-sulfur cluster binding sites.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "NADH DEHYDROGENASE SUBUNIT 1", "target": "IRON\u2013SULFUR CLUSTER BINDING SITE"}, {"weight": 1.0, "description": "Mutations in MT-ND1 can cause Leber optic atrophy.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1", "target": "LEBER OPTIC ATROPHY"}, {"weight": 2.0, "description": "Mutations in MT-ND1 can cause mitochondrial complex I deficiency.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1", "target": "MITOCHONDRIAL COMPLEX I DEFICIENCY"}, {"weight": 3.0, "description": "Mutations in MT-ND1 can cause MELAS (mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes).)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "MT-ND1", "target": "MELAS"}, {"weight": 4.0, "description": "Mutations in COQ2 have been reported to cause coenzyme Q10 deficiency.)", "source_id": "chunk-5d67fc9ddf960da009981b77d8d37f33", "order": 1, "source": "COQ2", "target": "COENZYME Q10 DEFICIENCY"}, {"weight": 1.0, "description": "Exome sequencing identifies genetic variants.)", "source_id": "chunk-b930cdd3706af881cfa771b341af097d", "order": 1, "source": "EXOME SEQUENCING", "target": "VARIANTS"}, {"weight": 6.0, "description": "The OPRM1 gene was not found to have a simple effect on alcohol craving, but there were significant interactions with other factors.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "OPRM1", "target": "ALCOHOL CRAVING"}, {"weight": 8.0, "description": "There was no significant simple effect of the OPRM1 gene on sedation response to alcohol.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "OPRM1", "target": "SUBJECTIVE RESPONSE TO ALCOHOL (SEDATION)"}, {"weight": 10.0, "description": "There was a significant three-way interaction between medication, genotype, and BrAC for stimulation response, suggesting a complex relationship.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "OPRM1", "target": "SUBJECTIVE RESPONSE TO ALCOHOL (STIMULATION)"}, {"weight": 8.0, "description": "Participants reported significantly more drowsiness on naltrexone compared to placebo.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NALTREXONE", "target": "SUBJECTIVE RESPONSE TO ALCOHOL (DROWSINESS)"}, {"weight": 1.0, "description": "Participants reported significantly more ringing in the ears on naltrexone compared to placebo.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "NALTREXONE", "target": "SUBJECTIVE RESPONSE TO ALCOHOL (RINGING IN THE EARS)"}, {"weight": 12.0, "description": "The ALDH2 genotype significantly affected alcohol craving levels.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "ALDH2", "target": "ALCOHOL CRAVING"}, {"weight": 6.0, "description": "Individuals with Asn40 variant consume significantly fewer drinks compared to those with Asp40.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ASN40", "target": "ALCOHOL SELF-ADMINISTRATION"}, {"weight": 7.0, "description": "Individuals with Asn40 variant have a shorter latency to first drink compared to those with Asp40.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ASN40", "target": "LATENCY TO FIRST DRINK"}, {"weight": 4.0, "description": "Asp40 is a specific variant of the OPRM1 gene.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ASP40", "target": "OPRM1 GENE"}, {"weight": 8.0, "description": "Individuals with Asp40 variant consume more drinks compared to those with Asn40.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ASP40", "target": "ALCOHOL SELF-ADMINISTRATION"}, {"weight": 14.0, "description": "The ADH1B genotype significantly affected sedation response to alcohol.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "SUBJECTIVE RESPONSE TO ALCOHOL (SEDATION)", "target": "ADH1B"}, {"weight": 10.0, "description": "Differences in AUDIT scores were observed across OPRM1 genotype groups.)", "source_id": "chunk-62d8719735e6c6eaa899d9ea64143544", "order": 1, "source": "AUDIT", "target": "DRINKING VARIABLES"}, {"weight": 10.0, "description": "ALDH2 genotype significantly influences alcohol consumption.)", "source_id": "chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6", "order": 1, "source": "ALCOHOL SELF-ADMINISTRATION", "target": "ALDH2 GENOTYPE"}, {"weight": 14.0, "description": "After adjusting for age, physical activity, smoking status, hypertension, diabetes, and education status, the association between daily alcohol consumption and blood cortisol level was similar in men but higher in women.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "EDUCATION STATUS", "target": "ALCOHOL CONSUMPTION AND CORTISOL"}, {"weight": 12.0, "description": "After adjusting for various covariates, the multivariate model revealed a stronger association between daily alcohol consumption and blood cortisol levels in women compared to men.)<SEP>Higher daily alcohol consumption was associated with elevated blood cortisol levels in both men and women.)<SEP>In both sexes, a univariate model showed a positive association between daily alcohol consumption and blood cortisol levels.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "BLOOD CORTISOL LEVELS", "target": "DAILY ALCOHOL CONSUMPTION"}, {"weight": 13.0, "description": "Sensitivity analysis was performed to evaluate the reliability of the association between genetically predicted alcohol consumption and cortisol levels.)<SEP>The MR analysis showed a positive association between genetically predicted daily alcohol consumption and cortisol levels in men.)", "source_id": "chunk-9e14f9bdee02839e4a6b12cff2020a5a", "order": 1, "source": "CORTISOL LEVELS", "target": "GENETICALLY PREDICTED ALCOHOL CONSUMPTION"}, {"weight": 2.0, "description": "The ABCG2 rs2231142 polymorphism is associated with serum uric acid (sUA) levels.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "ABCG2", "target": "SUA LEVEL"}, {"weight": 6.0, "description": "The SLC22A12 rs893006 polymorphism is associated with serum uric acid (sUA) levels.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "SLC22A12", "target": "SUA LEVEL"}, {"weight": 8.0, "description": "Individuals carrying the risk allele of the ABCG2 rs2231142 SNP have a higher risk of HUA.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HUA", "target": "RS2231142 ABCG2"}, {"weight": 10.0, "description": "Individuals carrying the risk allele of the SLC2A9 rs3733591 SNP have a higher risk of HUA.)", "source_id": "chunk-befd5ea20007b1d02d987897c798dadd", "order": 1, "source": "HUA", "target": "RS3733591 SLC2A9"}, {"weight": 4.0, "description": "The T allele of rs2231142 in the ABCG2 gene is associated with increased risk of HUA.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "HUA", "target": "RS2231142"}, {"weight": 1.0, "description": "The C allele of rs3733951 in the SLC2A9 gene is associated with lower sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA", "target": "RS3733951"}, {"weight": 6.0, "description": "The C allele of rs893006 in the SLC22A12 gene is associated with lower sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA", "target": "RS893006"}, {"weight": 5.0, "description": "Higher LDL levels are associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA", "target": "LDL"}, {"weight": 6.0, "description": "Lower HDL levels are associated with increased sUA levels.)", "source_id": "chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00", "order": 1, "source": "SUA", "target": "HDL"}, {"weight": 2.0, "description": "The rs2231142 T allele carriers have significantly higher sUA levels compared to non-carriers.)", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142", "target": "SYSTOLIC URIC ACID"}, {"weight": 2.0, "description": "Carriers of the rs2231142 T allele have a significantly increased risk of developing hypertension associated with high uric acid levels.)", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142", "target": "HYPERTENSION RISK"}, {"weight": 3.0, "description": "Carriers of the rs2231142 T allele have a significantly increased risk of developing hypertension associated with high uric acid levels.)", "source_id": "chunk-7091ed039203b69ad83d281b22c89579", "order": 1, "source": "RS2231142", "target": "URIC ACID LEVEL-ASSOCIATED HYPERTENSION"}, {"weight": 2.0, "description": "The LRP2 gene has been associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "LRP2", "target": "EGFR"}, {"weight": 2.0, "description": "The NFATC1 gene has been associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "NFATC1", "target": "EGFR"}, {"weight": 2.0, "description": "Cyclosporine A targets NFATC1 as part of its immunosuppressive mechanism.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "NFATC1", "target": "CYCLOSPORINE A"}, {"weight": 8.0, "description": "NFATC1 plays a central role in inducible gene transcription during the immune response.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "NFATC1", "target": "IMMUNE RESPONSE"}, {"weight": 6.0, "description": "NFATC1 plays a role in kidney function.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NFATC1", "target": "KIDNEY FUNCTION"}, {"weight": 2.0, "description": "The UNCX gene variant rs62435145 is associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "UNCX", "target": "CKD"}, {"weight": 2.0, "description": "The UNCX gene variant rs62435145 is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "UNCX", "target": "EGFR"}, {"weight": 2.0, "description": "The ALMS1 gene variant rs7587577 is associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "ALMS1", "target": "CKD"}, {"weight": 2.0, "description": "The ALMS1 gene variant rs7587577 is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "ALMS1", "target": "EGFR"}, {"weight": 9.0, "description": "The PDILT-UMOD gene and its variant rs77924615 are associated with eGFR.)<SEP>The PDILT-UMOD gene and its variant rs77924615 are associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PDILT-UMOD", "target": "EGFR"}, {"weight": 3.0, "description": "The PDILT-UMOD gene and its variant rs77924615 are associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PDILT-UMOD", "target": "CKD"}, {"weight": 8.0, "description": "The PRKAG2 gene is associated with eGFR in individuals with diabetes.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "PRKAG2", "target": "EGFR"}, {"weight": 12.0, "description": "The DCDC5-MPPED2 gene is associated with kidney function.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "DCDC5-MPPED2", "target": "EGFR"}, {"weight": 14.0, "description": "The SLC34A1 gene is associated with eGFR.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "SLC34A1", "target": "EGFR"}, {"weight": 4.0, "description": "Lead SNPs at the 20 eGFR loci were associated with increased risk of CKD.)", "source_id": "chunk-3edc72730d68b4c7fd6ba397aa087391", "order": 1, "source": "EGFR", "target": "CKD"}, {"weight": 6.0, "description": "Variants overlapping HDAC8 binding sites are associated with eGFR.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "EGFR", "target": "HDAC8"}, {"weight": 12.0, "description": "CKD (Chronic Kidney Disease) also leads to reduced expression of Rgs14 in the kidneys.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "CKD", "target": "RENAL MRNA EXPRESSION OF RGS14"}, {"weight": 16.0, "description": "CKD (Chronic Kidney Disease) shows a trend towards decreased expression of Nfatc1 in the kidneys.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "CKD", "target": "RENAL MRNA EXPRESSION OF NFATC1"}, {"weight": 5.0, "description": "Reduced loco expression is associated with longer lifespan in Drosophila.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "LOCO", "target": "LIFESPAN"}, {"weight": 6.0, "description": "Reduced loco expression is associated with increased stress resistance in Drosophila.)", "source_id": "chunk-45a965c3c3013c70d0fa0f1680283083", "order": 1, "source": "LOCO", "target": "STRESS RESISTANCE"}, {"weight": 2.0, "description": "The loco gene confers resistance to salt stress.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "LOCO", "target": "SALT STRESS"}, {"weight": 8.0, "description": "RGS14 plays a role in kidney function.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "RGS14", "target": "KIDNEY FUNCTION"}, {"weight": 4.0, "description": "NaCl supplementation induces salt stress in the experiments.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "NACL", "target": "SALT STRESS"}, {"weight": 9.0, "description": "Glomerulosclerosis is characterized by scarring of glomeruli.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "GLOMERULOSCLEROSIS", "target": "GLOMERULUS"}, {"weight": 10.0, "description": "High-salt diet exposure significantly decreases renal mRNA expression of Rgs14.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "HIGH-SALT DIET", "target": "RENAL MRNA EXPRESSION OF RGS14"}, {"weight": 14.0, "description": "High-salt diet exposure significantly decreases renal mRNA expression of Nfatc1.)", "source_id": "chunk-5ac437b050552f5db2abf19f1bf897cf", "order": 1, "source": "HIGH-SALT DIET", "target": "RENAL MRNA EXPRESSION OF NFATC1"}, {"weight": 2.0, "description": "Quinolone resistance is a type of Campylobacter infection where the bacteria are resistant to quinolone antibiotics.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTIONS", "target": "QUINOLONE-RESISTANT CAMPYLOBACTER"}, {"weight": 4.0, "description": "Erythromycin resistance is a type of Campylobacter infection where the bacteria are resistant to erythromycin antibiotics.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "CAMPYLOBACTER INFECTIONS", "target": "ERYTHROMYCIN-RESISTANT CAMPYLOBACTER"}, {"weight": 6.0, "description": "Traveling abroad, particularly to regions in Southern Europe and Southeast Asia, was significantly associated with a higher proportion of quinolone-resistant Campylobacter infections.)", "source_id": "chunk-6264e17a8290bc0a9e24c68c21c1f15c", "order": 1, "source": "QUINOLONE-RESISTANT CAMPYLOBACTER", "target": "FOREIGN TRAVEL"}, {"weight": 2.0, "description": "C. coli infection can cause illness in humans, similar to C. jejuni.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "C. COLI", "target": "CAMPYLOBACTERIOSIS"}, {"weight": 5.0, "description": "Some strains of C. coli exhibit resistance to erythromycin.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "C. COLI", "target": "ERYTHROMYCIN RESISTANCE"}, {"weight": 1.0, "description": "C. jejuni infection leads to the disease campylobacteriosis.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "C. JEJUNI", "target": "CAMPYLOBACTERIOSIS"}, {"weight": 4.0, "description": "Certain strains of C. jejuni are resistant to nalidixic acid, an antibiotic.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "C. JEJUNI", "target": "NALIDIXIC ACID RESISTANCE"}, {"weight": 3.0, "description": "This is the data source used in the study.)", "source_id": "chunk-0d155c005072e55d94179ce7952bf5a9", "order": 1, "source": "CAMPYLOBACTER ISOLATES FROM RETAIL FOOD PRODUCTS AND BROILER CHICKENS", "target": "STUDY SAMPLE"}, {"weight": 1.0, "description": "The rs9534511 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION"}, {"weight": 4.0, "description": "The minor allele of rs9534511 is associated with an increase in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS9534511", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 2.0, "description": "The rs4938056 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION"}, {"weight": 6.0, "description": "The minor allele of rs4938056 is associated with an increase in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS4938056", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 0.0, "description": "Variation in HTR3B (rs45460698) was not associated with acute or delayed CINV, suggesting no direct link between HTR3B and nausea severity.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "HTR3B", "target": "PATIENT-REPORTED ACUTE NAUSEA"}, {"weight": 3.0, "description": "The rs1998220 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1998220", "target": "SOCIAL DISINHIBITION"}, {"weight": 1.0, "description": "The minor allele of rs1998220 is associated with an increase in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1998220", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 4.0, "description": "The rs1003921 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION"}, {"weight": 12.0, "description": "The minor allele of rs1003921 is associated with a decrease in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS1003921", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 5.0, "description": "The rs16116 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION"}, {"weight": 8.0, "description": "The minor allele of rs16116 is associated with a decrease in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16116", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 6.0, "description": "The rs16870286 SNP is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "RS16870286", "target": "SOCIAL DISINHIBITION"}, {"weight": 10.0, "description": "The minor allele of rs16870286 is associated with a decrease in social disinhibition score.)", "source_id": "chunk-36d70bb8409856300dd77669e7c1f9ed", "order": 1, "source": "RS16870286", "target": "SOCIAL DISINHIBITION SCORE"}, {"weight": 8.0, "description": "Higher linguistic acculturation scores were associated with higher mean social disinhibition scores.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION", "target": "LINGUISTIC ACCULTURATION"}, {"weight": 9.0, "description": "A higher TAS score is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION", "target": "TAS (TEMPERAMENT AND CHARACTER INVENTORY - REWARD DEPENDENCE SCALE)"}, {"weight": 10.0, "description": "A higher DAS score is associated with increased risk of social disinhibition.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION", "target": "DAS (DIFFICULTIES AT SCHOOL SCALE)"}, {"weight": 11.0, "description": "Youth with at least one parent who had completed high school or attained additional education reported higher mean social disinhibition scores compared to those whose parents did not graduate high school.)", "source_id": "chunk-d4e04dd6cd6ea28f04fd72d964574ec1", "order": 1, "source": "SOCIAL DISINHIBITION", "target": "PARENTAL EDUCATION"}, {"weight": 1.0, "description": "The interaction between rs2023239 genotype (CT vs TT) and olanzapine treatment influences self-reported reward and high from alcohol consumption.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "OLANZAPINE"}, {"weight": 1.0, "description": "Genotype variation at rs2023239 influences individuals\' experiences of reward from alcohol consumption.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "REWARD"}, {"weight": 2.0, "description": "Genotype variation at rs2023239 influences individuals\' experiences of positive affect after drinking alcohol.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "POSITIVE AFFECT"}, {"weight": 3.0, "description": "Genotype variation at rs2023239 influences individuals\' experiences of \'high\' after consuming alcohol, particularly in combination with certain medications.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "HIGH"}, {"weight": 4.0, "description": "Genotype variation at rs2023239 interacts with medication treatment to influence cue-elicited craving for alcohol.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "CRAVING"}, {"weight": 5.0, "description": "Genotype variation at rs2023239 influences the number of drinks consumed per day, particularly when treated with placebo compared to olanzapine.)", "source_id": "chunk-7542fe4e6d1c727325a6be02a71f8e59", "order": 1, "source": "RS2023239", "target": "DRINKS PER DRINKING DAY"}, {"weight": 2.0, "description": "The LPL gene encodes the lipoprotein lipase protein.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL", "target": "LIPOPROTEIN LIPASE"}, {"weight": 14.0, "description": "The LPL gene is expressed in myocytes, which produce lipoprotein lipase.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL", "target": "MYOCYTES"}, {"weight": 4.0, "description": "Lipoprotein lipase hydrolyzes chylomicrons.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "CHYLOMICRON"}, {"weight": 12.0, "description": "Lipoprotein lipase deficiency leads to impaired exogenous lipid metabolism, resulting in the accumulation of triglycerides.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "LPL DEFICIENCY"}, {"weight": 16.0, "description": "GPIHBP1 is essential for the transport of lipoprotein lipase to the capillary lumen.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "GPIHBP1"}, {"weight": 1.0, "description": "The LPL gene provides instructions for making lipoprotein lipase.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "LPL GENE"}, {"weight": 3.0, "description": "Lipoprotein lipase breaks down triglyceride-rich lipoproteins.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPOPROTEIN LIPASE", "target": "TRIGLYCERIDE-RICH LIPOPROTEINS"}, {"weight": 6.0, "description": "Mutations in the LPL gene cause LPL deficiency.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "LPL GENE"}, {"weight": 10.0, "description": "LPL deficiency disrupts lipid metabolism, leading to elevated triglyceride levels.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "LIPID METABOLISM"}, {"weight": 7.0, "description": "Lipoprotein lipase deficiency can cause eruptive xanthomas due to the accumulation of triglycerides in tissues.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "ERUPTIVE XANTHOMAS"}, {"weight": 8.0, "description": "Lipoprotein lipase deficiency can cause melina due to recurrent pancreatitis and lower gastrointestinal bleeding.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "MELENA"}, {"weight": 9.0, "description": "Lipoprotein lipase deficiency can lead to hemochromatosis due to impaired lipid metabolism.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "HEMOCHROMATOSIS"}, {"weight": 10.0, "description": "Lipoprotein lipase deficiency can cause a papular rash due to the accumulation of triglycerides in tissues.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "PAPULAR RASH"}, {"weight": 11.0, "description": "Lipoprotein lipase deficiency can cause lipemia retinalis due to elevated triglyceride levels in the blood.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "LIPEMIA RETINALIS"}, {"weight": 12.0, "description": "Lipoprotein lipase deficiency can cause pancreatitis due to elevated triglyceride levels in the blood.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "PANCREATITIS"}, {"weight": 13.0, "description": "Lipoprotein lipase deficiency can cause gastrointestinal bleeding due to pancreatitis.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "LPL DEFICIENCY", "target": "GASTROINTESTINAL BLEEDING"}, {"weight": 7.0, "description": "Limiting dietary fat intake is a cornerstone treatment for LPL deficiency.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LPL DEFICIENCY", "target": "DIETARY FAT RESTRICTION"}, {"weight": 8.0, "description": "The initial step of exogenous lipid metabolism involves packaging of dietary fat into chylomicrons.)", "source_id": "chunk-bbdb97da6903bfbdae42d4c3cb9c9c63", "order": 1, "source": "CHYLOMICRON", "target": "EXOGENOUS LIPID METABOLISM"}, {"weight": 4.0, "description": "High triglyceride levels can lead to eruptive xanthomas.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "ERUPTIVE XANTHOMAS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 5.0, "description": "Elevated triglycerides can cause lipemia retinalis.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "LIPEMIA RETINALIS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 6.0, "description": "High triglyceride levels increase the risk of pancreatitis.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "PANCREATITIS", "target": "HYPERTRIGLYCERIDEMIA"}, {"weight": 8.0, "description": "MCT supplements can help manage hypertriglyceridemia.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "MCT SUPPLEMENTS"}, {"weight": 9.0, "description": "Gemfibrozil is used to lower triglyceride levels.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "GEMFIBROZIL"}, {"weight": 11.0, "description": "Orlistat can lower triglycerides by blocking fat absorption.)", "source_id": "chunk-1e1db26cd046378fc4ac9fd4c4d35c86", "order": 1, "source": "HYPERTRIGLYCERIDEMIA", "target": "ORLISTAT"}, {"weight": 2.0, "description": "Topiramate treatment led to fewer HDDs (heavy drinking days) compared to placebo in the full sample and specific subgroups.)<SEP>Topiramate treatment led to fewer HDDs compared to placebo in the full sample and specific subgroups.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "HDDS"}, {"weight": 6.0, "description": "The topiramate group experienced more adverse events compared to the placebo group, although most were mild.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "ADVERSE EVENTS"}, {"weight": 5.0, "description": "Topiramate had a lower NNT compared to placebo for reducing HDDs.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "NNT"}, {"weight": 7.0, "description": "Individuals homozygous for the rs2832407*C allele experienced a greater benefit from topiramate in reducing HDDs compared to placebo.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "RS2832407*C-HOMOZYGOTES"}, {"weight": 8.0, "description": "For individuals carrying the A allele of rs2832407, topiramate had no significant effect on reducing HDDs.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "RS2832407*A-ALLELE CARRIERS"}, {"weight": 5.0, "description": "Topiramate had a higher NNT-AEmod+ compared to placebo, indicating that the reduction in HDDs was partially offset by more adverse events.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "NNT-AEMOD+"}, {"weight": 7.0, "description": "Topiramate had a higher NNT-AEsev+ compared to placebo, indicating that the reduction in HDDs was partially offset by more severe adverse events.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "TOPIRAMATE", "target": "NNT-AESEV+"}, {"weight": 9.0, "description": "The rs2832407 genetic variant showed a different effect on topiramate efficacy in European-Americans compared to other subgroups.)", "source_id": "chunk-0c7ab28db433187759e760725a105836", "order": 1, "source": "RS2832407", "target": "EUROPEAN-AMERICAN SUBGROUP (EA)"}, {"weight": 2.0, "description": "Heterozygotes for the ABCB1 (rs1045642) variant reported more severe acute nausea compared to individuals with homozygous wild type or homozygous variant genotypes.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1", "target": "ACUTE NAUSEA"}, {"weight": 1.0, "description": "rs1045642 is a variant within the ABCB1 gene.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ABCB1", "target": "RS1045642"}, {"weight": 0.0, "description": "CYP2D6 phenotype was not associated with acute or delayed CINV, suggesting no direct link between CYP2D6 and nausea severity.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CYP2D6", "target": "PATIENT-REPORTED ACUTE NAUSEA"}, {"weight": 1.0, "description": "Patients reported their level of acute nausea as part of the CINV assessment.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "PATIENT REPORTED ACUTE NAUSEA"}, {"weight": 1.0, "description": "The CTCAE grade was used to assess the severity of CINV.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "CTCAE GRADE OF NAUSEA"}, {"weight": 1.0, "description": "Nearly all participants received palonosetron as part of their anti-emetic regimen.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "PALONOSETRON"}, {"weight": 1.0, "description": "Nearly all participants received dexamethasone as part of their anti-emetic regimen.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "DEXAMETHASONE"}, {"weight": 1.0, "description": "Prochlorperazine was commonly used as an anti-emetic in some participants.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "PROCHLORPERAZINE"}, {"weight": 1.0, "description": "Ondansetron was used by some participants as part of their anti-emetic regimen.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "ONDANSETRON"}, {"weight": 1.0, "description": "Fosaprepitant was used by some participants as part of their anti-emetic regimen.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "CINV", "target": "FOSAPREPITANT"}, {"weight": 1.0, "description": "The majority of patients had gastrointestinal malignancies.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "GASTROINTESTINAL CANCER", "target": "PATIENT CHARACTERISTIC"}, {"weight": 1.0, "description": "A significant proportion of patients had thoracic malignancies.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "THORACIC CANCER", "target": "PATIENT CHARACTERISTIC"}, {"weight": 1.0, "description": "Most patients were diagnosed with gastrointestinal, thoracic, or breast malignancies.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "MALIGNANCY", "target": "PATIENT CHARACTERISTIC"}, {"weight": 1.0, "description": "Most patients had advanced stage disease.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "ADVANCED STAGE DISEASE", "target": "PATIENT CHARACTERISTIC"}, {"weight": 1.0, "description": "Most patients received highly-emetogenic chemotherapy regimens.)", "source_id": "chunk-1ddde2b1bbb4b6e6dc1fbd9d0a8701a8", "order": 1, "source": "HIGHLY EMETOGENIC CHEMOTHERAPY REGIMENS", "target": "PATIENT CHARACTERISTIC"}, {"weight": 2.0, "description": "Higher DNA modification density is associated with lower LCT mRNA levels in both humans and mice.)", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA MODIFICATION", "target": "LCT MRNA"}, {"weight": 6.0, "description": "DNA modification patterns differ between enterocytes and jejunum lacking enterocytes, suggesting cell-type specific regulation of LCT.)", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "DNA MODIFICATION", "target": "ENTEROCYTES"}, {"weight": 1.0, "description": "Changes in DNA modifications at MCM6 intron 13 occur after conception and influence lactase persistence.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "DNA MODIFICATION", "target": "MCM6 INTRON 13"}, {"weight": 2.0, "description": "DNA modifications increase in LCT intron 2 with age in mice.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "DNA MODIFICATION", "target": "LCT INTRON 2"}, {"weight": 6.0, "description": "The presence of H3K4me1 marks identifies an enhancer element within the MCM6 intron 13 region.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "H3K4ME1", "target": "ENHANCER ELEMENT"}, {"weight": 10.0, "description": "Peaks of histone mark monomethylated histone H3 lysine 4 (H3K4Me1) were found at rs35923643 in GM12878.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "H3K4ME1", "target": "GM12878"}, {"weight": 5.0, "description": "The presence of H3K27ac marks identifies an enhancer element within the LCT intron 2 region.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "H3K27AC", "target": "ENHANCER ELEMENT"}, {"weight": 7.0, "description": "The presence of H3K4me3 marks indicates a promoter region within the LCT exon 1-intron 1 region.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "H3K4ME3", "target": "PROMOTER REGION"}, {"weight": 1.0, "description": "The LCT intron 5 region maps to the promoter of the lncRNA LOCN100507600.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "LOCN100507600", "target": "LCT INTRON 5"}, {"weight": 4.0, "description": "The MCM6 exon 17 region maps to the 3\u2032 untranslated region (3\u2032-UTR) of MCM6.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "MCM6 3\u2032UTR", "target": "MCM6 EXON 17"}, {"weight": 4.0, "description": "Epigenetic modifications within the MCM6 gene, particularly intron 13-exon 13 and exon 16, are correlated with inter-individual differences in LCT mRNA levels.)", "source_id": "chunk-ec104044b3aa65560be8d81dbb3940d6", "order": 1, "source": "LCT MRNA", "target": "MCM6 REGION"}, {"weight": 2.0, "description": "Different C-13910 haplotypes result in distinct levels of LCT mRNA expression with age.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "C-13910 HAPLOTYPE"}, {"weight": 15.0, "description": "The LOC100507600 lncRNA negatively regulates LCT mRNA levels.)<SEP>The expression level of LOC100507600 lncRNA is positively correlated with LCT mRNA levels.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "LCT MRNA", "target": "LOC100507600 LNCRNA"}, {"weight": 4.0, "description": "Increased LCT mRNA levels are associated with lactase persistence.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA", "target": "LACTASE PERSISTENCE"}, {"weight": 1.0, "description": "Caco-2 cells in an undifferentiated state resemble cancer-like cells.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CACO-2", "target": "UNDIFFERENTIATED STATE"}, {"weight": 2.0, "description": "Caco-2 cells in a differentiated state resemble enterocyte-like cells of the small intestine.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CACO-2", "target": "DIFFERENTIATED STATE"}, {"weight": 3.0, "description": "Silencing LOC100507600 lncRNA with small-interfering RNAs reduces its expression.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LOC100507600", "target": "SMALL-INTERFERING RNAS"}, {"weight": 2.0, "description": "Increased DNA methylation inhibits CTCF binding at insulator sites.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "CTCF", "target": "DNA METHYLATION"}, {"weight": 2.0, "description": "Individuals with the lactase persistence genotype are more likely to consume milk.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "LACTASE PERSISTENCE", "target": "MILK DRINKING"}, {"weight": 1.0, "description": "The \'C\' allele at rs4988235 was found at a frequency of 0.26 in the UK, opposite to the observed pattern in southern and eastern Europe.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "LACTASE PERSISTENCE", "target": "UK"}, {"weight": 6.0, "description": "LCT exon 1 had an abundance of H3K4me3 and H3K27ac, indicative of an active promoter.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE PROMOTER", "target": "LCT EXON 1"}, {"weight": 8.0, "description": "Histone marks characteristic of active enhancers, H3K4me1 and H3K27ac were detected at LCT introns 2 and 3.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE ENHANCER", "target": "LCT INTRON 2 & 3"}, {"weight": 10.0, "description": "Histone marks characteristic of active enhancers, H3K4me1 and H3K27ac were detected at MCM6 intron 13 and exon 16 to 3\u2032-UTR.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "ACTIVE ENHANCER", "target": "MCM6 INTRON 13 & EXON 16"}, {"weight": 12.0, "description": "The seven LCT\u2013MCM6 regions facilitate the cell-type specificity of LCT modification.)", "source_id": "chunk-4964b2db9e3ddddb4967fb7150e4404d", "order": 1, "source": "CELL-TYPE SPECIFIC EXPRESSION", "target": "LCT\u2013MCM6 REGIONS"}, {"weight": 8.0, "description": "The presence of POLR2A indicates an active promoter region within the LCT exon 1-intron 1 region.)", "source_id": "chunk-ea45644d73f260cf365527dcc3af86e1", "order": 1, "source": "PROMOTER REGION", "target": "POLR2A"}, {"weight": 4.0, "description": "Deletion of Lct introns 1 and 2 causes widespread downregulation of Lct mRNA throughout the duodenum and jejunum.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT DELETION", "target": "LCT MRNA LEVELS"}, {"weight": 5.0, "description": "Deleting regions within the Lct gene, including introns 1 and 2, leads to a reduction in Lct mRNA levels.)", "source_id": "chunk-512b044cf65a4e519d519c6239959c6c", "order": 1, "source": "LCT MRNA LEVELS", "target": "CRISPR-CAS9 DELETION"}, {"weight": 3.0, "description": "A higher risk of RCC was observed among individuals who consumed milk.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RCC", "target": "MILK CONSUMPTION"}, {"weight": 4.0, "description": "Higher educational attainment was associated with increased milk consumption in all countries.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "EDUCATION", "target": "MILK CONSUMPTION"}, {"weight": 1.0, "description": "Data on milk consumption was collected in Romania.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "ROMANIA", "target": "MILK CONSUMPTION"}, {"weight": 1.0, "description": "Data on milk consumption was collected in Poland.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "POLAND", "target": "MILK CONSUMPTION"}, {"weight": 1.0, "description": "Data on milk consumption was collected in Russia.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "RUSSIA", "target": "MILK CONSUMPTION"}, {"weight": 2.0, "description": "The Czech Republic showed the strongest association between milk consumption and RCC risk.)", "source_id": "chunk-7a423a439657efc1126fb6a075919ea5", "order": 1, "source": "CZECH REPUBLIC", "target": "MILK CONSUMPTION"}, {"weight": 1.0, "description": "Patients\' baseline HbF levels are measured before commencing hydroxyurea treatment.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HYDROXYUREA TREATMENT", "target": "BASELINE HBF"}, {"weight": 2.0, "description": "Hydroxyurea treatment aims to increase MTD HbF levels, indicating the maximum tolerated dose of hydroxyurea achieved.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HYDROXYUREA TREATMENT", "target": "MTD HBF"}, {"weight": 1.0, "description": "Hydroxyurea treatment is a common therapy for managing sickle cell disease.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HYDROXYUREA TREATMENT", "target": "SICKLE CELL DISEASE"}, {"weight": 3.0, "description": "There is a correlation between baseline HbF and MTD HbF; patients with higher baseline HbF tend to have higher MTD HbF.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BASELINE HBF", "target": "MTD HBF"}, {"weight": 4.0, "description": "Delta HbF represents the difference in HbF levels from the baseline measurement after treatment.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BASELINE HBF", "target": "DELTA HBF"}, {"weight": 6.0, "description": "This SNP was associated with increased baseline HbF levels in the study cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BASELINE HBF", "target": "BCL11A RS1427407"}, {"weight": 9.0, "description": "This SNP was associated with increased baseline HbF levels in the study cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BASELINE HBF", "target": "HMIP-2 RS9399137"}, {"weight": 7.0, "description": "This SNP was associated with increased MTD HbF levels in the study cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "MTD HBF", "target": "BCL11A RS4671393"}, {"weight": 10.0, "description": "This SNP was associated with increased MTD HbF levels in the study cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "MTD HBF", "target": "HMIP-2 RS9402686"}, {"weight": 2.0, "description": "The C-A haplotype of the HMIP-2 gene was associated with an increase in MTD HbF, but this association lost significance after adjusting for baseline HbF.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "MTD HBF", "target": "C-A HAPLOTYPE"}, {"weight": 8.0, "description": "This SNP showed an association with increased delta HbF levels in the study cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "DELTA HBF", "target": "BCL11A RS11886868"}, {"weight": 5.0, "description": "This SNP had a very low allele frequency in the Brazilian cohort and was excluded from further analysis.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBG2-XMN1-RS7482144", "target": "STUDY EXCLUSION"}, {"weight": 2.0, "description": "The HBG2-Xmn1-rs7482144 SNP analysis was conducted on a Brazilian cohort.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HBG2-XMN1-RS7482144", "target": "BRAZILIAN COHORT"}, {"weight": 4.0, "description": "Regression analysis was used to evaluate the association between SNPs and various HbF measurements.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "REGRESSION ANALYSIS", "target": "BASELINE HBF, MTD HBF, DELTA HBF"}, {"weight": 4.0, "description": "The HMIP-2 gene is being investigated for its role in regulating or influencing Mean Target HbF and Delta HbF.)", "source_id": "chunk-3ae06e9a3330573da28ca0a76aa685ce", "order": 1, "source": "HMIP-2", "target": "PHYSIOLOGICAL PROCESS"}, {"weight": 10.0, "description": "CD subjects with the C-A haplotype had a higher prevalence of MAPbacteremia compared to healthy controls.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "C-A HAPLOTYPE", "target": "MAPBACTEREMIA"}, {"weight": 5.0, "description": "Haplotype analysis was performed to assess the combined effect of BCL11A and HMIP-2 SNPs.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "BCL11A SNPS, HMIP-2 SNPS", "target": "HAPLOTYPE ANALYSIS"}, {"weight": 6.0, "description": "Linkage disequilibrium testing revealed that HMIP-2 rs9399137 and rs9402686 are in strong linkage.)", "source_id": "chunk-3cf4e094a5312845a1cc4da4304d4bdf", "order": 1, "source": "HMIP-2 RS9399137, HMIP-2 RS9402686", "target": "LINKAGE DISEQUILIBRIUM TESTING"}, {"weight": 2.0, "description": "Fanconi anemia can present with radial aplasia as a congenital abnormality.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA", "target": "RADIAL APLASIA"}, {"weight": 4.0, "description": "Fanconi anemia can manifest as microcephaly, an abnormally small head size.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA", "target": "MICROCEPHALY"}, {"weight": 6.0, "description": "Individuals with Fanconi anemia may exhibit micrognathia, a small jaw size.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA", "target": "MICROGNATHIA"}, {"weight": 8.0, "description": "Caf\u00e9 au lait spots are sometimes associated with Fanconi anemia.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA", "target": "CAF\u00c9 AU LAIT SPOTS"}, {"weight": 10.0, "description": "Kidney abnormalities, including absent kidneys, can occur in individuals with Fanconi anemia.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCONI ANEMIA", "target": "ABSENT LEFT KIDNEY"}, {"weight": 12.0, "description": "Fibroblasts derived from the subject (RA2627) are hypersensitive to crosslinking agents and display elevated chromosomal breakage levels.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "CHROMOSOMAL BREAKAGE", "target": "FIBROBLASTS FROM SUBJECT RA2627"}, {"weight": 10.0, "description": "Overexpression of UBE2T restored monoubiquitination of FANCD2.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "FANCD2", "target": "UBE2T"}, {"weight": 4.0, "description": "Similarly to FANCI, the URD interacts with FANCD2, suggesting a common binding mechanism for substrates.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCD2", "target": "RING"}, {"weight": 1.0, "description": "URD interacts with FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCD2", "target": "URD"}, {"weight": 2.0, "description": "The L248A/F252A/L254A/I265A URD variant reduces binding with FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCD2", "target": "L248A/F252A/L254A/I265A"}, {"weight": 3.0, "description": "The W212A/L214A URD variant reduces binding with FANCD2.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCD2", "target": "W212A/L214A"}, {"weight": 4.0, "description": "The FAAP20 protein interacts with FANCA through its N-terminal region.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FANCA", "target": "FAAP20"}, {"weight": 11.0, "description": "Overexpression of UBE2T rescued cellular defects in RA2627 cells.)<SEP>Overexpression of UBE2T rescued cellular hypersensitivity to crosslinking agents MMC, DEB and cisplatin in RA2627 fibroblasts.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "UBE2T", "target": "RA2627 CELLULAR DEFECTS"}, {"weight": 12.0, "description": "Overexpression of UBE2T restored monoubiquitination of FANCI.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "UBE2T", "target": "FANCI"}, {"weight": 2.0, "description": "The RING domain of the URD interacts with Ube2T via a 1:1 stoichiometry.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "UBE2T", "target": "URD"}, {"weight": 16.0, "description": "The subject\'s fibroblasts (RA2627) are deficient in FANCD2 monoubiquitination.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCD2 MONOUBIQUITINATION", "target": "SUBJECT\'S FIBROBLASTS"}, {"weight": 18.0, "description": "The subject\u2019s lymphoblastoid cell line (LCLs) carry a FANCA mutation, but normal levels of FANCA protein are detected.)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "FANCA MUTATION C.2574C>G/P.SER858ARG", "target": "SUBJECT\'S LCLS"}, {"weight": 20.0, "description": "Markedly reduced UBE2T transcript levels were detected in RA2627 fibroblasts compared to non-FA patient cell line (RA3380).)", "source_id": "chunk-b3b792ab4e6f6251de68ef6e959aee1f", "order": 1, "source": "RA2627 FIBROBLASTS", "target": "UBE2T TRANSCRIPT LEVELS"}, {"weight": 4.0, "description": "RA2627 cells exhibit hypersensitivity to MMC.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLULAR DEFECTS", "target": "MMC"}, {"weight": 6.0, "description": "RA2627 cells exhibit hypersensitivity to DEB.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLULAR DEFECTS", "target": "DEB"}, {"weight": 8.0, "description": "RA2627 cells exhibit hypersensitivity to cisplatin.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLULAR DEFECTS", "target": "CISPLATIN"}, {"weight": 14.0, "description": "Analysis of cell cycle distribution following treatment with MMC revealed an accumulation of RA2627 cells in G2 that was rescued by UBE2T overexpression to the levels observed in wild type BJ cells.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLULAR DEFECTS", "target": "G2"}, {"weight": 8.0, "description": "The cell cycle distribution of RA2627 cells after MMC treatment was similar to that of wild type BJ cells after UBE2T overexpression.)", "source_id": "chunk-ffd1276c89bcac745a7e58082e97236f", "order": 1, "source": "RA2627 CELLULAR DEFECTS", "target": "WILD TYPE BJ CELLS"}, {"weight": 3.0, "description": "The URD, containing the RING domain, binds to FANCI, indicating its role in substrate recruitment.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "FANCI", "target": "RING"}, {"weight": 1.0, "description": "URD interacts with FANCI.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "URD"}, {"weight": 2.0, "description": "The L248A/F252A/L254A/I265A URD variant reduces binding with FANCI.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "L248A/F252A/L254A/I265A"}, {"weight": 3.0, "description": "The W212A/L214A URD variant reduces binding with FANCI.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "FANCI", "target": "W212A/L214A"}, {"weight": 13.0, "description": "PRMT2 plays a role in the RAR activation pathway.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "PRMT2", "target": "RAR ACTIVATION PATHWAY"}, {"weight": 2.0, "description": "Mutations in the RPS19 gene are found in individuals with DBA.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "RPS19 GENE"}, {"weight": 8.0, "description": "Genes involved in aminoacyl-tRNA biosynthesis are differentially expressed in DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY"}, {"weight": 10.0, "description": "Genes involved in glycine, serine and threonine metabolism are differentially expressed in DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "GLYCINE, SERINE AND THREONINE METABOLISM PATHWAY"}, {"weight": 12.0, "description": "Genes involved in death receptor signaling are differentially expressed in DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "DEATH RECEPTOR SIGNALING PATHWAY"}, {"weight": 14.0, "description": "Genes involved in the role of PKR in interferon induction and antiviral response are differentially expressed in DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "ROLE OF PKR IN INTERFERON INDUCTION AND ANTIVIRAL RESPONSE"}, {"weight": 16.0, "description": "Genes involved in RAR activation are differentially expressed in DBA patients.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DBA PATIENTS", "target": "RAR ACTIVATION PATHWAY"}, {"weight": 6.0, "description": "The RPS19 protein is involved in ribosome biogenesis, a crucial cellular process.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RIBOSOME BIOGENESIS", "target": "RPS19 PROTEIN"}, {"weight": 10.0, "description": "These proteins are all essential components of the aminoacyl-tRNA biosynthesis pathway.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "AMINOACYL-TRNA BIOSYNTHESIS PATHWAY", "target": "LARS, WARS, GARS, SARS, QARS, EPRS"}, {"weight": 11.0, "description": "These proteins participate in the metabolism of glycine, serine and threonine.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "GLYCINE, SERINE AND THREONINE METABOLISM PATHWAY", "target": "PSAT1, PHGDH, GARS, CTH, SARS, SHMT2"}, {"weight": 12.0, "description": "These proteins are involved in the death receptor signaling pathway, which regulates cell death.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "DEATH RECEPTOR SIGNALING PATHWAY", "target": "CASP9, NFKBIA, NFKBIE, APAF1, NFKB2, NFKB1"}, {"weight": 18.0, "description": "Mutations in RPS19, particularly c.1-1G>A, can lead to exon skipping and activation of Nonsense-mediated decay (NMD).)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "NMD", "target": "RPS19 MUTATIONS"}, {"weight": 14.0, "description": "These proteins are all ribosomal proteins.)", "source_id": "chunk-34ffb077c584b98555081f882f8f8b94", "order": 1, "source": "RIBOSOMAL PROTEINS", "target": "RPL22, RPL27A, RPL29, RPL31, RPL14, RPL18A, RPS3, RPL18, RPL13, RPL3, RPL34, RPS2, RPS12, RPL15, RPL28"}, {"weight": 2.0, "description": "Patients developed paradoxical psoriasiform reactions after treatment with adalimumab.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "ADALIMUMAB", "target": "PARADOXICAL PSORIASIS"}, {"weight": 4.0, "description": "Patient 1 had severe HS (Hurley III, Sartorius score: 41.5).)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 1", "target": "HS"}, {"weight": 4.0, "description": "Patient 1 had HS classified as Hurley III.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 1", "target": "HURLEY III"}, {"weight": 5.0, "description": "Patient 1\'s Sartorius score was 41.5.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 1", "target": "SARTORIUS SCORE"}, {"weight": 9.0, "description": "Patient 1\'s PASI score was 6.8.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 1", "target": "PASI"}, {"weight": 1.0, "description": "Patient 1 experienced recurrent urinary tract, pulmonary infections requiring antibiotics.)  (relationship", "source_id": "chunk-825b9a3dd613f4c55dbf49fa3998d0d5", "order": 1, "source": "PATIENT 1", "target": "RECURRENT INFECTIONS"}, {"weight": 10.0, "description": "Patient 2\'s PASI score was 5.2.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 2", "target": "PASI"}, {"weight": 13.0, "description": "Patient 2 developed psoriasiform dermatitis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 2", "target": "PSORIASIFORM DERMATITIS"}, {"weight": 14.0, "description": "Patient 2 developed alopecia areata.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 2", "target": "ALOPECIA AREATA"}, {"weight": 15.0, "description": "Patient 2 had eczematous-like skin lesions.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 2", "target": "ECZEMATOUS-LIKE SKIN LESIONS"}, {"weight": 11.0, "description": "Patient 3\'s PASI score was 5.6.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PATIENT 3", "target": "PASI"}, {"weight": 6.0, "description": "Patients with HS often develop nodules.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "NODULES"}, {"weight": 7.0, "description": "Patients with HS often develop fistulas.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "FISTULAS"}, {"weight": 8.0, "description": "Patients with HS often develop sinus tracts.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "HS", "target": "SINUS TRACTS"}, {"weight": 6.0, "description": "Paradoxical psoriasis manifested as psoriasiform eruptions, pustular lesions, and erythemato-scaly plaques.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "SKIN LESIONS"}, {"weight": 12.0, "description": "Patient 1 and Patient 2 developed erythematous-pustular lesions as part of their paradoxical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "ERYTHEMATOUS-PUSTULAR LESIONS"}, {"weight": 1.0, "description": "A significant increase of mast cells was observed in the dermis of paradoxical skin reactions.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "MAST CELLS"}, {"weight": 36.0, "description": "A decrease in dendritic cells was observed in paradoxical skin reactions compared to classical psoriasis.)<SEP>Dendritic cells were present in paradoxical skin lesions.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a<SEP>chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "DENDRITIC CELLS"}, {"weight": 20.0, "description": "A decrease in IFN-\u03b3+ CD3+ cells was observed in paradoxical skin reactions compared to classical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "T LYMPHOCYTES"}, {"weight": 25.0, "description": "Enhanced IL-36\u03b3 expression was observed in the dermis of paradoxical reactions compared to classical psoriasis.)", "source_id": "chunk-0380fd029b3eda680c87c1b8bcbe7f4c", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IL-36\u0393"}, {"weight": 5.0, "description": "The type I IFN\u2010\u03b2 was expressed in paradoxical skin lesions at levels significantly higher than classical psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "TYPE I IFN\u2010\u0392"}, {"weight": 6.0, "description": "The epidermis of psoriasiform reactions was also immunoreactive for IFN\u2010\u03ba, another keratinocyte\u2010derived type I IFN 34.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IFN\u2010\u039a"}, {"weight": 8.0, "description": "LL\u201037 was strongly expressed in psoriasiform skin lesions, at levels higher than classical psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "LL\u201037"}, {"weight": 9.0, "description": "Both lymphotoxins were strongly overexpressed in paradoxical skin reactions, especially in keratinocytes of the basal layer epidermis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "LT\u2010\u0391"}, {"weight": 10.0, "description": "Both lymphotoxins were strongly overexpressed in paradoxical skin reactions, especially in keratinocytes of the basal layer epidermis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "LT\u2010\u0392"}, {"weight": 13.0, "description": "Both lymphotoxins were strongly overexpressed in paradoxical skin reactions, especially in keratinocytes of the basal layer epidermis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "TNF\u2010\u0391"}, {"weight": 14.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IL\u201017F"}, {"weight": 15.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IL\u201017RA"}, {"weight": 16.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IL\u201023R"}, {"weight": 18.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IL\u201012B"}, {"weight": 19.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "IKB\u0396"}, {"weight": 20.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "A20"}, {"weight": 21.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "A20 BINDING PROTEIN"}, {"weight": 22.0, "description": "Genetic variants of pathogenic cytokines, receptors and signal transducers (i.e. TNF\u2010\u03b1, IL\u201017F, IL\u201017RA, IL\u201023R, IL-12B, IKB\u03b6, A20, A20 binding protein, Tyk2), were analyzed.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "PARADOXICAL PSORIASIS", "target": "TYK2"}, {"weight": 2.0, "description": "CD3+ skin T cells from HS patients were enriched in CD8+, but not in CD4+ cells, when compared to PBMC isolated from the same patients.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "CD3+ CELLS", "target": "CD8+"}, {"weight": 3.0, "description": "CD3+ skin T cells from HS patients were enriched in CD8+, but not in CD4+ cells, when compared to PBMC isolated from the same patients.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "CD3+ CELLS", "target": "CD4+"}, {"weight": 4.0, "description": "IFN\u2010\u03b2 expression was detected in cells with a T\u2010cell\u2010 and DC\u2010like morphology, as well as in endothelial cells. The type I IFN\u2010\u03b2 was expressed in paradoxical skin lesions, mainly in keratinocytes.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "KERATINOCYTES", "target": "TYPE I IFN\u2010\u0392"}, {"weight": 7.0, "description": "The expression of type I IFN\u2010\u03b2 in paradoxical skin lesions is similar to the expression in classical psoriasis.)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "TYPE I IFN\u2010\u0392", "target": "PARADOXICALLY PSORIASIS"}, {"weight": 11.0, "description": "All HS patients showed variants of ERAP1 and the HLA\u2010C region, either homozygosis or heterozygosis)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "HLA\u2010C", "target": "HS PATIENTS"}, {"weight": 12.0, "description": "All HS patients showed variants of ERAP1 and the HLA\u2010C region, either homozygosis or heterozygosis)", "source_id": "chunk-56c37d6045382dda8cc6037b2680282a", "order": 1, "source": "ERAP1", "target": "HS PATIENTS"}, {"weight": 2.0, "description": "rs130079 is a SNP within the CCHCR1 gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1", "target": "RS130079"}, {"weight": 3.0, "description": "rs746647 is a SNP within the CCHCR1 gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "CCHCR1", "target": "RS746647"}, {"weight": 4.0, "description": "rs11209026 is a SNP in the IL23R gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS11209026"}, {"weight": 5.0, "description": "rs72676067 was detected in patient 2, who has an IL23R gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS72676067"}, {"weight": 6.0, "description": "rs1004819 was detected in patient 1, who has an IL23R gene.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "RS1004819"}, {"weight": 2.0, "description": "Variants in the IL23R gene have been previously associated with paradoxical psoriasiform reactions to anti-TNFs.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "IL23R", "target": "PARADOXICAL PSORIASIFORM REACTIONS"}, {"weight": 3.0, "description": "HS patients are individuals experiencing paradoxical psoriasiform reactions.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "HS PATIENTS", "target": "PARADOXICAL PSORIASIFORM REACTIONS"}, {"weight": 4.0, "description": "Paradoxical psoriasiform reactions occur as a response to anti-TNF therapy.)", "source_id": "chunk-72f4505e43f67f3564607392cb178656", "order": 1, "source": "PARADOXICAL PSORIASIFORM REACTIONS", "target": "ANTI\u2010TNFS"}, {"weight": 1.0, "description": "FANCL and DmFANCL are homologous proteins, with FANCL being the human version and DmFANCL being the Drosophila version.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "FANCL", "target": "DMFANCL"}, {"weight": 3.0, "description": "DmFANCL exhibits the RWD fold.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "DMFANCL", "target": "RWD FOLD"}, {"weight": 4.0, "description": "DmFANCL shares structural similarity with E2 UBC enzymes in certain regions.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "DMFANCL", "target": "E2 UBC ENZYMES"}, {"weight": 2.0, "description": "The DRWD domain contains \u03b1-helices as secondary structure elements.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "DRWD DOMAIN", "target": "\u0391-HELIX"}, {"weight": 5.0, "description": "The URD contains a cysteine residue.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "CYSTEINE", "target": "URD"}, {"weight": 6.0, "description": "The URD possesses hydrophobic patches on its surface.)", "source_id": "chunk-6b6599f2e169a7aa2a4822b71605cbc8", "order": 1, "source": "HYDROPHOBIC PATCH", "target": "URD"}, {"weight": 1.0, "description": "The URD and DmDRWD are homologous proteins, sharing structural similarities.)", "source_id": "chunk-e097891654194982dfc0ef87401d3aa9", "order": 1, "source": "URD", "target": "DMDRWD"}, {"weight": 2.0, "description": "Mutations in the N-terminal lobe of URD do not affect substrate binding.)", "source_id": "chunk-6135f8baf39fe26dcea3d987aa6100ac", "order": 1, "source": "URD", "target": "N-TERMINAL LOBE"}, {"weight": 2.0, "description": "The FGFR4 rs351855 genotype influences the effect of colesevelam treatment on AC t1/2 and GC24.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS351855", "target": "COLESEVELAM"}, {"weight": 4.0, "description": "The FGFR4 rs351855 genotype affects the GC24 value in individuals receiving colesevelam treatment.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "FGFR4 RS351855", "target": "GC24"}, {"weight": 9.0, "description": "The KLB rs4975017 genotype influences the effect of colesevelam treatment on GC24.)", "source_id": "chunk-5c78814fb7c198ee95071ee5a8462070", "order": 1, "source": "COLESEVELAM", "target": "KLB RS4975017"}, {"weight": 2.0, "description": "Elevated serum C4 levels were observed in patients with IBS-D compared to IBS-C and HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "SERUM C4"}, {"weight": 3.0, "description": "Higher 48-hour stool bile acid excretion was observed in patients with IBS-D compared to IBS-C, but not compared to HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "STOOL BA"}, {"weight": 1.0, "description": "Increased bile acid synthesis is observed in IBS-D patients compared to healthy controls.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-D", "target": "BA SYNTHESIS"}, {"weight": 2.0, "description": "Lower stool bile acid excretion was observed in IBS-C patients compared to HV.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "IBS-C", "target": "STOOL BA"}, {"weight": 3.0, "description": "Healthy volunteers exhibit normal levels of bile acid synthesis.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "HV", "target": "BA SYNTHESIS"}, {"weight": 6.0, "description": "There was a significant negative correlation between serum FGF19 levels and serum C4 concentrations.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "FGF19", "target": "SERUM C4"}, {"weight": 5.0, "description": "Previous cholecystectomy was associated with higher stool bile acid excretion.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA", "target": "CHOLECYSTECTOMY"}, {"weight": 7.0, "description": "A strong positive correlation was observed between total stool bile acid excretion and stool weight.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA", "target": "STOOL WEIGHT"}, {"weight": 8.0, "description": "A moderate positive correlation was observed between total stool bile acid excretion and stool fat content.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "STOOL BA", "target": "STOOL FAT"}, {"weight": 4.0, "description": "Previous cholecystectomy was associated with elevated serum C4 levels.)", "source_id": "chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6", "order": 1, "source": "SERUM C4", "target": "CHOLECYSTECTOMY"}, {"weight": 2.0, "description": "FAAP20-UBZ binds to K63-linked ubiquitin chains, as evidenced by the crystal structure and SPR data.)", "source_id": "chunk-cc528af98598e1adb4684c0166430cf4", "order": 1, "source": "FAAP20-UBZ", "target": "K63-UB2"}, {"weight": 1.0, "description": "The hydrophobic patch Ile44 on ubiquitin (Ub) interacts with the FAAP20-UBZ protein.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "ILE44"}, {"weight": 8.0, "description": "The Cys150 residue in FAAP20-UBZ is essential for ubiquitin binding.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "CYS150"}, {"weight": 9.0, "description": "The C150S mutation disrupts the function of FAAP20-UBZ by preventing ubiquitin binding.)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "FAAP20-UBZ", "target": "C150S"}, {"weight": 2.0, "description": "Both WRNIP1-UBZ and FAAP20-UBZ interact with Ub, and have similar amino acid residues involved in binding.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "WRNIP1-UBZ"}, {"weight": 4.0, "description": "Both Pol\u03b7-UBZ and FAAP20-UBZ have conserved residues involved in Ub binding, suggesting a similar interaction mode.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "POL\u0397-UBZ"}, {"weight": 5.0, "description": "NEMO-UBZ has different amino acids than FAAP20-UBZ in the region responsible for interacting with ubiquitin.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "FAAP20-UBZ", "target": "NEMO-UBZ"}, {"weight": 3.0, "description": "The Trp180 residue in FAAP20-UBZ participates in hydrophobic interactions with Ile44 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ILE44", "target": "TRP180"}, {"weight": 2.0, "description": "The Asp164 residue in FAAP20-UBZ forms a hydrogen bond with Gly47 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "GLY47", "target": "ASP164"}, {"weight": 4.0, "description": "The Ser174 residue in FAAP20-UBZ forms a hydrogen bond with Arg72 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "SER174", "target": "ARG72"}, {"weight": 5.0, "description": "The Thr175 residue in FAAP20-UBZ forms a hydrogen bond with Arg72 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "THR175", "target": "ARG72"}, {"weight": 6.0, "description": "The Asp177 residue in FAAP20-UBZ forms a hydrogen bond with Arg42 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "ASP177", "target": "ARG42"}, {"weight": 7.0, "description": "The Val178 residue in FAAP20-UBZ forms a hydrogen bond with Gln49 on ubiquitin (Ub).)", "source_id": "chunk-fa32a208a2f004c10c1b6777c3be13f2", "order": 1, "source": "VAL178", "target": "GLN49"}, {"weight": 3.0, "description": "NEMO-UBZ and WRNIP1-UBZ both belong to the group of UBZ domains that interact with ubiquitin through their \u03b2-loop.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "WRNIP1-UBZ", "target": "NEMO-UBZ"}, {"weight": 1.0, "description": "Both NEMO-UBZ and Pol\u03b7-UBZ interact with ubiquitin (Ub) but through different mechanisms.)", "source_id": "chunk-5bfe051a79e5e215dd3fc65296825591", "order": 1, "source": "POL\u0397-UBZ", "target": "NEMO-UBZ"}, {"weight": 4.0, "description": "Patients with rs28383172 AG or GG and rs7775228 TC or CC genotypes were examined for HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carrier status.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "RS7775228", "target": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"weight": 1.0, "description": "The rs1128503 variant in the ABCB1 gene was significantly associated with grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ANEMIA", "target": "RS1128503"}, {"weight": 3.0, "description": "The rs363717 variant in the ABCA1 gene was significantly associated with grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ANEMIA", "target": "RS363717"}, {"weight": 4.0, "description": "The rs11615 variant in the ERCC1 gene was significantly associated with grade 3\u20134 anemia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ANEMIA", "target": "RS11615"}, {"weight": 2.0, "description": "The rs12762549 variant in the ABCC2 gene was significantly associated with a reduced risk of grade 3\u20134 thrombocytopenia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "THROMBOCYTOPENIA", "target": "RS12762549"}, {"weight": 5.0, "description": "The rs4986910 variant in the CYP3A4 gene was significantly associated with grade 3\u20134 thrombocytopenia.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "THROMBOCYTOPENIA", "target": "RS4986910"}, {"weight": 9.0, "description": "The rs1799793 variant in the ERCC2 gene was significantly associated with a longer progression-free interval.)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "RS1799793", "target": "PROGRESSION FREE INTERVAL"}, {"weight": 0.8, "description": "The rs1799793 variant in the ERCC2 gene was significantly associated with improved patient survival (PFI).>", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS1799793", "target": "PATIENT SURVIVAL (PFI)"}, {"weight": 0.6, "description": "The rs12762549 variant in the ABCC2 gene was associated with improved patient survival (PFI), but only in the fully-adjusted model.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS12762549", "target": "PATIENT SURVIVAL (PFI)"}, {"weight": 0.6, "description": "The rs6104 variant in the SERPINB2 gene was associated with improved patient survival (PFI), but only in the fully-adjusted model.)", "source_id": "chunk-e8f81fdd25a22582c6ce3d1e15f74af3", "order": 1, "source": "RS6104", "target": "PATIENT SURVIVAL (PFI)"}, {"weight": 6.0, "description": "The rs2074087 variant in the ABCC1 gene was associated with an increased risk of using erythropoiesis-stimulating agents (ESAs).)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "ESA USE", "target": "RS2074087"}, {"weight": 7.0, "description": "The rs2073337 variant in the ABCC2 gene was associated with a reduced risk of using colony-stimulating factors (CSFs).)", "source_id": "chunk-561eacb5d916258d3ed4f08f53587404", "order": 1, "source": "CSF USE", "target": "RS2073337"}, {"weight": 1.0, "description": "A de novo 6.4 Mb deletion on chromosome 3 was found in individual I1, encompassing the UMPS gene.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "DELETION ON CHROMOSOME 3"}, {"weight": 2.0, "description": "Heterozygous alterations in UMPS were found in several individuals, predicted to lead to premature stop codons and subsequent protein truncation or NMD.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "PROTEIN TRUNCATION/NONSENSE-MEDIATED MRNA DECAY (NMD)"}, {"weight": 3.0, "description": "The 6.4 Mb deletion containing UMPS did not include genes known to cause agenesis of the corpus callosum when deleted.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "AGENESIS OF THE CORPUS CALLOSUM"}, {"weight": 4.0, "description": "Seven different heterozygous missense alterations were detected in UMPS across several individuals.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "MISSENSE ALTERATIONS"}, {"weight": 5.0, "description": "Individual I7 harbored this maternally inherited variant in UMPS which is predicted to lead to a premature stop codon.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "UMPS C.385G>T (P.GLY129*)"}, {"weight": 6.0, "description": "This variant was found in both individuals I10 and I11, maternally inherited in I10 and paternally in I11.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "UMPS C.889G>T (P.GLU297*)"}, {"weight": 7.0, "description": "This variant was detected in twelve family members within pedigree 2, with both maternal and paternal inheritance patterns observed.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "C.224C>A (P.PRO75HIS)"}, {"weight": 8.0, "description": "This variant was found in I3 along with c.286A>G (p.Arg96Gly), suggesting they are on the same allele.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "C.1285G>C (P.GLY429ARG)"}, {"weight": 9.0, "description": "This variant was found in I6 and is maternally inherited.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "C.689G>A (P.ARG230HIS)"}, {"weight": 10.0, "description": "This variant was detected in I7 and is maternally inherited.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "C.688C>T (P.ARG230CYS)"}, {"weight": 11.0, "description": "This variant was detected in I11 and both parents were not tested.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "C.451G>A (P.VAL151MET)"}, {"weight": 12.0, "description": "Amino acids affected by UMPS variants are well-conserved from H. sapiens (down) to D. melanogaster or C. elegans.)", "source_id": "chunk-b5a1267b747ee0cf908d98fa3fc26199", "order": 1, "source": "UMPS", "target": "H. SAPIENS"}, {"weight": 2.0, "description": "rs1800469 C/T is a variation located within the TGF-\u00df1 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TGF-SS1", "target": "RS1800469 C/T"}, {"weight": 1.0, "description": "rs4073 T/A is a variation located within the IL-8 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-8", "target": "RS4073 T/A"}, {"weight": 1.0, "description": "rs17855750 T/G is a variation located within the IL-27 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "IL-27", "target": "RS17855750T/G"}, {"weight": 1.0, "description": "rs4986790 A/G is a variation located within the TLR4 gene.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "TLR4", "target": "RS4986790 A/G"}, {"weight": 3.0, "description": "The heterozygous AG genotype of the IL-10 (rs1800896 A/G) polymorphism was significantly decreased among patients with CRC.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CRC", "target": "IL-10 RS1800896 A/G POLYMORPHISM"}, {"weight": 9.0, "description": "The G allele frequency of the IL-22 (rs1179251 C/G) polymorphism was significantly decreased in patients with CRC.)<SEP>The homozygous GG genotype of the IL-22 (rs1179251 C/G) polymorphism was decreased among patients with CRC, although it did not reach significance.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CRC", "target": "IL-22 RS1179251 C/G POLYMORPHISM"}, {"weight": 6.0, "description": "A decrease in the GG genotype of the IL-27 (rs17855750 T/G) polymorphism was observed in patients with CRC, suggesting a potential protective effect.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CRC", "target": "IL-27 RS17855750T/G POLYMORPHISM"}, {"weight": 15.0, "description": "A clear tendency for a decrease in the CT genotype of the TGF-\u00df1 (rs1800469 C/T) polymorphism was observed in patients with CRC.)<SEP>The TT genotype was significantly decreased in the patients with CRC, suggesting a potential association.)", "source_id": "chunk-bd81c38d10d8773bc4076cbb20bc289f", "order": 1, "source": "CRC", "target": "TGF-SS1 RS1800469 C/T POLYMORPHISM"}, {"weight": 1.0, "description": "The rs4073 genotype is associated with an increased risk of asthma development.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "RS4073"}, {"weight": 2.0, "description": "The rs2227306 genotype is associated with an increased risk of asthma susceptibility.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "RS2227306"}, {"weight": 4.0, "description": "Elevated IL-8 serum levels are found in patients with asthma compared to healthy controls.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 SERUM"}, {"weight": 6.0, "description": "Increased IL-8 mRNA expression is observed in patients with asthma compared to healthy controls.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA", "target": "IL-8 MRNA"}, {"weight": 4.0, "description": "The risk of asthma was increased for SNP rs1898671 when analyzed in the subgroup of ex-smokers.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "EX-SMOKERS", "target": "RS1898671"}, {"weight": 2.0, "description": "SNP rs1898671 was nominally associated with asthma susceptibility.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMA SUSCEPTIBILITY", "target": "RS1898671"}, {"weight": 8.0, "description": "The second most frequent haplotype (GAGGGCAAAG) showed a significant increased risk with asthma after adjusting age, BMI and population stratification.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "ASTHMA SUSCEPTIBILITY", "target": "TSLP HAPLOTYPE (GAGGGCAAAG)"}, {"weight": 4.0, "description": "The rs2227306 CC or CT genotypes are associated with increased susceptibility to asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA SUSCEPTIBILITY", "target": "RS2227306"}, {"weight": 6.0, "description": "SNP rs1898671 did not show significant association with the risk of asthma in the subgroup of never-smokers.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "RS1898671", "target": "NEVER-SMOKERS"}, {"weight": 5.0, "description": "Never-smokers were a control group in the study.)", "source_id": "chunk-6f7ce1c71bd46f223756da44b0d0bb2c", "order": 1, "source": "NEVER-SMOKERS", "target": "ASTHMA RISK"}, {"weight": 3.0, "description": "The rs4073 TT genotype is associated with an increased risk of developing asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "ASTHMA RISK", "target": "RS4073"}, {"weight": 2.0, "description": "Heterozygous (TC) alleles in PTPN2:rs478582 are associated with an increased risk of MAPbacteremia in CD subjects.)<SEP>Heterozygous (TC) alleles in PTPN2:rs478582 are associated with an increased risk of MAPbacteremia.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "RS478582", "target": "MAPBACTEREMIA"}, {"weight": 4.0, "description": "Heterozygous (GA) alleles in PTPN22:rs2476601 are associated with an increased risk of MAPbacteremia in CD subjects.)<SEP>Heterozygous (GA) alleles in PTPN22:rs2476601 are associated with an increased risk of MAPbacteremia.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "RS2476601", "target": "MAPBACTEREMIA"}, {"weight": 3.0, "description": "LYP-620R is a variant of the protein encoded by the PTPN22 gene.)<SEP>The PTPN22 gene variant, LYP-620R, encodes for the LYP protein with a specific amino acid sequence.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "PTPN22", "target": "LYP-620R"}, {"weight": 4.0, "description": "LYP-620W is a variant of the protein encoded by the PTPN22 gene.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "PTPN22", "target": "LYP-620W"}, {"weight": 6.0, "description": "The T-G haplotype, which combines the major alleles of both PTPN2:rs478582 and PTPN22:rs2476601, was more prevalent in healthy controls compared to CD patients.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "HEALTHY CONTROLS", "target": "T-G HAPLOTYPE"}, {"weight": 8.0, "description": "The rs179009 AG genotype was more common in healthy controls compared to HIV-infected individuals.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HEALTHY CONTROLS", "target": "RS179009 AG GENOTYPE"}, {"weight": 6.0, "description": "CD subjects with the C-G haplotype (heterozygous or minor/major) of PTPN2:rs478582 and PTPN22:rs2476601 alleles had a higher prevalence of MAPbacteremia.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "C-G HAPLOTYPE"}, {"weight": 8.0, "description": "CD subjects with the T-A haplotype had a higher prevalence of MAPbacteremia compared to healthy controls.)", "source_id": "chunk-6a657cd0a000b6df4db8f1305b795021", "order": 1, "source": "MAPBACTEREMIA", "target": "T-A HAPLOTYPE"}, {"weight": 4.0, "description": "This SNP has been previously linked to various inflammatory autoimmune diseases.)", "source_id": "chunk-84ec948f22126cef7d93b1d7465b79db", "order": 1, "source": "PTPN22:RS2476601", "target": "INFLAMMATORY AUTOIMMUNE DISEASES"}, {"weight": 4.0, "description": "Subjects with heterozygous or minor alleles of PTPN22:rs2476601 had significantly lower CD average relative gene expression compared to healthy controls with similar SNPs.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22:RS2476601", "target": "CD AVERAGE RELATIVE GENE EXPRESSION"}, {"weight": 8.0, "description": "Healthy controls with heterozygous or minor alleles of PTPN22:rs2476601 had significantly higher IFN-\u03b3 relative gene expression compared to those with normal alleles.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22:RS2476601", "target": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"weight": 12.0, "description": "There was no significant correlation between PTPN22:rs2476601 and MAP infection susceptibility.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN22:RS2476601", "target": "MAP INFECTION"}, {"weight": 5.0, "description": "PHA stimulated proliferation in T cells from both CD and healthy control subjects.)<SEP>Treatment with PHA induced T-cell proliferation in both CD and healthy control subjects.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "PHA", "target": "T-CELLS"}, {"weight": 5.0, "description": "Treatment with MAP PPD-like induced T-cell proliferation in both CD and healthy control subjects.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "MAP PPD-LIKE", "target": "T-CELLS"}, {"weight": 2.0, "description": "T-cell proliferation responses in healthy controls were lower than in CD subjects when stimulated with PHA and MAP PPD-like.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELLS", "target": "HEALTHY CONTROL"}, {"weight": 4.0, "description": "T-cell proliferation in CD subjects with MAPbacteremia was higher when stimulated with both PHA and MAP PPD-like compared to those without MAPbacteremia.)", "source_id": "chunk-883c371ea1f500a1ba8af8366328e8b0", "order": 1, "source": "T-CELLS", "target": "CD SUBJECTS WITH MAPBACTEREMIA"}, {"weight": 1.0, "description": "Subjects with heterozygous or homozygous alleles of PTPN2:rs478582 had significantly lower CD average relative gene expression compared to healthy controls with similar SNPs.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "CD AVERAGE RELATIVE GENE EXPRESSION"}, {"weight": 6.0, "description": "Subjects with heterozygous or minor alleles of PTPN2:rs478582 had significantly higher IFN-\u03b3 relative gene expression in CD subjects compared to those with normal alleles.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "IFN-\u0393 RELATIVE GENE EXPRESSION"}, {"weight": 10.0, "description": "Subjects with heterozygous or minor alleles of PTPN2:rs478582 had a significantly higher presence of MAPbacteremia compared to healthy controls with similar SNPs.)", "source_id": "chunk-6cb127717713bd0ab5be9436fc0c7568", "order": 1, "source": "PTPN2:RS478582", "target": "MAP INFECTION"}, {"weight": 3.0, "description": "LYP-620R inhibits TCR signaling events.)<SEP>Overexpression of LYP-620R decreases TCR signaling events like Ca2+ flux and pERK activation.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "TCR SIGNALING"}, {"weight": 2.0, "description": "Overexpression of LYP-620R in na\u00efve Tconv cells leads to decreased TCR signaling.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "NA\u00cfVE TCONV"}, {"weight": 2.0, "description": "Overexpression of LYP-620R in memory Tconv cells leads to decreased TCR signaling.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "MEMORY TCONV"}, {"weight": 8.0, "description": "Overexpression of LYP-620R in Treg cells leads to increased suppressive capacity.)<SEP>Overexpression of LYP-620R in Tregs leads to decreased TCR signaling.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d<SEP>chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "TREG"}, {"weight": 2.0, "description": "Overexpression of LYP-620R leads to decreased Ca2+ flux.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "CA2+ FLUX"}, {"weight": 2.0, "description": "Overexpression of LYP-620R leads to decreased pERK signaling.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620R", "target": "PERK SIGNALING"}, {"weight": 7.0, "description": "Overexpression of LYP-620R blunts T cell activation marker kinetics and proliferation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620R", "target": "T CELL ACTIVATION"}, {"weight": 10.0, "description": "Overexpression of LYP-620R in Treg cells suppresses the proliferation of Tresp cells.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620R", "target": "TRESP"}, {"weight": 1.0, "description": "Overexpression of LYP-620W has a lesser effect on decreasing TCR signaling events compared to LYP-620R.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "LYP-620W", "target": "TCR SIGNALING"}, {"weight": 8.0, "description": "Overexpression of LYP-620W has a less pronounced effect on T cell activation compared to LYP-620R.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "LYP-620W", "target": "T CELL ACTIVATION"}, {"weight": 8.0, "description": "Overexpression of LYP-620W in Treg cells leads to a slightly increased suppressive capacity.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TREG"}, {"weight": 12.0, "description": "Overexpression of LYP-620W in Treg cells shows reduced suppression of Tresp cell proliferation compared to LYP-620R.)", "source_id": "chunk-dee0a8a550579bff19f48d41446e842d", "order": 1, "source": "LYP-620W", "target": "TRESP"}, {"weight": 1.0, "description": "CD69 is expressed following Tconv activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD69", "target": "TCONV ACTIVATION"}, {"weight": 12.0, "description": "Expression of CD69 is induced on TAG72-BB\u03b6 CAR T cells upon activation by plate-bound TAG72.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "CD69", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 2.0, "description": "ICOS is expressed following Tconv activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "ICOS", "target": "TCONV ACTIVATION"}, {"weight": 3.0, "description": "CD25 is expressed following Tconv activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD25", "target": "TCONV ACTIVATION"}, {"weight": 4.0, "description": "CD226 is expressed following Tconv activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CD226", "target": "TCONV ACTIVATION"}, {"weight": 5.0, "description": "PD-1 is expressed following Tconv activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PD-1", "target": "TCONV ACTIVATION"}, {"weight": 6.0, "description": "CTLA-4 is expressed following Treg activation.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "CTLA-4", "target": "TREGS ACTIVATION"}, {"weight": 3.0, "description": "OVCAR3 cells were genetically engineered to express eGFP, allowing for visualization of tumor cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "EGFP", "target": "OVCAR3"}, {"weight": 14.0, "description": "Production of IL-2 is observed in TAG72-BB\u03b6 CAR T cells upon co-culture with TAG72-positive tumor targets.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "IL-2", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 2.0, "description": "CAR T cells produce IL-2 to support their own growth and proliferation.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "IL-2", "target": "CAR T CELLS"}, {"weight": 13.0, "description": "Production of IFN\u03b3 is observed in TAG72-BB\u03b6 CAR T cells upon co-culture with TAG72-positive tumor targets.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "IFN\u0393", "target": "TAG72-BB\u0396 CAR T CELLS"}, {"weight": 1.0, "description": "CAR T cells produce IFN\u03b3 as a result of their anti-tumor activity.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "IFN\u0393", "target": "CAR T CELLS"}, {"weight": 2.0, "description": "The LYP variants impact the kinetics of CD69 and other activation markers on T cells.)", "source_id": "chunk-daf8d8b6d90cc3f92b645357f7c1294b", "order": 1, "source": "CD69 EXPRESSION", "target": "LYP VARIANT"}, {"weight": 9.0, "description": "The PTPN22 risk variant permits proliferation in Tconv but not in Tregs.)", "source_id": "chunk-d53a9f0fba772a7b52b906f476f0aef7", "order": 1, "source": "PTP N22 RISK VARIANT", "target": "TCONV PROLIFERATION"}, {"weight": 16.0, "description": "The TAG72-BB\u03b6 CAR T cells are designed to target the TAG72 protein on cancer cells.)<SEP>The TAG72-BB\u03b6 CAR construct targets the TAG72 protein on tumor cells for destruction.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TAG72"}, {"weight": 2.0, "description": "The 4-1BB co-stimulatory domain is incorporated into the TAG72-BB\u03b6 CAR construct to enhance T cell activation and function.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "4-1BB INTRACELLULAR CO-STIMULATORY DOMAIN"}, {"weight": 3.0, "description": "The CD3\u03b6 domain is incorporated into the TAG72-BB\u03b6 CAR construct to mediate T cell killing of target cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CD3\u0396 CYTOLYTIC DOMAIN"}, {"weight": 4.0, "description": "The truncated CD19 (CD19t) is expressed on the surface of TAG72-BB\u03b6 CAR T cells to allow for their tracking and identification.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TRUNCATED CD19 (CD19T)"}, {"weight": 5.0, "description": "The CC49 antibody fragment is incorporated into the TAG72-BB\u03b6 CAR construct to recognize and bind to TAG72 on target cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CC49"}, {"weight": 6.0, "description": "The \u0394CH2 domain is incorporated into the TAG72-BB\u03b6 CAR construct to improve its stability and binding properties.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "HUMAN IGG4 FC EXTRACELLULAR SPACER LACKING A CH2 DOMAIN (\u0394CH2)"}, {"weight": 7.0, "description": "The CD4 transmembrane domain is incorporated into the TAG72-BB\u03b6 CAR construct to anchor it to the T cell membrane.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CD4 TRANSMEMBRANE DOMAIN"}, {"weight": 8.0, "description": "The TAG72-BB\u03b6 CAR construct is introduced into human healthy donor-derived peripheral blood mononuclear cells to generate the engineered T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "HUMAN HEALTHY DONOR-DERIVED PERIPHERAL BLOOD MONONUCLEAR CELLS"}, {"weight": 9.0, "description": "The TAG72-BB\u03b6 CAR construct is introduced into dPBMC to generate the engineered T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "DPBMC"}, {"weight": 10.0, "description": "Untransduced T cells serve as a control group for comparison with the engineered TAG72-BB\u03b6 CAR T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "MOCK (UNTRANSDUCED) T CELLS"}, {"weight": 11.0, "description": "Expression of CD137 is upregulated on TAG72-BB\u03b6 CAR T cells upon activation by plate-bound TAG72.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CD137"}, {"weight": 16.0, "description": "The TAG72-BB\u03b6 CAR T cells kill LS174T cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "LS174T"}, {"weight": 17.0, "description": "The TAG72-BB\u03b6 CAR T cells kill OVCAR3 cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR3"}, {"weight": 18.0, "description": "The TAG72-BB\u03b6 CAR T cells kill OV90 cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90"}, {"weight": 19.0, "description": "The TAG72-BB\u03b6 CAR T cells do not kill SKOV3 cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "SKOV3"}, {"weight": 20.0, "description": "The TAG72-BB\u03b6 CAR T cells do not kill OVCAR8 cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR8"}, {"weight": 21.0, "description": "The TAG72-BB\u03b6 CAR T cells minimally kill COV362.4 cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "COV362.4"}, {"weight": 22.0, "description": "CAR T cells targeting PSCA are used as a control in experiments with TAG72-BB\u03b6 CAR T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "PSCA"}, {"weight": 23.0, "description": "The expression of CD19 is used to track the engineered TAG72-BB\u03b6 CAR T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "CD19"}, {"weight": 24.0, "description": "Anti-CD3 antibodies are sometimes used for activation and expansion of TAG72-BB\u03b6 CAR T cells in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "ANTI-HUMAN CD3 ANTIBODY (E.G., OKT3)"}, {"weight": 25.0, "description": "IL-15 is often used in culture media to enhance the persistence and function of TAG72-BB\u03b6 CAR T cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "IL-15"}, {"weight": 26.0, "description": "The anti-TAG72 antibody, such as 8H9, can be used for validating target expression on cancer cells.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "ANTI-TAG72 ANTIBODY (E.G., 8H9)"}, {"weight": 27.0, "description": "The killing activity of TAG72-BB\u03b6 CAR T cells against cancer cells is assessed in vitro.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "IN VITRO"}, {"weight": 28.0, "description": "The efficacy of TAG72-BB\u03b6 CAR T cell therapy is evaluated in animal models.)", "source_id": "chunk-bdeb2c0c1ba80048874f6dedb2c2b619", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "IN VIVO"}, {"weight": 8.0, "description": "TAG72-BB\u03b6 CAR T cells effectively control and reduce the growth of OVCAR3 tumors in mice.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OVCAR3 TUMOR"}, {"weight": 2.0, "description": "TAG72-BB\u03b6 CAR T cells were tested in the OV90 ovarian cancer xenograft model.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "OV90 MODEL"}, {"weight": 4.0, "description": "Repeated administration of TAG72-BB\u03b6 CAR T cells resulted in tumor regression but eventual recurrences.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72-BB\u0396 CAR T CELLS", "target": "TUMOR RECURRENCE"}, {"weight": 1.0, "description": "The TAG72 protein is expressed at a low level in OAS3 ascites sample compared to other patient samples.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "OAS3"}, {"weight": 2.0, "description": "The TAG72 protein is highly expressed in OAS4 ascites sample.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "OAS4"}, {"weight": 3.0, "description": "The TAG72 protein is expressed at a moderate level in OAS7 ascites sample.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "OAS7"}, {"weight": 5.0, "description": "CAR T cells targeting TAG72 demonstrate potent anti-tumor activity against TAG72 positive ovarian cancer cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "TAG72", "target": "CAR T CELLS"}, {"weight": 10.0, "description": "Tumor recurrences were associated with reduced TAG72 expression, suggesting antigen escape as a resistance mechanism.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "TAG72", "target": "ANTIGEN ESCAPE"}, {"weight": 4.0, "description": "CAR T cells effectively target and kill OVCAR3 tumor cells.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "OVCAR3", "target": "CAR T CELLS"}, {"weight": 4.0, "description": "OVCAR3 cells were genetically engineered to express ffluc, enabling non-invasive tracking of tumor growth.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "OVCAR3", "target": "FFLUC"}, {"weight": 6.0, "description": "i.p. (intraperitoneal) delivery is a regional therapeutic approach for treating tumors in the abdomen.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "I.P. DELIVERY", "target": "REGIONAL TREATMENT"}, {"weight": 9.0, "description": "Regional intraperitoneal delivery of TAG72-BB\u03b6 CAR T cells is more effective than intravenous delivery in controlling tumor growth and extending survival in mice.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "I.P. DELIVERY", "target": "MORE EFFECTIVE THAN I.V. "}, {"weight": 7.0, "description": "i.v. (intravenous) delivery is a systemic therapeutic approach that delivers medication throughout the body.)", "source_id": "chunk-183db5c908df609bb5289896b4ba09d0", "order": 1, "source": "I.V. DELIVERY", "target": "SYSTEMIC TREATMENT"}, {"weight": 8.0, "description": "Repeat dosing of TAG72-BB\u03b6 CAR T cells led to more durable anti-tumor responses compared with single dosing.)", "source_id": "chunk-7fe5e7a40fe11afeb152e614de7ef1cf", "order": 1, "source": "IMPROVED THERAPEUTIC RESPONSES", "target": "REPEAT DOSING"}, {"weight": 2.0, "description": "The number of \'low FEV1/FVC alleles\' is associated with a decreased mean residual FEV1/FVC.)<SEP>The number of low FEV1/FVC alleles is associated with a decreased mean residual FEV1/FVC.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "FEV1/FVC", "target": "LOW FEV1/FVC ALLELES"}, {"weight": 2.0, "description": "GWAS SNPs were identified as being associated with variations in FEV1/FVC levels.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "FEV1/FVC", "target": "GWAS SNPS"}, {"weight": 2.0, "description": "The \u03b2-defensin genes are functionally connected to chemokine genes (CCL18 and CXCL12).)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CHEMOKINE GENES (CCL18 AND CXCL12)", "target": "\u0392-DEFENSIN GENES"}, {"weight": 2.0, "description": "TNFRSF13B is functionally connected to the \u03b2-defensin genes.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES", "target": "TNFRSF13B"}, {"weight": 2.0, "description": "The CCL23-CCL18 locus is functionally connected to the \u03b2-defensin genes.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "\u0392-DEFENSIN GENES", "target": "CCL23-CCL18 LOCUS"}, {"weight": 2.0, "description": "The CCL23-CCL18 locus is functionally connected to TNFRSF13B.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "TNFRSF13B", "target": "CCL23-CCL18 LOCUS"}, {"weight": 2.0, "description": "The CCL23-CCL18 locus is functionally connected to CXCL12.)", "source_id": "chunk-7efd4f037425eeac77e329347b16beb2", "order": 1, "source": "CCL23-CCL18 LOCUS", "target": "CXCL12"}, {"weight": 5.0, "description": "The CTLA4 gene encodes a protein involved in immune checkpoint regulation.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4", "target": "IMMUNE CHECKPOINT REGULATION"}, {"weight": 6.0, "description": "Genetic variants in the CTLA4 gene are associated with an increased risk of type 1 diabetes (T1D).)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4", "target": "T1D"}, {"weight": 7.0, "description": "Genetic variants in the CTLA4 gene are also associated with rheumatoid arthritis (RA).)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4", "target": "RA"}, {"weight": 8.0, "description": "The expression levels of CTLA4 are inversely correlated with DNA methylation at a CpG site near its second exon.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "CTLA4", "target": "EXPRESSION LEVELS"}, {"weight": 2.0, "description": "The rs231775 polymorphism of CTLA4 was significantly associated with PBC susceptibility.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231775", "target": "PBC"}, {"weight": 3.0, "description": "The rs231775 polymorphism of CTLA4 was significantly associated with PBC susceptibility in Asians.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231775", "target": "ASIANS"}, {"weight": 4.0, "description": "The rs231775 polymorphism of CTLA4 was significantly associated with PBC susceptibility in Caucasians.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231775", "target": "CAUCASIANS"}, {"weight": 4.0, "description": "The rs231725 polymorphism also showed significant association with PBC susceptibility.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231725", "target": "PBC"}, {"weight": 5.0, "description": "The rs231725 polymorphism of CTLA4 was significantly associated with PBC susceptibility in Asians.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231725", "target": "ASIANS"}, {"weight": 6.0, "description": "The rs231725 polymorphism of CTLA4 was significantly associated with PBC susceptibility in Caucasians.)", "source_id": "chunk-f02653cb486dbf68cc259f74ea8b2b2e", "order": 1, "source": "RS231725", "target": "CAUCASIANS"}, {"weight": 1.0, "description": "The IKBKE gene plays a role in regulating inflammatory responses to viral infections.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "IBKBKE", "target": "INFLAMMATORY RESPONSES"}, {"weight": 2.0, "description": "The STAT6 gene is involved in T cell differentiation.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STAT6", "target": "T CELL DIFFERENTIATION"}, {"weight": 3.0, "description": "The STX2 gene encodes syntaxin 2, which is involved in intracellular transport of vesicles.)", "source_id": "chunk-bec60ce5d500ee78c6792a2d92b048ca", "order": 1, "source": "STX2", "target": "INTRACELLULAR TRANSPORT"}, {"weight": 2.0, "description": "The rs1131017 SNP is located in the 5\'UTR of the RPS26 gene and acts as a lead trans-acting regulatory locus influencing hundreds of genes.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RPS26", "target": "RS1131017"}, {"weight": 4.0, "description": "The missense variant rs181206 is located within the IL27 gene.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "IL27", "target": "RS181206"}, {"weight": 3.0, "description": "IL-27, through its receptor IL27RA and gp130, activates the STAT1/STAT3 pathway leading to increased STAT1 expression.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "IL27", "target": "STAT1"}, {"weight": 6.0, "description": "The rs181206 variant causes decreased expression of STAT1.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "STAT1", "target": "RS181206"}, {"weight": 1.0, "description": "The rs181206[G] SNP is associated with decreased expression of STAT1.)", "source_id": "chunk-1b40d071abac0ba432a9fb0096796f45", "order": 1, "source": "STAT1", "target": "RS181206[G]"}, {"weight": 7.0, "description": "The rs181206 variant causes decreased expression of REC8.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "REC8", "target": "RS181206"}, {"weight": 3.0, "description": "These genes are located in the trans-acting regulatory locus on chromosome 12q13.2 influenced by rs1131017.)", "source_id": "chunk-5b68770e1b446d6cba0d4e1ecabf497b", "order": 1, "source": "RS1131017", "target": "CDK2, RAB5B, SUOX, IKZF4, ERBB3"}, {"weight": 5.0, "description": "The rs4073 TT genotype is associated with an increased risk of atopic asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "RS4073", "target": "ATOPIC ASTHMA"}, {"weight": 6.0, "description": "The rs2227306 CC genotype is associated with an increased risk of atopic asthma.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "RS2227306", "target": "ATOPIC ASTHMA"}, {"weight": 7.0, "description": "IL-8 protein plays a role in inflammation and immune responses.)", "source_id": "chunk-3c66ee37333cba1e51a2bdc729038b68", "order": 1, "source": "IL-8 PROTEIN", "target": "INFLAMMATION"}, {"weight": 4.0, "description": "The ASAH1 gene consists of 14 typed SNPs on the Illumina HumanHap550 array.)<SEP>The ASAH1 gene region is made up of SNPs with a good correlation structure, in which the typed SNPs are typically in good LD with each other and with the causal SNPs.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "TYPED SNPS"}, {"weight": 2.0, "description": "The ASAH1 gene consists of 86 HapMap SNPs.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "HAPMAP SNPS"}, {"weight": 2.0, "description": "The ASAH1 gene consists of 14 typed SNPs on the Illumina HumanHap550 array.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "ASAH1 GENE", "target": "ILLUMINA HUMANHAP550 ARRAY"}, {"weight": 8.0, "description": "The kernel machine SNP-set test was used to evaluate the overall effect of the ASAH1 gene.)<SEP>The kernel machine SNP-set test was used to study the overall effect of the ASAH1 gene.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1 GENE", "target": "KERNEL MACHINE SNP-SET TEST"}, {"weight": 7.0, "description": "The ASAH1 gene is described as having a good LD structure.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "ASAH1 GENE", "target": "GOOD LD STRUCTURE"}, {"weight": 2.0, "description": "The NAT2 gene has 4 typed SNPs: rs1390358, rs1112005, rs7832071 and rs1208.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2 GENE", "target": "TYPED SNPS"}, {"weight": 2.0, "description": "The NAT2 gene has 4 typed SNPs: rs1390358, rs1112005, rs7832071 and rs1208.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2 GENE", "target": "RS1390358"}, {"weight": 2.0, "description": "The NAT2 gene has 4 typed SNPs: rs1390358, rs1112005, rs7832071 and rs1208.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2 GENE", "target": "RS1112005"}, {"weight": 2.0, "description": "The NAT2 gene has 4 typed SNPs: rs1390358, rs1112005, rs7832071 and rs1208.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2 GENE", "target": "RS7832071"}, {"weight": 2.0, "description": "The NAT2 gene has 4 typed SNPs: rs1390358, rs1112005, rs7832071 and rs1208.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "NAT2 GENE", "target": "RS1208"}, {"weight": 2.0, "description": "In regions of high LD, the kernel machine method outperforms the min test for the FGFR2 gene.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "FGFR2 GENE", "target": "HIGH LD REGIONS"}, {"weight": 2.0, "description": "There are only 6 HapMap SNPs and 2 typed SNPs (rs1058026 and rs2523608) in the SNP-set for the HLA-B gene.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE", "target": "TYPED SNPS"}, {"weight": 2.0, "description": "The weighted IBS kernel upweights rare alleles, as shown by its higher power when the causal SNP with a lower MAF (rs1058026) was simulated.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE", "target": "MAF"}, {"weight": 2.0, "description": "There are only 6 HapMap SNPs and 2 typed SNPs (rs1058026 and rs2523608) in the SNP-set for the HLA-B gene.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE", "target": "RS1058026"}, {"weight": 2.0, "description": "There are only 6 HapMap SNPs and 2 typed SNPs (rs1058026 and rs2523608) in the SNP-set for the HLA-B gene.)", "source_id": "chunk-2e31819d63b80079cb6422efd6e684e0", "order": 1, "source": "HLA-B GENE", "target": "RS2523608"}, {"weight": 1.0, "description": "The weighted IBS kernel (0.358) had greater power than the linear kernel (0.214).)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "LINEAR KERNEL", "target": "WEIGHTED IBS KERNEL"}, {"weight": 5.0, "description": "For simulations with imputed data, the linear kernel had an empirical Type 1 error rate of 0.0566.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "LINEAR KERNEL", "target": "IMPUTED DATA"}, {"weight": 2.0, "description": "When a common allele is causal, the linear kernel may be more powerful than the weighted IBS kernel.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "LINEAR KERNEL", "target": "COMMON ALLELE"}, {"weight": 2.0, "description": "When rs2523608 was the causal SNP, the weighted IBS kernel (0.634) had lower power than the IBS kernel (0.712).)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "WEIGHTED IBS KERNEL"}, {"weight": 3.0, "description": "In cases studied with epistasis, the IBS kernel always had higher power compared to the min test.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "MIN TEST"}, {"weight": 3.0, "description": "The IBS kernel measures the similarity between individuals based on their genotypes.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "IBS KERNEL", "target": "GENOTYPE SIMILARITY"}, {"weight": 1.0, "description": "The weighted IBS kernel incorporates information about rare variants.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "WEIGHTED IBS KERNEL", "target": "RARE VARIANTS"}, {"weight": 6.0, "description": "For simulations with imputed data, the min test had an empirical Type 1 error rate of 0.0404.)", "source_id": "chunk-076f6aeeb369546413bc63c9f305553a", "order": 1, "source": "MIN TEST", "target": "IMPUTED DATA"}, {"weight": 2.0, "description": "Anti-CTLA-4 therapy is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-CTLA-4", "target": "METASTATIC MELANOMA"}, {"weight": 1.0, "description": "There was no significant association between anti-CTLA-4 treatment and treatment response in the pooled analysis.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-CTLA-4", "target": "TREATMENT RESPONSE"}, {"weight": 4.0, "description": "Anti-PD-1 therapy is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "ANTI-PD-1", "target": "METASTATIC MELANOMA"}, {"weight": 1.0, "description": "There was no significant association between anti-PD-1 treatment and treatment response in the pooled analysis.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "ANTI-PD-1", "target": "TREATMENT RESPONSE"}, {"weight": 6.0, "description": "Combination therapy (anti-CTLA-4 and anti-PD-1) is used to treat metastatic melanoma.)", "source_id": "chunk-2b5346dfc62015294aa57aeab3960cd1", "order": 1, "source": "COMBINATION THERAPY", "target": "METASTATIC MELANOMA"}, {"weight": 1.0, "description": "There was no significant association between combination therapy and treatment response in the pooled analysis.)", "source_id": "chunk-0d49552280a277a8a26456d06f8f26a8", "order": 1, "source": "COMBINATION THERAPY", "target": "TREATMENT RESPONSE"}, {"weight": 11.0, "description": "EBNA2 binds to MS risk loci dependent on the risk allele.)<SEP>EBNA2 interacts with MS risk loci, dependent on genotype.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7<SEP>chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "MS RISK LOCI"}, {"weight": 4.0, "description": "EBNA2 preferentially binds to the risk allele of the TRAF3/RCOR1 locus.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2", "target": "TRAF3/RCOR1"}, {"weight": 2.0, "description": "EBNA2 binds preferentially to the risk allele of TRAF3, leading to lower expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TRAF3"}, {"weight": 6.0, "description": "EBNA2 binds preferentially to the protective allele of TNFAIP8, leading to relatively lower expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFAIP8"}, {"weight": 8.0, "description": "EBNA2 binds preferentially to the protective allele of TNFRSF1A, leading to relatively lower expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2", "target": "TNFRSF1A"}, {"weight": 14.0, "description": "Inhibition of EBNA2 with TAT treatment increases TNFAIP8 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFAIP8", "target": "EBNA2-TAT"}, {"weight": 16.0, "description": "Inhibition of EBNA2 with TAT treatment decreases TNFRSF1A expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "TNFRSF1A", "target": "EBNA2-TAT"}, {"weight": 8.0, "description": "EBNA2-TAT reduces the expression of the LMP1 gene.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "LMP1"}, {"weight": 10.0, "description": "EBNA2-TAT inhibits the EBV latency III growth program.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "EBV LATENCY III GROWTH PROGRAM"}, {"weight": 12.0, "description": "EBNA2-TAT\'s inhibitory effects are due to its interaction with RBP-J\u03ba.)", "source_id": "chunk-bb351b97d99fce93d17df522db92dda7", "order": 1, "source": "EBNA2-TAT", "target": "RBP-J\u039a"}, {"weight": 10.0, "description": "Inhibition of EBNA2 with TAT treatment increases TRAF3 expression.)", "source_id": "chunk-03962ffc6066ee5da582bdc89310b1d6", "order": 1, "source": "EBNA2-TAT", "target": "TRAF3"}, {"weight": 1.0, "description": "The rs20417 polymorphism in the COX-2 gene is associated with aspirin insensitivity.)", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS20417", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 4.0, "description": "Heterogeneity", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS20417", "target": "PERCENTAGE OF CAD"}, {"weight": 2.0, "description": "The rs1126643 polymorphism in the ITGA2 gene is associated with aspirin insensitivity.)", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS1126643", "target": "ASPIRIN INSENSITIVITY"}, {"weight": 3.0, "description": "Association Strength", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS1126643", "target": "CHINESE POPULATION"}, {"weight": 5.0, "description": "Heterogeneity", "source_id": "chunk-54c4fede216a6c4183b95ee1a2edcb17", "order": 1, "source": "RS1126643", "target": "AVERAGED PLATELET NUMBER"}, {"weight": 4.0, "description": "Genomic variant rs1126643 is significantly associated with variations in averaged platelet number.)", "source_id": "chunk-734cac289b42d37dad32bd51ea24a1ea", "order": 1, "source": "RS1126643", "target": "PLATELET NUMBER"}, {"weight": 1.0, "description": "STAT5B deficiency leads to increased proportions of memory CD8+ T cells over time.)", "source_id": "chunk-e323b0d4f82733a78f687e51f47b500a", "order": 1, "source": "STAT5B", "target": "MEMORY CD8+ T CELLS"}, {"weight": 1.0, "description": "The STAT5B gene plays a critical role in CD8+ T cell activation and homeostasis, as evidenced by the elevation of CD8+ memory T cells in patients with STAT5B deficiency.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "STAT5B", "target": "CD8+ T CELL ACTIVATION AND HOMEOSTASIS"}, {"weight": 5.0, "description": "Peptides are presented by HLA molecules to TCRs.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA", "target": "PEPTIDE"}, {"weight": 4.0, "description": "Patients with STAT5B deficiency carried elevated proportions of CD8+ memory T cells from infancy, suggesting a role for this variant in T cell development and function.)", "source_id": "chunk-4389e37ac64d551cdf89e7f4230a3589", "order": 1, "source": "CD8+ MEMORY T CELL PROPORTIONS", "target": "STAT5B VARIANT"}, {"weight": 1.0, "description": "Carrying the G allele of rs28383172 was in perfect concordance with the HLA\u2010DRB1*07:01 allele carrier status.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "RS28383172", "target": "HLA\u2010DRB1*07:01 ALLELE"}, {"weight": 2.0, "description": "Two-thirds of the patients harboring HLA\u2010DRB1*07:01 allele were HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carriers.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "RS28383172", "target": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE"}, {"weight": 3.0, "description": "Algorithms III and IV were designed to identify the same group of patients who are HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype carriers.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE", "target": "RS2395182, RS4713586 AND RS7775228"}, {"weight": 5.0, "description": "The 2-SNP tagging approach (algorithm V) seems to be the most suitable for clinical utilization with sensitivity, specificity, positive and negative predictive values all greater than 95%.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "HLA\u2010DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 HAPLOTYPE", "target": "ALGORITHM V"}, {"weight": 6.0, "description": "In the EUR super population, sensitivity and the negative predictive value of algorithm V were significantly higher compared to algorithms III and IV.)", "source_id": "chunk-0dd0781947ec4a92007eb1736b1888c2", "order": 1, "source": "EUR SUPER POPULATION", "target": "ALGORITHM V"}, {"weight": 0.8, "description": "The HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype is a genetic marker associated with an increased risk of developing E. coli ASP hypersensitivity.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02", "target": "E. COLI ASP HYPERSENSITIVITY"}, {"weight": 0.9, "description": "Algorithm V is designed to identify individuals carrying the HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02 haplotype.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "HLA-DRB1*07:01\u2013DQA1*02:01\u2013DQB1*02:02", "target": "ALGORITHM V"}, {"weight": 0.8, "description": "In the EUR super population, algorithm V demonstrated significantly higher specificity compared to algorithm II.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "SPECIFICITY"}, {"weight": 0.6, "description": "In the EUR super population, algorithm V exhibited a significantly higher negative predictive value compared to algorithms III and IV.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "NEGATIVE PREDICTIVE VALUE"}, {"weight": 0.7, "description": "In the EUR super population, algorithm V achieved a significantly higher positive predictive value compared to algorithm II.)", "source_id": "chunk-1f50436a36721971a0a256131d7fca62", "order": 1, "source": "ALGORITHM V", "target": "POSITIVE PREDICTIVE VALUE"}, {"weight": 2.0, "description": "Polymorphisms in the TLR7 gene were investigated as potential risk factors for HIV disease progression, but were not found to be independent risk factors.)", "source_id": "chunk-2c91cdebb36ef064eb01a7021a961302", "order": 1, "source": "TLR7", "target": "HIV DISEASE PROGRESSION"}, {"weight": 2.0, "description": "The rs179008 SNP is located within the TLR7 gene.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "RS179008", "target": "TLR7 GENE"}, {"weight": 4.0, "description": "The rs179009 SNP is located within the TLR7 gene.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "RS179009", "target": "TLR7 GENE"}, {"weight": 6.0, "description": "Individuals infected with HIV showed a significantly reduced frequency of the rs179009 AG genotype compared to healthy controls.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "HIV-INFECTED INDIVIDUALS", "target": "RS179009 AG GENOTYPE"}, {"weight": 10.0, "description": "The frequency of the rs179009 AG genotype decreased as HIV disease progressed from early to advanced stages.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "RS179009 AG GENOTYPE", "target": "HIV DISEASE STAGES"}, {"weight": 12.0, "description": "There was a trend towards a higher prevalence of the TLR7 rs179009AG genotype among tobacco-consuming HIV-infected individuals compared to nonusers, although this did not reach statistical significance.)", "source_id": "chunk-05d583f893b703816ad8de9561aa5292", "order": 1, "source": "TLR7 RS179009AG GENOTYPE", "target": "TOBACCO CONSUMPTION"}, {"weight": 1.0, "description": "The ALK R1275Q mutation is found in some patients with Neuroblastoma (NBL).)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "ALK R1275Q", "target": "NEUROBLASTOMA"}, {"weight": 2.0, "description": "The ALK R1275Q neoepitope binds strongly to HLA-B*15:01, forming a stable complex.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "ALK R1275Q", "target": "HLA-B*15:01"}, {"weight": 2.0, "description": "ALK R1275Q is a neoepitope that forms a peptide recognized by HLA molecules.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "ALK R1275Q", "target": "PEPTIDE"}, {"weight": 4.0, "description": "Mutations in the ALK gene can lead to the formation of neoepitopes.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "ALK", "target": "NEOEPITOPE"}, {"weight": 2.0, "description": "The NRAS Q61K mutation is frequently found in these cancer types.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NRAS Q61K", "target": "MELANOMA, THYROID, COLORECTAL CANCERS"}, {"weight": 1.0, "description": "The ProTECT software is used to predict neoepitopes arising from tumor mutations.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "PROTECT", "target": "NEOEPITOPE PREDICTION"}, {"weight": 2.0, "description": "The TARGET cohort includes neuroblastoma (NBL) samples used in the study.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "TARGET", "target": "NEUROBLASTOMA SAMPLES"}, {"weight": 3.0, "description": "The HLA-B*15:01 allele binds to neoepitopes derived from the ALK R1275Q mutation.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "HLA-B*15:01", "target": "NEOEPITOPE BINDING"}, {"weight": 1.0, "description": "The HLA-B*15:01 protein binds to the nonamer peptide AQDIYRASY.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HLA-B*15:01", "target": "AQDIYRASY"}, {"weight": 4.0, "description": "The HLA-B*15:01 protein binds to the decamer peptide AQDIYRASYY.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "HLA-B*15:01", "target": "AQDIYRASYY"}, {"weight": 4.0, "description": "The self-antigen ARDIYRASY has low binding affinity to HLA-B*15:01, suggesting immune tolerance.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "ARDIYRASY"}, {"weight": 4.0, "description": "T cell receptors (TCRs) bind to peptide-MHC complexes presented on antigen-presenting cells.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "HLA-B*15:01", "target": "TCR"}, {"weight": 4.0, "description": "HLA-B*15:01 is used as a template for modeling interactions between ALK peptides and HLA molecules.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-B*15:01", "target": "PEPTIDE"}, {"weight": 2.0, "description": "HLA-B*15:01 presents neoepitopes to TCRs.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "HLA-B*15:01", "target": "NEOEPITOPE"}, {"weight": 4.0, "description": "The AQDIYRASY neoepitope binds to HLA-B*15:01 with a high affinity.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "AQDIYRASY", "target": "HLA-B*15:01 BINDING"}, {"weight": 5.0, "description": "The AQDIYRASYY neoepitope binds to HLA-B*15:01 with a high affinity.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "AQDIYRASYY", "target": "HLA-B*15:01 BINDING"}, {"weight": 5.0, "description": "The TCR recognizes and binds to neoepitopes presented by MHC molecules.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "TCR", "target": "NEOEPITOPE"}, {"weight": 6.0, "description": "ALK peptides can be refolded with HLA-A*01:01 to form stable p/MHC complexes.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "HLA-A*01:01", "target": "PEPTIDE"}, {"weight": 6.0, "description": "Neoepitopes are novel antigens arising from mutations, while self-antigens are typically recognized as \'self\' by the immune system.)", "source_id": "chunk-de413ae6100407d8dadd5bdee87c1074", "order": 1, "source": "NEOEPITOPE", "target": "SELF-ANTIGEN"}, {"weight": 7.0, "description": "MHC tetramers are used to identify T cells that recognize specific neoepitopes.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "NEOEPITOPE", "target": "MHC TETRAMER"}, {"weight": 9.0, "description": "The SARS coronavirus can produce neoepitopes.)", "source_id": "chunk-d3a9c93928447522ce3df4209f8ac803", "order": 1, "source": "NEOEPITOPE", "target": "SARS CORONAVIRUS"}, {"weight": 3.0, "description": "A mutation in the ZNF717 gene, specifically at codon 716, is found in some NBL samples.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "NEUROBLASTOMA", "target": "ZNF717 Q716"}, {"weight": 7.0, "description": "SEC was used to purify the recombinant HLA-B*15:01/neoepitope complexes.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "PROTEIN PURIFICATION", "target": "SEC"}, {"weight": 8.0, "description": "LC\u2013MS was used to confirm the presence of the neoepitopes in the MHC complexes.)", "source_id": "chunk-52a8c1d4352526a90e26deb6f06682d2", "order": 1, "source": "LC\u2013MS", "target": "PEPTIDE IDENTIFICATION"}, {"weight": 6.0, "description": "The nonamer peptide AQDIYRASY is a shorter version of the decamer peptide AQDIYRASYY.)", "source_id": "chunk-830d8819004960d1d149ac70149c72a0", "order": 1, "source": "DECAMER PEPTIDE", "target": "NONAMER PEPTIDE"}, {"weight": 6.0, "description": "Researchers used the EMBL-EBI database to select HLA alleles for their study.)", "source_id": "chunk-614333487e4b92705503909d34155179", "order": 1, "source": "DATA SOURCE", "target": "RESEARCHERS"}, {"weight": 10.0, "description": "The GRAM domain containing 1B (GRAMD1B) gene is located within the LD block associated with rs35923643-G.)", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS35923643-G", "target": "GRAMD1B"}, {"weight": 4.0, "description": "The rs735665-A SNP is also a risk allele for CLL, as indicated by GWAS meta-analyses.)", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS735665-A", "target": "CLL"}, {"weight": 6.0, "description": "The rs735665-A SNP is associated with increased levels of general IgM.)", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS735665-A", "target": "IGM"}, {"weight": 8.0, "description": "The rs735665-A SNP is shared between IgM anti-PC and CLL, suggesting a potential connection between these conditions.)", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "RS735665-A", "target": "IGM ANTI-PC"}, {"weight": 12.0, "description": "PRSs based on IgM anti-PC increasing alleles are associated with higher risk of CLL.)", "source_id": "chunk-0dc1ddaa86432d222da7fc75090f700a", "order": 1, "source": "CLL", "target": "POLYGENIC RISK SCORE"}, {"weight": 3.0, "description": "The top locus 11q24.1 shared between IgM anti-PC and CLL is rs35923643.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "CLL", "target": "RS35923643"}, {"weight": 10.0, "description": "Higher IgM anti-PC levels were associated with a lower risk of developing CLL in the nested case-control study.)<SEP>Prevalent CLL cases had lower IgM anti-PC levels compared to matched controls, suggesting a potential association.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "CLL", "target": "IGM ANTI-PC"}, {"weight": 5.0, "description": "The difference in IgM anti-PC levels between CLL cases and matched controls showed a declining trend over time.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC", "target": "TIME BETWEEN SAMPLING AND DIAGNOSIS"}, {"weight": 7.0, "description": "Levels of IgM anti-PC were lower in prevalent CLL cases compared to matched controls.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "IGM ANTI-PC", "target": "PREVALENT CLL CASES"}, {"weight": 1.0, "description": "The SNP rs35923643 overlaps with the binding motif of RUNX3, and switching from the major allele T/A to the minor C/G allele impedes RUNX3 binding affinity.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "RUNX3 BINDING"}, {"weight": 2.0, "description": "Regulatory marks such as H3K4Me1 and DNaseI hypersensitivity were found at rs35923643 in immune cell lines like GM12878, CD34+ cells, and GM12865.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "RS35923643", "target": "IMMUNE-CELL LINES"}, {"weight": 8.0, "description": "The study investigated both prevalent and incident CLL cases.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "INCIDENT CLL CASES", "target": "PREVALENT CLL CASES"}, {"weight": 9.0, "description": "IgM anti-PC levels in matched controls were compared to those in prevalent CLL cases.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "MATCHED CONTROLS", "target": "PREVALENT CLL CASES"}, {"weight": 1.0, "description": "DNaseI hypersensitivity was found at rs35923643 in CD34+ cells.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "CD34+", "target": "DNASEI HYPERSENSITIVITY"}, {"weight": 12.0, "description": "DNaseI hypersensitivity was found at rs35923643 in GM12865.)", "source_id": "chunk-83ee45fa1acb6546ff72e454c7880f7b", "order": 1, "source": "DNASEI HYPERSENSITIVITY", "target": "GM12865"}]}